Sentence,class,file
The Effect of the Evolvement of ERT in Acute BAO http://dx.doi.org/10.5853/jos.2016.00171 http://j-stroke.orgSupplementary  Figure 3.,Non-OADS,/arxiv_data1/oa_pdf/1b/32/jos-2016-00171.PMC5066433.pdf
"Copyright © 2016  Korean Stroke Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which  permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/cf/4c/jos-2016-00283.PMC5066434.pdf
"pISSN: 2287-6391 • eISSN: 2287-6405 352 http://j-stroke.orgImaging Predictors for Atherosclerosis-Related  Intracranial Large Artery Occlusions in Acute Anterior  Circulation Stroke Hong Il Suh,a Ji Man Hong,a Kyu Sun Lee,a Miran Han,b Jin Wook Choi,b Jong S. Kim,c   Andrew M. Demchuk,d Jin Soo Leea aDepartment of Neurology, Ajou University School of Medicine, Ajou University Hospital, Suwon, Korea bDepartment of Radiology, Ajou University School of Medicine, Ajou University Medical Center, Suwon, Korea cDepartment of Neurology, Asan Medical Centre, University of Ulsan, Seoul, Korea d Calgary Stroke Program, Departments of Clinical Neurosciences and Radiology, Hotchkiss Brain Institute, University of Calgary, Calgary, AB,  CanadaLetter to the Editor Dear Sir:   Recent randomized clinical trials have demonstrated the ben - eficial effects of new thrombectomy devices as an endovascular  treatment for patients with intracranial large artery occlusion.1-5  However, treatment plans may vary according to different etiolo - gies of arterial occlusion.",Non-OADS,/arxiv_data1/oa_pdf/cf/4c/jos-2016-00283.PMC5066434.pdf
"A 10-point scale was used to assign the clot burden  score, which indirectly represented the clot length, as previously  described.10 Points were subtracted from a total of 10 and the  following values were assigned: intracranial ICA involvement= 3,  proximal MCA=2, distal MCA=2, superior division of the Journal of Stroke  201 6;18(3):352- 354 http://dx.doi.org/10.5853/ jos.2016.00283",OADS,/arxiv_data1/oa_pdf/cf/4c/jos-2016-00283.PMC5066434.pdf
"3 / September 2016 http://dx.doi.org/10.5853/jos.2016.00283 http://j-stroke.org  353MCA= 1, inferior division of the MCA= 1, and ACA= 1; where a  higher clot burden score indicated less of a clot burden.",OADS,/arxiv_data1/oa_pdf/cf/4c/jos-2016-00283.PMC5066434.pdf
"Intracranial Atherosclerosis in Occlusions http://dx.doi.org/10.5853/jos.2016.00283 354 http://j-stroke.orgCorrespondence:  Jin Soo Lee Department of Neurology, Ajou University School of Medicine, Ajou University  Medical Centre, 164 Worldcup-ro, Yeongtong-gu, Suwon 16499, Korea Tel: +82-31-219-5175 Fax: +82-31-219-5178 E-mail: jinsoo22@gmail.com Received: April 12, 2016 Revised: April 27, 2016 Accepted: April 29, 2016 This work was supported by the Basic Science Research Program through the Na - tional Research Foundation of Korea, funded by the Ministry of Education (NRF- 2014R1A1A1008249).",Non-OADS,/arxiv_data1/oa_pdf/cf/4c/jos-2016-00283.PMC5066434.pdf
"Copyright © 2016  Korean Stroke Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which  permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d9/c2/jos-2016-00206.PMC5066435.pdf
"pISSN: 2287-6391 • eISSN: 2287-6405 httphttp://j-stroke.org  267Neural Stem Cells and Ischemic Brain Zhenggang Zhang,a Michael Choppa,b aHenry Ford Hospital, Michigan, United States bDepartment of Physics, Oakland University, Rochester, Michigan, United States Correspondence:  Zhenggang Zhang Henry Ford Hospital, Michigan, United  States Tel: +1-313-916-5456 Fax: +1-313-916-1318 E-mail: zhazh@neuro.hfh.edul Received: March 25, 2016 Revised: May 13, 2016 Accepted: May 18, 2016 NIH, R01 NS 088656 (MC) and R01  NS079612 (ZG).",Non-OADS,/arxiv_data1/oa_pdf/d9/c2/jos-2016-00206.PMC5066435.pdf
"In this review, we will detail the effect of Journal of Stroke  201 6;18(3):267- 272 http://dx.doi.org/10.5853/ jos.2016.00206",Non-OADS,/arxiv_data1/oa_pdf/d9/c2/jos-2016-00206.PMC5066435.pdf
Zhang and Chopp Stem Cells in Ischemic Brain http://dx.doi.org/10.5853/jos.2016.00206 268 http://j-stroke.orgstroke-induced neuroblasts and OPCs on brain parenchymal cells  in ischemic brain with a focus on the brain repair processes.,Non-OADS,/arxiv_data1/oa_pdf/d9/c2/jos-2016-00206.PMC5066435.pdf
"3 / September 2016 http://dx.doi.org/10.5853/jos.2016.00206 http://j-stroke.org  269nals of axons mediate axonal regeneration after axonal injury.53  Thus, it will be important to determine whether the stromal-de - rived factor-1 α/CXCR4 signaling pathway and exosomes re - leased by neural stem cells in the V/SVZ and neuroblasts in peri- infarct regions regulate axonal remodeling in ischemic brain.",Non-OADS,/arxiv_data1/oa_pdf/d9/c2/jos-2016-00206.PMC5066435.pdf
Zhang and Chopp Stem Cells in Ischemic Brain http://dx.doi.org/10.5853/jos.2016.00206 270 http://j-stroke.orgbral vasculature and other brain parenchymal cells.,Non-OADS,/arxiv_data1/oa_pdf/d9/c2/jos-2016-00206.PMC5066435.pdf
3 / September 2016 http://dx.doi.org/10.5853/jos.2016.00206 http://j-stroke.org  271J Neurosci  2009;29:5075-5087.,Non-OADS,/arxiv_data1/oa_pdf/d9/c2/jos-2016-00206.PMC5066435.pdf
Zhang and Chopp Stem Cells in Ischemic Brain http://dx.doi.org/10.5853/jos.2016.00206 272 http://j-stroke.organd growth-associated protein-43 gene transcription in peri- infarct areas in the rat brain.,Non-OADS,/arxiv_data1/oa_pdf/d9/c2/jos-2016-00206.PMC5066435.pdf
"Copyright © 2016  Korean Stroke Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which  permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b7/8b/jos-2016-00885.PMC5066436.pdf
"pISSN: 2287-6391 • eISSN: 2287-6405 http://j-stroke.org  273Traditional Risk Factors for Stroke in East Asia Young Dae Kim,a Yo Han Jung,b Gustavo Saposnikc aDepartment of Neurology, Yonsei University College of Medicine, Seoul, Korea bDepartment of Neurology, Changwon Fatima Hospital, Changwon, Korea cStroke Outcomes Research Unit, Division of Neurology, University of Toronto, Toronto, Canada Correspondence:  Young Dae Kim Department of Neurology, Yonsei  University College of Medicine 50-1 Yonsei-ro, Seodaemoon-gu,  Seoul 03722, Korea Tel.",Non-OADS,/arxiv_data1/oa_pdf/b7/8b/jos-2016-00885.PMC5066436.pdf
Because there is considerable Journal of Stroke  201 6;18(3):273- 285 http://dx.doi.org/10.5853/ jos.2016.00885,Non-OADS,/arxiv_data1/oa_pdf/b7/8b/jos-2016-00885.PMC5066436.pdf
"Risk Factors in East Asia http://dx.doi.org/10.5853/jos.2016.00885 274 http://j-stroke.orgheterogeneity in ethnicity, as well as epidemiologic differences in  Asia,17 we mainly focused on data from five East Asian countries:  China, Japan, the Republic of Korea, Mongolia, and Taiwan.",OADS,/arxiv_data1/oa_pdf/b7/8b/jos-2016-00885.PMC5066436.pdf
"3 / September 2016 http://dx.doi.org/10.5853/jos.2016.00885 http://j-stroke.org  275these estimated data were systematically standardized and vali - dated, which enabled us to compare the burden of risk factors  across countries (Table 3).",OADS,/arxiv_data1/oa_pdf/b7/8b/jos-2016-00885.PMC5066436.pdf
"Risk Factors in East Asia http://dx.doi.org/10.5853/jos.2016.00885 276 http://j-stroke.orgDiabetes Globally, the number of diabetic adults has more than doubled  over the last 30 years.19 In Asia, the pattern of increasing diabe - tes prevalence has been different from that found in other re - gions in that the increase has occurred over a much shorter time  period.",Non-OADS,/arxiv_data1/oa_pdf/b7/8b/jos-2016-00885.PMC5066436.pdf
"3 / September 2016 http://dx.doi.org/10.5853/jos.2016.00885 http://j-stroke.org  277East Asian countries were associated with increasingly older  populations, changes in dietary patterns, and rapid urbaniza - tion.32,33,54 As mentioned earlier, because of the epidemic transi - tion over the past decades in East Asia, westernized diet patterns  of total and saturated fat consumption, foods from animal  sources, and processed foods, together with low levels of physi - cal activity, have become more common.20,55,56 The incidence of  obesity has also increased over the past decades, even among  Asian young adults and children.57-60 These changes have played  a role in the increase in average cholesterol levels in East Asia.",Non-OADS,/arxiv_data1/oa_pdf/b7/8b/jos-2016-00885.PMC5066436.pdf
"Risk Factors in East Asia http://dx.doi.org/10.5853/jos.2016.00885 278 http://j-stroke.orglence of current smoking in men has decreased over the past de - cades,37,63 although it is still high.",Non-OADS,/arxiv_data1/oa_pdf/b7/8b/jos-2016-00885.PMC5066436.pdf
"3 / September 2016 http://dx.doi.org/10.5853/jos.2016.00885 http://j-stroke.org  27911 Western countries and 11 Asian countries (mainly China, Ja - pan, and the Republic of Korea), also demonstrated that the risk  of stroke associated with elevated blood pressure was greater  among Asians than Western populations.",OADS,/arxiv_data1/oa_pdf/b7/8b/jos-2016-00885.PMC5066436.pdf
Risk Factors in East Asia http://dx.doi.org/10.5853/jos.2016.00885 280 http://j-stroke.orgimply that stroke or stroke burden can be effectively prevented  by better hypertension management in Asia.,Non-OADS,/arxiv_data1/oa_pdf/b7/8b/jos-2016-00885.PMC5066436.pdf
3 / September 2016 http://dx.doi.org/10.5853/jos.2016.00885 http://j-stroke.org  281proaches for reducing the burdens of risk factors and stroke in  East Asia.,Non-OADS,/arxiv_data1/oa_pdf/b7/8b/jos-2016-00885.PMC5066436.pdf
"http://www.who.int/healthinfo/global_bur - den_disease/en/ (assessed Aug 10, 2015).",Non-OADS,/arxiv_data1/oa_pdf/b7/8b/jos-2016-00885.PMC5066436.pdf
Risk Factors in East Asia http://dx.doi.org/10.5853/jos.2016.00885 282 http://j-stroke.org26.,Non-OADS,/arxiv_data1/oa_pdf/b7/8b/jos-2016-00885.PMC5066436.pdf
3 / September 2016 http://dx.doi.org/10.5853/jos.2016.00885 http://j-stroke.org  283with diabetes in Taiwan: an analysis of nationwide data for  2000-2009.,Non-OADS,/arxiv_data1/oa_pdf/b7/8b/jos-2016-00885.PMC5066436.pdf
Risk Factors in East Asia http://dx.doi.org/10.5853/jos.2016.00885 284 http://j-stroke.org79.,Non-OADS,/arxiv_data1/oa_pdf/b7/8b/jos-2016-00885.PMC5066436.pdf
3 / September 2016 http://dx.doi.org/10.5853/jos.2016.00885 http://j-stroke.org  285tive study of statin use and its effectiveness in Taiwanese.,Non-OADS,/arxiv_data1/oa_pdf/b7/8b/jos-2016-00885.PMC5066436.pdf
"Copyright © 2016  Korean Stroke Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which  permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/57/43/jos-2016-00360.PMC5066437.pdf
"pISSN: 2287-6391 • eISSN: 2287-6405 http://j-stroke.org  297Difference in the Location and Risk Factors of Cerebral  Microbleeds According to Ischemic Stroke Subtypes Bum Joon Kim,a Youngshin Yoon,b Hoyon Sohn,b Dong-Wha Kang,b Jong S. Kim,b Sun U. Kwonb aDepartment of Neurology, Kyung Hee University Hospital, Seoul, Korea bDepartment of Neurology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea Correspondence:  Sun U. Kwon Department of Neurology, Asan Medical  Center, University of Ulsan College of  Medicine, 88 Olympic-ro 43-gil, Songpa- gu, Seoul 05505, Korea  Tel: +82-2-3010-3960 Fax: +82-2-474-4691 E-mail: sukwon@amc.seoul.kr Received: April 27, 2016 Revised: July 27, 2016 Accepted: August 7, 2016 This study was supported by a grant of the  Korean Health Technology R &D Project,  Ministry of Health & Welfare, Republic of  Korea (HI14C1731).",Non-OADS,/arxiv_data1/oa_pdf/57/43/jos-2016-00360.PMC5066437.pdf
"The prevalence has been found to  be highest in patients with small lacunar infarctions;9-11 however, Journal of Stroke  201 6;18(3):297- 303 http://dx.doi.org/10.5853/ jos.2016.00360",Non-OADS,/arxiv_data1/oa_pdf/57/43/jos-2016-00360.PMC5066437.pdf
"Cerebral Microbleeds in Various Stroke Subtypes http://dx.doi.org/10.5853/jos.2016.00360 298 http://j-stroke.orgCMBs in other subtypes of stroke are also common.12,13 In fact, up  to one-third of cardioembolic stroke (CE) cases demonstrate  CMBs.14-16 Considering that patients with CE require long-term  anticoagulation, and that anticoagulation increases the risk of  intracerebral hemorrhage, especially in patients with multiple  CMBs, understanding the pathomechanism of CMBs according  to ischemic stroke subtype or location may be important in de - termining the treatment strategy for secondary stroke prevention.",Non-OADS,/arxiv_data1/oa_pdf/57/43/jos-2016-00360.PMC5066437.pdf
"3 / September 2016 http://dx.doi.org/10.5853/jos.2016.00360 http://j-stroke.org  299history, CE group: hypertension and previous use of antithrom - botic agents were entered.",Non-OADS,/arxiv_data1/oa_pdf/57/43/jos-2016-00360.PMC5066437.pdf
Cerebral Microbleeds in Various Stroke Subtypes http://dx.doi.org/10.5853/jos.2016.00360 300 http://j-stroke.orgdiffered according to the subtype of ischemic stroke ( P= 0.004).,Non-OADS,/arxiv_data1/oa_pdf/57/43/jos-2016-00360.PMC5066437.pdf
3 / September 2016 http://dx.doi.org/10.5853/jos.2016.00360 http://j-stroke.org  301and previous stroke history were higher in patients with CMBs  than in those without.,Non-OADS,/arxiv_data1/oa_pdf/57/43/jos-2016-00360.PMC5066437.pdf
Cerebral Microbleeds in Various Stroke Subtypes http://dx.doi.org/10.5853/jos.2016.00360 302 http://j-stroke.orgsociated with the presence of lobar CMB.,Non-OADS,/arxiv_data1/oa_pdf/57/43/jos-2016-00360.PMC5066437.pdf
3 / September 2016 http://dx.doi.org/10.5853/jos.2016.00360 http://j-stroke.org  30315.,Non-OADS,/arxiv_data1/oa_pdf/57/43/jos-2016-00360.PMC5066437.pdf
"Copyright © 2016  Korean Stroke Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which  permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/99/77/jos-2016-00262.PMC5066438.pdf
"pISSN: 2287-6391 • eISSN: 2287-6405 328 http://j-stroke.orgReduction of Midline Shift Following Decompressive  Hemicraniectomy for Malignant Middle Cerebral  Artery Infarction Sang-Beom Jeon,a Sun U. Kwon,a Jung Cheol Park,b Deok Hee Lee,c Sung-Cheol Yun,d Yeon-Jung Kim,a  Jae-Sung Ahn,b Byung-Duk Kwun,b Dong-Wha Kang,a H. Alex Choi,e Kiwon Lee,e Jong S. Kima aDepartment of Neurology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea bDepartment of Neurosurgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea cDepartment of Radiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea dDivision of Epidemiology and Biostatistics Clinical Research Center, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea eDepartments of Neurology and Neurosurgery, TheUniversity of Texas Medical School at Houston, Houston, Texas, USA Correspondence:  Sang-Beom Jeon   Department of Neurology, Asan Medical Center, University of Ulsan  College of Medicine, 88 Olympic-ro  43-gil, Songpa-gu, Seoul 05505, Korea Tel: +82-2-3010-3440 Fax: +82-2-474-4691 E-mail: sbjeonmd@gmail.com Received: April 8, 2016 Revised: June 4, 2016 Accepted: June 30, 2016 The authors have no financial conflicts of  interest.Background and Purpose Hemicraniectomy is a decompressive surgery used to remove a large  bone flap to allow edematous brain tissue to bulge extracranially.",Non-OADS,/arxiv_data1/oa_pdf/99/77/jos-2016-00262.PMC5066438.pdf
"Keywords Middle cerebral artery; Infarction; Decompressive craniectomy; MortalityOriginal Article Introduction  Malignant middle cerebral artery (MCA) infarction (MMI) is a  large hemispheric infarction due to the occlusion of the proximal middle cerebral artery or the internal carotid artery.1 Mortality of  MMI can be as high as 70–80% with medical treatments mainly  aimed at cerebral edema.2-5 The surgical treatment for this type  of stroke is hemicraniectomy, which removes a large bone flap Journal of Stroke  201 6;18(3):328- 336 http://dx.doi.org/10.5853/ jos.2016.00262",Non-OADS,/arxiv_data1/oa_pdf/99/77/jos-2016-00262.PMC5066438.pdf
3 / September 2016 http://dx.doi.org/10.5853/jos.2016.00262 http://j-stroke.org  329on the side of the MMI and allows the infarcted brain tissue to  bulge extracranially.,Non-OADS,/arxiv_data1/oa_pdf/99/77/jos-2016-00262.PMC5066438.pdf
"Midline Shift Following Hemicraniectomy  http://dx.doi.org/10.5853/jos.2016.00262 330 http://j-stroke.orgtions (reduction of ≥ 1 mm), no change (-1 mm < reduction < 1  mm), and progression (reduction of ≤ -1 mm) for further analy - sis.",Non-OADS,/arxiv_data1/oa_pdf/99/77/jos-2016-00262.PMC5066438.pdf
3 / September 2016 http://dx.doi.org/10.5853/jos.2016.00262 http://j-stroke.org  331were included in a multivariate model as candidate variables and  then removed using a backward stepwise selection procedure.,OADS,/arxiv_data1/oa_pdf/99/77/jos-2016-00262.PMC5066438.pdf
"Midline Shift Following Hemicraniectomy  http://dx.doi.org/10.5853/jos.2016.00262 332 http://j-stroke.orgcheal intubation, mechanical ventilation, and osmotherapy.",Non-OADS,/arxiv_data1/oa_pdf/99/77/jos-2016-00262.PMC5066438.pdf
3 / September 2016 http://dx.doi.org/10.5853/jos.2016.00262 http://j-stroke.org  333gression of SPS were alive at 180 days post-stroke.,OADS,/arxiv_data1/oa_pdf/99/77/jos-2016-00262.PMC5066438.pdf
"Midline Shift Following Hemicraniectomy  http://dx.doi.org/10.5853/jos.2016.00262 334 http://j-stroke.orgfrom preoperative to postoperative CT, preoperative use of hy - perosmotic agents, and preoperative mechanical ventilation  were not related to changes in SPS and PGS (Table 2).",Non-OADS,/arxiv_data1/oa_pdf/99/77/jos-2016-00262.PMC5066438.pdf
"3 / September 2016 http://dx.doi.org/10.5853/jos.2016.00262 http://j-stroke.org  335poralis muscle, and strokectomy were not analyzed.",OADS,/arxiv_data1/oa_pdf/99/77/jos-2016-00262.PMC5066438.pdf
Midline Shift Following Hemicraniectomy  http://dx.doi.org/10.5853/jos.2016.00262 336 http://j-stroke.orgcation of midline shift as a predictor of poor outcome follow - ing head injury.,Non-OADS,/arxiv_data1/oa_pdf/99/77/jos-2016-00262.PMC5066438.pdf
3 / September 2016 http://dx.doi.org/10.5853/jos.2016.00262 http://j-stroke.orgSupplementary Figure 1.,Non-OADS,/arxiv_data1/oa_pdf/99/77/jos-2016-00262.PMC5066438.pdf
The Effect of the Evolvement of ERT in Acute BAO http://dx.doi.org/10.5853/jos.2016.00262 http://j-stroke.org Supplementary Figure 2.,Non-OADS,/arxiv_data1/oa_pdf/99/77/jos-2016-00262.PMC5066438.pdf
3 / September 2016 http://dx.doi.org/10.5853/jos.2016.00262 http://j-stroke.org Supplementary Figure 3.,Non-OADS,/arxiv_data1/oa_pdf/99/77/jos-2016-00262.PMC5066438.pdf
The Effect of the Evolvement of ERT in Acute BAO http://dx.doi.org/10.5853/jos.2016.00262 http://j-stroke.orgSupplementary Figure 4.,Non-OADS,/arxiv_data1/oa_pdf/99/77/jos-2016-00262.PMC5066438.pdf
3 / September 2016 http://dx.doi.org/10.5853/jos.2016.00262 http://j-stroke.orgSupplementary Table 1.,Non-OADS,/arxiv_data1/oa_pdf/99/77/jos-2016-00262.PMC5066438.pdf
"Copyright © 2016  Korean Stroke Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which  permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ee/3f/jos-2016-00906.PMC5066439.pdf
"pISSN: 2287-6391 • eISSN: 2287-6405 286 http://j-stroke.orgDirect Thrombus Imaging in Stroke Jongseong Kim,a,b Jung E. Park,c Matthias Nahrendorf,b,d Dong-Eog Kima,b,c aMolecular Imaging and Neurovascular Research (MINER) Laboratory, Dongguk University Ilsan Hospital, Goyang, Korea b Global Research Laboratory for Thrombus-targeted Theranostics at Dongguk University Ilsan Hospital (Korea) and Massachusetts General  Hospital (USA) cDepartment of Neurology, Dongguk University Ilsan Hospital, Goyang, Korea dCenter for Systems Biology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA Correspondence:  Dong-Eog Kim Stroke Center, Dongguk University Ilsan Hospital, 27 Dongguk-ro, Ilsandong-gu,  Goyang 10326, Korea E-mail: kdongeog@duih.org Fax: +82-31-961-7212 Received: July 19, 2016 Revised: September 1, 2016 Accepted: September 17, 2016 This work was supported by Global  Research Lab (GRL) program (NRF- 2015K1A1A2028228 to Drs.",Non-OADS,/arxiv_data1/oa_pdf/ee/3f/jos-2016-00906.PMC5066439.pdf
"Stroke-related therapy is estimated to cost ~$33 billion each  year in the United States.1  Approximately 80% of strokes are infarction, which is typically  caused by atherothrombosis.1 The only FDA-approved thrombo - lytic drug for acute cerebral infarction is tissue plasminogen ac - tivator (tPA),3 which is a fibrinolytic agent with limited efficacy  and a narrow therapeutic index.4 Moreover, tPA has a short half-life and often leads to hemorrhagic complications.5 Thus, despite  the proven efficacy of tPA to improve stroke outcomes, ~60% of  patients with stroke die or become functionally dependent de - spite adequate treatment.2 This emphasizes the need for im - provement in our current therapeutic regimens for stroke.6 Current clinical guidelines recommend intravenous adminis - tration of a fixed dose of tPA (0.9 mg/kg) for acute stroke treat - ment.3 Without an in vivo  imaging tool to provide clinicians with  critical information on the size, distribution, and nature of  thrombi in individual patients, the tPA dosage could be insuffi - cient in some patients or excessive in others, resulting in either  decreased rates of thrombolysis or increased rates of hemor - rhagic complications, respectively.7 Present thrombolysis guidelines are based on the results of  previous studies3 conducted before advanced imaging modalities Journal of Stroke  201 6;18(3):286- 296 http://dx.doi.org/10.5853/ jos.2016.00906",Non-OADS,/arxiv_data1/oa_pdf/ee/3f/jos-2016-00906.PMC5066439.pdf
http://dx.doi.org/10.5853/jos.2016.00906 Vol.,Non-OADS,/arxiv_data1/oa_pdf/ee/3f/jos-2016-00906.PMC5066439.pdf
3 / September 2016 http://j-stroke.org  287were available to determine thrombus location and size.,OADS,/arxiv_data1/oa_pdf/ee/3f/jos-2016-00906.PMC5066439.pdf
Direct Thrombus Imaging in Stroke http://dx.doi.org/10.5853/jos.2016.00906 288 http://j-stroke.orgTable 1.,Non-OADS,/arxiv_data1/oa_pdf/ee/3f/jos-2016-00906.PMC5066439.pdf
http://dx.doi.org/10.5853/jos.2016.00906 Vol.,Non-OADS,/arxiv_data1/oa_pdf/ee/3f/jos-2016-00906.PMC5066439.pdf
"3 / September 2016 http://j-stroke.org  289concentration and relaxivity of MR probes at the site of interest,  thereby making the optimization of target-to-background signal  ratio necessary.",Non-OADS,/arxiv_data1/oa_pdf/ee/3f/jos-2016-00906.PMC5066439.pdf
"Direct Thrombus Imaging in Stroke http://dx.doi.org/10.5853/jos.2016.00906 290 http://j-stroke.orgfurcation will considerably improve spatial resolution, and imag - ing will better reflect the true nature of the atheromatous lesion.",Non-OADS,/arxiv_data1/oa_pdf/ee/3f/jos-2016-00906.PMC5066439.pdf
http://dx.doi.org/10.5853/jos.2016.00906 Vol.,Non-OADS,/arxiv_data1/oa_pdf/ee/3f/jos-2016-00906.PMC5066439.pdf
"3 / September 2016 http://j-stroke.org  291thrombosis, Muhlen et al.41 used MRI and microparticles of iron  oxide (MPIO) conjugated with a single-chain antibody targeting  ligand-induced binding sites (LIBS) on the platelet integrin GPIIb/ IIIa.",OADS,/arxiv_data1/oa_pdf/ee/3f/jos-2016-00906.PMC5066439.pdf
"Direct Thrombus Imaging in Stroke http://dx.doi.org/10.5853/jos.2016.00906 292 http://j-stroke.orgsystemic clearance, low off-target retention, and small size of  the probe may allow for the detection of small thrombi using a  clinical PET scanner; however, clinical validation studies still need  to be performed in different settings.",Non-OADS,/arxiv_data1/oa_pdf/ee/3f/jos-2016-00906.PMC5066439.pdf
http://dx.doi.org/10.5853/jos.2016.00906 Vol.,Non-OADS,/arxiv_data1/oa_pdf/ee/3f/jos-2016-00906.PMC5066439.pdf
"3 / September 2016 http://j-stroke.org  293indicating that AuNP-microCT thrombus imaging probably serves  as a new, simple, and robust tool in neurovascular studies.",Non-OADS,/arxiv_data1/oa_pdf/ee/3f/jos-2016-00906.PMC5066439.pdf
Direct Thrombus Imaging in Stroke http://dx.doi.org/10.5853/jos.2016.00906 294 http://j-stroke.orgThrombus imaging studies have most commonly used small- animal imaging equipment in rodent models of stroke (Table 1).,Non-OADS,/arxiv_data1/oa_pdf/ee/3f/jos-2016-00906.PMC5066439.pdf
"The United States National Cancer Institute states that, “Most  engineered nanoparticles are far less toxic than household  cleaning products.” (http://nano.cancer.gov/learn/now/safety.",Non-OADS,/arxiv_data1/oa_pdf/ee/3f/jos-2016-00906.PMC5066439.pdf
http://dx.doi.org/10.5853/jos.2016.00906 Vol.,Non-OADS,/arxiv_data1/oa_pdf/ee/3f/jos-2016-00906.PMC5066439.pdf
3 / September 2016 http://j-stroke.org  29517.,Non-OADS,/arxiv_data1/oa_pdf/ee/3f/jos-2016-00906.PMC5066439.pdf
Direct Thrombus Imaging in Stroke http://dx.doi.org/10.5853/jos.2016.00906 296 http://j-stroke.org43.,Non-OADS,/arxiv_data1/oa_pdf/ee/3f/jos-2016-00906.PMC5066439.pdf
"Copyright © 2016  Korean Stroke Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which  permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7f/de/jos-2016-01263.PMC5066440.pdf
"pISSN: 2287-6391 • eISSN: 2287-6405 256 http://j-stroke.orgAdult Stem Cell Therapy for Stroke: Challenges and  Progress Oh Young Bang,a,b Eun Hee Kim,b Jae Min Cha,c,d Gyeong Joon Moonb,e aDepartment of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea bTranslational and Stem Cell Research Laboratory on Stroke, Samsung Medical Center, Seoul, Korea cSamsung Biomedical Research Institute, Samsung Advanced Institute of Technology, Samsung Electronics Co., Ltd., Seoul, Korea dMedical Device Research Center, Research Institute for Future Medicine, Samsung Medical Center, Seoul, Korea eStem cell and Regenerative Medicine Institute, Samsung Biomedical Research Institute, Seoul, Korea Correspondence:  Oh Young Bang Department of Neurology, Samsung  Medical Center, Sungkyunkwan  University, 81 Irwon-ro, Gangnam-gu,  Seoul 06351, Korea Tel: +82-2-3410-3599 Fax: +82-2-3410-0052 E-mail: ohyoung.bang@samsung.com  Received: September 1, 2016 Revised: September 15, 2016 Accepted: September 18, 2016 This study was supported by the Korea  Health Technology R&D Project, the  Ministry of Health & Welfare  (HI14C16240000).",Non-OADS,/arxiv_data1/oa_pdf/7f/de/jos-2016-01263.PMC5066440.pdf
Embryonic stem cells  (ESCs) and induced pluripotent stem cells (iPSCs) can replace the Journal of Stroke  201 6;18(3):256- 266 http://dx.doi.org/10.5853/ jos.2016.01263,Non-OADS,/arxiv_data1/oa_pdf/7f/de/jos-2016-01263.PMC5066440.pdf
http://dx.doi.org/10.5853/jos.2016.01263 Vol.,Non-OADS,/arxiv_data1/oa_pdf/7f/de/jos-2016-01263.PMC5066440.pdf
3 / September 2016 http://j-stroke.org  257missing brain cells in the infarcted area.,Non-OADS,/arxiv_data1/oa_pdf/7f/de/jos-2016-01263.PMC5066440.pdf
"Adult Stem Cell Therapy for Stroke http://dx.doi.org/10.5853/jos.2016.01263 258 http://j-stroke.orggenerative potential of stem cells in aged patients with stroke  could result from aging in either the donor cells (e.g., bone mar - row stem cells) or the recipient cells (e.g., NSCs in the innate  neurogenesis system of the brain).",Non-OADS,/arxiv_data1/oa_pdf/7f/de/jos-2016-01263.PMC5066440.pdf
http://dx.doi.org/10.5853/jos.2016.01263 Vol.,Non-OADS,/arxiv_data1/oa_pdf/7f/de/jos-2016-01263.PMC5066440.pdf
3 / September 2016 http://j-stroke.org  259address the apparent decrease in the number and function of  bone marrow MSCs in aged persons.,Non-OADS,/arxiv_data1/oa_pdf/7f/de/jos-2016-01263.PMC5066440.pdf
"Adult Stem Cell Therapy for Stroke http://dx.doi.org/10.5853/jos.2016.01263 260 http://j-stroke.orgsion of MSCs with serum obtained in the acute phase of stroke  increased cell proliferation rates, increased trophic factor release,  and decreased senescence via circulating signals from the in - farcted brain area.64 A clinical trial (Clinical trial identifier NCT   01716481) will determine the effectiveness and safety of autolo - gous MSCs that are culture expanded in autologous serum ob - tained as soon after stroke as possible.61 In addition, hypoxic  conditions (i.e., 0.1–2% O 2, conditions similar to bone marrow)  were beneficial to MSCs and might stimulate MSCs to exhibit  adaptive responses.65–69 Treatment with trophic factors or chemical agents may alter  MSC characteristics.",Non-OADS,/arxiv_data1/oa_pdf/7f/de/jos-2016-01263.PMC5066440.pdf
http://dx.doi.org/10.5853/jos.2016.01263 Vol.,Non-OADS,/arxiv_data1/oa_pdf/7f/de/jos-2016-01263.PMC5066440.pdf
"3 / September 2016 http://j-stroke.org  261therapeutic response.86 For example, MSC administration in - creased miR-133b expression levels in rat brain after stroke and  exosomal miR-133b transferred from MSCs to neurons and as - trocytes regulated neurite outgrowth87 and neurovascular re - modeling to promote stroke recovery.82 The efficacy of stem cells  could be enhanced in principle by regulating miR expression in  stem cells or EVs.",Non-OADS,/arxiv_data1/oa_pdf/7f/de/jos-2016-01263.PMC5066440.pdf
Adult Stem Cell Therapy for Stroke http://dx.doi.org/10.5853/jos.2016.01263 262 http://j-stroke.orgReferences 1.,Non-OADS,/arxiv_data1/oa_pdf/7f/de/jos-2016-01263.PMC5066440.pdf
http://dx.doi.org/10.5853/jos.2016.01263 Vol.,Non-OADS,/arxiv_data1/oa_pdf/7f/de/jos-2016-01263.PMC5066440.pdf
3 / September 2016 http://j-stroke.org  26317.,Non-OADS,/arxiv_data1/oa_pdf/7f/de/jos-2016-01263.PMC5066440.pdf
Adult Stem Cell Therapy for Stroke http://dx.doi.org/10.5853/jos.2016.01263 264 http://j-stroke.org45.,Non-OADS,/arxiv_data1/oa_pdf/7f/de/jos-2016-01263.PMC5066440.pdf
http://dx.doi.org/10.5853/jos.2016.01263 Vol.,Non-OADS,/arxiv_data1/oa_pdf/7f/de/jos-2016-01263.PMC5066440.pdf
3 / September 2016 http://j-stroke.org  265genitor cell therapy for treatment of myocardial infarction by  inducing CXCR4 expression.,Non-OADS,/arxiv_data1/oa_pdf/7f/de/jos-2016-01263.PMC5066440.pdf
Adult Stem Cell Therapy for Stroke http://dx.doi.org/10.5853/jos.2016.01263 266 http://j-stroke.org365-380.,Non-OADS,/arxiv_data1/oa_pdf/7f/de/jos-2016-01263.PMC5066440.pdf
"Copyright © 2016  Korean Stroke Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which  permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d4/cd/jos-2016-00451.PMC5066441.pdf
"pISSN: 2287-6391 • eISSN: 2287-6405 http://j-stroke.org  355Overall and Gender-specific Associations between  C-reactive Protein and Stroke Occurrence:   A Cross-sectional Study in US Yang Peng, Bin Dong, Zhiqiang Wang Centre for Chronic Disease, School of Medicine, University of Queensland, Herston, AustraliaLetter to the Editor Dear Sir: C-reactive protein (CRP), a marker of systemic inflammation,  has been proposed to increase the risk of stroke, a common car - diovascular disease, in multiple cross-sectional and prospective  studies.1,2 While, a few reports found CRP had no apparent value  for stroke predictions.3 Furthermore, the gender-specific associa - tions between CRP concentration and stroke occurrence are not  well clarified.",Non-OADS,/arxiv_data1/oa_pdf/d4/cd/jos-2016-00451.PMC5066441.pdf
Removal of higher CRP level was Journal of Stroke  201 6;18(3):355- 357 http://dx.doi.org/10.5853/ jos.2016.00451,Non-OADS,/arxiv_data1/oa_pdf/d4/cd/jos-2016-00451.PMC5066441.pdf
C-reactive Protein and Stroke in US http://dx.doi.org/10.5853/jos.2016.00451 356 http://j-stroke.orglinked with 16% of stroke risk reduction in females (95% CI:  0.01-0.28).,Non-OADS,/arxiv_data1/oa_pdf/d4/cd/jos-2016-00451.PMC5066441.pdf
"3 / September 2016 http://dx.doi.org/10.5853/jos.2016.00451 http://j-stroke.org  357Correspondence:  Yang Peng Centre for Chronic Disease, School of Medicine, University of Queensland,   280 Herston Road, Herston 4029, Australia Tel: +61-7-3346-5149, Fax: +61-7-3346-5149 E-mail: yang.peng@uq.net.au Received: May 22, 2016 Revised: May 23, 2016 Accepted: May 23, 2016 We gratefully acknowledge the staff at the National Center for Health Statistics who were responsible for planning and conducting the National Health  and Nutrition Examination Survey (NHANES).",Non-OADS,/arxiv_data1/oa_pdf/d4/cd/jos-2016-00451.PMC5066441.pdf
"Copyright © 2016  Korean Stroke Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which  permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/02/8c/jos-2016-00962.PMC5066442.pdf
"pISSN: 2287-6391 • eISSN: 2287-6405 http://j-stroke.org  361Herbs and Rehabilitation after Stroke Study:   A Multi-center, Double-blinded, Randomized Trial in  Hong Kong Raymond Cheung,a Li Xiong,b Shek Kwan Chang,a Choi Ting Tse,a Yin Yu Pang,a Vincent Mok,b  Thomas Leung,b Tak Hong Tsoi,c Richard Li,c May Mok,c Chee My Chang,d Kwok Kwong Lau,e   Bun Sheng,e Terrence Li,e Jonas Yeung,f Ping Chung Leung,g Ping Chook,g Ka Sing Wongb aDepartment of Medicine, The University of Hong Kong, Hong Kong, Hong Kong bDepartment of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, Hong Kong cDepartment of Medicine, Pamela Youde Nethersole Eastern Hospital, Hong Kong, Hong Kong dDepartment of Medicine, Ruttonjee Hospital, Hong Kong, Hong Kong eDepartment of Medicine, Princess Margaret Hospital, Hong Kong, Hong Kong fDepartment of Medicine, Alice Ho Miu Ling Nethersole Hospital, Hong Kong, Hong Kong gInstitute of Chinese Medicine, The Chinese University of Hong Kong, Hong Kong, Hong KongLetter to the Editor Dear Sir: Stroke is the leading cause of long-term adult disability  throughout the world.1 Even with rehabilitation by physiotherapy  and occupational therapy, about half of all stroke survivors are  disabled with significant functional impairment.",Non-OADS,/arxiv_data1/oa_pdf/02/8c/jos-2016-00962.PMC5066442.pdf
"Secondary outcomes were the scores of NIHSS, Barthel Index  and Mini Mental State Examination (MMSE) at month 3 and Journal of Stroke  201 6;18(3):361- 363 http://dx.doi.org/10.5853/ jos.2016.00962",Non-OADS,/arxiv_data1/oa_pdf/02/8c/jos-2016-00962.PMC5066442.pdf
"Herbs Trial in Hong Kong http://dx.doi.org/10.5853/jos.2016.00962 362 http://j-stroke.orgmonth 6, and mRS at month 6.",Non-OADS,/arxiv_data1/oa_pdf/02/8c/jos-2016-00962.PMC5066442.pdf
"3 / September 2016 http://dx.doi.org/10.5853/jos.2016.00962 http://j-stroke.org  363press platelet aggregation, protect against ischemic reperfusion  injury, and enhance the tolerance of ischemic tissue to hypoxia.10 Our study had the limitation of having a small sample size,  which may lead the non-significant difference on the efficacy of  the herbal formula in post-stroke recovery treatment.",Non-OADS,/arxiv_data1/oa_pdf/02/8c/jos-2016-00962.PMC5066442.pdf
"The Korean Society for Radiation Oncologywww.e-roj.orgThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f7/db/roj-2016-01739.PMC5066443.pdf
"Tel: +1-502-561-2700, Fax: +1-502-561-2709, E-mail: mark.amsbaugh@louisville.eduRadiat Oncol J 2016;34(3):209-215 http://dx.doi.org/10.3857/roj.2016.01739 pISSN 2234-1900 · eISSN 2234-3156   Purpose:  We sought to determine if organ preservation (OP) with neoadjuvant chemoradiation (CRT) was feasible in patients with  sinonasal cancer determined to require exenteration.",Non-OADS,/arxiv_data1/oa_pdf/f7/db/roj-2016-01739.PMC5066443.pdf
Neoadjuvant chemoradiation in sinonasal cancer with orbital invasion210 www.e-roj.org http://dx.doi.org/10.3857/roj.2016.01739tissue involvement of the orbit.,Non-OADS,/arxiv_data1/oa_pdf/f7/db/roj-2016-01739.PMC5066443.pdf
"Mark J. Amsbaugh, et al211 www.e-roj.org http://dx.doi.org/10.3857/roj.2016.01739variables.",OADS,/arxiv_data1/oa_pdf/f7/db/roj-2016-01739.PMC5066443.pdf
"Neoadjuvant chemoradiation in sinonasal cancer with orbital invasion212 www.e-roj.org http://dx.doi.org/10.3857/roj.2016.01739target volume (PTV), accounting for any possible deviations in  plan targeting and delivery.",Non-OADS,/arxiv_data1/oa_pdf/f7/db/roj-2016-01739.PMC5066443.pdf
"Mark J. Amsbaugh, et al213 www.e-roj.org http://dx.doi.org/10.3857/roj.2016.01739resection compared to 58% for patients who received OP and  was not statistically different between treatment groups (p =  0.815).",Non-OADS,/arxiv_data1/oa_pdf/f7/db/roj-2016-01739.PMC5066443.pdf
Neoadjuvant chemoradiation in sinonasal cancer with orbital invasion214 www.e-roj.org http://dx.doi.org/10.3857/roj.2016.01739demonstrates the difficulty of assessing disease response in the  paranasal sinuses based on current imaging techniques and  also suggests that doses of 50 Gy in standard fraction sizes are  adequate preoperative therapy in these patients.,Non-OADS,/arxiv_data1/oa_pdf/f7/db/roj-2016-01739.PMC5066443.pdf
"Mark J. Amsbaugh, et al215 www.e-roj.org http://dx.doi.org/10.3857/roj.2016.01739References    1.",OADS,/arxiv_data1/oa_pdf/f7/db/roj-2016-01739.PMC5066443.pdf
"The Korean Society for Radiation Oncologywww.e-roj.orgThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/3d/c0/roj-2016-01816.PMC5066444.pdf
"Tel: +82-2-3410-2612, Fax: +82-2-3410-2619,  E-mail: rodrno@skku.eduRadiat Oncol J 2016;34(3):223-229 http://dx.doi.org/10.3857/roj.2016.01816 pISSN 2234-1900 · eISSN 2234-3156   Purpose:  This study is to investigate the effect of captopril when combined with irradiation.",Non-OADS,/arxiv_data1/oa_pdf/3d/c0/roj-2016-01816.PMC5066444.pdf
"Combination of captopril and radiation224 www.e-roj.org http://dx.doi.org/10.3857/roj.2016.01816probably pro-tumor N2 TAN, in several human cancers  such as renal cell carcinoma, non-small cell lung cancer,  hepatocellular carcinoma, and cervical cancer [5-8].",Non-OADS,/arxiv_data1/oa_pdf/3d/c0/roj-2016-01816.PMC5066444.pdf
"Won Kyung Cho, et al225 www.e-roj.org http://dx.doi.org/10.3857/roj.2016.01816at room temperature.",OADS,/arxiv_data1/oa_pdf/3d/c0/roj-2016-01816.PMC5066444.pdf
Combination of captopril and radiation226 www.e-roj.org http://dx.doi.org/10.3857/roj.2016.01816was induced by captopril administration.,Non-OADS,/arxiv_data1/oa_pdf/3d/c0/roj-2016-01816.PMC5066444.pdf
"Won Kyung Cho, et al227 www.e-roj.org http://dx.doi.org/10.3857/roj.2016.01816captopril when combined with irradiation through MDSC  modulation.",OADS,/arxiv_data1/oa_pdf/3d/c0/roj-2016-01816.PMC5066444.pdf
"Combination of captopril and radiation228 www.e-roj.org http://dx.doi.org/10.3857/roj.2016.01816and TANs, suggesting induction of apoptosis.",Non-OADS,/arxiv_data1/oa_pdf/3d/c0/roj-2016-01816.PMC5066444.pdf
"Won Kyung Cho, et al229 www.e-roj.org http://dx.doi.org/10.3857/roj.2016.0181612.",OADS,/arxiv_data1/oa_pdf/3d/c0/roj-2016-01816.PMC5066444.pdf
"The Korean Society for Radiation Oncologywww.e-roj.orgThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f0/1f/roj-2016-01865.PMC5066445.pdf
193Radiat Oncol J 2016;34(3):193-201 http://dx.doi.org/10.3857/roj.2016.01865 pISSN 2234-1900 · eISSN 2234-3156   Purpose:  To assess the clinical outcomes of radiotherapy (RT) using two-dimensional (2D) and three-dimensional conformal RT  (3D-CRT) for patients with gastric mucosa-associated lymphoid tissue (MALT) lymphoma to evaluate the effectiveness of involved  field RT with moderate-dose and to evaluate the benefit of 3D-CRT comparing with 2D-RT.,Non-OADS,/arxiv_data1/oa_pdf/f0/1f/roj-2016-01865.PMC5066445.pdf
RT for Gastric MALT lymphoma194 www.e-roj.org http://dx.doi.org/10.3857/roj.,Non-OADS,/arxiv_data1/oa_pdf/f0/1f/roj-2016-01865.PMC5066445.pdf
"Hyeon Woo Lim, et al195 www.e-roj.org http://dx.doi.org/10.3857/roj.",OADS,/arxiv_data1/oa_pdf/f0/1f/roj-2016-01865.PMC5066445.pdf
RT for Gastric MALT lymphoma196 www.e-roj.org http://dx.doi.org/10.3857/roj.,Non-OADS,/arxiv_data1/oa_pdf/f0/1f/roj-2016-01865.PMC5066445.pdf
"Hyeon Woo Lim, et al197 www.e-roj.org http://dx.doi.org/10.3857/roj.",OADS,/arxiv_data1/oa_pdf/f0/1f/roj-2016-01865.PMC5066445.pdf
RT for Gastric MALT lymphoma198 www.e-roj.org http://dx.doi.org/10.3857/roj.,Non-OADS,/arxiv_data1/oa_pdf/f0/1f/roj-2016-01865.PMC5066445.pdf
"Hyeon Woo Lim, et al199 www.e-roj.org http://dx.doi.org/10.3857/roj.",OADS,/arxiv_data1/oa_pdf/f0/1f/roj-2016-01865.PMC5066445.pdf
RT for Gastric MALT lymphoma200 www.e-roj.org http://dx.doi.org/10.3857/roj.,Non-OADS,/arxiv_data1/oa_pdf/f0/1f/roj-2016-01865.PMC5066445.pdf
"Hyeon Woo Lim, et al201 www.e-roj.org http://dx.doi.org/10.3857/roj.",OADS,/arxiv_data1/oa_pdf/f0/1f/roj-2016-01865.PMC5066445.pdf
"The Korean Society for Radiation Oncologywww.e-roj.orgThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f5/14/roj-2016-01802.PMC5066446.pdf
202Original Article Radiat Oncol J 2016;34(3):202-208 http://dx.doi.org/10.3857/roj.2016.01802 pISSN 2234-1900 · eISSN 2234-3156   Purpose:  Our institution has implemented two different adjuvant protocols in treating patients with non-small cell lung cancer  (NSCLC): chemotherapy followed by concurrent chemoradiotherapy (CT-CCRT) and sequential postoperative radiotherapy (PORT)  followed by postoperative chemotherapy (POCT).,Non-OADS,/arxiv_data1/oa_pdf/f5/14/roj-2016-01802.PMC5066446.pdf
"Hwan-Ik Kim, et al203 www.e-roj.org http://dx.doi.org/10.3857/roj.",OADS,/arxiv_data1/oa_pdf/f5/14/roj-2016-01802.PMC5066446.pdf
Sequential RT-CT vs. CT-CCRT in NSCLC204 www.e-roj.org http://dx.doi.org/10.3857/roj.,Non-OADS,/arxiv_data1/oa_pdf/f5/14/roj-2016-01802.PMC5066446.pdf
"Hwan-Ik Kim, et al205 www.e-roj.org http://dx.doi.org/10.3857/roj.",OADS,/arxiv_data1/oa_pdf/f5/14/roj-2016-01802.PMC5066446.pdf
Sequential RT-CT vs. CT-CCRT in NSCLC206 www.e-roj.org http://dx.doi.org/10.3857/roj.,Non-OADS,/arxiv_data1/oa_pdf/f5/14/roj-2016-01802.PMC5066446.pdf
"Hwan-Ik Kim, et al207 www.e-roj.org http://dx.doi.org/10.3857/roj.",OADS,/arxiv_data1/oa_pdf/f5/14/roj-2016-01802.PMC5066446.pdf
Sequential RT-CT vs. CT-CCRT in NSCLC208 www.e-roj.org http://dx.doi.org/10.3857/roj.,Non-OADS,/arxiv_data1/oa_pdf/f5/14/roj-2016-01802.PMC5066446.pdf
Available from:  https://www.r-project.org/.,Non-OADS,/arxiv_data1/oa_pdf/f5/14/roj-2016-01802.PMC5066446.pdf
"The Korean Society for Radiation Oncologywww.e-roj.orgThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/0f/ad/roj-2016-01970.PMC5066447.pdf
"160Review Article Radiat Oncol J 2016;34(3):160-167 http://dx.doi.org/10.3857/roj.2016.01970 pISSN 2234-1900 · eISSN 2234-3156   In oncologic practice, treatment guidelines provide appropriate treatment strategies based on evidence.",Non-OADS,/arxiv_data1/oa_pdf/0f/ad/roj-2016-01970.PMC5066447.pdf
"Chai Hong Rim, Jinsil Seong161 www.e-roj.org http://dx.doi.org/10.3857/roj.",Non-OADS,/arxiv_data1/oa_pdf/0f/ad/roj-2016-01970.PMC5066447.pdf
RT in current clinical guidelines of HCC162 www.e-roj.org http://dx.doi.org/10.3857/roj.,Non-OADS,/arxiv_data1/oa_pdf/0f/ad/roj-2016-01970.PMC5066447.pdf
"Chai Hong Rim, Jinsil Seong163 www.e-roj.org http://dx.doi.org/10.3857/roj.",Non-OADS,/arxiv_data1/oa_pdf/0f/ad/roj-2016-01970.PMC5066447.pdf
RT in current clinical guidelines of HCC164 www.e-roj.org http://dx.doi.org/10.3857/roj.,Non-OADS,/arxiv_data1/oa_pdf/0f/ad/roj-2016-01970.PMC5066447.pdf
"Chai Hong Rim, Jinsil Seong165 www.e-roj.org http://dx.doi.org/10.3857/roj.",Non-OADS,/arxiv_data1/oa_pdf/0f/ad/roj-2016-01970.PMC5066447.pdf
RT in current clinical guidelines of HCC166 www.e-roj.org http://dx.doi.org/10.3857/roj.,Non-OADS,/arxiv_data1/oa_pdf/0f/ad/roj-2016-01970.PMC5066447.pdf
http://dx.doi.org/10.1111/liv.13191.,Non-OADS,/arxiv_data1/oa_pdf/0f/ad/roj-2016-01970.PMC5066447.pdf
Available from: https://www.cancer.gov/publications/pdq/ levels-evidence/treatment.,Non-OADS,/arxiv_data1/oa_pdf/0f/ad/roj-2016-01970.PMC5066447.pdf
Available from: https://www.nccn.org/professionals/ physician_gls/categories_of_consensus.asp.,Non-OADS,/arxiv_data1/oa_pdf/0f/ad/roj-2016-01970.PMC5066447.pdf
Available from: https://www.nccn.,Non-OADS,/arxiv_data1/oa_pdf/0f/ad/roj-2016-01970.PMC5066447.pdf
Available from:  http://www.nccn.org/professionals/physician_gls/f_guidelines.,Non-OADS,/arxiv_data1/oa_pdf/0f/ad/roj-2016-01970.PMC5066447.pdf
"Chai Hong Rim, Jinsil Seong167 www.e-roj.org http://dx.doi.org/10.3857/roj.",Non-OADS,/arxiv_data1/oa_pdf/0f/ad/roj-2016-01970.PMC5066447.pdf
Available from:  http://www.uicc.org.,Non-OADS,/arxiv_data1/oa_pdf/0f/ad/roj-2016-01970.PMC5066447.pdf
"The Korean Society for Radiation Oncologywww.e-roj.orgThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/19/8f/roj-2016-01746.PMC5066448.pdf
"Tel: +82-2-3140-2612, Fax: +82-2-3140-2619,  E-mail: doho.choi@samsung.comRadiat Oncol J 2016;34(3):186-192 http://dx.doi.org/10.3857/roj.2016.01746 pISSN 2234-1900 · eISSN 2234-3156   Purpose:  To determine whether large rectal volume on planning computed tomography (CT) results in lower tumor regression  grade (TRG) after neoadjuvant concurrent chemoradiotherapy (CCRT) in rectal cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/19/8f/roj-2016-01746.PMC5066448.pdf
"Hong Seok Lee, et al187 www.e-roj.org http://dx.doi.org/10.3857/roj.2016.01746[4,5].",OADS,/arxiv_data1/oa_pdf/19/8f/roj-2016-01746.PMC5066448.pdf
Tumor regression grade and rectal volume188 www.e-roj.org http://dx.doi.org/10.3857/roj.2016.01746treatment was assessed for 29 patients whose mid-treatment  planning CT was obtainable.,Non-OADS,/arxiv_data1/oa_pdf/19/8f/roj-2016-01746.PMC5066448.pdf
"Hong Seok Lee, et al189 www.e-roj.org http://dx.doi.org/10.3857/roj.2016.01746showed downstaging and 14 patients (12%) showed no stage  reduction.",OADS,/arxiv_data1/oa_pdf/19/8f/roj-2016-01746.PMC5066448.pdf
Tumor regression grade and rectal volume190 www.e-roj.org http://dx.doi.org/10.3857/roj.2016.01746significant difference between TRG groups was found for ARA  (p = 0.126 by Kruskal-Wallis test) (Table 3).,OADS,/arxiv_data1/oa_pdf/19/8f/roj-2016-01746.PMC5066448.pdf
"Hong Seok Lee, et al191 www.e-roj.org http://dx.doi.org/10.3857/roj.2016.01746reluctant to correlate this finding towards clinical significance,  because the cut-off value is too close to zero, which makes it  problematic to have statistical significance.",OADS,/arxiv_data1/oa_pdf/19/8f/roj-2016-01746.PMC5066448.pdf
Tumor regression grade and rectal volume192 www.e-roj.org http://dx.doi.org/10.3857/roj.2016.01746complete response with increased interval between  preoperative combined modality therapy and rectal cancer  resection.,Non-OADS,/arxiv_data1/oa_pdf/19/8f/roj-2016-01746.PMC5066448.pdf
"The Korean Society for Radiation Oncologywww.e-roj.orgThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f7/aa/roj-2016-01788.PMC5066449.pdf
230Original Article Radiat Oncol J 2016;34(3):230-238 http://dx.doi.org/10.3857/roj.2016.01788 pISSN 2234-1900 · eISSN 2234-3156   Purpose:  Hypoxia can impair the therapeutic efficacy of radiotherapy (RT).,Non-OADS,/arxiv_data1/oa_pdf/f7/aa/roj-2016-01788.PMC5066449.pdf
"Mi Sun Kim, et al231 www.e-roj.org http://dx.doi.org/10.3857/roj.",OADS,/arxiv_data1/oa_pdf/f7/aa/roj-2016-01788.PMC5066449.pdf
Nanoparticle combined with radiotherapy232 www.e-roj.org http://dx.doi.org/10.3857/roj.,Non-OADS,/arxiv_data1/oa_pdf/f7/aa/roj-2016-01788.PMC5066449.pdf
"Mi Sun Kim, et al233 www.e-roj.org http://dx.doi.org/10.3857/roj.",OADS,/arxiv_data1/oa_pdf/f7/aa/roj-2016-01788.PMC5066449.pdf
"Positive reactions showed under the  microscope, and stained cells were quantified by stereological  analysis using Image-J software (https://imagej.nih.gov/ij/).",OADS,/arxiv_data1/oa_pdf/f7/aa/roj-2016-01788.PMC5066449.pdf
Nanoparticle combined with radiotherapy234 www.e-roj.org http://dx.doi.org/10.3857/roj.,Non-OADS,/arxiv_data1/oa_pdf/f7/aa/roj-2016-01788.PMC5066449.pdf
"Mi Sun Kim, et al235 www.e-roj.org http://dx.doi.org/10.3857/roj.",OADS,/arxiv_data1/oa_pdf/f7/aa/roj-2016-01788.PMC5066449.pdf
Nanoparticle combined with radiotherapy236 www.e-roj.org http://dx.doi.org/10.3857/roj.,Non-OADS,/arxiv_data1/oa_pdf/f7/aa/roj-2016-01788.PMC5066449.pdf
"Mi Sun Kim, et al237 www.e-roj.org http://dx.doi.org/10.3857/roj.",OADS,/arxiv_data1/oa_pdf/f7/aa/roj-2016-01788.PMC5066449.pdf
Nanoparticle combined with radiotherapy238 www.e-roj.org http://dx.doi.org/10.3857/roj.,Non-OADS,/arxiv_data1/oa_pdf/f7/aa/roj-2016-01788.PMC5066449.pdf
"The Korean Society for Radiation Oncologywww.e-roj.orgThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/63/95/roj-2016-01669.PMC5066450.pdf
168Original Article Radiat Oncol J 2016;34(3):168-176 http://dx.doi.org/10.3857/roj.2016.01669 pISSN 2234-1900 · eISSN 2234-3156   Purpose:  The purpose of current study is to evaluate the response of the patients with portal vein thrombosis (PVT) or hepatic  vein thrombosis (HVT) in hepatocellular carcinoma (HCC) treated with three-dimensional conformal radiation therapy (3D-CRT).,Non-OADS,/arxiv_data1/oa_pdf/63/95/roj-2016-01669.PMC5066450.pdf
"Bong Kyung Bae, Jae-Chul Kim169 www.e-roj.org http://dx.doi.org/10.3857/roj.2016.01669consequences.",Non-OADS,/arxiv_data1/oa_pdf/63/95/roj-2016-01669.PMC5066450.pdf
"Response of PVT or HVT to radiotherapy170 www.e-roj.org http://dx.doi.org/10.3857/roj.2016.01669the previous imaging study, we defined it as progression.",Non-OADS,/arxiv_data1/oa_pdf/63/95/roj-2016-01669.PMC5066450.pdf
"Bong Kyung Bae, Jae-Chul Kim171 www.e-roj.org http://dx.doi.org/10.3857/roj.2016.01669Table 2.",Non-OADS,/arxiv_data1/oa_pdf/63/95/roj-2016-01669.PMC5066450.pdf
"Response of PVT or HVT to radiotherapy172 www.e-roj.org http://dx.doi.org/10.3857/roj.2016.01669surface antigen (HBsAg), 8 patients were positive for hepatitis  B envelope antigen (HBeAg), and 4 patients were positive for  hepatitis C antibody (HCVAb).",Non-OADS,/arxiv_data1/oa_pdf/63/95/roj-2016-01669.PMC5066450.pdf
"Bong Kyung Bae, Jae-Chul Kim173 www.e-roj.org http://dx.doi.org/10.3857/roj.2016.01669Pugh score were evaluated.",OADS,/arxiv_data1/oa_pdf/63/95/roj-2016-01669.PMC5066450.pdf
Response of PVT or HVT to radiotherapy174 www.e-roj.org http://dx.doi.org/10.3857/roj.2016.01669normal tissues were relatively higher for the conventionally  fractionated group.,Non-OADS,/arxiv_data1/oa_pdf/63/95/roj-2016-01669.PMC5066450.pdf
"Bong Kyung Bae, Jae-Chul Kim175 www.e-roj.org http://dx.doi.org/10.3857/roj.2016.01669between the prognostic factors determining the patients’  survival.",Non-OADS,/arxiv_data1/oa_pdf/63/95/roj-2016-01669.PMC5066450.pdf
Response of PVT or HVT to radiotherapy176 www.e-roj.org http://dx.doi.org/10.3857/roj.2016.0166920.,Non-OADS,/arxiv_data1/oa_pdf/63/95/roj-2016-01669.PMC5066450.pdf
"The Korean Society for Radiation Oncologywww.e-roj.orgThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/19/c2/roj-2016-01858.PMC5066451.pdf
216Original Article Radiat Oncol J 2016;34(3):216-222 http://dx.doi.org/10.3857/roj.2016.01858 pISSN 2234-1900 · eISSN 2234-3156   Purpose:  To evaluate the benefit of adjuvant radiation therapy (RT) for retroperitoneal liposarcoma (RPLS) following gross tumor  removal.,Non-OADS,/arxiv_data1/oa_pdf/19/c2/roj-2016-01858.PMC5066451.pdf
"Hong Seok Lee, et al217 www.e-roj.org http://dx.doi.org/10.3857/roj.",OADS,/arxiv_data1/oa_pdf/19/c2/roj-2016-01858.PMC5066451.pdf
RT for retroperitoneal liposarcoma218 www.e-roj.org http://dx.doi.org/10.3857/roj.,Non-OADS,/arxiv_data1/oa_pdf/19/c2/roj-2016-01858.PMC5066451.pdf
"Hong Seok Lee, et al219 www.e-roj.org http://dx.doi.org/10.3857/roj.",OADS,/arxiv_data1/oa_pdf/19/c2/roj-2016-01858.PMC5066451.pdf
RT for retroperitoneal liposarcoma220 www.e-roj.org http://dx.doi.org/10.3857/roj.,Non-OADS,/arxiv_data1/oa_pdf/19/c2/roj-2016-01858.PMC5066451.pdf
"Hong Seok Lee, et al221 www.e-roj.org http://dx.doi.org/10.3857/roj.",OADS,/arxiv_data1/oa_pdf/19/c2/roj-2016-01858.PMC5066451.pdf
RT for retroperitoneal liposarcoma222 www.e-roj.org http://dx.doi.org/10.3857/roj.,Non-OADS,/arxiv_data1/oa_pdf/19/c2/roj-2016-01858.PMC5066451.pdf
"The Korean Society for Radiation Oncologywww.e-roj.orgThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a0/83/roj-2016-01872.PMC5066452.pdf
177Radiat Oncol J 2016;34(3):177-185 http://dx.doi.org/10.3857/roj.2016.01872 pISSN 2234-1900 · eISSN 2234-3156   Purpose:  To investigate whether preoperative chemoradiotherapy (PCRT) followed by local excision (LE) is feasible approach in  clinical T2N0 rectal cancer patients.,Non-OADS,/arxiv_data1/oa_pdf/a0/83/roj-2016-01872.PMC5066452.pdf
Local excision in T2N0 rectal cancer178 www.e-roj.org http://dx.doi.org/10.3857/roj.,Non-OADS,/arxiv_data1/oa_pdf/a0/83/roj-2016-01872.PMC5066452.pdf
"Young Seob Shin, et al179 www.e-roj.org http://dx.doi.org/10.3857/roj.",OADS,/arxiv_data1/oa_pdf/a0/83/roj-2016-01872.PMC5066452.pdf
Local excision in T2N0 rectal cancer180 www.e-roj.org http://dx.doi.org/10.3857/roj.,Non-OADS,/arxiv_data1/oa_pdf/a0/83/roj-2016-01872.PMC5066452.pdf
"Young Seob Shin, et al181 www.e-roj.org http://dx.doi.org/10.3857/roj.",OADS,/arxiv_data1/oa_pdf/a0/83/roj-2016-01872.PMC5066452.pdf
Local excision in T2N0 rectal cancer182 www.e-roj.org http://dx.doi.org/10.3857/roj.,Non-OADS,/arxiv_data1/oa_pdf/a0/83/roj-2016-01872.PMC5066452.pdf
"Young Seob Shin, et al183 www.e-roj.org http://dx.doi.org/10.3857/roj.",OADS,/arxiv_data1/oa_pdf/a0/83/roj-2016-01872.PMC5066452.pdf
Local excision in T2N0 rectal cancer184 www.e-roj.org http://dx.doi.org/10.3857/roj.,Non-OADS,/arxiv_data1/oa_pdf/a0/83/roj-2016-01872.PMC5066452.pdf
"Young Seob Shin, et al185 www.e-roj.org http://dx.doi.org/10.3857/roj.",OADS,/arxiv_data1/oa_pdf/a0/83/roj-2016-01872.PMC5066452.pdf
"This is an Open Access article distributed under the terms of the CreativeCommons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/07/13/ofw183.PMC5066456.pdf
"This is an Open Access article distributed under the terms of the CreativeCommons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/5f/07/ofw082.PMC5066457.pdf
"This is an Open Access article distributed under the terms of the CreativeCommons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/22/f4/ofw189.PMC5066458.pdf
Available at: http://programme.aids2016.org/Abstract/Abstract/10535 .,Non-OADS,/arxiv_data1/oa_pdf/22/f4/ofw189.PMC5066458.pdf
Available at: http://www.croiconference.org/sessions/effect-sequential-vacc-4xgm-csf- immunization-and-romidepsin-hiv-reservoir .,Non-OADS,/arxiv_data1/oa_pdf/22/f4/ofw189.PMC5066458.pdf
Available at: http://www.croiconference.org/sites/default/ ﬁles/posters-2015/417.,Non-OADS,/arxiv_data1/oa_pdf/22/f4/ofw189.PMC5066458.pdf
Available at: http://www.croiconference.org/sessions/ treatment-tlr7-agonist-induces-transient -viremia-siv-infected-art-suppressed- monkeys .,Non-OADS,/arxiv_data1/oa_pdf/22/f4/ofw189.PMC5066458.pdf
Available at: http://www.croiconference.org/sessions/safety-immunologic- and-virologic-activity-anti- pd-l1-hiv-1-participants-art .,Non-OADS,/arxiv_data1/oa_pdf/22/f4/ofw189.PMC5066458.pdf
Available at: http://www.croiconference.org/sessions/viral-and-immune- characteristics-hiv-post-treatment-controllers-actg-studies .,Non-OADS,/arxiv_data1/oa_pdf/22/f4/ofw189.PMC5066458.pdf
Available at: http://www.hiv- persistence.com/index.php/abstract .90.,Non-OADS,/arxiv_data1/oa_pdf/22/f4/ofw189.PMC5066458.pdf
Available at: http://www.hiv- persistence.com/index.php/abstract .,Non-OADS,/arxiv_data1/oa_pdf/22/f4/ofw189.PMC5066458.pdf
"2205 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/15/72/tow175.PMC5066475.pdf
"(http://www.mississippi-crops.com/ 2015/07/17/bollworms-showing-up-in-soybeans/) (accessed June 13, 2016).",Non-OADS,/arxiv_data1/oa_pdf/15/72/tow175.PMC5066475.pdf
"Pesticide Fact Sheet, Chlorantraniliprole, (http://www3.epa.gov/ pesticides/chem_search/reg_actions/registration/fs_PC-090100_01-Apr-08.",OADS,/arxiv_data1/oa_pdf/15/72/tow175.PMC5066475.pdf
(http://www.irac-online.org/documents/irac-croplife-irm-booklet/?ext¼pdf).,OADS,/arxiv_data1/oa_pdf/15/72/tow175.PMC5066475.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/32/30/tow188.PMC5066476.pdf
DOI: http://dx.doi.org/ 10.1155/2013/393787.,Non-OADS,/arxiv_data1/oa_pdf/bb/9e/tow154.PMC5066477.pdf
DOI: http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/bb/9e/tow154.PMC5066477.pdf
"5, 196 –202 http://dx.doi.org/10.1080/21541264.2016.1210370",Non-OADS,/arxiv_data1/oa_pdf/46/dd/ktrn-07-05-1210370.PMC5066509.pdf
Dev Growth Dif- fer 2015; 58:94-105; PMID:26667894; http://dx.doi.org/10.1111/dgd.12248 [2] Gehring WJ.,OADS,/arxiv_data1/oa_pdf/46/dd/ktrn-07-05-1210370.PMC5066509.pdf
"Evol Dev 2012;14:34-46; PMID:23016973; http://dx.doi.org/10.1111/j.1525-142X.2011.00528.x [3] Komura-Kawa T, Hirota K, Shimada-Niwa Y, Yamauchi R, Shimell M, Shinoda T, Fukamizu A, O ’Connor MB, Niwa R. The Drosophila zinc ﬁnger transcription factor Ouija board controls ecdysteroid biosynthesis throughspeciﬁc regulation of spookier .",OADS,/arxiv_data1/oa_pdf/46/dd/ktrn-07-05-1210370.PMC5066509.pdf
"; PMID:26658797; http://dx.doi.org/10.1371/journal.pgen.1005712 [4] Omura T, Morohashi K. Gene regulation of steroidogenesis.",OADS,/arxiv_data1/oa_pdf/46/dd/ktrn-07-05-1210370.PMC5066509.pdf
"J Steroid Biochem Mol Biol 1995; 53:19-25; PMID:7626452; http://dx.doi.org/10.1016/0960-0760(95)00036-Y [5] Luo X, Ikeda Y, Parker KL.",OADS,/arxiv_data1/oa_pdf/46/dd/ktrn-07-05-1210370.PMC5066509.pdf
"Cell 1994; 77:481-490; PMID:8187173;http://dx.doi.org/10.1016/0092-8674(94)90211-9 [6] Sadovsky Y, Crawford PA, Woodson KG, Polish JA, Clements MA, Tourtellotte LM, Simburger K, Milbrandt J.Mice de ﬁcient in the orphan receptor steroidogenic factor 1 lack adrenal glands and gonads but express P450200 Y. S. NIWA AND R. NIWA",Non-OADS,/arxiv_data1/oa_pdf/46/dd/ktrn-07-05-1210370.PMC5066509.pdf
"Endocrinol- ogy 2006; 147:4104-4111; PMID:16728492; http://dx.doi.org/10.1210/en.2006-0162 [8] Yamada M, Murata T, Hirose S, Lavorgna G, Suzuki E, Ueda H. Temporally restricted expression of transcrip-tion factor bFTZ-F1: signi ﬁcance for embryogenesis, molting and metamorphosis in Drosophila melanogaster .",OADS,/arxiv_data1/oa_pdf/46/dd/ktrn-07-05-1210370.PMC5066509.pdf
"Biosci Bio-technol Biochem 2014; 78:1283-1292; PMID:25130728; http://dx.doi.org/10.1080/09168451.2014.942250 [11] Uryu O, Ameku T, Niwa R. Recent progress in under- standing the role of ecdysteroids in adult insects: Germ-line development and circadian clock in the fruit ﬂy Drosophila melanogaster .",OADS,/arxiv_data1/oa_pdf/46/dd/ktrn-07-05-1210370.PMC5066509.pdf
"Dev Biol 2016; in press; PMID:27297887; http://dx.doi.org/10.1016/j.ydbio.2016.06.013 [13] Parvy J-P, Wang P, Garrido D, Maria A, Blais C, Poidevin M, Montagne J.",OADS,/arxiv_data1/oa_pdf/46/dd/ktrn-07-05-1210370.PMC5066509.pdf
"Develop- ment 2014; 141:3955-3965; PMID:25252945; http://dx.doi.org/http://dx.doi.org/10.1242/dev.102020 [14] Moeller ME, Danielsen ET, Herder R, O ’Connor MB, Rewitz KF.",OADS,/arxiv_data1/oa_pdf/46/dd/ktrn-07-05-1210370.PMC5066509.pdf
"Development 2013; 140:4730-4739; PMID:24173800; http://dx.doi.org/http://dx.doi .org/10.1242/dev.099739 [15] Ou Q, Magico A, King-Jones K. Nuclear receptor DHR4 controls the timing of steroid hormone pulsesduring Drosophila development.",Non-OADS,/arxiv_data1/oa_pdf/46/dd/ktrn-07-05-1210370.PMC5066509.pdf
PLOS Biol 2011; 9: e1001160; PMID:21980261; http://dx.doi.org/http://dx.,OADS,/arxiv_data1/oa_pdf/46/dd/ktrn-07-05-1210370.PMC5066509.pdf
"Dev Biol 2005; 282:84-94; PMID:15936331; http://dx.doi.org/http://dx.doi.org/10.1016/j.ydbio.2005.02.028 [17] Ueda H, Sonoda S, Brown JL, Scott MP, Wu C. A sequence- speciﬁc DNA-binding protein that activates fushi tarazusegmentation gene expression.",OADS,/arxiv_data1/oa_pdf/46/dd/ktrn-07-05-1210370.PMC5066509.pdf
"Genes Dev 1990; 4:624-635; PMID:2113881; http://dx.doi.org/http://dx.doi.org/10.1101/gad.4.4.624 [18] Lavorgna G, Ueda H, Clos J, Wu C. FTZ-F1, a steroid hor- mone receptor-like protein implicated in the activation offushi tarazu .",OADS,/arxiv_data1/oa_pdf/46/dd/ktrn-07-05-1210370.PMC5066509.pdf
"Science 1991; 252:848-851; PMID:1709303; http://dx.doi.org/http://dx.doi.org/10.1126/science.1709303 [19] Ono H, Rewitz KF, Shinoda T, Itoyama K, Petryk A, Rybczynski R, Jarcho M, Warren JT, Marqu /C19es G, Shimell MJ et al.",OADS,/arxiv_data1/oa_pdf/46/dd/ktrn-07-05-1210370.PMC5066509.pdf
"Spook and Spookier code for stage-speci ﬁc com- ponents of the ecdysone biosynthetic pathway in Diptera.Dev Biol 2006; 298:555-570; PMID:16949568; http://dx.doi.org/http://dx.doi.org/10.1016/j.ydbio.2006.07.023 [20] Gilbert LI, Rybczynski R, Warren JT.",OADS,/arxiv_data1/oa_pdf/46/dd/ktrn-07-05-1210370.PMC5066509.pdf
"Annu Rev Ento- mol 2002; 47:883-916; PMID:11729094; http://dx.doi.org/ http://dx.doi.org/10.1146/annurev.ento.47.091201.145302 [21] Neubueser D, Warren JT, Gilbert LI, Cohen SM.",Non-OADS,/arxiv_data1/oa_pdf/46/dd/ktrn-07-05-1210370.PMC5066509.pdf
"Dev Biol 2005; 280:362-372; PMID:15882578; http://dx.doi.org/http://dx.doi.org/10.1016/j.ydbio.2005.01.023 [22] Danielsen ET, Moeller ME, Dorry E, Komura-Kawa T, Fujimoto Y, Troelsen JT, Herder R, O ’Connor MB, Niwa R, Rewitz KF.",OADS,/arxiv_data1/oa_pdf/46/dd/ktrn-07-05-1210370.PMC5066509.pdf
"PLOS Genet 2014; 10:e1004343; PMID:24945799; http://dx.doi.org/http://dx.doi.org/10.1371/journal.pgen.1004343 [23] Pankotai T, Popescu C, Mart /C19ın D, Grau B, Zsindely N, Bodai L, Tora L, Ferr /C19us A, Boros I.",OADS,/arxiv_data1/oa_pdf/46/dd/ktrn-07-05-1210370.PMC5066509.pdf
"Mol Cell Biol 2010; 30:4254-4266; PMID:20584983; http://dx.doi.org/http://dx.doi.org/10.1128/MCB.00142-10 [24] Borsos BN, Pankotai T, Kov /C19acs D, Popescu C, P /C19ahi Z, Boros IM.",Non-OADS,/arxiv_data1/oa_pdf/46/dd/ktrn-07-05-1210370.PMC5066509.pdf
Dev Biol 2015; 404:80-87; PMID:25959239; http://dx.doi.org/http://dx.,OADS,/arxiv_data1/oa_pdf/46/dd/ktrn-07-05-1210370.PMC5066509.pdf
"Biol Open 2015; 4:852-857; PMID:25979705;http://dx.doi.org/http://dx.doi.org/10.1242/bio.012344 [26] Namiki T, Niwa R, Sakudoh T, Shirai K-I, Takeuchi H, Kataoka H. Cytochrome P450 C YP307A1/Spook: a regulator for ecdysone synthesis in insects.",OADS,/arxiv_data1/oa_pdf/46/dd/ktrn-07-05-1210370.PMC5066509.pdf
Biochem Biophys Res Commun 2005; 337:367-374; PMID:16188237; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/46/dd/ktrn-07-05-1210370.PMC5066509.pdf
"org/http://dx.doi.org/10.1016/j.bbrc.2005.09.043 [27] Chen S, Zhang YE, Long M. New genes in Drosophila quickly become essentia l. Science 2010; 330:1682- 1685; PMID:21164016; http://dx.doi.org/http://dx.doi.org/10.1126/science.1196380 [28] Ou Q, Zeng J, Yamanaka N, Brakken-Thal C, O ’Connor MB, King-Jones K. The insect prothoracic gland as a model for steroid hormone biosynthesis and regulation.TRANSCRIPTION 201",OADS,/arxiv_data1/oa_pdf/46/dd/ktrn-07-05-1210370.PMC5066509.pdf
Cell Rep 2016; 16:247 –62; PMID:27320926; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/46/dd/ktrn-07-05-1210370.PMC5066509.pdf
"DevCell 2016; 37:558-570; PMID:27326933; http://dx.doi.org/ http://dx.doi.org/10.1016/j.devcel.2016.05.015 [30] Chung H-R, L €ohr U, J €ackle H. Lineage-speci ﬁc expansion of the zinc ﬁnger associated domain ZAD.",OADS,/arxiv_data1/oa_pdf/46/dd/ktrn-07-05-1210370.PMC5066509.pdf
Mol Biol Evol 2007; 24:1934-1943; PMID:17569752; http://dx.doi.org/http://dx.doi.org/10.1093/molbev/msm121202 Y. S. NIWA AND R. NIWA,Non-OADS,/arxiv_data1/oa_pdf/46/dd/ktrn-07-05-1210370.PMC5066509.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License ( http://creativecommons.org/licenses/by-nc/3.0/ ), which per- mits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c0/19/ktrn-07-05-1221491.PMC5066521.pdf
"5, 164 –187 http://dx.doi.org/10.1080/21541264.2016.1221491",Non-OADS,/arxiv_data1/oa_pdf/c0/19/ktrn-07-05-1221491.PMC5066521.pdf
"Cell 2015; 161:1058-1073;PMID:26000482; http://dx.doi.org/10.1016/j.cell.2015.04.029 [132] Luhtala N, Parker R. T2 Family ribonucleases: ancient enzymes with diverse roles.",OADS,/arxiv_data1/oa_pdf/c0/19/ktrn-07-05-1221491.PMC5066521.pdf
Pharmacological and metabolomic investigations have revealed that histological lesions and metabolic http://dx.doi.org/10.1016/j.redox.2016.09.014 Received 13 July 2016; Received in revised form 21 September 2016; Accepted 26 September 2016⁎Corresponding author.,Non-OADS,/arxiv_data1/oa_pdf/8e/10/main.PMC5066525.pdf
This is an open access article under the  CC BY-NC-ND license (http://creativecommons.org/licenses/by/4.0/).Available online 28 September 2016 crossmark,Non-OADS,/arxiv_data1/oa_pdf/8e/10/main.PMC5066525.pdf
Supplementary material Supplementary data associated with this article can be found in the online version at http://dx.doi.org/10.1016/j.redox.2016.09.014 .,OADS,/arxiv_data1/oa_pdf/8e/10/main.PMC5066525.pdf
http://dx.doi.org/ 10.1021/acs.jproteome.6b00583 .,Non-OADS,/arxiv_data1/oa_pdf/8e/10/main.PMC5066525.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/d1/46/10.1177_2325967116667920.PMC5066526.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/20/a9/ceor-8-573.PMC5066562.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/20/a9/ceor-8-573.PMC5066562.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).ClinicoEconomics and Outcomes Research 2016:8 573–581ClinicoEconomics and Outcomes Research Dovepress submit your manuscript | www.dovepress.com Dovepress  573 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CEOR.S113569Methods to construct a step-by-step beginner’s  guide to decision analytic cost-effectiveness  modeling Tamlyn Rautenberg1 Claire Hulme2 Richard Edlin3 1Health Economics and HIV/ AIDS Research Division (HEARD),   University of Kwazulu Natal, KwaZulu Natal, South Africa;  2Leeds Institute  of Health Sciences (LIHS), Academic Unit of Health Economics (AUHE),  University of Leeds, West Y orkshire,  United Kingdom;  3Faculty of Medical  and Health Sciences, University of Auckland, Auckland, New ZealandBackground: Although guidance on good research practice in health economic modeling is  widely available, there is still a need for a simpler instructive resource which could guide a  beginner modeler alongside modeling for the first time.",Non-OADS,/arxiv_data1/oa_pdf/20/a9/ceor-8-573.PMC5066562.pdf
"1–7 These publications set out  the “gold standard” of modeling practice; however, by their own admission they are Correspondence: Tamlyn Rautenberg Health Economics and HIV/AIDS Research Division (HEARD), University of Kwazulu Natal, KwaZulu Natal, 6 Cherron Avenue, La Lucia, 4051 Durban, South AfricaTel + 27 31 260 31 8774mob + 27 711771881Email rautenbergt@ukzn.ac.zaJournal name: ClinicoEconomics and Outcomes Research Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 8Running head verso: Rautenberg et alRunning head recto: Beginner’ s guide to cost-effectiveness modelingDOI: http://dx.doi.org/10.2147/CEOR.S113569",Non-OADS,/arxiv_data1/oa_pdf/20/a9/ceor-8-573.PMC5066562.pdf
Available from: http://student.telum.ru/images/6/66/Sargent_VV_2010.pdf.,Non-OADS,/arxiv_data1/oa_pdf/20/a9/ceor-8-573.PMC5066562.pdf
"ClinicoEconomics and Outcomes Research 2016:8submit your manuscript | www.dovepress.com Dovepress Dovepress ClinicoEconomics and Outcomes Research Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/clinicoeconomics-and-outcomes-research-journalClinicoEconomics and Outcomes Research is an international, peer- reviewed open-access journal focusing on health technology assess-ment, pharmacoeconomics and outcomes research in the areas of   diagnosis, medical devices, and clinical, surgical and pharmacological intervention.",Non-OADS,/arxiv_data1/oa_pdf/20/a9/ceor-8-573.PMC5066562.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 581 Beginner’s guide to cost-effectiveness modeling  33.,Non-OADS,/arxiv_data1/oa_pdf/20/a9/ceor-8-573.PMC5066562.pdf
2006; Available from: http://www.york.ac.uk/che/pdf/rp9.pdf.,Non-OADS,/arxiv_data1/oa_pdf/20/a9/ceor-8-573.PMC5066562.pdf
Available from: http://www.shef.ac.uk/polopoly_fs/1.172572!/file/HEDSDP1205.pdf.,Non-OADS,/arxiv_data1/oa_pdf/20/a9/ceor-8-573.PMC5066562.pdf
Available from: http://etheses.whiterose.ac.uk/2205/.,Non-OADS,/arxiv_data1/oa_pdf/20/a9/ceor-8-573.PMC5066562.pdf
"CDC’s diagnostic criteria for Creutzfeldt-Jakob disease (CJD),  2010, http://www.cdc.gov/ncidod/dvrd/cjd/diagnostic_criteria.html (accessed 7 February 2016).",Non-OADS,/arxiv_data1/oa_pdf/7e/e4/10.1177_2050313X16672153.PMC5066582.pdf
"Definitions, http://www.together- forshortlives.org.uk/professionals/childrens_palliative_care_essentials/definitions (accessed March 2016).",Non-OADS,/arxiv_data1/oa_pdf/b5/8c/10.1177_2050312116666429.PMC5066583.pdf
"Johnston B, Jindal-Snape D and Pringle P. Understanding  the life issues of young adults with life-limiting conditions,  and the impact on their parents, siblings and professionals: a  systematic literature review, 2015, http://www.eapc-2015.org/tl_files/eapc15/Downloads/EAPC_2015_Abstract_Book.pdf 23.",Non-OADS,/arxiv_data1/oa_pdf/b5/8c/10.1177_2050312116666429.PMC5066583.pdf
Data sharing statement Information on how to obtain the Add Health data files used in this  study is available on the Add Health website (http://www.cpc.unc.edu/addhealth).,OADS,/arxiv_data1/oa_pdf/a0/3b/10.1177_2050312116665997.PMC5066584.pdf
"Safe and unsafe induced abortion:  global and regional levels in 2008, and trends during 1995– 2008, 2012, http://apps.who.int/iris/bitstream/10665/75174/1/WHO_RHR_12.02_eng.pdf  3.",OADS,/arxiv_data1/oa_pdf/a0/3b/10.1177_2050312116665997.PMC5066584.pdf
"Report of the Task Force on Mental Health and Abortion (Washington, DC: 2008), http://www.apa.org/pi/wpo/mental-health-abortion-report.pdf  5.",Non-OADS,/arxiv_data1/oa_pdf/a0/3b/10.1177_2050312116665997.PMC5066584.pdf
"NRL News Today, 10 December 2011, http://www.nationalrighttolifenews.org/ news/2011/12/flawed-new-study-claims-abortion-does-not- affect-women%E2%80%99s-mental-health/ (accessed 3 September 2015).",Non-OADS,/arxiv_data1/oa_pdf/a0/3b/10.1177_2050312116665997.PMC5066584.pdf
"Harris K. The add health study: design and accomplishments,  2013. http://www.cpc.unc.edu/projects/addhealth/data/guides/DesignPaperWIIV.pdf (accessed 31 October 2015).",Non-OADS,/arxiv_data1/oa_pdf/a0/3b/10.1177_2050312116665997.PMC5066584.pdf
"Chapel Hill, NC: Carolina Population Center, 2004, http://www.cpc.unc.edu/projects/addhealth/documentation/guides/W4_nonresponse.pdf  (accessed 15 February 2016).",Non-OADS,/arxiv_data1/oa_pdf/a0/3b/10.1177_2050312116665997.PMC5066584.pdf
"Chapel Hill: Carolina Population Center, University of North Carolina, 2011, https://www.researchgate.net/ profile/Eric_Jay_Daza/publication/259579018_Non- response_in_Wave_IV_of_the_Add_Health_Study/links/0046352cbae89a1237000000.pdf (accessed 15 February 2016).",Non-OADS,/arxiv_data1/oa_pdf/a0/3b/10.1177_2050312116665997.PMC5066584.pdf
"March 2014, http://www.cpc.unc.edu/projects/addhealth/data/guides/wt-guidelines.pdf  51.",Non-OADS,/arxiv_data1/oa_pdf/a0/3b/10.1177_2050312116665997.PMC5066584.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/c0/4b/amep-7-585.PMC5066586.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/c0/4b/amep-7-585.PMC5066586.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Advances in Medical Education and Practice 2016:7 585–586Advances in Medical Education and Practice Dovepress submit your manuscript | www.dovepress.com Dovepress 585 LETTER open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/AMEP .S119175 Peer-assisted learning: a platform for long-term  development for both tutors and tutees Shiraz Jamshaid1 Mohammad Farwana2 Faisal Jamshaid2 Wasim Jamshaid1 Reem Farwana3 Sharaf Sheik-Ali4 1Imperial College London, School  of Medicine, 2Kings College  London, School of Medicine,   London, 3Birmingham University,   School of Medicine and Dentistry,  Birmingham, 4Barts and the London  University, School of Medicine and Dentistry, London, UKDear editor We read with great interest the perspective of peer-assisted learning (PAL) in medical  school by Menezes et al and agree with the high importance placed on PAL.1 Its use  throughout undergraduate and postgraduate medicine should not be underestimated, as mentioned by Ah-Kee et al, 2 and is integral in preparing the future teachers in medical  education.",Non-OADS,/arxiv_data1/oa_pdf/c0/4b/amep-7-585.PMC5066586.pdf
"4 As the author suggests, the PAL schemes help to bring out many useful  qualities in medical professionals – skills that are not commonly taught through a rigid  curriculum, but through strong engagement with students having relatable Correspondence: Shiraz Jamshaid Imperial College London School of Medicine, Imperial College London Faculty Building, South Kensington, London, SW7 2AZ, UKEmail: shiraz.jamshaid12@imperial.ac.ukJournal name: Advances in Medical Education and Practice Article Designation: LETTERY ear: 2016V olume: 7Running head verso: Jamshaid et alRunning head recto: Peer-assisted learningDOI: http://dx.doi.org/10.2147/AMEP .S119175",Non-OADS,/arxiv_data1/oa_pdf/c0/4b/amep-7-585.PMC5066586.pdf
"Advances in Medical Education and Practice Publish your work in this journal Submit your manuscript here: http://www.dovepress.com/advances-in-medical-education-and-practice-journalAdvances in Medical Education and Practice is an international, peer-  reviewed, open access journal that aims to present and publish research on Medical Education covering medical, dental, nursing and allied   health care professional education.",Non-OADS,/arxiv_data1/oa_pdf/c0/4b/amep-7-585.PMC5066586.pdf
"Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Advances in Medical Education and Practice 2016:7submit your manuscript | www.dovepress.com Dovepress Dovepress Dovepress 586 Jamshaid et al  experience.1 But what is less commonly noted is that  through PAL, you are exposed to numerous styles of teach- ing, which enables the development of your own unique teaching style, having learnt first-hand as to what works well and what does not.",Non-OADS,/arxiv_data1/oa_pdf/c0/4b/amep-7-585.PMC5066586.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/66/cf/main.PMC5066589.pdf
Contents lists available at ScienceDirect Contemporary Clinical Trials Communications journal homepage: www.elsevier.com/locate/conctc http://dx.doi.org/10.1016/j.conctc.2016.09.001 2451-8654/ ©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/66/cf/main.PMC5066589.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Contemporary Clinical Trials Communications 4 (2016) 161 e169,Non-OADS,/arxiv_data1/oa_pdf/66/cf/main.PMC5066589.pdf
"Available at, https://www.hsph.",Non-OADS,/arxiv_data1/oa_pdf/66/cf/main.PMC5066589.pdf
This in vivo example lends credence to recent [Keywords : miRNAs; cell identity; C. elegans ; carbon dioxide] Corresponding author: apasquinelli@ucsd.eduArticle is online at http://www.genesdev.org/cgi/doi/10.1101/gad.290023.116.© 2016 Pasquinelli This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issue publi-cation date (see http://genesdev.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/34/a2/2019.PMC5066609.pdf
"Aftersix months, it is available under a Creative Commons License (At-tribution-NonCommercial 4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/34/a2/2019.PMC5066609.pdf
"[Keywords : chromatin; epigenetics; hematopoiesis; histone] Corresponding author: ash@northwestern.eduArticle is online at http://www.genesdev.org/cgi/doi/10.1101/gad.284109.116.© 2016 Hu and Shilatifard This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issuepublication date (see http://genesdev.cshlp.org/site/misc/terms.xhtml).After six months, it is available under a Creative Commons License (At-tribution-NonCommercial 4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/af/e4/2021.PMC5066610.pdf
"In a typical plant, sympo-dial vegetative meristems (SYMs) develop in the axils of Corresponding author: lippman@cshl.edu Article is online at http://www.genesdev.org/cgi/doi/10.1101/gad.288415.116.© 2016 Xu et al.",OADS,/arxiv_data1/oa_pdf/75/9f/2048.PMC5066612.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issue publi-cation date (see http://genesdev.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/75/9f/2048.PMC5066612.pdf
"Aftersix months, it is available under a Creative Commons License (At-tribution-NonCommercial 4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/75/9f/2048.PMC5066612.pdf
Multiple sequence alignments and phylogenetic analysis Full-length SlBOP1/2 gene and protein sequences were identified by BLASTN using the sequences obtained from yeast two-hybridscreening as queries against the coding sequences of ITAG 2.4 (https://blast.ncbi.nlm.nih.gov/Blast.cgi).,OADS,/arxiv_data1/oa_pdf/75/9f/2048.PMC5066612.pdf
SlBOP3 was obtained by BLAST searches using the sequences of SlBOP1/2 andArabi- dopsis BOP1/2 as queries against the coding sequences of ITAG 2.4 (https://blast.ncbi.nlm.nih.gov/Blast.cgi).,OADS,/arxiv_data1/oa_pdf/75/9f/2048.PMC5066612.pdf
"We identified theOryza sativa ,Selaginella moellendorffii , and Physcomitrella patens BOP family members using BLASTP through the NCBI BLAST database (https://blast.ncbi.nlm.nih.gov/Blast.cgi).A tomato BTB/POZ complex controls flowering GENES &DEVELOPMENT 2057",OADS,/arxiv_data1/oa_pdf/75/9f/2048.PMC5066612.pdf
"The expression patterns of SlBOP1 ,SlBOP2 ,SlBOP3 , and TMF were acquired from the tomato tissue RNA sequencing (RNA-seq) database (http://tomatolab.cshl.edu/~lippmanlab2/allexp_query.html).",OADS,/arxiv_data1/oa_pdf/75/9f/2048.PMC5066612.pdf
Article and publication date areonline at http://www.genesdev.org/cgi/doi/10.1101/gad.283317.116.© 2016 Li et al.,OADS,/arxiv_data1/oa_pdf/40/73/2062.PMC5066613.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issue publi-cation date (see http://genesdev.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/40/73/2062.PMC5066613.pdf
"Aftersix months, it is available under a Creative Commons License (At-tribution-NonCommercial 4.0 International), as described at http://creati-vecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/40/73/2062.PMC5066613.pdf
Corresponding author: chris_sullivan@austin.utexas.eduArticle is online at http://www.genesdev.org/cgi/doi/10.1101/gad.282616.116.© 2016 Burke et al.,Non-OADS,/arxiv_data1/oa_pdf/ce/3e/2076.PMC5066614.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issue publi-cation date (see http://genesdev.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/ce/3e/2076.PMC5066614.pdf
"Aftersix months, it is available under a Creative Commons License (At-tribution-NonCommercial 4.0 International), as described at http://creati-vecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/ce/3e/2076.PMC5066614.pdf
Adapter sequences were trimmed from the reads using FastX clipper from the FastX toolkit software (http://hannonlab.cshl.edu/fastx_toolkit).,OADS,/arxiv_data1/oa_pdf/ce/3e/2076.PMC5066614.pdf
"Host miRNAs were quantitated using mir-Utils, a custom script provided by Anna Battenhouse, Nathan Abell, and Vishy Iyer (http://mirutils.sourceforge.net).",OADS,/arxiv_data1/oa_pdf/ce/3e/2076.PMC5066614.pdf
Article and publication date areonline at http://www.genesdev.org/cgi/doi/10.1101/gad.285775.116.© 2016 Eychenne et al.,Non-OADS,/arxiv_data1/oa_pdf/06/6a/2119.PMC5066617.pdf
"This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issuepublication date (see http://genesdev.cshlp.org/site/misc/terms.xhtml).After six months, it is available under a Creative Commons License (At-tribution-NonCommercial 4.0 International), as described at http://creati-vecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/06/6a/2119.PMC5066617.pdf
"Several hundred assembly factors contribute to ribosome biogenesis by supporting the processing, modification, andfolding of rRNAs, by facilitating the assembly of ribosomal proteins into pre-ribosomes, by enabling the nuclear export of pre-ribosomal particles, and by performing proofreadingroles to ensure completion of upstream steps of biogenesis Corresponding author: basilgreber@berkeley.edu Article and publication date are at http://www.rnajournal.org/cgi/doi/10.",Non-OADS,/arxiv_data1/oa_pdf/6e/14/1643.PMC5066618.pdf
"After 12 months, it is available under aCreative Commons License (Attribution-NonCommercial 4.0 Inter-national), as described at http://creativecommons.org/licenses/by-nc/4.0/.REVIEW RNA 22:1643 –1662; Published by Cold Spring Harbor Laboratory Press for the RNA Society 1643",Non-OADS,/arxiv_data1/oa_pdf/6e/14/1643.PMC5066618.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.048025.114.© 2016 Guo et al.,OADS,/arxiv_data1/oa_pdf/ce/65/1663.PMC5066619.pdf
"After 12 months, it is availableunder a Creative Commons License (Attribution-NonCommercial 4.0 Inter-national), as described at http://creativecommons.org/licenses/by-nc/4.0/.BIOINFORMATICS RNA 22:1663 –1672; Published by Cold Spring Harbor Laboratory Press for the RNA Society 1663",Non-OADS,/arxiv_data1/oa_pdf/ce/65/1663.PMC5066619.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.058107.116.© 2016 Lackey et al.,OADS,/arxiv_data1/oa_pdf/99/8c/1673.PMC5066620.pdf
"After 12 months, it is availableunder a Creative Commons License (Attribution-NonCommercial 4.0 Inter-national), as described at http://creativecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/99/8c/1673.PMC5066620.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.057422.116.© 2016 Walczyk et al.,OADS,/arxiv_data1/oa_pdf/54/7c/1699.PMC5066622.pdf
This article is distributed exclusively by the RNA Society for the first 12 months after the full-issue publication date (see http://rnajournal.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/54/7c/1699.PMC5066622.pdf
"After 12 months, it is available under a Creative Commons License (Attribution-NonCommercial4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/54/7c/1699.PMC5066622.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.057646.116.© 2016 Binzel et al.,OADS,/arxiv_data1/oa_pdf/91/ea/1710.PMC5066623.pdf
This article is distributed exclusively by the RNA Society for the first 12 months after the full-issue publication date (see http://rnajournal.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/91/ea/1710.PMC5066623.pdf
"After 12 months, it is available under a Creative Commons License (Attribution-NonCommercial4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/91/ea/1710.PMC5066623.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.058180.116.© 2016 Saikia et al.,OADS,/arxiv_data1/oa_pdf/86/4d/1719.PMC5066624.pdf
This article is distributed exclusively by the RNA Society for the first 12 months after the full-issue publication date (see http://rnajournal.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/86/4d/1719.PMC5066624.pdf
"After 12 months, it is available under a Creative Commons License (Attribution-NonCommercial4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/86/4d/1719.PMC5066624.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.057935.116.© 2016 Ruff et al.,OADS,/arxiv_data1/oa_pdf/30/96/1728.PMC5066625.pdf
"After 12 months, it is availableunder a Creative Commons License (Attribution-NonCommercial 4.0 Inter-national), as described at http://creativecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/30/96/1728.PMC5066625.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.058461.116.© 2016 Kristiansen et al.,OADS,/arxiv_data1/oa_pdf/ce/72/1739.PMC5066626.pdf
"After 12 months, it is availableunder a Creative Commons License (Attribution-NonCommercial 4.0 Inter-national), as described at http://creativecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/ce/72/1739.PMC5066626.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.058909.116.© 2016 Nasiri et al.,OADS,/arxiv_data1/oa_pdf/68/f1/1750.PMC5066627.pdf
"After 12 months, it is available under aCreative Commons License (Attribution-NonCommercial 4.0 International),as described at http://creativecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/68/f1/1750.PMC5066627.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.057513.116.,OADS,/arxiv_data1/oa_pdf/27/b2/1760.PMC5066628.pdf
"This article, published in RNA , is available under a Creative Commons License (Attribution-NonCommercial 4.0 Inter-national), as described at http://creativecommons.org/licenses/by-nc/4.0/.METHOD 1760 RNA 22:1760 –1770; Published by Cold Spring Harbor Laboratory Press for the RNA Society",Non-OADS,/arxiv_data1/oa_pdf/27/b2/1760.PMC5066628.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.056531.116.© 2016 Clark et al.,OADS,/arxiv_data1/oa_pdf/b2/cc/1771.PMC5066629.pdf
"After 12 months, it is available undera Creative Commons License (Attribution-NonCommercial 4.0 Inter-national), as described at http://creativecommons.org/licenses/by-nc/4.0/.METHOD RNA 22:1771 –1784; Published by Cold Spring Harbor Laboratory Press for the RNA Society 1771",Non-OADS,/arxiv_data1/oa_pdf/b2/cc/1771.PMC5066629.pdf
"Briefly, thetRNA library was adapted from the tRNAScan-SE library (http://gtrnadb.ucsc.edu/Hsapi19/; Chan and Lowe 2009) by appending3 ′CCA to tRNAs from the genomic tRNA database.",OADS,/arxiv_data1/oa_pdf/b2/cc/1771.PMC5066629.pdf
Available at:http://www.unscn.org/ ﬁles/Announcements/Scaling_Up_ Nutrition-A_Framework_for_ Action.pdf (Accessed 11 May 2015).,Non-OADS,/arxiv_data1/oa_pdf/d8/5c/MCN-11-1.PMC5066633.pdf
"ICH.ICHharmonizedtripartiteguideline:guidelineforgoodclinicalpracticeE6 (R1),1996.AvailablefromURL:http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Efficacy/E6/E6_R1_Guideline.pdf.",OADS,/arxiv_data1/oa_pdf/00/3c/DOM-18-375.PMC5066635.pdf
Available: https://www.nice.org.uk/about/what-we-do/nice-inter- national/nice-international-projects/methods-for-economic-evaluation-project-and-the-gates-reference-case [Accessed 8 December 2015.,Non-OADS,/arxiv_data1/oa_pdf/77/4b/HEC-25-1.PMC5066637.pdf
To view this mini commentary visit http://dx.doi.org/10.1111/1471-0528.13908.,Non-OADS,/arxiv_data1/oa_pdf/b9/3f/BJO-123-1693.PMC5066640.pdf
"Methodology Data source Aid data was extracted for 2002 –2011 from the open-access Creditor Reporting System (CRS) database, available athttp://stats.oecd.org/Index.aspx?datasetcode=CRS1.",OADS,/arxiv_data1/oa_pdf/b9/3f/BJO-123-1693.PMC5066640.pdf
http://fts.unocha.org/ (accessed 17 March 2015).,Non-OADS,/arxiv_data1/oa_pdf/b9/3f/BJO-123-1693.PMC5066640.pdf
[http://iawg.net/].,Non-OADS,/arxiv_data1/oa_pdf/b9/3f/BJO-123-1693.PMC5066640.pdf
"1See Revised Code of Washington, Title 51.12 ’Employments and Occupations Covered ’- http://apps.leg.wa.gov/RCW/default.aspx?",Non-OADS,/arxiv_data1/oa_pdf/5f/5f/AJIM-59-274.PMC5066642.pdf
"Unemployment insurance data UI data serves as the SOII sampling frame, in the form of the Quarterly Census of Employment and Wages 3See Revised Code of Washington, Title 51.28.050 - http://apps.leg.wa.",OADS,/arxiv_data1/oa_pdf/5f/5f/AJIM-59-274.PMC5066642.pdf
"gov/RCW/default.aspx?cite=51.28.0504See Revised Code of Washington, Title 51.28.055 - http://apps.leg.wa.gov/RCW/default.aspx?cite=51.28.055 5The claim establishment date documents the date that L&I entered theclaim into the system.",OADS,/arxiv_data1/oa_pdf/5f/5f/AJIM-59-274.PMC5066642.pdf
A claim is ﬁled by the worker and physician; a claim is established by L&I 6See Washington Administrative Code 296-15-450 http://app.leg.wa.gov/WAC/default.aspx?cite=296-15-450 7See Washington Administrative Code 296-15-420 http://app.leg.wa.gov/WAC/default.aspx?cite=296-15-420276 Wuellner et al.,OADS,/arxiv_data1/oa_pdf/5f/5f/AJIM-59-274.PMC5066642.pdf
Accessed at http://www.bls.gov/news.release/ union2.nr0.htm on 3/20/2015.,Non-OADS,/arxiv_data1/oa_pdf/5f/5f/AJIM-59-274.PMC5066642.pdf
"Accessed at http://www.bls.gov/osmr/pdf/st080120.pdf on April 30, 2015.",Non-OADS,/arxiv_data1/oa_pdf/5f/5f/AJIM-59-274.PMC5066642.pdf
"Accessed at http://www.gao.gov/products/GAO-10-10 on March 20, 2013.",OADS,/arxiv_data1/oa_pdf/5f/5f/AJIM-59-274.PMC5066642.pdf
Available from: http://globocan.iarc.fr [Accessed 20 October 2014].,Non-OADS,/arxiv_data1/oa_pdf/30/e6/HEC-25-162.PMC5066643.pdf
Science Epub http://www.sciencemag.org/cgi/content/abstract/ science.1193748v1.,Non-OADS,/arxiv_data1/oa_pdf/6f/a8/HEC-25-116.PMC5066644.pdf
(Available at: http://data.worldbank.org/news/new-country-classi ﬁcations accessed 1.26.15).DYNAMIC TRANSMISSION MODELLING IN LOW-INCOME SETTINGS 139 © 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/69/bb/HEC-25-124.PMC5066646.pdf
A more detailed description of existing frameworks and the development of DEFINE is published [10] and the current DEFINE framework and associated interactive tools are available at http://tndms.ca/ research/deﬁne/index.html.,OADS,/arxiv_data1/oa_pdf/a8/55/JEP-22-644.PMC5066647.pdf
"Subsequently, both cases contributed to the development of FORGE AHEAD, a community-driven, culturally relevant quality improvement research and evaluation programme in Indigenous communities across Canada (http://tndms.ca/forgeahead/index.html).",Non-OADS,/arxiv_data1/oa_pdf/a8/55/JEP-22-644.PMC5066647.pdf
Support for the Diabetes Evaluation Framework for Innovative National Evaluations (DEFINE) was provided by The National Diabetes Management Strategy (TNDMS); http://www.tndms.ca/.,Non-OADS,/arxiv_data1/oa_pdf/a8/55/JEP-22-644.PMC5066647.pdf
Available at: http://www.diabetes.ca/documents/get-involved/WEB_Eng.CDA _Report_.pdf (last accessed 17 September 2015).,Non-OADS,/arxiv_data1/oa_pdf/a8/55/JEP-22-644.PMC5066647.pdf
Available at: http://www.who.int/features/factﬁles/diabetes/en/ (last accessed 17 September 2015).,Non-OADS,/arxiv_data1/oa_pdf/a8/55/JEP-22-644.PMC5066647.pdf
Available at: http://tndms.ca/documentation/DEFINE/DEFINE%20user-guide- PDF.pdf (last accessed 17 September 2015).16.,Non-OADS,/arxiv_data1/oa_pdf/a8/55/JEP-22-644.PMC5066647.pdf
Available at: http://tndms.ca/research/deﬁne/ index.html (last accessed 17 September 2015).,OADS,/arxiv_data1/oa_pdf/a8/55/JEP-22-644.PMC5066647.pdf
Available at: http://www.health.gov.on.ca/en/pro/programs/ cdpm/pdf/framework_full.pdf (last accessed 17 September 2015).,Non-OADS,/arxiv_data1/oa_pdf/a8/55/JEP-22-644.PMC5066647.pdf
Available at: http://www.IHI.org (last accessed 17 September 2015).,Non-OADS,/arxiv_data1/oa_pdf/a8/55/JEP-22-644.PMC5066647.pdf
http://www.cms.,Non-OADS,/arxiv_data1/oa_pdf/d9/5e/NER-19-196.PMC5066649.pdf
http://www.anzaag.com/MgmtResources.aspx (accessed 26/08/2014).,Non-OADS,/arxiv_data1/oa_pdf/92/b6/ANAE-71-389.PMC5066652.pdf
Available at: http://www.trust.org/item/20130917103218-xhvg1/ (Accessed 23 November 2015).,Non-OADS,/arxiv_data1/oa_pdf/cc/36/MCN-11-39.PMC5066664.pdf
Available at: http://hope.icrisat.org/?p=1724; http://hope.icrisat.org/?p=758 (Accessed 23 November 2015).,Non-OADS,/arxiv_data1/oa_pdf/cc/36/MCN-11-39.PMC5066664.pdf
"Available at: http://www.ipsnews.net/2010/12/ food-crisis-two-new-varieties- of-vegetables-on-kenyan-foo d-market/ (Accessed November 23, 2015).",Non-OADS,/arxiv_data1/oa_pdf/cc/36/MCN-11-39.PMC5066664.pdf
"Available at: http://www.pubmedcentral.nih.gov/ articlerender.fcgi?artid=2628647&tool=pmcentrez&rendertype=abstract [Accessed September 26, 2014].",OADS,/arxiv_data1/oa_pdf/be/8d/HEC-25-53.PMC5066665.pdf
"Available at: http://www.croiwebcasts.org/console/player/22178 [Accessed October 27, 2015].",Non-OADS,/arxiv_data1/oa_pdf/be/8d/HEC-25-53.PMC5066665.pdf
"Available at: http://ac.els-cdn.com/S2214109X1500100X/1-s2.0-S2214109X1500100X-main.pdf?_tid=a91481a4-400e-11e5-b663-0000 0aab0f6c&acdnat=1439286921_17664dd8fc375f35c6fa79a0cc830651 [Accessed October 27, 2015].",Non-OADS,/arxiv_data1/oa_pdf/be/8d/HEC-25-53.PMC5066665.pdf
"Available at: http://www.heapol.oupjournals.org/cgi/doi/10.1093/heapol/czh015 [Accessed March 24, 2014].",Non-OADS,/arxiv_data1/oa_pdf/be/8d/HEC-25-53.PMC5066665.pdf
"Available at: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3129293&tool=pm centrez&rendertype=abstract [Accessed October 27, 2015].",OADS,/arxiv_data1/oa_pdf/be/8d/HEC-25-53.PMC5066665.pdf
"Available at: http://www.futuresinstitute.org/onehealth.aspx [Accessed October 27, 2015].",Non-OADS,/arxiv_data1/oa_pdf/be/8d/HEC-25-53.PMC5066665.pdf
"Available at: http://www.ncbi.nlm .nih.gov/pubmed/25779621 [Accessed October 27, 2015].",Non-OADS,/arxiv_data1/oa_pdf/be/8d/HEC-25-53.PMC5066665.pdf
"Available at: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=4016301&tool=pmcentrez&rendertype=abstract [Accessed November 6, 2014].",OADS,/arxiv_data1/oa_pdf/be/8d/HEC-25-53.PMC5066665.pdf
"Available at: http://www.sahivsoc.org/upload/documents/NTCP_Adult_TBGuidelines 27.5.2014.pdf [Accessed October 27, 2015].",Non-OADS,/arxiv_data1/oa_pdf/be/8d/HEC-25-53.PMC5066665.pdf
"GeneXpert MTB/RIF Progress report, Available at: http://www.nhls.ac.",Non-OADS,/arxiv_data1/oa_pdf/be/8d/HEC-25-53.PMC5066665.pdf
"Available at: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2800325& tool=pmcentrez&rendertype=abstract [Accessed November 10, 2014].",OADS,/arxiv_data1/oa_pdf/be/8d/HEC-25-53.PMC5066665.pdf
Available at: http://onlinelibrary.wiley.com/doi/10.1002/14651858.,Non-OADS,/arxiv_data1/oa_pdf/be/8d/HEC-25-53.PMC5066665.pdf
"Available at: http://www.tac.org.za/ news/nhls-oversight-crisis-patients-pay-price [Accessed August 12, 2015].",Non-OADS,/arxiv_data1/oa_pdf/be/8d/HEC-25-53.PMC5066665.pdf
"Available at: http://www.unaids.org/en/media/unaids/ contentassets/documents/document/2011/20110523_manual_costing_HIV_facilities_en.pdf [Accessed October 27, 2015].",Non-OADS,/arxiv_data1/oa_pdf/be/8d/HEC-25-53.PMC5066665.pdf
"Available at: http://dx.plos.org/ 10.1371/journal.pmed.1001120 [Accessed March 22, 2014].",Non-OADS,/arxiv_data1/oa_pdf/be/8d/HEC-25-53.PMC5066665.pdf
"Available at: http://www.ncbi.nlm.nih.gov/pubmed/15772871 [Accessed November 20, 2014].",Non-OADS,/arxiv_data1/oa_pdf/be/8d/HEC-25-53.PMC5066665.pdf
Available at: http://www.who.,Non-OADS,/arxiv_data1/oa_pdf/be/8d/HEC-25-53.PMC5066665.pdf
"Available at: http://apps.who.int/iris/bitstream/10665/112472/1/9789241506335_eng.pdf [Accessed October 27, 2015].",Non-OADS,/arxiv_data1/oa_pdf/be/8d/HEC-25-53.PMC5066665.pdf
Available at: http://www.who.,Non-OADS,/arxiv_data1/oa_pdf/be/8d/HEC-25-53.PMC5066665.pdf
Priority-setting methods to inform prioritisation: an evidence check rapid review brokered by the Sax Institute (http://www.saxinstitute.org.au) for the NSW Treasury and the Agency for ClinicalInnovation.,Non-OADS,/arxiv_data1/oa_pdf/3d/a9/HEC-25-140.PMC5066677.pdf
https://www.saxinstitute.org.au/wp-content/uploads/01_Priority-setting-methods-to-inform-prioritisation.pdf Mortimer D. 2010.,Non-OADS,/arxiv_data1/oa_pdf/3d/a9/HEC-25-140.PMC5066677.pdf
"2014. http://www.nice.org.uk/about/what-we-do/nice-international/projects/asia-paci ﬁc-regional- capacity-building-for-hta-initiative-arch Noorani HZ, Husereau DR, Boudreau R. 2007.",Non-OADS,/arxiv_data1/oa_pdf/3d/a9/HEC-25-140.PMC5066677.pdf
http://data.worldbank.org/about/country-and-lending-groupsZarate V. 2007.,Non-OADS,/arxiv_data1/oa_pdf/3d/a9/HEC-25-140.PMC5066677.pdf
"The ex- act countries included in the term ‘Central and Eastern Europe ’could be contentious, as it does not refer to an ofﬁcial de ﬁnition or prede ﬁned group of countries (e.g., by OECD, see http://stats.oecd.org/glossary/detail.",Non-OADS,/arxiv_data1/oa_pdf/d5/31/HEC-25-179.PMC5066682.pdf
"For example, according to the International Monetary Fund World Eco-nomic Outlook Database October 2014 Edition (see http://www.imf.org/external/pubs/ft/weo/2014/02/ weodata/index.aspx), even higher income CEE countries such as Poland and Hungary have more than three times lower GDP per capita compared with France, Germany, or UK.",Non-OADS,/arxiv_data1/oa_pdf/d5/31/HEC-25-179.PMC5066682.pdf
We plan to use the scorecard at international training courses (such as the ISPOR Health Technology As- sessment Training Program –see http://www.ispor.org/Education/HTATraining/Index) to facilitate workshops on HTA implementation.,Non-OADS,/arxiv_data1/oa_pdf/d5/31/HEC-25-179.PMC5066682.pdf
"European Commission, Available at http://ec.europa.eu/economy_ ﬁnance/publications/economic_paper/ 2012/pdf/ecp_461_en.pdf (accessed December 2014) Danguole J.",Non-OADS,/arxiv_data1/oa_pdf/d5/31/HEC-25-179.PMC5066682.pdf
"Economic Reforms (Transition to a Market-Based Economy), European Transition Compendium, European Commission, Available at https://webgate.ec.europa.eu/multisite/etc./en/content/economic-reforms-transition-market-based-economy (accessed January 2015) Endrei D, Molics B, Agoston I.",Non-OADS,/arxiv_data1/oa_pdf/d5/31/HEC-25-179.PMC5066682.pdf
"http://www.euro.who.int/__data/assets/pdf_ ﬁle/0003/ 90426/E91922.pdf (accessed December 2014) Gibis B, Artiles J, Corabian P, Meiesaar K, Koppel A, Jacobs P, Serrano P, Menon D. 2001.",OADS,/arxiv_data1/oa_pdf/d5/31/HEC-25-179.PMC5066682.pdf
"Available at http://www.inahta.org/hta-tools-resources/ (accessed December 2014) Innvaer S, Vist G, Trommald M, Oxman A.",OADS,/arxiv_data1/oa_pdf/d5/31/HEC-25-179.PMC5066682.pdf
http://ec.europa.eu/health/technology_assessment/ docs/study_ecorys_european_cooperation_hta_en.pdf (accessed December 2014) Tesar T. 2012.,Non-OADS,/arxiv_data1/oa_pdf/d5/31/HEC-25-179.PMC5066682.pdf
"http://www.euro.who.int/__data/assets/ pdf_ﬁle/0018/90432/E87866.pdf (accessed December 2014) Welte R, Feenstra F, Jager H, Leidl RA.",OADS,/arxiv_data1/oa_pdf/d5/31/HEC-25-179.PMC5066682.pdf
(Available from: http://old.ecmwf.int/ publications/library/ecpublications/_pdf/tm/701-800/tm719.pdf.),Non-OADS,/arxiv_data1/oa_pdf/a0/2f/ENV-27-116.PMC5066685.pdf
"(Available from: http://www.weather.gov/asos/aum-toc.p df) [Accessed on 27 July 2015] Raftery AE, Gneiting T, Balabdaoui F, Polakowski M. 2005.",Non-OADS,/arxiv_data1/oa_pdf/a0/2f/ENV-27-116.PMC5066685.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/05/a4/ccid-9-347.PMC5066687.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/05/a4/ccid-9-347.PMC5066687.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Clinical, Cosmetic and Investigational Dermatology 2016:9 347–355Clinical, Cosmetic and Investigational Dermatology Dovepress submit your manuscript | www.dovepress.com Dovepress 347 REVIEW open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CCID.S81160 Treatment challenges in the management of  moderate-to-severe plaque psoriasis – role of  secukinumab Mona Malakouti Sharon E Jacob Nancy J Anderson Department of Dermatology, Loma  Linda University, Loma Linda, CA, USAAbstract:  Psoriasis is a chronic inflammatory skin disease that has a negative impact on psy- chosocial well-being and cardiometabolic health.",Non-OADS,/arxiv_data1/oa_pdf/05/a4/ccid-9-347.PMC5066687.pdf
"6 Although phototherapy remains  an efficacious treatment option, its use has been limited by cost, access, and incon-venience; the use of home ultraviolet therapy decreases these obstacles, yet remains Correspondence: Sharon E Jacob Department of Dermatology, Loma Linda University, 11370 Anderson Street, Suite 2600, Loma Linda, CA 92354, USATel +1 909 558 2890Fax +1 909 558 2448Email sjacob@contactderm.netJournal name: Clinical, Cosmetic and Investigational Dermatology Article Designation: REVIEWY ear: 2016V olume: 9Running head verso: Malakouti et alRunning head recto: Role of secukinumab in the treatment of moderate-to-severe psoriasisDOI: http://dx.doi.org/10.2147/CCID.S81160",Non-OADS,/arxiv_data1/oa_pdf/05/a4/ccid-9-347.PMC5066687.pdf
Available from http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Derma-tologicandOphthalmicDrugsAdvisoryCommittee/UCM419023.pdf.,Non-OADS,/arxiv_data1/oa_pdf/05/a4/ccid-9-347.PMC5066687.pdf
"Clinical, Cosmetic and Investigational Dermatology 2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress Clinical, Cosmetic and Investigational Dermatology Publish your work in this journal Submit your manuscript here:  https://www.dovepress.com/clinical-cosmetic-and-investigational-dermatology-journal Clinical, Cosmetic and Investigational Dermatology is an interna- tional, peer-reviewed, open access, online journal that focuses on   the latest clinical and experimental research in all aspects of skin   disease and cosmetic interventions.",Non-OADS,/arxiv_data1/oa_pdf/05/a4/ccid-9-347.PMC5066687.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authorsDovepress 355 Role of secukinumab in the treatment of moderate-to-severe psoriasis  37.,Non-OADS,/arxiv_data1/oa_pdf/05/a4/ccid-9-347.PMC5066687.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/21/36/cia-11-1433.PMC5066688.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Interventions in Aging 2016:11 1433–1440Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  1433CAse reportopen access to scientific and medical research open Access Full text Article http: //dx.doi.org/10.2147/CIA.S11182 1 pseN1 L226F mutation in a patient with  early-onset Alzheimer’s disease in Korea eva Bagyinszky1,* sun Ah park2,* Hyung Jun Kim2 seong Hye Choi3 seong soo A An1 sangYun Kim4 1Department of BioNano technology,   Gachon University, seongnam-si,   2Department of Neurology,   soonchunhyang University Bucheon  Hospital, Bucheon, 3Department of  Neurology, Inha University school of  Medicine, Incheon, 4Department of  Neurology, seoul National University  College of Medicine & Neurocognitive  Behavior Center, seoul National  University Bundang Hospital,   seongnam-si, republic of Korea *these authors contributed equally  to this workAbstract:  In this study, we report a first 226leucine (Leu) mutation to phenylalanine (Phe)  in (PSEN1, CTC TTC, L226F) in Asia from a Korean early-onset Alzheimer’s disease  (EOAD) patient.",Non-OADS,/arxiv_data1/oa_pdf/21/36/cia-11-1433.PMC5066688.pdf
"The APP  gene encodes a 770-amino acid long protein, which is cleaved by two enzymes, Correspondence: seong soo A An Department of BioNano technology,  Gachon Medical research Institute,  Gachon University, 1342 seongnam-daero,  seongnam-si 461-701, republic of Korea tel/fax +82 31 750 8755 email seongaan@gachon.ac.k r  sangYun Kim Department of Neurology, seoul  National University College of  Medicine & Neurocognitive Behavior  Center, seoul National University  Bundang Hospital, 300 Gumidong,  Bundang-gu, seongnam-si, Gyeonggi-do  463-707, republic of Korea tel +82 31 787 7462 Fax +82 31 719 6815 email neuroksy@snu.ac.k r Journal name: Clinical Interventions in Aging Article Designation: Case report Y ear: 2016 Volume: 11 Running head verso: Bagyinszky et al Running head recto: PSEN1 L226F mutation in an EOAD patient in Korea DOI: http://dx.doi.org/10.2147/CIA.S111821",Non-OADS,/arxiv_data1/oa_pdf/21/36/cia-11-1433.PMC5066688.pdf
alzforum.org/mutation s)9 and AD and frontotemporal  dementia (FTD) mutations database ( http://www.molgen.,OADS,/arxiv_data1/oa_pdf/21/36/cia-11-1433.PMC5066688.pdf
"Sequencing results were aligned by NCBI Blast ( http://blast.ncbi.nlm.nih.gov/Blast.cg i), and the  chromatograms were analyzed by DNA BASER ( http://www.",OADS,/arxiv_data1/oa_pdf/21/36/cia-11-1433.PMC5066688.pdf
Mutations and sequence variants  were identified by NCBI Gene ( http://www.ncbi.nlm.nih.gov/ gene) and UniProt ( http://www.unipr ot.org) databases.,OADS,/arxiv_data1/oa_pdf/21/36/cia-11-1433.PMC5066688.pdf
"Clinical Interventions in Aging 2016:11submit your manuscript | www.dovepress.co m Dove press Dove press 1436Bagyinszky et al In silico modeling Mutation was analyzed by two kinds of in silico  online tools:  PolyPhen-2 ( http://genetics.bwh.harvard.edu/pph2 /) and  Sorting Intolerant from Tolerant (SIFT; http://sift.j cvi.org /),  which make predictions on the pathogenic properties of  missense mutations.",Non-OADS,/arxiv_data1/oa_pdf/21/36/cia-11-1433.PMC5066688.pdf
"PSEN1 (chromosome 14, 73,603,142-73,690,399) L226F  was checked in the Korean Centers for Disease Control  and Prevention (KCDC) database ( http://www.cdc.go.kr /).",OADS,/arxiv_data1/oa_pdf/21/36/cia-11-1433.PMC5066688.pdf
"Available from: http://www.alzforum.org/mutation s. Accessed  September 18, 2016.",Non-OADS,/arxiv_data1/oa_pdf/21/36/cia-11-1433.PMC5066688.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/21/36/cia-11-1433.PMC5066688.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/21/36/cia-11-1433.PMC5066688.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/22/1e/clep-8-373.PMC5066690.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/22/1e/clep-8-373.PMC5066690.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Clinical Epidemiology 2016:8 373–380Clinical Epidemiology Dovepress submit your manuscript | www.dovepress.com Dovepress  373 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CLEP .S113415An algorithm for identification and classification  of individuals with type 1 and type 2 diabetes  mellitus in a large primary care database Manuj Sharma1 Irene Petersen1,2 Irwin Nazareth1 Sonia J Coton1 1Department of Primary Care and  Population Health, University College  London, London, UK; 2Department  of Clinical Epidemiology, Aarhus University, Aarhus, DenmarkBackground: Research into diabetes mellitus (DM) often requires a reproducible method for  identifying and distinguishing individuals with type 1 DM (T1DM) and type 2 DM (T2DM).",Non-OADS,/arxiv_data1/oa_pdf/22/1e/clep-8-373.PMC5066690.pdf
"3 T2DM is an acquired form of DM that is strongly associ- ated with being overweight and accounts for ~90% of all cases of DM.4 The prevalence Correspondence: Manuj Sharma Department of Primary Care and Population Health, University College London, Rowland Hill St, London NW3 2PF, UKTel +44 20 7508 3702 40Fax +44 20 7472 6871Email manuj.sharma.11@ucl.ac.ukJournal name: Clinical Epidemiology Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 8Running head verso: Sharma et alRunning head recto: Algorithm for identification & classification of diabetes mellitusDOI: http://dx.doi.org/10.2147/CLEP .S113415",Non-OADS,/arxiv_data1/oa_pdf/22/1e/clep-8-373.PMC5066690.pdf
Available from: http://www.who.int/features/factfiles/diabetes/en/.,Non-OADS,/arxiv_data1/oa_pdf/22/1e/clep-8-373.PMC5066690.pdf
"Clinical Epidemiology 2016:8submit your manuscript | www.dovepress.com Dovepress Dovepress Clinical Epidemiology Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/clinical-epidemiology-journalClinical Epidemiology is an international, peer-reviewed, open access,  online journal focusing on disease and drug epidemiology, identifica-tion of risk factors and screening procedures to develop optimal pre-ventative initiatives and programs.",Non-OADS,/arxiv_data1/oa_pdf/22/1e/clep-8-373.PMC5066690.pdf
Available from: http://www.who.int/diabetes/publications/diag-nosis_diabetes2006/en/.,Non-OADS,/arxiv_data1/oa_pdf/22/1e/clep-8-373.PMC5066690.pdf
Available from: https://www.gov.uk/government/publications/adult-obesity-and-type-2-diabetes.,Non-OADS,/arxiv_data1/oa_pdf/22/1e/clep-8-373.PMC5066690.pdf
Available from: https://www.nice.org.uk/guidance/ng28/resources/type-2-diabetes-in-adults-manage-ment-1837338615493.,Non-OADS,/arxiv_data1/oa_pdf/22/1e/clep-8-373.PMC5066690.pdf
Available from: https://www.nice.org.uk/guidance/ng17/resources/type-1-diabetes-in-adults-diagnosis-and-management-1837276469701.,Non-OADS,/arxiv_data1/oa_pdf/22/1e/clep-8-373.PMC5066690.pdf
Available from: http://www.sdrn.org.uk/sites/sdrn.org.uk/files/nhs%20diagnosis%20classification%20report.pdf.,Non-OADS,/arxiv_data1/oa_pdf/22/1e/clep-8-373.PMC5066690.pdf
Available from: http://www.who.int/diabetes/publications/diagnosis_diabetes2006/en/.,Non-OADS,/arxiv_data1/oa_pdf/22/1e/clep-8-373.PMC5066690.pdf
Available from: http://www.hscic.gov.uk/qof.,Non-OADS,/arxiv_data1/oa_pdf/22/1e/clep-8-373.PMC5066690.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/c4/3c/cia-11-1429.PMC5066692.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Interventions in Aging 2016:11 1429–1432Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  1429OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S9769 4 The prevalence of glaucoma in patients undergoing  surgery for eyelid entropion or ectropion shani golan gilad rabina shimon Kurtz Igal leibovitch Division of Orbital and Ophthalmic  Plastic surgery, Department of  Ophthalmology, Tel Aviv Medical  Center, sackler Faculty of Medicine,   T el Aviv University, T el Aviv, IsraelPurpose and design:  The aim of this study was to establish the prevalence of known glau - coma in patients undergoing ectropion or entropion surgical repair.",Non-OADS,/arxiv_data1/oa_pdf/c4/3c/cia-11-1429.PMC5066692.pdf
"Involutional changes include lower eyelid laxity, disinsertion of the retractor muscles  (capsulopalpebral and inferior tarsal muscles), canthal ligament weakness, and over - riding orbicularis muscle in entropion.1 Cicatricial ectropion occurs from scarring of  the anterior lamella by conditions such as facial burns, trauma, chronic dermatitis, or  excessive skin excision during surgery.1 The treatment of most forms of glaucoma includes the use of topical agents that  enhance aqueous humor outflow, reduce aqueous production, or both.2 The list of side  effects of these agents is long and includes eyelid dermatitis, lacrimal system scarring,  ocular discomfort upon instillation, tear film instability, conjunctival inflammation,  subconjunctival fibrosis, conjunctival epithelium changes, and corneal surface and  endothelial impairment.2Correspondence: shani golan Division of Orbital and Ophthalmic  Plastic surgery, Department of  Ophthalmology, Tel Aviv Medical Center,  sackler Faculty of Medicine, 6 Weizman  street, Tel Aviv 64239, Israel Tel +972 3 697 3408 Fax +972 3 697 3867 email shanigola2@gmail.co m Journal name: Clinical Interventions in Aging Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Golan et al Running head recto: Glaucoma in patients undergoing entropion or ectropion surgery DOI: http://dx.doi.org/10.2147/CIA.S97694",Non-OADS,/arxiv_data1/oa_pdf/c4/3c/cia-11-1429.PMC5066692.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/c4/3c/cia-11-1429.PMC5066692.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/c4/3c/cia-11-1429.PMC5066692.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/61/cd/ccid-9-307.PMC5066693.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/61/cd/ccid-9-307.PMC5066693.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Clinical, Cosmetic and Investigational Dermatology 2016:9 307–313Clinical, Cosmetic and Investigational Dermatology Dovepress submit your manuscript | www.dovepress.com Dovepress 307 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CCID.S115192 T olerability and camouflaging effect of corrective  makeup for acne: results of a clinical study of a  novel face compact cream Giuseppe Monfrecola Sara Cacciapuoti Claudia Capasso Mario DelfinoGabriella Fabbrocini Department of Clinical Medicine and  Surgery, Section of Dermatology,  University of Naples Federico II,  Naples, ItalyBackground: A novel face compact cream (FCC) containing a new patented formulation was  recently developed to provide acne patients with cosmetic camouflage for their lesions and to  have beneficial effects on the multifactorial components of the disease.",Non-OADS,/arxiv_data1/oa_pdf/61/cd/ccid-9-307.PMC5066693.pdf
"7Correspondence: Giuseppe Monfrecola Department of Clinical Medicine and Surgery, Section of Dermatology, University of Naples Federico II, Via S. Pansini 5, 80131 Naples, Italy  Tel +39 81 746 2455Fax +39 81 746 2442Email giuseppe.monfrecola@unina.itJournal name: Clinical, Cosmetic and Investigational Dermatology Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 9Running head verso: Monfrecola et alRunning head recto: Face compact cream for acneDOI: http://dx.doi.org/10.2147/CCID.S115192",Non-OADS,/arxiv_data1/oa_pdf/61/cd/ccid-9-307.PMC5066693.pdf
"Clinical, Cosmetic and Investigational Dermatology 2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress Clinical, Cosmetic and Investigational Dermatology Publish your work in this journal Submit your manuscript here:  https://www.dovepress.com/clinical-cosmetic-and-investigational-dermatology-journal Clinical, Cosmetic and Investigational Dermatology is an interna- tional, peer-reviewed, open access, online journal that focuses on   the latest clinical and experimental research in all aspects of skin   disease and cosmetic interventions.",Non-OADS,/arxiv_data1/oa_pdf/61/cd/ccid-9-307.PMC5066693.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authorsDovepress 313 Face compact cream for acne  27.,Non-OADS,/arxiv_data1/oa_pdf/61/cd/ccid-9-307.PMC5066693.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/68/4e/ccid-9-333.PMC5066694.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/68/4e/ccid-9-333.PMC5066694.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Clinical, Cosmetic and Investigational Dermatology 2016:9 333–338Clinical, Cosmetic and Investigational Dermatology Dovepress submit your manuscript | www.dovepress.com Dovepress 333 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CCID.S116995 Effectiveness of topical peppermint oil on  symptomatic treatment of chronic pruritus Lotfy T Elsaie1,†  Abdelraouf M El Mohsen1  Ibrahim M Ibrahim1  Mahmoud H Mohey-Eddin1  Mohamed L Elsaie2 1Department of Dermatology,    Al Azhar University, 2Department  of Dermatology, National Research  Centre, Cairo, Egypt †Dr Lotfy T Elsaie passed away on  December 17, 2014Background: Pruritus is one of the commonest skin complaints.",Non-OADS,/arxiv_data1/oa_pdf/68/4e/ccid-9-333.PMC5066694.pdf
"5Correspondence: Mohamed L Elsaie   Department of Dermatology, National  Research Centre, 15 Tarablos Street off Abbas Akkad Street, Nasr City 11371, Cairo, Egypt Email Egydoc77@yahoo.comJournal name: Clinical, Cosmetic and Investigational Dermatology Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 9Running head verso: Elsaie et alRunning head recto: Treatment of chronic pruritus with peppermint oilDOI: http://dx.doi.org/10.2147/CCID.S116995",Non-OADS,/arxiv_data1/oa_pdf/68/4e/ccid-9-333.PMC5066694.pdf
"Clinical, Cosmetic and Investigational Dermatology 2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress Clinical, Cosmetic and Investigational Dermatology Publish your work in this journal Submit your manuscript here:  https://www.dovepress.com/clinical-cosmetic-and-investigational-dermatology-journal Clinical, Cosmetic and Investigational Dermatology is an interna- tional, peer-reviewed, open access, online journal that focuses on   the latest clinical and experimental research in all aspects of skin   disease and cosmetic interventions.",Non-OADS,/arxiv_data1/oa_pdf/68/4e/ccid-9-333.PMC5066694.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authorsDovepress 338 Elsaie et al References  1.,Non-OADS,/arxiv_data1/oa_pdf/68/4e/ccid-9-333.PMC5066694.pdf
"If unavail- able, crude data were estimated from published sur- vival curves employing validated techniques in R (version 3.1.2; R Foundation for Statistical Comput- ing, Vienna, Austria) and Digitizeit (http://www.digi-tieit.de; DigitizeIt, Braunschweig, Germany).",OADS,/arxiv_data1/oa_pdf/ec/d3/JHM-11-373.PMC5066695.pdf
Available at: http://www.ohri.ca/programs/clinical_epidemi- ology/oxford.htm.,Non-OADS,/arxiv_data1/oa_pdf/ec/d3/JHM-11-373.PMC5066695.pdf
"Available at: http://www.cdc.gov/mmwr/pdf/other/su6203.pdf,accessed on June 18, 2015.",OADS,/arxiv_data1/oa_pdf/f3/ce/AJHB-28-510.PMC5066698.pdf
"Available at: http://minorityhealth.hhs.gov/omh/browse.aspx?lvl 53&lvlid 561, accessed on June 16, 2015.",Non-OADS,/arxiv_data1/oa_pdf/f3/ce/AJHB-28-510.PMC5066698.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/e3/41/clep-8-363.PMC5066699.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/e3/41/clep-8-363.PMC5066699.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Clinical Epidemiology 2016:8 363–371Clinical Epidemiology Dovepress submit your manuscript | www.dovepress.com Dovepress 363 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CLEP .S116160 Agreement between PRE2DUP register data  modeling method and comprehensive drug use  interview among older persons Heidi Taipale1–4,* Antti Tanskanen3–5,* Marjaana Koponen1,2 Anna-Maija T olppanen2,6 Jari Tiihonen3,4 Sirpa Hartikainen1,2,7 1Kuopio Research Centre of Geriatric  Care, University of Eastern Finland,   2School of Pharmacy, University  of Eastern Finland, Kuopio,   Finland; 3Department of Clinical  Neuroscience, Karolinska Institutet,  Stockholm, Sweden;  4Department  of Forensic Psychiatry, Niuvanniemi Hospital, University of Eastern Finland, Kuopio,  5National Institute  for Health and Welfare, Helsinki,   6Research Centre for Comparative  Effectiveness and Patient Safety (RECEPS), University of Eastern Finland,  7Department of Psychiatry,   Kuopio University Hospital,  Kuopio,  Finland *These authors contributed equally to this work.Background: PRE2DUP is a modeling method that generates drug use periods (ie, when  drug use started and ended) from drug purchases recorded in dispensing-based register data.",Non-OADS,/arxiv_data1/oa_pdf/e3/41/clep-8-363.PMC5066699.pdf
"Correspondence: Heidi Taipale Kuopio Research Centre of Geriatric Care, University of Eastern Finland, PO Box 1627, 70211 Kuopio, FinlandTel +358 44 336 1265Fax +358 17 162 424Email heidi.taipale@uef.fiJournal name: Clinical Epidemiology Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 8Running head verso: Taipale et alRunning head recto: Agreement between interview data and PRE2DUPDOI: http://dx.doi.org/10.2147/CLEP .S116160",Non-OADS,/arxiv_data1/oa_pdf/e3/41/clep-8-363.PMC5066699.pdf
"Clinical Epidemiology 2016:8submit your manuscript | www.dovepress.com Dovepress Dovepress Clinical Epidemiology Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/clinical-epidemiology-journalClinical Epidemiology is an international, peer-reviewed, open access,  online journal focusing on disease and drug epidemiology, identifica-tion of risk factors and screening procedures to develop optimal pre-ventative initiatives and programs.",Non-OADS,/arxiv_data1/oa_pdf/e3/41/clep-8-363.PMC5066699.pdf
Available from: http://www.whocc.no/atc/structure_and_principles/.,Non-OADS,/arxiv_data1/oa_pdf/e3/41/clep-8-363.PMC5066699.pdf
Available from: http://www.whocc.no/ddd/definition_and_general_considera/.,Non-OADS,/arxiv_data1/oa_pdf/e3/41/clep-8-363.PMC5066699.pdf
Available from URL: http://ec.europa.eu/health/documents/community- register/2013/20130121124986/anx_124986_en.pdf.AccessedAugust2015.,Non-OADS,/arxiv_data1/oa_pdf/db/ab/DOM-18-274.PMC5066701.pdf
Available from URL:http://www.fda.gov/downloads/Drugs/ …/Guidances/ucm071624.pdf.Accessed August2015.,Non-OADS,/arxiv_data1/oa_pdf/db/ab/DOM-18-274.PMC5066701.pdf
Available from URL: http://www.idf.org/publications/global-guideline-type-2-diabetes.AccessedAugust2015.,Non-OADS,/arxiv_data1/oa_pdf/db/ab/DOM-18-274.PMC5066701.pdf
Available from URL: http://www.japi.org/may_2015_special_issue/003_review_of_clinical.pdf.AccessedAugust2015.,Non-OADS,/arxiv_data1/oa_pdf/db/ab/DOM-18-274.PMC5066701.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/1c/22/ceor-8-583.PMC5066703.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/1c/22/ceor-8-583.PMC5066703.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).ClinicoEconomics and Outcomes Research 2016:8 583–590ClinicoEconomics and Outcomes Research Dovepress submit your manuscript | www.dovepress.com Dovepress  583 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CEOR.S107831Cost-effectiveness of eplerenone in NYHA class II  chronic heart failure patients with reduced LVEF:  an analysis for Greece Kostas Athanasakis1 Aikaterini Bilitou2 Dawn Lee3 Eleftheria Karampli1 Apostolos Karavidas4 John Parissis5 Georgia Sykara2 John Kyriopoulos1 1Department of Health Economics,   National School of Public Health,   Athens, Greece; 2Pfizer Hellas,   Athens, Greece; 3BresMed, Sheffield,   UK; 4Department of Cardiology, G.   Gennimatas Hospital, Athens, Greece;   5Heart Failure Unit, Department  of Cardiology, Athens University Hospital Attikon, National and Kapodistrian University of Athens,  Athens, GreeceObjectives:  The aim of the study was to evaluate the cost-effectiveness (CE) of treatment  with eplerenone versus standard care in adult patients with New Y ork Heart Association class  II chronic heart failure and reduced left ventricular ejection fraction from the perspective of  the Greek national health care payer.",Non-OADS,/arxiv_data1/oa_pdf/1c/22/ceor-8-583.PMC5066703.pdf
"6 Correspondence: Aikaterini Bilitou Pfizer Hellas SA, 243 Messogion Avenue, 15451, Athens, GreeceTel +30 21 0678 5883Fax +30 21 0674 8680Email Katerina.bilitou@pfizer.comJournal name: ClinicoEconomics and Outcomes Research Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 8Running head verso: Athanasakis et alRunning head recto: Cost-effectiveness of eplerenone in heart failure in GreeceDOI: http://dx.doi.org/10.2147/CEOR.S107831",Non-OADS,/arxiv_data1/oa_pdf/1c/22/ceor-8-583.PMC5066703.pdf
"ClinicoEconomics and Outcomes Research 2016:8submit your manuscript | www.dovepress.com Dovepress Dovepress ClinicoEconomics and Outcomes Research Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/clinicoeconomics-and-outcomes-research-journalClinicoEconomics and Outcomes Research is an international, peer- reviewed open-access journal focusing on health technology assess-ment, pharmacoeconomics and outcomes research in the areas of   diagnosis, medical devices, and clinical, surgical and pharmacological intervention.",Non-OADS,/arxiv_data1/oa_pdf/1c/22/ceor-8-583.PMC5066703.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 590 Athanasakis et al 14.,Non-OADS,/arxiv_data1/oa_pdf/1c/22/ceor-8-583.PMC5066703.pdf
Available from: http://services.eof.gr/drugsearch/block/resource/Mjk1MTU5OTIy/SPC_2650002_3.pdf.,OADS,/arxiv_data1/oa_pdf/1c/22/ceor-8-583.PMC5066703.pdf
Available  from: http://www.nice.org.uk/article/pmg9/resources/non-guidance-guide-to-the-methods-of-technology-appraisal-2013-pdf; 2013.,Non-OADS,/arxiv_data1/oa_pdf/1c/22/ceor-8-583.PMC5066703.pdf
Available from: http://www.hqip.org.uk/assets/NCAPOP-Library/Heart-Failure-Audit-Report-NICOR-2010-2011.pdf.,Non-OADS,/arxiv_data1/oa_pdf/1c/22/ceor-8-583.PMC5066703.pdf
"Heart failure risk score To evaluate heart failure severity, we used heart failure risk score accessible by the website http://www.heartfailurerisk.org.8This is the generalizable easily used integer risk score for mortality in patients with heart failure, including 13 independent predictors: age, LVEF, New York Heart Association (NYHA) class, serum creatinine, dia- betes mellitus, 𝛽-blocker, systolic blood pressure, body mass index, time since diagnosis, current smoker, chronic obstructive pulmonary disease, male gender, and ACE inhibitor or ARB.",Non-OADS,/arxiv_data1/oa_pdf/b2/d1/EJHF-18-375.PMC5066704.pdf
Sources: http://www.druginteractioninfo.org (a metabolism and transport drug interaction database built by the University of Washington; used to search for metabolic pathway and CYP enzymes involved for the concomitant medications in the table); http://www.pdr3d.com (used to search for metabolic pathway and drug-drug interaction information from package inserts [labels] for the concomitant medications listed in the table); http://en.wikipedia.org/wiki (used to search for pharmacokinetic information formedicationswhosepharmacokineticandmetabolisminformationwasnot identified from the other two Web sites).,OADS,/arxiv_data1/oa_pdf/37/a3/JCPH-56-693.PMC5066705.pdf
http://www.esur.org /guidelines/2012 [17 August 2015].,Non-OADS,/arxiv_data1/oa_pdf/91/b7/CMMI-11-245.PMC5066707.pdf
"LTCFocus files are publicly available as part of the Shaping Long-Term Care in America Project at the Center for Gerontology and Healthcare Research at Brown University (funded in part by the National Institute on Aging; http://ltcfocus.org), and combine multiple data sources, including the Minimum Data Set, OSCAR, state policy data, and the Area Resource File (LTCFocus, 2015).",OADS,/arxiv_data1/oa_pdf/80/f7/10.1177_2333721416653561.PMC5066711.pdf
Retrieved from http://ltcfocus.org/1/ about-us,Non-OADS,/arxiv_data1/oa_pdf/80/f7/10.1177_2333721416653561.PMC5066711.pdf
http://www.nice.org.uk/ guidance/cg127 (accessed 15/01/2015).,Non-OADS,/arxiv_data1/oa_pdf/04/f0/ANAE-71-326.PMC5066735.pdf
Available from http://aspe.hhs.gov/ daltcp/reports/2007/advdirlr.htm .,OADS,/arxiv_data1/oa_pdf/7e/e6/IJN-22-247.PMC5066738.pdf
"[cited 2005], Available from: http://www.medethics.",Non-OADS,/arxiv_data1/oa_pdf/7e/e6/IJN-22-247.PMC5066738.pdf
Available from URL: http://www.governo.it/bio etica/eng/opinions.html.,OADS,/arxiv_data1/oa_pdf/7e/e6/IJN-22-247.PMC5066738.pdf
38 Patient Protection and Affordable Care Act [cited 2/2/ 2012] available from: http://www.medscape.com/viewarticle/ 765825_4 39 Bentur N. The attitudes of physicians toward the new “Dying Patient Act ”enacted in Israel.,Non-OADS,/arxiv_data1/oa_pdf/7e/e6/IJN-22-247.PMC5066738.pdf
(Continued) Classification QTLaChr Peak_BinbBin interval Peak_Pos(Mb)cPhysical_interval (Mb)cPeak_PosLinkage interval (cM) LOD Var(%)dAdd Bin locatione Seminal SAL 2 Bin2_454 Bin2_448-Bin2_469 181.10 179.8 –185.3 134.94 133.22 –139.39 4.28 7.03 44.25 Bin2.06 Seminal SAL 9 Bin9_390 Bin9_371-Bin9_408 110.10 107.9 –116.1 126.53 120.13 –131.23 2.82 5.02 /C038.25 Bin9.04 Seminal SLP 2 Bin2_436 Bin2_390-Bin2_443 176.20 153.6 –178.2 129.26 121.86 –132.23 2.84 7.06 0.04 Bin2.06 Seminal SLP 9 Bin9_467 Bin9_449-Bin9_480 134.10 128.2 –136.6 147.30 141.61 –152 3.02 7.50 /C00.04 Bin9.05 Total TRL 2 Bin2_420 Bin2_394-Bin2_442 169.80 155.9 –178 126.30 122.6 –131.99 3.60 2.63 35.96 Bin2.06 Total TRL 9 Bin9_470 Bin9_455-Bin9_478 134.50 130.5 –136.3 148.29 143.59 –151.5 3.45 5.99 /C058.22 Bin9.05 Total SDW 4 Bin4_23 Bin4_15-Bin4_28 3.10 2.1 –3.7 11.46 5.96 –15.46 2.56 1.61 0.01 Bin4.01 Total SDW 4 Bin4_576 Bin4_568-Bin4_584 213.70 209.3 –217.6 159.12 157.39 –160.86 6.04 9.24 /C00.02 Bin4.09 Total SDW 5 Bin5_1005 Bin5_999-Bin5_1009 204.90 203.9 –205.4 347.69 342.67 –350.68 4.21 5.68 0.02 Bin5.06/07 Total SDW 9 Bin9_152 Bin9_148-Bin9_157 23.40 22.9 –24.1 67.87 66.14 –70.6 3.56 6.41 /C00.02 Bin9.03 Total RDW 4 Bin4_571 Bin4_557-Bin4_584 211.50 204.1 –217.6 158.13 154.92 –160.86 4.53 6.45 0.00 Bin4.09 Total RDW 4 Bin4_673 Bin4_670-Bin4_677 239.20 238.9 –239.6 195.72 194.23 –199.73 2.82 5.02 0.00 Bin4.1 Total RSR 1 Bin1_711 Bin1_702-Bin1_716 193.30 192.2 –194.5 291.36 286.65 –296.41 3.11 2.80 0.02 Bin1.06 Total RSR 5 Bin5_900 Bin5_894-Bin5_907 190.00 189.3 –190.8 286.74 283.25 –292.5 3.97 4.43 /C00.03 Bin5.05 Total RSR 7 Bin7_12 Bin7_1-Bin7_21 2.30 0 –3.7 5.48 0 –10.69 2.85 4.07 /C00.02 Bin7.00 Total RSR 8 Bin8_660 Bin8_654-Bin8_664 159.10 157.9 –159.5 235.69 231.16 –241.83 2.64 4.91 /C00.02 Bin8.06 Total RSR 9 Bin9_470 Bin9_465-Bin9_477 134.50 133.7 –136.1 148.29 146.31 –150.76 5.90 11.58 0.03 Bin9.05 Total ARL 4 Bin4_673 Bin4_664-Bin4_678 239.20 238.1 –239.8 195.72 190.25 –200.48 2.79 3.08 7.33 Bin4.1 Total LRL 9 Bin9_472 Bin9_465-Bin9_477 135.20 133.7 –136.1 148.78 146.31 –150.76 4.22 6.76 /C056.93 Bin9.05 Total TLP 2 Bin2_689 Bin2_672-Bin2_699 230.20 225.8 –231.8 240.36 235.92 –244.83 3.09 6.60 0.02 Bin2.09 Total TLP 9 Bin9_473 Bin9_455-Bin9_486 135.60 130.5 –137.9 149.27 143.59 –153.97 3.03 6.05 /C00.02 Bin9.05 Total SRL_T 1 Bin1_82 Bin1_70-Bin1_86 11.30 10.1 –11.7 50.56 42.33 –52.81 2.82 3.10 0.62 Bin1.01 Total SRL_T 1 Bin1_708 Bin1_699-Bin1_716 193.00 191.7 –194.5 289.88 284.66 –296.41 4.07 5.97 0.85 Bin1.06 Total SRL_T 9 Bin9_473 Bin9_465-Bin9_485 135.60 133.7 –137.6 149.27 146.31 –153.73 6.26 10.73 1.17 Bin9.05 aThe abbreviations of trait names is listed in Table 1 ;bthe peak position with the highest LOD of each QTL;cthe positions of the identi ﬁed QTL according to B73 reference sequence Version 5.60;dpercentage of phenotypic variation explained by additive effect of the identi ﬁed QTL;ethe bins were de ﬁned according to the B73 physical map using the data from the website: http://www.maizegdb.org .,Non-OADS,/arxiv_data1/oa_pdf/30/1e/JIPB-58-266.PMC5066741.pdf
"http://www.iycn.org/resource/engag-ing-men-to-increase-support-for-optimal-infant-feeding-in- western-kenya/ McLeroy K.R., Bibeau D., Steckler A.",Non-OADS,/arxiv_data1/oa_pdf/b3/11/MCN-11-21.PMC5066745.pdf
Clinical Pharmacology and Biopharmaceutics Re- view:ApplicationNumber:21-2822002.http://www.accessdata.,OADS,/arxiv_data1/oa_pdf/dc/10/JCPH-56-894.PMC5066754.pdf
"Clinical growth charts: Stature-for-age and Weight-for-age, 2000. http://www.cdc.gov/growthcharts/clinical_charts.htm.",Non-OADS,/arxiv_data1/oa_pdf/dc/10/JCPH-56-894.PMC5066754.pdf
NICE 2016. https://www.nice.org.uk/about/what-we-do/nice-international/nice-international-projects/methods-for-economic- evaluation-project-and-the-gates-reference-case (accessed 3rd January 2016).,Non-OADS,/arxiv_data1/oa_pdf/94/e7/HEC-25-6.PMC5066756.pdf
The custom program code and sample-wise tabulated data are available at http://vartak.org/liver .,OADS,/arxiv_data1/oa_pdf/bb/35/HEP-63-951.PMC5066759.pdf
"patients reporting MTX use at baseline, were generally con- sistent among randomized treatment groups (see Supplemen-tary Table 1 available on the Arthritis Care & Research website at http://onlinelibrary.wiley.com/doi/10.1002/acr.22576/ abstract) and were generally consistent between patients whocontinued and discontinued study agent (data not shown).Table 2.",Non-OADS,/arxiv_data1/oa_pdf/bc/36/ACR-68-267.PMC5066795.pdf
(See Supplementary Table 1 available on the Arthritis Care & Research web site at http://onlinelibrary.wiley.co m/doi/10.1002/acr.22576/abstract for baseline SHS values).,Non-OADS,/arxiv_data1/oa_pdf/bc/36/ACR-68-267.PMC5066795.pdf
Dec reases from baseline in HAQ DI represent improve- ment and increases in PtGA indicate worsening disease activity (See Su pplementary Table 1 available on the Arthritis Care & Research web site at http://onlinelibrary.wiley.com/doi/10.1002/ac r.22576/abstract for baseline HAQ DI and PtGA values).,OADS,/arxiv_data1/oa_pdf/bc/36/ACR-68-267.PMC5066795.pdf
Decreases from baseline indicate improved activity (See Supplementary Table 1 available on the Arthritis Care & Research web site at http://onlinelibrary.wiley.com/doi/10.1002/acr.22576/abstract for baseline PASI values).,OADS,/arxiv_data1/oa_pdf/bc/36/ACR-68-267.PMC5066795.pdf
http://oig.hhs.gov/oei/reports/oei-01-97-00195.pdf.,Non-OADS,/arxiv_data1/oa_pdf/bd/cf/JCPH-56-1151.PMC5066799.pdf
"http://www.tops.org.uk/site/cms/contentChapterView.asp?chapt er=1.AccessedSeptember,2012.",Non-OADS,/arxiv_data1/oa_pdf/bd/cf/JCPH-56-1151.PMC5066799.pdf
http://www.fda.gov/downloads/AboutFDA/ReportsManualsFor ms/Reports/BudgetReports/UCM298331.pdf.,Non-OADS,/arxiv_data1/oa_pdf/bd/cf/JCPH-56-1151.PMC5066799.pdf
http://www.fda.gov/downloads/Drugs/..../UCM 071665.pdf.,Non-OADS,/arxiv_data1/oa_pdf/bd/cf/JCPH-56-1151.PMC5066799.pdf
"OECD Publishing: Paris http://dx.doi.org/10.1787/ dcr-2013-en Drummond M, Jefferson TO.",Non-OADS,/arxiv_data1/oa_pdf/e0/f5/HEC-25-42.PMC5066802.pdf
Journal of Epidemiology and Community Health 54: 381 –7.http://www.pubmedcentral.nih.,Non-OADS,/arxiv_data1/oa_pdf/e0/f5/HEC-25-42.PMC5066802.pdf
"http://www.ncbi.nlm.nih.gov/pubmed/8844932 Siedner MJ, Lankowski A, Tsai AC et al.",OADS,/arxiv_data1/oa_pdf/e0/f5/HEC-25-42.PMC5066802.pdf
"http://www.who.int/health-accounts/en/ (accessed 15 Mar 2015).Xu K, Evans DB, Kawabata K et al.",OADS,/arxiv_data1/oa_pdf/e0/f5/HEC-25-42.PMC5066802.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4e/21/ircmj-18-08-26130.PMC5066803.pdf
"Discriminate-detect map BrainMap’s Sleuth software (version 2.32) was used to identify all fMRI studies in the BrainMap database (http://www.brainmap.org) that reported activation for innocuous cutaneous tactile stimulation with task instruc-tions to detect or to discriminate the stimulus, regardless of stimulation site or stimulus type (for example, a task to determine the orientation of a textured gradient, or the presence or absence of a tactile stimulus).",OADS,/arxiv_data1/oa_pdf/32/7e/HBM-37-1308.PMC5066805.pdf
The sta- tistical maps were visualized on the Montreal NeurologicalInstitute (MNI) anatomical template using MRIcron soft-ware (http://www.mccauslandcenter.sc.edu/mricro/mricron).,OADS,/arxiv_data1/oa_pdf/32/7e/HBM-37-1308.PMC5066805.pdf
Each used the BrainMap database via Sleuth software (http://www.brainmap.,OADS,/arxiv_data1/oa_pdf/32/7e/HBM-37-1308.PMC5066805.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/2a/0f/bhw216.PMC5066826.pdf
Supplementary Material Supplementary material can be found at: http://www.cercor.,Non-OADS,/arxiv_data1/oa_pdf/2a/0f/bhw216.PMC5066826.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b6/ce/bhw222.PMC5066827.pdf
All raw fMRI data are publically posted at: http://www.weizmann.ac.il/neurobiology/worg/materials.html .,OADS,/arxiv_data1/oa_pdf/b6/ce/bhw222.PMC5066827.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a5/b2/bhw225.PMC5066828.pdf
Behavioral Data Analysis Behavioral data was analyzed using the R software for statis-tical computing ( http://www.R-project.org/ ).,OADS,/arxiv_data1/oa_pdf/a5/b2/bhw225.PMC5066828.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/0d/d2/bhw238.PMC5066829.pdf
Languagematerials can be found at http://web.mit.edu/evelina9/www/ funcloc/funcloc_localizers.html and details on how they were constructed can be found at Fedorenko et al.,OADS,/arxiv_data1/oa_pdf/0d/d2/bhw238.PMC5066829.pdf
Supplementary Material Supplementary material can be found at: http://www.cercor.,Non-OADS,/arxiv_data1/oa_pdf/0d/d2/bhw238.PMC5066829.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/1a/87/bhw241.PMC5066830.pdf
"Image Preprocessing All data were processed using the Connectome Computation System (CCS) ( https://github.com/zuoxinian/CCS ), which pro- vides a platform for multimodal image analysis by combining components of AFNI ( Cox 1996 ), FSL ( Smith et al.",OADS,/arxiv_data1/oa_pdf/1a/87/bhw241.PMC5066830.pdf
This was handled by calculatingthe gradient of each vertex on a plane perpendicular to the sur- face normal vector extending from that vertex (Caret 5.65 “met- ric-gradient ”function http://brainvis.wustl.edu/wiki/index.php/ Caret:About ).,OADS,/arxiv_data1/oa_pdf/1a/87/bhw241.PMC5066830.pdf
The model estimations were implemented using the lme function from the nlme R package ( http://cran.r-project.org/ web/packages/nlme ).,OADS,/arxiv_data1/oa_pdf/1a/87/bhw241.PMC5066830.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/83/b5/bhw249.PMC5066831.pdf
Supplementary Material Supplementary material can be found at: http://www.cercor.,Non-OADS,/arxiv_data1/oa_pdf/83/b5/bhw249.PMC5066831.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/05/bd/bhw263.PMC5066835.pdf
"Images were decon-volved using LAS AF 2.5 software (Leica, Germany), and spine analysis was performed using the semiautomated software NeuronStudio ( http://research.mssm.edu/cnic/tools-ns.html ).",OADS,/arxiv_data1/oa_pdf/05/bd/bhw263.PMC5066835.pdf
"Published by Oxford University Press.This is an Open Access article distributed under the terms of the Creative Commons Attributio n Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduc tion in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f0/fb/bhw266.PMC5066836.pdf
Supplementary Material Supplementary material can be found at: http://www.cercor.,Non-OADS,/arxiv_data1/oa_pdf/f0/fb/bhw266.PMC5066836.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/82/e8/bhw274.PMC5066837.pdf
"Thanks to HP internalization properties ( Joliot and Prochiantz,  This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/f6/2b/emss-70137.PMC5066840.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/d7/0d/ijwh-8-599.PMC5066846.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Women’s Health 2016:8 599–607International Journal of Women’s Health Dove press submit your manuscript | www.dovepress.co m Dove press  599RevIeWopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJWH.S11621 2 Has testosterone passed the test in premenopausal  women with low libido?",Non-OADS,/arxiv_data1/oa_pdf/d7/0d/ijwh-8-599.PMC5066846.pdf
"Despite these data, testosterone prescriptions in women have been increasing,2 which  leaves us to ponder the role of testosterone in women.Correspondence: Bruce R Carr Department of Obstetrics and  Gynecology, Division of Reproductive  endocrinology & Infertility, University of  Texas Southwestern Medical Center, 5353  Harry Hines Blvd, Dallas, TX 75390, USA Tel +1 214 648 4747 Fax +1 214 648 8066 email bruce.carr@utsouthwestern.ed u Journal name: International Journal of Women’s Health Article Designation: Review Y ear: 2016 Volume: 8 Running head verso: Reed et al Running head recto: Review of testosterone in premenopausal women DOI: http://dx.doi.org/10.2147/IJWH.S116212",Non-OADS,/arxiv_data1/oa_pdf/d7/0d/ijwh-8-599.PMC5066846.pdf
"International Journal of Women’s Health Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-womens-health-journa lThe International Journal of Women’s Health is an international, peer- reviewed open-access journal publishing original research, reports,  editorials, reviews and commentaries on all aspects of women’s  healthcare including gynecology, obstetrics, and breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/d7/0d/ijwh-8-599.PMC5066846.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/d7/0d/ijwh-8-599.PMC5066846.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/db/31/ijwh-8-589.PMC5066847.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Women’s Health 2016:8 589–598International Journal of Women’s Health Dove press submit your manuscript | www.dovepress.co m Dove press  589RevIeWopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJWH.S9970 5 Levonorgestrel-releasing intrauterine systems for  long-acting contraception: current perspectives,  safety, and patient counseling Dustin J Costescu Department of Obstetrics and  Gynaecology, McMaster University,   Hamilton, ON, CanadaAbstract:  Unintended pregnancy is a significant global problem.",Non-OADS,/arxiv_data1/oa_pdf/db/31/ijwh-8-589.PMC5066847.pdf
"The need for long-acting contraception: the Canadian  experience In Canada, precise estimates of unintended pregnancy are difficult to obtain, but a recent  economic evaluation suggests that 39% of pregnancies are unintended, translating to Correspondence: Dustin J Costescu HSC 2F45, 1200 Main Street West,  Hamilton, ON L8N 3Z5, Canada Tel +1 905 521 2100 email costesd@mcmaster.c a Journal name: International Journal of Women’s Health Article Designation: Review Y ear: 2016 Volume: 8 Running head verso: Costescu Running head recto: LNG IUS for long-acting contraception DOI: http://dx.doi.org/10.2147/IJWH.S99705",Non-OADS,/arxiv_data1/oa_pdf/db/31/ijwh-8-589.PMC5066847.pdf
"Available  from: http://www.un.org/en/development/desa/population/publications/ dataset/contraception/wcu2015.shtm l. Accessed June 30, 2016.",Non-OADS,/arxiv_data1/oa_pdf/db/31/ijwh-8-589.PMC5066847.pdf
Available  from: http://www.statcan.gc.ca/pub/11-630-x/11-630-x2014002-eng.,OADS,/arxiv_data1/oa_pdf/db/31/ijwh-8-589.PMC5066847.pdf
"Available  from: http://omr.bayer.ca/omr/online/mirena-pm-en.pd f. Accessed  June 30, 2016.",OADS,/arxiv_data1/oa_pdf/db/31/ijwh-8-589.PMC5066847.pdf
"Available  from: http://omr.bayer.ca/omr/online/jaydess-pm-en.pd f. Accessed  June 30, 2016.",OADS,/arxiv_data1/oa_pdf/db/31/ijwh-8-589.PMC5066847.pdf
"Available from:  http://www.prnewswire.com/news-releases/bayer-submits-new-drug- application-for-lcs-16-for-pregnancy-prevention-for-up-to-five-years- 300182419.htm l. Accessed June 30, 2016.",Non-OADS,/arxiv_data1/oa_pdf/db/31/ijwh-8-589.PMC5066847.pdf
"International Journal of Women’s Health Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-womens-health-journa lThe International Journal of Women’s Health is an international, peer- reviewed open-access journal publishing original research, reports,  editorials, reviews and commentaries on all aspects of women’s  healthcare including gynecology, obstetrics, and breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/db/31/ijwh-8-589.PMC5066847.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/db/31/ijwh-8-589.PMC5066847.pdf
Available from: http://www.medicines.ie/medicine/2707/SPC/   Mirena+52mg+Intrauterine +Delivery+System /.,Non-OADS,/arxiv_data1/oa_pdf/db/31/ijwh-8-589.PMC5066847.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/46/72/copd-11-2543.PMC5066848.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2016:11 2543–2551International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  2543OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S11140 8 Efficacy and safety of indacaterol/glycopyrronium  in Japanese patients with COPD: a subgroup  analysis from the SHINE study shu hashimoto1 hisataro Ikeuchi2 shujiro Murata2 T etsuji Kitawaki2 Kimitoshi Ikeda2 Donald Banerji3 1Division of Respiratory Medicine,   Department of Internal Medicine,   Nihon University School of Medicine,   T okyo, Japan; 2Novartis Pharma KK,   Minato-ku, T okyo, Japan; 3novartis  Pharmaceuticals Corporation,   East Hanover, NJ, USABackground:  COPD-related deaths are increasing in Japan, with ~5.3 million people at risk.",Non-OADS,/arxiv_data1/oa_pdf/46/72/copd-11-2543.PMC5066848.pdf
"An estimated population of 5.3 million Japanese are now  at risk of developing COPD; however, only a small proportion (9.4%) were diagnosed  to have COPD.2,3 Decline in quality of life due to breathlessness is the major challenge in the  management of COPD that demands sustained improvement in lung function.4 Long- acting bronchodilators of different pharmacological classes, either as monotherapy  or in combination, are now the preferred choice and proven cornerstone for treating Correspondence: shu hashimoto Division of Respiratory Medicine,  Department of Internal Medicine,  Nihon University School of Medicine,  30-1, Ohyaguchikamimachi, Itabashi-ku,  Tokyo 173-8610, Japan Tel +81 3 3972 7552 email hashimoto.shu@nihon-u.ac.j p Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Hashimoto et al Running head recto: Efficacy and safety of IND/GLY in Japanese population DOI: http://dx.doi.org/10.2147/COPD.S111408",Non-OADS,/arxiv_data1/oa_pdf/46/72/copd-11-2543.PMC5066848.pdf
Available from: http://www.mhlw.go.jp/english/new-info /.,Non-OADS,/arxiv_data1/oa_pdf/46/72/copd-11-2543.PMC5066848.pdf
Available from: https://www.jrs.or.jp/modules/guidelines/index.,Non-OADS,/arxiv_data1/oa_pdf/46/72/copd-11-2543.PMC5066848.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/46/72/copd-11-2543.PMC5066848.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/46/72/copd-11-2543.PMC5066848.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/28/56/dddt-10-3331.PMC5066849.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2016:10 3331–3343Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3331Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S11644 3 Development of a microparticle-based dry  powder inhalation formulation of ciprofloxacin  hydrochloride applying the quality by  design approach Keyhaneh Karimi edina Pallagi Piroska szabó-révész ildikó csóka rita ambrus Faculty of Pharmacy, institute of  Pharmaceutical Technology and  regulatory affairs, University of  szeged, szeged, hungaryAbstract:  Pulmonary drug delivery of ciprofloxacin hydrochloride offers effective local  antibacterial activity and convenience of easy application.",Non-OADS,/arxiv_data1/oa_pdf/28/56/dddt-10-3331.PMC5066849.pdf
"Lung is a highly absorptive tissue with a large  surface area and a limited proteolytic activity, sufficient capillaries, and rapid absorp - tion rate and can be targeted by non-invasive methods.4,5 Therefore, direct delivery  of antibiotics to a lung infection site leads to much higher drug concentrations in the  pulmonary tissue; thus, it may produce therapeutic effects at smaller doses compared  to those required by the oral or parenteral routes,6 while it is associated with a reduced  systemic antibiotic exposure and a reduced risk of toxicity.7correspondence: edina Pallagi Faculty of Pharmacy, institute of  Pharmaceutical Technology and  regulatory affairs, University of szeged,  eötvos u 6, h-6720 szeged, hungary Tel +36 62 545 575 Fax +36 62 545 571 email edina.pallagi@pharm.u-szeged.h uJournal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Karimi et al Running head recto: DPI development of an antibiotic applying the QbD approach DOI: http://dx.doi.org/10.2147/DDDT.S116443",Non-OADS,/arxiv_data1/oa_pdf/28/56/dddt-10-3331.PMC5066849.pdf
"Available from: http://www.ich.org/fileadmin/ Public_Web_Site/ICH_Products/Guidelines/Quality/Q8_R1/Step4/ Q8_R2_Guideline.pd f. Accessed September 30, 2016.",OADS,/arxiv_data1/oa_pdf/28/56/dddt-10-3331.PMC5066849.pdf
"Available from: http://www.ich.org/fileadmin/ Public_Web_Site/ICH_Products/Guidelines/Quality/Q9/Step4/Q9_   Guideline.pd f. Accessed September 30, 2016.",OADS,/arxiv_data1/oa_pdf/28/56/dddt-10-3331.PMC5066849.pdf
"Available from: http://www.ich.org/fileadmin/ Public_Web_Site/ICH_Products/Guidelines/Quality/Q10/Step4/ Q10_Guideline.pd f. Accessed September 30, 2016.Figure 7 Kinetic plots of free ciprofloxacin release from the microparticles investigated.",OADS,/arxiv_data1/oa_pdf/28/56/dddt-10-3331.PMC5066849.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug­design­development­and­therapy­journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/28/56/dddt-10-3331.PMC5066849.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/28/56/dddt-10-3331.PMC5066849.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/4a/6f/itt-5-081.PMC5066850.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/4a/6f/itt-5-081.PMC5066850.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).ImmunoTargets and Therapy 2016:5 81–91ImmunoTargets and Therapy Dovepress submit your manuscript | www.dovepress.com Dovepress 81 REVIEW open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/ITT .S91058Insights into the pathogenesis of Langerhans   cell histiocytosis: the development of  targeted therapies Caroline Hutter1,2 Milen Minkov1–3 1International LCH Study Reference  Center, Children’s Cancer Research  Institute, Vienna, Austria; 2St.",Non-OADS,/arxiv_data1/oa_pdf/4a/6f/itt-5-081.PMC5066850.pdf
"2 Therefore, the experience gathered from patient care  and empirically developed treatment regimens was the main resource of knowledge until recently.Correspondence: Milen Minkov St. Anna Children's Hospital, University Clinic of Pediatrics and Adolescent Medicine, Medical University of Vienna, Kinderspitalgasse 6, A-1090 Vienna, AustriaTel +43 1 40170 4760Fax +43 1 40170 7430Email milen.minkov@stanna.atJournal name: ImmunoTargets and Therapy  Article Designation: REVIEWY ear: 2016V olume: 5Running head verso: Hutter and MinkovRunning head recto: Insights into the pathogenesis of Langerhans cell histiocytosisDOI: http://dx.doi.org/10.2147/ITT.S91058",Non-OADS,/arxiv_data1/oa_pdf/4a/6f/itt-5-081.PMC5066850.pdf
"There are few ongoing trials listed on https://clinicaltrials.gov/ (eg, NCT02281760,  NCT 02649972 , NCT 02089724 , and NCT 01677741 ), evaluat - ing the role of MAPK inhibitors in patients with histiocytic disorders.",Non-OADS,/arxiv_data1/oa_pdf/4a/6f/itt-5-081.PMC5066850.pdf
"ImmunoTargets and Therapy 2016:5submit your manuscript | www.dovepress.com Dovepress Dovepress ImmunoTargets and Therapy Publish your work in this journal Submit your manuscript here: http://www.dovepress.com/immunotargets-and-therapy-journalImmunoTargets and Therapy is an international, peer-reviewed open access journal  focusing on the immunological basis of diseases, potential targets for immune  based therapy and treatment protocols employed to improve patient management.",Non-OADS,/arxiv_data1/oa_pdf/4a/6f/itt-5-081.PMC5066850.pdf
Visit http://www.dovepress.com/testimonials.php to read  real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/4a/6f/itt-5-081.PMC5066850.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/b8/7e/dddt-10-3163.PMC5066851.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2016:10 3163–3181Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3163Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S11736 9 looking for inhibitors of the dengue virus ns5  rna-dependent rna-polymerase using a  molecular docking approach Vicente galiano1 Pablo garcia-Valtanen2 Vicente Micol3,4 José antonio encinar3 1Physics and computer architecture  Department, Miguel hernández  University (UM h), elche, spain;   2experimental Therapeutics  laboratory, hanson and sansom  institute for health research, school  of Pharmacy and Medical science,   University of south australia, adelaide,   australia; 3Molecular and cell Biology  institute, Miguel hernández University  (UMh), elche, spain; 4ciBer:   cB12/03/30038, Physiopathology of  the Obesity and nutrition, ciBerobn,   instituto de salud carlos iii, Palma de  Mallorca, spainAbstract:  The dengue virus (DENV) nonstructural protein 5 (NS5) contains both an N-terminal  methyltransferase domain and a C-terminal RNA-dependent RNA polymerase domain.",Non-OADS,/arxiv_data1/oa_pdf/b8/7e/dddt-10-3163.PMC5066851.pdf
"Globally, in 2013, 18% of DENV -infected  patients were admitted to hospital, 48% received medical attention or advise outside a  hospital, and 34% did not need, find, or seek medical attention.5 Clinical manifestations correspondence: José antonio encinar Molecular and cell Biology institute,  Miguel Hernández University, Edificio  Torregaitán, avenida de la Universidad,  elche, spain Tel +34 96 65 8453 Fax +34 96 665 8758 email jant.encinar@umh.e s Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Galiano et al Running head recto: Investigation of putative inhibitors for the DENV RdRp DOI: http://dx.doi.org/10.2147/DDDT.S117369",Non-OADS,/arxiv_data1/oa_pdf/b8/7e/dddt-10-3163.PMC5066851.pdf
"Models are available at http://docking.umh.es / Abbreviations:  ns5, nonstructural protein 5; rdrp, rna-dependent rna polymerase; PDB, Protein Data Bank.",OADS,/arxiv_data1/oa_pdf/b8/7e/dddt-10-3163.PMC5066851.pdf
"Drug Design, Development and Therapy 2016:10submit your manuscript | www.dovepress.co m Dove press Dove press 3170galiano et al Table 2  (Continued ) Ligand   name∆G (kcal/mol)   mean ± SDLigand   name∆G (kcal/mol)   mean ± SDLigand   name∆G (kcal/mol)   mean ± SDLigand   name∆G (kcal/mol)   mean ± SD NS5 RdRp of DENV-4 60117771 −11.4±0.4 5330699 −11.2±1.4 41273686 −11.0±1.1 52886452 −11.0±0.5 25138229 −11.4±0.8 25065773 −11.2±0.8 46228828 −11.0±0.9 66604312 −11.0±0.9 46228865 −11.4±0.7 56057109 −11.2±0.6 57483762 −11.0±0.4 68714559 −11.0±1.1 10342132 −11.4±1.0 58550574 −11.2±0.9 68701232 −11.0±1.0 6129075 −11.0±0.6 67133415 −11.4±1.4 10228015 −11.2±0.9 53018993 −11.0±0.5 11752081 −11.0±0.6 71815570 −11.4±0.6 39906246 −11.2±0.5 58069426 −11.0±1.0 16065158 −11.0±1.2 16675341 −11.4±1.0 58064300 −11.2±1.2 11760627 −11.0±1.1 18710165 −11.0±0.7 24320265 −11.4±1.0 60402580 −11.2±1.1 16583630 −11.0±0.6 19665288 −11.0±1.0 68695702 −11.4±1.2 68698167 −11.2±0.9 20637893 −11.0±1.0 22556747 −11.0±1.3 50848923 −11.4±0.9 20765438 −11.2±1.1 22909360 −11.0±0.9 24512675 −11.0±0.8 87254968 −11.4±1.3 51038723 −11.2±0.5 57483761 −11.0±0.4 25138237 −11.0±0.9 16749628 −11.4±1.1 60481456 −11.2±0.8 58607039 −11.0±1.1 57483734 −11.0±0.5 25066203 −11.4±0.9 56085277 −11.2±1.2 59615666 −11.0±0.9 57878492 −11.0±1.0 86608192 −11.4±1.3 56025347 −11.1±1.3 59986516 −11.0±0.9 88042824 −11.0±0.8 362451 −11.3±1.3 11999940 −11.1±0.7 60481455 −11.0±0.8 90299314 −11.0±0.9 10477276 −11.3±0.9 53019143 −11.1±0.9 66599533 −11.0±0.6 5330694 −11.0±1.4 71815377 −11.3±0.5 58117326 −11.1±0.2 69138857 −11.0±0.4 45856807 −11.0±0.6 59375107 −11.3±1.9 67023384 −11.1±0.7 76541767 −11.0±0.9 2647295 −11.0±0.8 67023200 −11.3±0.7 44251670 −11.1±1.0 89856954 −11.0±1.4 6197109 −11.0±0.7 68490845 −11.3±0.9 44178168 −11.1±1.0 10002281 −11.0±0.8 9804722 −11.0±1.3 44419986 −11.3±0.8 53019026 −11.1±1.1 42623761 −11.0±0.9 20637894 −11.0±0.7 5280143 −11.3±0.8 58064137 −11.1±1.1 51035546 −11.0±0.6 21378092 −11.0±0.6 57878498 −11.3±0.8 16327670 −11.1±0.8 51035547 −11.0±0.4 25070620 −11.0±1.5 18710166 −11.3±1.2 24548686 −11.1±0.9 56214202 −11.0±1.1 31895387 −11.0±0.8 59880286 −11.3±1.2 86608206 −11.1±1.3 59558378 −11.0±1.0 54347717 −11.0±1.3 59144489 −11.3±1.2 68700123 −11.1±1.2 71149319 −11.0±0.6 55760732 −11.0±1.0 18710167 −11.3±1.5 46885245 −11.1±1.0 25065560 −11.0±1.1 57955372 −11.0±1.0 60402567 −11.3±0.9 53019136 −11.1±0.9 58117279 −11.0±0.6 58975131 −11.0±0.5 71815441 −11.3±0.6 60621794 −11.1±0.8 90731410 −11.0±1.0 59121588 −11.0±1.1 25065987 −11.3±1.2 68559862 −11.1±1.0 102119533 −11.0±1.1 59558337 −11.0±0.8 11317629 −11.3±1.0 85874649 −11.1±1.0 44605023 −11.0±0.7 59880283 −11.0±1.2 44419982 −11.3±0.9 5330697 −11.1±1.4 46231533 −11.0±0.6 66605319 −11.0±0.7 47037799 −11.3±0.7 16376567 −11.1±0.8 54087042 −11.0±0.5 66661799 −11.0±0.9 50848762 −11.3±0.8 53019095 −11.1±0.9 57391501 −11.0±0.5 74937104 −11.0±0.5 53019046 −11.3±0.9 20765417 −11.1±1.2 59973115 −11.0±1.4 58518208 −11.3±1.8 22556882 −11.1±1.2 69707773 −11.0±0.9 89856935 −11.3±1.2 99455350 −11.1±0.9 59212517 −11.0±0.6 10239163 −11.3±1.1 2947808 −11.1±0.8 41927843 −11.0±0.7 Notes:  The name of each ligand was obtained from the Pubchem database ( https://pubchem.ncbi.nlm.nih.gov /).22 The name of the compounds niTD-1, -2, and -29 was taken  from niyomrattanakit et al.21 The table shows the estimated binding free energy variation31 (mean ± sD).",Non-OADS,/arxiv_data1/oa_pdf/b8/7e/dddt-10-3163.PMC5066851.pdf
"The maps of the interacting residues of the protein with the best  ligands and ∆g values among the candidate compounds are available at http://docking.umh.es / Abbreviations:  ns5, nonstructural protein 5; rdrp, rna-dependent rna polymerase; sD, standard deviation.",Non-OADS,/arxiv_data1/oa_pdf/b8/7e/dddt-10-3163.PMC5066851.pdf
in the process of drug design.28 Several compounds have ∆G  values in the range of −10.5 to −10.0 kcal/mol (see full list  at http://docking.umh.es /).,Non-OADS,/arxiv_data1/oa_pdf/b8/7e/dddt-10-3163.PMC5066851.pdf
"Most orally administered drugs have an  MW of 500, a calculated logP 5, five or fewer hydrogen  bond donor sites, and ten or fewer hydrogen bond acceptor Table 3  Molecular docking analysis for natural compounds RdRp of DENV-1 RdRp of DENV-2 RdRp of DENV-4 Ligand  name∆G (kcal/mol)  mean ± SDLigand  name∆G (kcal/mol)  mean ± SDLigand  name∆G (kcal/mol)   mean ± SD sn00091933 −10.8±0.7 sn00151425 −11.1±0.8 sn00016053 −11.2±1.0 sn00074091 −10.7±0.7 sn00010280 −10.9±0.8 sn00057073 −11.1±1.1 sn00091667 −10.7±0.8 sn00023794 −10.9±0.7 sn00063622 −11.1±1.2 sn00306679 −10.6±1.0 sn00372243 −10.9±0.9 sn00058424 −11.1±1.1 sn00151425 −10.6±0.9 sn00115885 −10.8±1.1 sn00058828 −11.1±1.1 sn00366028 −10.5±1.0 sn00018927 −10.8±0.5 sn00057669 −11.1±1.1 sn00372243 −10.5±1.0 sn00016053 −10.8±0.5 sn00230471 −11.1±1.3 sn00074088 −10.5±0.9 sn00057073 −10.7±1.1 sn00057220 −11.0±1.2 sn00010280 −10.5±0.6 sn00081933 −10.6±1.1 sn00057061 −11.0±1.2 sn00127203 −10.5±1.1 sn00127203 −10.6±1.3 sn00303561 −11.0±1.2 sn00016053 −10.5±0.6 sn00058424 −10.6±1.1 sn00058587 −10.9±1.1 sn00230471 −10.5±0.9 sn00063622 −10.6±1.0 sn00366028 −10.9±0.8 sn00245001 −10.5±0.7 sn00379696 −10.6±0.6 sn00127203 −10.8±0.8 sn00396968 −10.6±0.8 sn00303525 −10.8±1.0 sn00014343 −10.6±0.9 sn00016042 −10.7±1.4 sn00057669 −10.5±1.0 sn00010280 −10.7±0.6 sn00282274 −10.5±0.9 sn00111882 −10.6±1.0 sn00381633 −10.5±1.2 sn00282274 −10.6±1.0 sn00004095 −10.5±0.6 sn00317979 −10.6±1.0 sn00245001 −10.5±0.4 sn00018896 −10.6±0.9 sn00058828 −10.5±1.0 sn00026414 −10.6±1.2 sn00397486 −10.5±0.9 sn00151956 −10.6±0.6 sn00282224 −10.5±0.9 sn00282224 −10.6±1.2 sn00009726 −10.5±0.9 sn00004146 −10.6±0.9 sn00151425 −10.6±1.1 sn00379696 −10.6±1.0 sn00012056 −10.5±0.7 sn00381633 −10.5±0.7 sn00115885 −10.5±0.8 sn00148919 −10.5±0.6 sn00276030 −10.5±0.8 sn00249137 −10.5±0.7 sn00091933 −10.5±0.9 Notes:  The maps of the interacting residues of the protein with the best ligands and ∆g values among the candidate compounds are available at http://docking.umh.es /.",Non-OADS,/arxiv_data1/oa_pdf/b8/7e/dddt-10-3163.PMC5066851.pdf
The name of each ligand was obtained from the supernatural database ( http://bioinf-applied.charite.de/supernatural_new/index.php?site =home).,OADS,/arxiv_data1/oa_pdf/b8/7e/dddt-10-3163.PMC5066851.pdf
The interaction  maps for the best compounds ( ∆G −10.5 kcal/mol) were  calculated and are available at http://docking.umh.es /.,OADS,/arxiv_data1/oa_pdf/b8/7e/dddt-10-3163.PMC5066851.pdf
ADME profiles of all compounds tested in this study are available  at http://docking.umh.es /.,OADS,/arxiv_data1/oa_pdf/b8/7e/dddt-10-3163.PMC5066851.pdf
"all parameters have been calculated using the http://lmmd.ecust.edu.cn:8000/predict/sit e.34 Abbreviations:  aDMe, absorption, distribution, metabolism, and elimination; BBB, blood–brain barrier; cYP450, cytochrome P450; cYP iP, cytochrome P450 inhibitory  promiscuity; hia, human intestinal absorption; ns5, nonstructural protein 5; P-gp, P-glycoprotein; rdrp, rna-dependent rna polymerase; rOcT, renal organic cation  transporter.",OADS,/arxiv_data1/oa_pdf/b8/7e/dddt-10-3163.PMC5066851.pdf
ADME profiles of all compounds tested in this study are available  at http://docking.umh.es /.,OADS,/arxiv_data1/oa_pdf/b8/7e/dddt-10-3163.PMC5066851.pdf
"all parameters have been calculated using the http://lmmd.ecust.edu.cn:8000/predict/sit e.34 Abbreviations:  aDMe, absorption, distribution, metabolism, and elimination; BBB, blood–brain barrier; cYP450, cytochrome P450; cYP iP, cytochrome P450 inhibitory  promiscuity; hia, human intestinal absorption; ns5, nonstructural protein 5; P-gp, P-glycoprotein; rdrp, rna-dependent rna polymerase; rOcT, renal organic cation  transporter.",OADS,/arxiv_data1/oa_pdf/b8/7e/dddt-10-3163.PMC5066851.pdf
Toxicity profile of all compounds tested in this study is available http://docking.umh.es /.,Non-OADS,/arxiv_data1/oa_pdf/b8/7e/dddt-10-3163.PMC5066851.pdf
"aThese parameters  were calculated using the DataWarrior v4.2.2 software ( http://www.openmolecules.org/datawarrior/download.htm l).33 bThese parameters were calculated using the http://lmmd.ecust.edu.cn:8000/predict/sit e.34 compound names are from  Pubchem22 and supernatural ii23 databases, respectively.",OADS,/arxiv_data1/oa_pdf/b8/7e/dddt-10-3163.PMC5066851.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/b8/7e/dddt-10-3163.PMC5066851.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/b8/7e/dddt-10-3163.PMC5066851.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/3c/85/ijn-11-5205.PMC5066852.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 5205–5220International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  5205OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S115956 synergistic effects of a-B-c-type amphiphilic  copolymer on reversal of drug resistance in  McF-7/aDr breast carcinoma lu Zhang1–3 Jiafei lu3 liyan Qiu1 1Ministry of education (MO e) Key  laboratory of Macromolecular  synthesis and Functionalization,   Department of Polymer science and  engineering, Zhejiang University,   hangzhou, 2Drug clinical Trial  Office, The First affiliated hospital  of Wenzhou Medical University,   Wenzhou, 3college of Pharmaceutical  sciences, Zhejiang University,   hangzhou, People’s republic of chinaAbstract : P-glycoprotein (P-gp) overexpression has become the most common cause of  occurrence of multidrug resistance in clinical settings.",Non-OADS,/arxiv_data1/oa_pdf/3c/85/ijn-11-5205.PMC5066852.pdf
"And  by means of increasing intracellular uptake, micelles can be helpful to improve the  cytotoxicity of drugs to MDR cancers.10 More notably, Batrakova et al discovered correspondence: liyan Qiu Ministry of education (MOe) Key  laboratory of Macromolecular synthesis  and Functionalization, Department  of Polymer science and engineering,  Zhejiang University, 38 Zheda  road, hangzhou 310027, People’s  republic of china Tel/fax +86 571 8795 2306 email lyqiu@zju.edu.c n Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Zhang et al Running head recto: Amphiphilic copolymers for drug resistance reversal DOI: http://dx.doi.org/10.2147/IJN.S115956",Non-OADS,/arxiv_data1/oa_pdf/3c/85/ijn-11-5205.PMC5066852.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/3c/85/ijn-11-5205.PMC5066852.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/3c/85/ijn-11-5205.PMC5066852.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/54/a8/ijn-11-5245.PMC5066853.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 5245–5256International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  5245OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S9499 5 Intracellular redox-responsive nanocarrier  for plasmid delivery: in vitro characterization  and in vivo studies in mice lifen Zhang1,2 Yushun Zhang1,2 Zhenzhen chen3 Yuling he1 1state Key laboratory of applied  Organic chemistry, 2Key laboratory  of Nonferrous Metals chemistry  and resources Utilization of gansu  Province, college of chemistry  and chemical engineering, lanzhou  University, lanzhou, 3Department of  Bioengineering, Zhengzhou University,   Zhengzhou, henan, People’s republic  of chinaAbstract:  Although some modifications of polyethyleneimine (PEI) properties have been  explored to balance the transfection efficiency and cytotoxicity, its successful plasmid delivery  in vitro and  in vivo  to realize its true therapeutic potentials remains a major challenge, mainly due  to intracellular trafficking barriers.",Non-OADS,/arxiv_data1/oa_pdf/54/a8/ijn-11-5245.PMC5066853.pdf
"Up to now, PEI has been modified with  chloroquine, polyethylene glycol, heparin, folic acid, Pluronic (poly[ethylene  oxide]-b-poly[propylene oxide]-b-poly[ethylene oxide]), and so on.10 For example,  hydrophilic Pluronic polymers can possess the unique ability to incorporate into cell correspondence: lifen Zhang state Key laboratory of applied  Organic chemistry, Key laboratory  of Nonferrous Metals chemistry and  resources Utilization of gansu Province,  college of chemistry and chemical  engineering, lanzhou University, lanzhou  730000, People’s republic of china Tel +86 931 891 2528 email lfzhang@lzu.edu.c n  Zhenzhen chen Department of Bioengineering,  Zhengzhou University, 100 science  road, Zhengzhou 450001, henan,  People’s republic of china email chenzz2010@lzu.edu.c nJournal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Zhang et al Running head recto: Intracellular redox-responsive nanocarrier for plasmid delivery DOI: http://dx.doi.org/10.2147/IJN.S94995",Non-OADS,/arxiv_data1/oa_pdf/54/a8/ijn-11-5245.PMC5066853.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/54/a8/ijn-11-5245.PMC5066853.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/54/a8/ijn-11-5245.PMC5066853.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/01/07/ijnrd-9-249.PMC5066854.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/01/07/ijnrd-9-249.PMC5066854.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).International Journal of Nephrology and Renovascular Disease 2016:9 249–251International Journal of Nephrology and Renovascular Disease Dovepress submit your manuscript | www.dovepress.com Dovepress 249 CASE REPORT open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJNRD.S116377 Acute kidney injury in a shepherd with severe  malaria: a case report Boushab Mohamed  Boushab1 Fatim-Zahra Fall-Malick2 Mamoudou Savadogo3 Leonardo Kishi Basco4 1Department of Internal Medicine,   Aïoun Regional Hospital, Hodh  El Gharbi, Mauritania; 2National  Institute of Hepatology-Virology in Nouakchott, School of Medicine,  Nouakchott, Mauritania;  3Department  of Infectious Diseases, University T eaching Hospital Yalgado Ouédrago,  Ouagadougou, Burkina Faso;  4Research  Unit of Infectious and Tropical Diseases, Institut de Recherche pour le Développement (Research Institute for Development), Aix-Marseille University, Marseille, FranceAbstract:  Malaria is one of the main reasons for outpatient consultation and hospitalization in  Mauritania.",Non-OADS,/arxiv_data1/oa_pdf/01/07/ijnrd-9-249.PMC5066854.pdf
"The patient developed a flu-like syndrome (fever, headache, and arthralgia) Correspondence: Boushab Mohamed  BoushabMedicine Interne, Centre Hospitalier d’Aïoun, BP 74, Hodh El Gharbi, MauritanieTel +222 4674 9087Email bboushab@gmail.comJournal name: International Journal of Nephrology and Renovascular Disease Article Designation: CASE REPORTY ear: 2016V olume: 9Running head verso: Boushab et alRunning head recto: Acute kidney injury in a shepherd with severe malariaDOI: http://dx.doi.org/10.2147/IJNRD.S116377",Non-OADS,/arxiv_data1/oa_pdf/01/07/ijnrd-9-249.PMC5066854.pdf
"International Journal of Nephrology and Renovascular Disease 2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress International Journal of Nephrology and Renovascular Disease Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/international-journal-of-nephrology-and-renovascular-disease-journalThe International Journal of Nephrology and Renovascular Disease is   an international, peer-reviewed open access journal focusing on the  pathophysiology of the kidney and vascular supply.",Non-OADS,/arxiv_data1/oa_pdf/01/07/ijnrd-9-249.PMC5066854.pdf
"Visit http://www.dovepress.com/testimonials.php to read real quotes from published   authors.Dovepress 251 Acute kidney injury in a shepherd with severe malaria Author contributions Boushab Mohamed Boushab was  involved in drafting the  manuscript, made substantial contributions to study concep-tion and design, helped in clinical data verification, and gave input for the “Discussion” section.",Non-OADS,/arxiv_data1/oa_pdf/01/07/ijnrd-9-249.PMC5066854.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/60/ea/ijgm-9-337.PMC5066855.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/60/ea/ijgm-9-337.PMC5066855.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).International Journal of General Medicine 2016:9 337–347International Journal of General Medicine Dovepress submit your manuscript | www.dovepress.com Dovepress 337 REVIEW open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJGM.S109104Minimizing bleeding risk in patients receiving  direct oral anticoagulants for stroke prevention Jeffrey Steven Habert Department of Family and Community  Medicine, University of T oronto,  T oronto, ON, CanadaAbstract: Many primary care physicians are wary about using direct oral anticoagulants  (DOACs) in patients with nonvalvular atrial fibrillation (AF).",Non-OADS,/arxiv_data1/oa_pdf/60/ea/ijgm-9-337.PMC5066855.pdf
"12Correspondence: Jeffrey Steven Habert Department of Family and Community Medicine, University of Toronto, 206-2900 Steeles Avenue East, Thornhill, ON, L3T4X1, CanadaMob +1 905 881 6667 Email jhabert@rogers.comJournal name: International Journal of General Medicine Article Designation: REVIEWY ear: 2016V olume: 9Running head verso: HabertRunning head recto: Minimizing bleeding risk in patients taking direct oral anticoagulantsDOI: http://dx.doi.org/10.2147/IJGM.S109104",Non-OADS,/arxiv_data1/oa_pdf/60/ea/ijgm-9-337.PMC5066855.pdf
Available from: https://www.nice.org.uk/guidance/cg180.,Non-OADS,/arxiv_data1/oa_pdf/60/ea/ijgm-9-337.PMC5066855.pdf
Available from: http://www.boehringer-ingelheim.ca/content/dam/internet/opu/ca_EN/documents/humanhealth/product_monograph/PradaxaPMEN.pdf.,Non-OADS,/arxiv_data1/oa_pdf/60/ea/ijgm-9-337.PMC5066855.pdf
Available from: http://www.jwatch.org/fw110754/2015/10/20/dabigatran-reversal-agent-price-set.,Non-OADS,/arxiv_data1/oa_pdf/60/ea/ijgm-9-337.PMC5066855.pdf
Available from: http://thrombosis-canada.ca/?page_id= 502&calc= perioperativeAnticoagulantAlgorithm.,Non-OADS,/arxiv_data1/oa_pdf/60/ea/ijgm-9-337.PMC5066855.pdf
"International Journal of General Medicine 2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress International Journal of General Medicine Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/international-journal-of-general-medicine-journalThe International Journal of General Medicine is an international,  peer-reviewed open-access journal that focuses on general and internal medicine, pathogenesis, epidemiology, diagnosis, monitoring and treat-ment protocols.",Non-OADS,/arxiv_data1/oa_pdf/60/ea/ijgm-9-337.PMC5066855.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 347 Minimizing bleeding risk in patients taking direct oral anticoagulants,Non-OADS,/arxiv_data1/oa_pdf/60/ea/ijgm-9-337.PMC5066855.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/1f/ad/dddt-10-3355.PMC5066856.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2016:10 3355–3361Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3355Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DDDT .S8505 0 Dasatinib for the treatment of chronic myeloid  leukemia: patient selection and special  considerations Dilek Keskin Sevil Sadri Ahmet emre eskazan  Department of internal Medicine,   Division of Hematology, Cerrahpasa  Faculty of Medicine, istanbul  University, istanbul, T urkeyAbstract:  Dasatinib is one of the second-generation tyrosine kinase inhibitors used in imatinib  resistance and/or intolerance, as well as in the frontline setting in patients with chronic myeloid  leukemia-chronic phase, and also in patients with advanced disease.",Non-OADS,/arxiv_data1/oa_pdf/1f/ad/dddt-10-3355.PMC5066856.pdf
"In this review, we mainly focus Correspondence: Ahmet emre eskazan Department of internal Medicine,  Division of Hematology, Cerrahpasa  Faculty of Medicine, istanbul  University, Kocamustafapasa/Fatih,  istanbul 34303, Turkey Tel +90 533 722 7376 Fax +90 212 589 7934 email emreeskazan@hotmail.co m Journal name: Drug Design, Development and Therapy Article Designation: Review Y ear: 2016 Volume: 10 Running head verso: Keskin et al Running head recto: Dasatinib therapy in patients with CML DOI: http://dx.doi.org/10.2147/DDDT.S85050",Non-OADS,/arxiv_data1/oa_pdf/1f/ad/dddt-10-3355.PMC5066856.pdf
"Available from: http://www.nccn.org/professionals/ physician_gls/pdf/cml.pd f. Accessed February 2, 2016.",Non-OADS,/arxiv_data1/oa_pdf/1f/ad/dddt-10-3355.PMC5066856.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/1f/ad/dddt-10-3355.PMC5066856.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/1f/ad/dddt-10-3355.PMC5066856.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/d1/55/dddt-10-3345.PMC5066857.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2016:10 3345–3353Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3345Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DDDT .S9960 0 Yellow fever vaccine-associated viscerotropic  disease: current perspectives Roger e Thomas Department of Family Medicine,   Faculty of Medicine, University of  Calgary, Research Office, G012,   Health Sciences Centre, Calgary,   AB, CanadaPurpose:  To assess those published cases of yellow fever (YF) vaccine-associated viscerotropic  disease that meet the Brighton Collaboration criteria and to assess the safety of YF vaccine with  respect to viscerotropic disease.",Non-OADS,/arxiv_data1/oa_pdf/d1/55/dddt-10-3345.PMC5066857.pdf
"In African savannah areas, Aedes species transmit the virus to monkeys or  humans as the intermediate hosts, and in urban areas Aedes aegyptii  (which breeds in  water containers in or near dwellings) transmits infection between humans (refer to the  transmission diagram by Quaresma et al).1,2 Because of the greater intensity of urban Correspondence: Roger e Thomas Department of Family Medicine, Faculty  of Medicine, University of Calgary,  Research Office, G012, Health Sciences  Centre, 3330 Hospital Drive Nw,  Calgary T2N 4N1, AB, Canada Tel +1 403 210 9208 Fax +1 403 270 4329 email rthomas@ucalgary.c aJournal name: Drug Design, Development and Therapy Article Designation: Review Y ear: 2016 Volume: 10 Running head verso: Thomas Running head recto: Y ellow fever vaccine-associated viscerotropic disease DOI: http://dx.doi.org/10.2147/DDDT.S99600",Non-OADS,/arxiv_data1/oa_pdf/d1/55/dddt-10-3345.PMC5066857.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/d1/55/dddt-10-3345.PMC5066857.pdf
"Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.Dove pres s Drug Design, Development and Therapy 2016:10submit your manuscript | www.dovepress.co m Dove press Dove press 3353Yellow fever vaccine-associated viscerotropic disease  49.",Non-OADS,/arxiv_data1/oa_pdf/d1/55/dddt-10-3345.PMC5066857.pdf
Available from: http://portal.saude.gov.br.,Non-OADS,/arxiv_data1/oa_pdf/d1/55/dddt-10-3345.PMC5066857.pdf
"Available from: http://portal.saude.gov.b r. Accessed  July 8, 2013.",Non-OADS,/arxiv_data1/oa_pdf/d1/55/dddt-10-3345.PMC5066857.pdf
Available from: http://portal.saude.,Non-OADS,/arxiv_data1/oa_pdf/d1/55/dddt-10-3345.PMC5066857.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/63/c8/ijn-11-5257.PMC5066858.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 5257–5276International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  5257OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S11203 0 amorphous silica nanoparticles trigger vascular  endothelial cell injury through apoptosis and  autophagy via reactive oxygen species-mediated  MaPK/Bcl-2 and PI3K/akt/mTOr signaling caixia guo1,2 Man Yang2,3 li Jing2,3 Ji Wang2,3 Yang Yu2,3 Yang li2,3 Junchao Duan2,3 Xianqing Zhou2,3 Yanbo li2,3 Zhiwei sun2,3 1Department of Occupational and  environmental health, school of  Public health, 2Beijing Key laboratory  of environmental T oxicology,   3Department of T oxicology and  sanitary chemistry, school of Public  health, capital Medical University,   Beijing, People’s republic of chinaAbstract:  Environmental exposure to silica nanoparticles (SiNPs) is inevitable due to their  widespread application in industrial, commercial, and biomedical fields.",Non-OADS,/arxiv_data1/oa_pdf/63/c8/ijn-11-5257.PMC5066858.pdf
"Specifically, due to many advantages, correspondence: Zhiwei sun; Yanbo li school of Public health, capital Medical  University, No 10 Xitoutiao, You an  Men, Beijing 100069, People’s republic  of china Tel/fax +86 10 8391 1507 email zwsun@ccmu.edu.c n;   ybli@ccmu.edu.c n Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Guo et al Running head recto: Amorphous SiNPs trigger vascular endothelial cell injury DOI: http://dx.doi.org/10.2147/IJN.S112030",Non-OADS,/arxiv_data1/oa_pdf/63/c8/ijn-11-5257.PMC5066858.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/63/c8/ijn-11-5257.PMC5066858.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/63/c8/ijn-11-5257.PMC5066858.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/8a/2d/ijn-11-5163.PMC5066859.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 5163–5185International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  5163RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJN.S11266 0 Carbon nanotubes as cancer therapeutic carriers  and mediators Kuk Hui Son1 Jeong Hee Hong2 Jin woo Lee3 1Department of Thoracic and  Cardiovascular Surgery, Gachon  University Gil Medical Center,   2Department of Physiology,   3Department of Molecular Medicine,   School of Medicine, Gachon  University, Incheon, Republic of KoreaAbstract:  Carbon nanotubes (CNTs) have received increasing attention in biomedical fields  because of their unique structures and properties, including high aspect ratios, large surface areas,  rich surface chemical functionalities, and size stability on the nanoscale.",Non-OADS,/arxiv_data1/oa_pdf/8a/2d/ijn-11-5163.PMC5066859.pdf
"Furthermore,  nanotechnology has been applied in biomedical fields for detection, diagnosis, imaging, Correspondence: Jin woo Lee Department of Molecular Medicine,  School of Medicine, Gachon University,  155, Gaetbeol-ro, Yeonsu-ku, Incheon  21999, Republic of Korea Tel +82 32 899 6516 Fax +82 32 899 6039 email jwlee@gachon.ac.k r Journal name: International Journal of Nanomedicine Article Designation: Review Y ear: 2016 Volume: 11 Running head verso: Son et al Running head recto: CNTs as cancer therapeutic carriers and mediators DOI: http://dx.doi.org/10.2147/IJN.S112660",Non-OADS,/arxiv_data1/oa_pdf/8a/2d/ijn-11-5163.PMC5066859.pdf
Available  from: http://www.who.int/mediacentre/factsheets/fs297/en/.,Non-OADS,/arxiv_data1/oa_pdf/8a/2d/ijn-11-5163.PMC5066859.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/8a/2d/ijn-11-5163.PMC5066859.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/8a/2d/ijn-11-5163.PMC5066859.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/a9/a8/ijwh-8-581.PMC5066860.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Women’s Health 2016:8 581–587International Journal of Women’s Health Dove press submit your manuscript | www.dovepress.co m Dove press  581OrIg Inal researcHopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJWH.S11594 8 effects of a new combination of nutraceuticals on  postmenopausal symptoms and metabolic profile:  a crossover, randomized, double-blind trial Valentina Trimarco1 Francesco rozza2 raffaele Izzo3 Vincenzo De leo4 Valentina cappelli4 carla riccardi1 costantino Di carlo1 1Department of n euroscience,   reproductive sciences and Dentistry,   2Department of Biomedical sciences,   3Department of Translational Medical  sciences, Federico II University  of naples, naples, 4Department  of Molecular and Developmental  Medicine, University of siena,   siena, ItalyObjectives:  This study was designed to measure the beneficial effects of a combination of  nutraceutics (NUT; AkP04, Morestril®, Akademy Pharma) containing soy isoflavones (80 mg),  dry extract of Angelica sinensis  (50 mg), dry extract of Morus alba  leaf (200 mg) and magnesium  (56.25 mg) in the relief of somatic, psychological, and urogenital symptoms in postmenopausal  patients, using the validated Menopause Rating Scale (MRS) and cardiovascular risk factors.",Non-OADS,/arxiv_data1/oa_pdf/a9/a8/ijwh-8-581.PMC5066860.pdf
"Moreover, long-term HT  with administration of estrogens and progestins has been associated with an increase in  the risk of breast cancer, while estrogens, alone or in association to progestins, increase correspondence: raffaele Izzo Department of Translational Medical  sciences, Federico II University  of naples, Building 2, 5 Via sergio  Pansini, naples 80131, Italy Tel +39 081 746 2250 Fax +39 081 746 2256 email raffaele.izzo@unina.i t Journal name: International Journal of Women’s Health Article Designation: Original Research Y ear: 2016 Volume: 8 Running head verso: Trimarco et al Running head recto: Nutraceutical combination for postmenopausal symptoms DOI: http://dx.doi.org/10.2147/IJWH.S115948",Non-OADS,/arxiv_data1/oa_pdf/a9/a8/ijwh-8-581.PMC5066860.pdf
"International Journal of Women’s Health Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-womens-health-journa lThe International Journal of Women’s Health is an international, peer- reviewed open-access journal publishing original research, reports,  editorials, reviews and commentaries on all aspects of women’s  healthcare including gynecology, obstetrics, and breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/a9/a8/ijwh-8-581.PMC5066860.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/a9/a8/ijwh-8-581.PMC5066860.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/e3/57/ijn-11-5187.PMC5066861.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 5187–5203International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  5187OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S11144 7 cytotoxic effects of ZnO nanoparticles on mouse  testicular cells Zhe han1,* Qi Yan1,* Wei ge2 Zhi-guo liu1 sangiliyandi gurunathan3 Massimo De Felici4 Wei shen2 Xi-Feng Zhang1 1college of Biological and  Pharmaceutical engineering, Wuhan  Polytechnic University, Wuhan,   People’s republic of china; 2Key  laboratory of animal reproduction  and germplasm enhancement in  Universities of shandong, college  of animal science and T echnology,   Qingdao agricultural University,   Qingdao, People’s republic of  china; 3Department of stem cell  and regenerative Biology, Konkuk  University, seoul, republic of Korea;   4Department of Biomedicine and  Prevention, University of rome  “T or Vergata”, rome, Italy *These authors contributed equally  to this workBackground:  Nanoscience and nanotechnology are developing rapidly, and the applications  of nanoparticles (NPs) have been found in several fields.",Non-OADS,/arxiv_data1/oa_pdf/e3/57/ijn-11-5187.PMC5066861.pdf
"ZnO NPs are well known and widely  used as metal oxides in many diverse products, and also as catalysts in electronics, correspondence: Xi-Feng Zhang college of Biological and Pharmaceutical  engineering, Wuhan Polytechnic  University, Wuhan 430023, People’s  republic of china email zhangxf9465@163.co m Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Han et al Running head recto: ZnO nanoparticles and their cytotoxicity DOI: http://dx.doi.org/10.2147/IJN.S111447",Non-OADS,/arxiv_data1/oa_pdf/e3/57/ijn-11-5187.PMC5066861.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/e3/57/ijn-11-5187.PMC5066861.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/e3/57/ijn-11-5187.PMC5066861.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/17/0f/cpaa-8-155.PMC5066862.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/17/0f/cpaa-8-155.PMC5066862.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Clinical Pharmacology: Advances and Applications 2016:8 155–162Clinical Pharmacology: Advances and Applications Dovepress submit your manuscript | www.dovepress.com Dovepress  155 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CPAA.S115679Bioavailability study of dronabinol oral solution  versus dronabinol capsules in healthy volunteers Neha Parikh1 William G Kramer2 Varun Khurana1 Christina Cognata Smith1 Santosh Vetticaden1 1INSYS Therapeutics, Inc., Chandler,   AZ, USA; 2Kramer Consulting LLC,   North Potomac, MD, USABackground: Dronabinol, a pharmaceutical Δ -9-tetrahydrocannabinol, was originally developed  as an oral capsule.",Non-OADS,/arxiv_data1/oa_pdf/17/0f/cpaa-8-155.PMC5066862.pdf
"In this capsule  formulation, oral dronabinol is almost completely absorbed (90%–95%) after Correspondence: Santosh Vetticaden Department of Clinical Development and Medical Affairs, INSYS Therapeutics, Inc., 1333 S Spectrum Boulevard, Suite 100, Chandler, AZ 85286, USA Tel +1 602 910 2617   Email svetticaden@insysrx.comJournal name: Clinical Pharmacology: Advances and Applications Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 8Running head verso: Parikh et alRunning head recto: Bioavailability of dronabinol oral solution versus capsulesDOI: http://dx.doi.org/10.2147/CPAA.S115679",Non-OADS,/arxiv_data1/oa_pdf/17/0f/cpaa-8-155.PMC5066862.pdf
2016;34(15 suppl):e21593: http://meeting.ascopubs.org/ cgi/content/abstract/34/15_suppl/e21593 .,Non-OADS,/arxiv_data1/oa_pdf/17/0f/cpaa-8-155.PMC5066862.pdf
Available from: http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulato   ryInformation/Guidances/UCM209294.pdf.,Non-OADS,/arxiv_data1/oa_pdf/17/0f/cpaa-8-155.PMC5066862.pdf
Available from: http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryin   formation/guidances/ucm199636.pdf.,Non-OADS,/arxiv_data1/oa_pdf/17/0f/cpaa-8-155.PMC5066862.pdf
Available from: http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm389370.pdf.,Non-OADS,/arxiv_data1/oa_pdf/17/0f/cpaa-8-155.PMC5066862.pdf
"Clinical Pharmacology: Advances and Applications 2016:8submit your manuscript | www.dovepress.com Dovepress Dovepress Clinical Pharmacology: Advances and Applications Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/clinical-pharmacology-advances-and-applications-journalClinical Pharmacology: Advances and Applications is an international,  peer-reviewed, open access journal publishing original research, reports, reviews and commentaries on all areas of drug experience in humans.",Non-OADS,/arxiv_data1/oa_pdf/17/0f/cpaa-8-155.PMC5066862.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 162 Parikh et al,Non-OADS,/arxiv_data1/oa_pdf/17/0f/cpaa-8-155.PMC5066862.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/34/ef/ibpc-9-095.PMC5066864.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/34/ef/ibpc-9-095.PMC5066864.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Integrated Blood Pressure Control  2016:9 95–104Integrated Blood Pressure Control Dovepress submit your manuscript | www.dovepress.com Dovepress 95 CLINICAL TRIAL REPORT open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IBPC.S99553Consumption of nattokinase is associated with  reduced blood pressure and von Willebrand  factor, a cardiovascular risk marker: results   from a randomized, double-blind,  placebo-controlled, multicenter North American  clinical trial Gitte S Jensen1  Miki Lenninger1  Michael P Ero2  Kathleen F Benson1 1NIS Labs, Klamath Falls, OR,   2Machaon Diagnostics, Inc., Oakland,   CA, USAObjective: The objective of this study is to evaluate the effects of consumption of nattokinase on  hypertension in a North American hypertensive population with associated genetic, dietary, and  lifestyle factors.",Non-OADS,/arxiv_data1/oa_pdf/34/ef/ibpc-9-095.PMC5066864.pdf
"Keywords: subtilisin NAT, systolic blood pressure, diastolic blood pressure, von Willebrand  factor, plasma renin activity Introduction Hypertension is a chronic medical condition involving increased arterial blood pressure  (BP) and is associated with increased risk of cardiovascular and renal disease, as well Correspondence: Gitte S Jensen NIS Labs, 1437 Esplanade, Klamath Falls, 97601, OR, USA Tel +1 541 884 0112   Fax +1 403 441 5236   Email gitte@nislabs.comJournal name: Integrated Blood Pressure Control  Article Designation: CLINICAL TRIAL REPORTY ear: 2016V olume: 9Running head verso: Jensen et alRunning head recto: Nattokinase and blood pressureDOI: http://dx.doi.org/10.2147/IBPC.S99553 Video abstract Point your SmartPhone at the code above.",Non-OADS,/arxiv_data1/oa_pdf/34/ef/ibpc-9-095.PMC5066864.pdf
Or use: http://youtu.be/ug0zwgf4bV0,Non-OADS,/arxiv_data1/oa_pdf/34/ef/ibpc-9-095.PMC5066864.pdf
"Integrated Blood Pressure Control  2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress Integrated Blood Pressure Control  Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/integrated-blood-pressure-control-journalIntegrated Blood Pressure Control is an international, peer-reviewed  open-access journal focusing on the integrated approach to managing hypertension and risk reduction.",Non-OADS,/arxiv_data1/oa_pdf/34/ef/ibpc-9-095.PMC5066864.pdf
Visit http://www.dovepress.com/   testimonials.php to read real quotes from published authors.Dovepress 104 Jensen et al  44.,Non-OADS,/arxiv_data1/oa_pdf/34/ef/ibpc-9-095.PMC5066864.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/90/8c/ijn-11-5125.PMC5066865.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 5125–5147International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  5125OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S11346 9 GE11 peptide modified and reduction-responsive  hyaluronic acid-based nanoparticles induced  higher efficacy of doxorubicin for breast  carcinoma therapy Danrong hu Omar Mezghrani lei Zhang Yi chen Xue Ke Tianyuan ci Department of Pharmaceutics, state  Key Laboratory of Natural Medicines,   china Pharmaceutical University,   Nanjing, People’s Republic of ChinaAbstract:  Novel breast carcinoma dual-targeted redox-responsive nanoparticles (NPs) based on  cholesteryl-hyaluronic acid conjugates were designed for intracellular delivery of the antitumor  drug doxorubicin (DOX).",Non-OADS,/arxiv_data1/oa_pdf/90/8c/ijn-11-5125.PMC5066865.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/90/8c/ijn-11-5125.PMC5066865.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/90/8c/ijn-11-5125.PMC5066865.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/0c/5e/jaa-9-183.PMC5066866.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/0c/5e/jaa-9-183.PMC5066866.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Asthma and Allergy 2016:9 183–189Journal of Asthma and Allergy Dovepress submit your manuscript | www.dovepress.com Dovepress 183 OriginAl reseArch open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JAA.S113747Anti-inflammatory dosing of theophylline in the  treatment of status asthmaticus in children nemr s eid1 Adrian O’hagan1 scott Bickel1 ronald Morton1 sarah Jacobson2 John A Myers3 1Division of Pediatric Pulmonology,   University of louisville, 2Department  of Pharmacy, Kosair children’s  hospital, 3Department of Pediatrics,   University of louisville, louisville,   KY, UsABackground: Low-dose theophylline has been recognized for its ability to restore histone  deacetylase-2 activity which leads to improved steroid responsiveness and thus improved clinical  outcome.",Non-OADS,/arxiv_data1/oa_pdf/0c/5e/jaa-9-183.PMC5066866.pdf
"More serious, but rare, side effects include cardiac dysrhythmias and seizures.correspondence: nemr s eid Division of Pediatric Pulmonology, University of louisville, 571 south Floyd street, suite 414, louisville, KY 40202, UsATel +1 502 852 3772Fax +1 502 852 4051email nseid@louisville.eduJournal name: Journal of Asthma and Allergy Article Designation: OrIGIn AL reSeArCH Y ear: 2016V olume: 9running head verso: eid et alrunning head recto: Theophylline in the treatment of status asthmaticusDOI: http://dx.doi.org/10.2147/JAA.S113747",Non-OADS,/arxiv_data1/oa_pdf/0c/5e/jaa-9-183.PMC5066866.pdf
"Journal of Asthma and Allergy 2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Asthma and Allergy Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/journal-of-asthma-and-allergy-journalThe Journal of Asthma and Allergy is an international, peer-reviewed  open access journal publishing original research, reports, editorials and commentaries on the following topics: Asthma; Pulmonary physi-ology; Asthma related clinical health; Clinical immunology and the immunological basis of disease; Pharmacological interventions and new therapies.",Non-OADS,/arxiv_data1/oa_pdf/0c/5e/jaa-9-183.PMC5066866.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/26/4e/ijn-11-5237.PMC5066867.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 5237–5244International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  5237OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S11913 0 New optical sensing technique of tissue viability  and blood flow based on nanophotonic iterative  multi-plane reflectance measurements Inbar Yariv1 Menashe haddad2,3 hamootal Duadi1 Menachem Motiei1 Dror Fixler1 1Faculty of engineering and the  Institute of Nanotechnology and  advanced Materials, Bar Ilan  University, ramat gan, Israel;  2sackler school of Medicine, Tel- aviv  University, T el-a viv, Israel; 3Mayanei  hayeshua Medical center, Benei  Brak, IsraelAbstract:  Physiological substances pose a challenge for researchers since their optical properties  change constantly according to their physiological state.",Non-OADS,/arxiv_data1/oa_pdf/26/4e/ijn-11-5237.PMC5066867.pdf
"However, Lister et al14 have reviewed some of the leading analyses correspondence: Dror Fixler Bar-Ilan University, Faculty of engineering  and the Institute of Nanotechnology  and advanced Materials, ramat-gan,  5290002, Israel Tel +972 3 531 7598 Fax +972 3 738 4050 email dror.fixler@biu.ac.i l Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Y ariv et al Running head recto: Tissues sensing by new nanophotonics iterative measurements DOI: http://dx.doi.org/10.2147/IJN.S119130",Non-OADS,/arxiv_data1/oa_pdf/26/4e/ijn-11-5237.PMC5066867.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/26/4e/ijn-11-5237.PMC5066867.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/26/4e/ijn-11-5237.PMC5066867.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/a0/9e/ijn-11-5149.PMC5066869.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 5149–5161International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  5149OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S10876 8 Increasing roughness of the human breast cancer  cell membrane through incorporation of gold  nanoparticles c lara-cruz1 Je Jiménez-salazar1 e ramón-gallegos2 P Damian-Matsumura1 N Batina3 1Department of Biology of  reproduction, Metropolitan  autonomous University, 2Department  of Morphology, National school  of Biological sciences, National  Polytechnic Institute, 3Department  of chemistry, Nanotechnology and  Molecular engineering laboratory,   Metropolitan autonomous University,   Mexico city, MexicoAbstract:  Gold nanoparticles (AuNPs) have been proposed for use in the treatment of different  types of cancer, including breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/a0/9e/ijn-11-5149.PMC5066869.pdf
"san rafael  atlixco 186, Iztapalapa, Mexico city,  09340, Mexico Tel +52 55 5804 4939 Fax +52 55 5804 4666 email bani@xanum.uam.m x Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Lara-Cruz et al Running head recto: Increasing roughness of the breast cancer cell membrane through AuNPs DOI: http://dx.doi.org/10.2147/IJN.S108768",Non-OADS,/arxiv_data1/oa_pdf/a0/9e/ijn-11-5149.PMC5066869.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/a0/9e/ijn-11-5149.PMC5066869.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/a0/9e/ijn-11-5149.PMC5066869.pdf
The camera was calibrated so that the images could be converted to eight-bitluminance images (camera spectral sensitivities areavailable at http://natural-scenes.cps.utexas.edu/db.,Non-OADS,/arxiv_data1/oa_pdf/7b/5e/i1534-7362-16-13-2.PMC5066913.pdf
"This entire image set, and some additional detailsabout the measurement system, image calibration, andregistration are available at http://natural-scenes.cps.",Non-OADS,/arxiv_data1/oa_pdf/7b/5e/i1534-7362-16-13-2.PMC5066913.pdf
"The ventriloquist effect results from near-optimal bimodal integration.Current Biology ,14, 257–262, http://doi.org/10.",OADS,/arxiv_data1/oa_pdf/7b/5e/i1534-7362-16-13-2.PMC5066913.pdf
"Retrieved from http://doi.org/10.1523/JNEUROSCI.5551-09.2010 Burge, J., & Geisler, W. S. (2011).",OADS,/arxiv_data1/oa_pdf/7b/5e/i1534-7362-16-13-2.PMC5066913.pdf
Retrieved from http://doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/7b/5e/i1534-7362-16-13-2.PMC5066913.pdf
Retrieved from http://doi.org/10.1117/12.,Non-OADS,/arxiv_data1/oa_pdf/7b/5e/i1534-7362-16-13-2.PMC5066913.pdf
"Retrieved from http://doi.org/10.1038/ncomms8900 Burge, J., Girshick, A. R., & Banks, M. S. (2010b).",OADS,/arxiv_data1/oa_pdf/7b/5e/i1534-7362-16-13-2.PMC5066913.pdf
"Retrieved from http://doi.org/10.1523/ JNEUROSCI.6427-09.2010 Clark, J. J., & Yuille, A. L. (1990).",OADS,/arxiv_data1/oa_pdf/7b/5e/i1534-7362-16-13-2.PMC5066913.pdf
"Retrieved from http://doi.org/10.1038/415429a Fleming, R. W., Holtmann-Rice, D., & Bulthoff, H. H. (2011).",Non-OADS,/arxiv_data1/oa_pdf/7b/5e/i1534-7362-16-13-2.PMC5066913.pdf
"Retrieved from http://doi.org/10.1016/S0042-6989(03)00458-9 Landy, M. S., Maloney, L. T., Johnston, E. B., & Young, M. (1995).",OADS,/arxiv_data1/oa_pdf/7b/5e/i1534-7362-16-13-2.PMC5066913.pdf
Retrieved from http://doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/7b/5e/i1534-7362-16-13-2.PMC5066913.pdf
Retrieved from http://doi.org/10.1523/JNEUROSCI.3887-03.,OADS,/arxiv_data1/oa_pdf/7b/5e/i1534-7362-16-13-2.PMC5066913.pdf
"Retrieved from http://doi.org/10.1037/h0057643 Palmer, S. E., & Ghose, T. (2008).",OADS,/arxiv_data1/oa_pdf/7b/5e/i1534-7362-16-13-2.PMC5066913.pdf
"Retrieved from http://doi.org/10.1111/j.1467-9280.2008.02049.x Peterson, M. A., & Gibson, B. S. (1993).",OADS,/arxiv_data1/oa_pdf/7b/5e/i1534-7362-16-13-2.PMC5066913.pdf
"Retrieved from http://doi.org/10.1523/JNEUROSCI.3174-13.2013 Sanada, T. M., Nguyenkim, J. D., & DeAngelis, G. C. (2012).",OADS,/arxiv_data1/oa_pdf/7b/5e/i1534-7362-16-13-2.PMC5066913.pdf
"Re- trieved from http://doi.org/10.1152/jn.00578.2011 Saxena, A., Chung, S. H., & Ng, A. Y.",OADS,/arxiv_data1/oa_pdf/7b/5e/i1534-7362-16-13-2.PMC5066913.pdf
"Retrieved from http://doi.org/10.1007/s11263-007-0071-y Saxena, A., Schulte, J., & Ng, A. Y.",OADS,/arxiv_data1/oa_pdf/7b/5e/i1534-7362-16-13-2.PMC5066913.pdf
"Retrieved from http://doi.org/10.3758/BF03202860 Tsutsui, K., Jiang, M., Yara, K., Sakata, H., & Taira, M. (2001).",OADS,/arxiv_data1/oa_pdf/7b/5e/i1534-7362-16-13-2.PMC5066913.pdf
"Retrieved from http://doi.org/10.1038/nn1461 Yang, Z., & Purves, D. (2003).",OADS,/arxiv_data1/oa_pdf/7b/5e/i1534-7362-16-13-2.PMC5066913.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License ( http://creativecommons.org/licenses/by-nc/3.0/ ), which permits unre- stricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/bf/3f/kaup-12-10-1207015.PMC5066936.pdf
"10, 1864 –1875 http://dx.doi.org/10.1080/15548627.2016.1207015",Non-OADS,/arxiv_data1/oa_pdf/bf/3f/kaup-12-10-1207015.PMC5066936.pdf
Lyso- Tracker Red staining was quanti ﬁed measuring the ﬂuorescence intensity of the area corresponding to the regenerating musclein pictures taken from craniectomized ﬁsh with ImageJ soft- ware ( http://rsbweb.nih.gov/ij/ ).,OADS,/arxiv_data1/oa_pdf/bf/3f/kaup-12-10-1207015.PMC5066936.pdf
"Nat Cell Biol 2013; 15:713-20; PMID:23817233; http://dx.doi.org/10.1038/ncb2788 [2] Mizushima N, Levine B. Autophagy in mammalian development and differentiation.",OADS,/arxiv_data1/oa_pdf/bf/3f/kaup-12-10-1207015.PMC5066936.pdf
"Nat Cell Biol 2010; 12:823-30; PMID:20811354; http://dx.doi.org/10.1038/ncb0910-823 [3] Wong E, Cuervo AM.",OADS,/arxiv_data1/oa_pdf/bf/3f/kaup-12-10-1207015.PMC5066936.pdf
"Oncogene 2011; 30:4687-96; PMID:21666712; http://dx.doi.org/10.1038/onc.2011.220 [5] Hitchcock PF, Raymond PA.",OADS,/arxiv_data1/oa_pdf/bf/3f/kaup-12-10-1207015.PMC5066936.pdf
"Zebra ﬁsh 2004; 1:257-71; PMID:18248236; http://dx.doi.org/10.1089/zeb.2004.1.257 [6] Rodrigues AM, Christen B, Marti M, Belmonte JC.",OADS,/arxiv_data1/oa_pdf/bf/3f/kaup-12-10-1207015.PMC5066936.pdf
"Bmc Dev Biol 2012; 12:9; PMID:22369050; http://dx.doi.org/10.1186/1471-213X-12-9 [7] Saera-Vila A, Kasprick DS, Junttila TL, Grzegorski SJ, Louie KW, Chiari EF, Kish PE, Kahana A. Myocyte dedifferentiation drivesextraocular muscle regeneration in adult zebra ﬁsh.",Non-OADS,/arxiv_data1/oa_pdf/bf/3f/kaup-12-10-1207015.PMC5066936.pdf
"Invest Ophth Vis Sci 2015; 56:4977-93; http://dx.doi.org/10.1167/iovs.14-16103 [8] Poss KD, Wilson LG, Keating MT.",Non-OADS,/arxiv_data1/oa_pdf/bf/3f/kaup-12-10-1207015.PMC5066936.pdf
"Science 2002; 298:2188-90; PMID:12481136; http://dx.doi.org/10.1126/science.1077857 [9] Raya A, Koth CM, Buscher D, Kawakami Y, Itoh T, Raya RM, Sternik G, Tsai HJ, Rodr /C19ıguez-Esteban C, Izpis /C19ua-Belmonte JC.",OADS,/arxiv_data1/oa_pdf/bf/3f/kaup-12-10-1207015.PMC5066936.pdf
P Natl Acad Sci USA 2003; 100:11889-95; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/bf/3f/kaup-12-10-1207015.PMC5066936.pdf
Regeneration 2015; 2:72-83; http://dx.doi.org/10.1002/reg2.33 [12] Goldman D. Muller glial cell reprogramming and retina regenera- tion.,Non-OADS,/arxiv_data1/oa_pdf/bf/3f/kaup-12-10-1207015.PMC5066936.pdf
"Prog Retin Eye Res 2014; 40:94-123; PMID:24412518; http://dx.doi.org/10.1016/j.preteyeres.2013.12.007 [14] Zhang RL, Han PD, Yang HB, Ouyang KF, Lee D, Lin YF, Ocorr K, Kang G, Chen J, Stainier DY, et al.",OADS,/arxiv_data1/oa_pdf/bf/3f/kaup-12-10-1207015.PMC5066936.pdf
"Nature 2013; 498:497- 501; PMID:23783515; http://dx.doi.org/10.1038/nature12322 [15] Tanida I, Ueno T, Kominami E. LC3 and Autophagy.",OADS,/arxiv_data1/oa_pdf/bf/3f/kaup-12-10-1207015.PMC5066936.pdf
"Methods Mol Biol 2008; 445:77-88; PMID:18425443; http://dx.doi.org/10.1007/ 978-1-59745-157-4_4 [16] He CC, Bartholomew CR, Zhou WB, Klionsky DJ.",OADS,/arxiv_data1/oa_pdf/bf/3f/kaup-12-10-1207015.PMC5066936.pdf
"Autophagy 2009; 5:520-6; PMID:19221467; http://dx.doi.org/10.4161/auto.5.4.7768 [17] Hu ZY, Zhang JP, Zhang QY.",Non-OADS,/arxiv_data1/oa_pdf/bf/3f/kaup-12-10-1207015.PMC5066936.pdf
"Auto- phagy 2011; 7:1514-27; PMID:22082871; http://dx.doi.org/10.4161/auto.7.12.18040 [18] Varga M, Sass M, Papp D, Takacs-Vellai K, Kobolak J, Dinnyes A, Klionsky DJ, Vellai T. Autophagy is required for zebra ﬁsh caudal ﬁn regeneration.",Non-OADS,/arxiv_data1/oa_pdf/bf/3f/kaup-12-10-1207015.PMC5066936.pdf
"Cell Death Differ 2014; 21:547-56; PMID:24317199;http://dx.doi.org/10.1038/cdd.2013.175 [19] Amaravadi RK, Yu D, Lum JJ, Bui T, Christophorou MA, Evan GI, Thomas-Tikhonenko A, Thompson CB.",OADS,/arxiv_data1/oa_pdf/bf/3f/kaup-12-10-1207015.PMC5066936.pdf
"Mol Cell Biol 2005; 25:1025-40; PMID:15657430; http://dx.doi.org/ 10.1128/MCB.25.3.1025-1040.2005 [21] Wang S, Xia PY, Rehm M, Fan Z. Autophagy and cell reprogram- ming.",OADS,/arxiv_data1/oa_pdf/bf/3f/kaup-12-10-1207015.PMC5066936.pdf
"Nat Med 2009; 15:1141-4; PMID:19812574; http://dx.doi.org/10.1038/nm1009-1141[23] Jopling C, Boue S, Belmonte JC.",Non-OADS,/arxiv_data1/oa_pdf/bf/3f/kaup-12-10-1207015.PMC5066936.pdf
"Nat Rev MolCell Bio 2011; 12:79-89; http://dx.doi.org/10.1038/nrm3043 [24] Semi K, Matsuda Y, Ohnishi K, Yamada Y.",OADS,/arxiv_data1/oa_pdf/bf/3f/kaup-12-10-1207015.PMC5066936.pdf
"Int J Cancer 2013; 132:1240-8; PMID:23180619; http://dx.doi.org/10.1002/ijc.27963 [25] Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult ﬁbroblast cultures by de ﬁned factors.",OADS,/arxiv_data1/oa_pdf/bf/3f/kaup-12-10-1207015.PMC5066936.pdf
"Cell 2006; 126:663-76; PMID:16904174; http://dx.doi.org/10.1016/j.cell.2006.07.024 [26] Pan HZ, Cai N, Li M, Liu GH, Belmonte JC.",OADS,/arxiv_data1/oa_pdf/bf/3f/kaup-12-10-1207015.PMC5066936.pdf
"Embo Mol Med 2013; 5:327-31; PMID:23495139; http://dx.doi.org/10.1002/emmm.201201999 [27] Hansson J, Ra ﬁee MR, Reiland S, Polo JM, Gehring J, Okawa S, Huber W, Hochedlinger K, Krijgsveld J.",OADS,/arxiv_data1/oa_pdf/bf/3f/kaup-12-10-1207015.PMC5066936.pdf
"Cell Rep 2012; 2:1579-92; PMID:23260666; http://dx.doi.org/10.1016/j.celrep.2012.10.014 [28] Mizushima N, Klionsky DJ.",OADS,/arxiv_data1/oa_pdf/bf/3f/kaup-12-10-1207015.PMC5066936.pdf
"Annu Rev Nutr 2007; 27:19-40; PMID:17311494; http://dx.doi.org/10.1146/annurev.nutr.27.061406.093749 [29] Dou ZX, Xu CY, Donahue G, Shimi T, Pan JA, Zhu J, Ivanov A, Capell BC, Drake AM, Shah PP, et al.",OADS,/arxiv_data1/oa_pdf/bf/3f/kaup-12-10-1207015.PMC5066936.pdf
"Nature 2015; 527:105-9; PMID:26524528;http://dx.doi.org/10.1038/nature15548 [30] Mochida K, Oikawa Y, Kimura Y, Kirisako H, Hirano H, Ohsumi Y, Nakatogawa H. Receptor-mediated selective autophagy degrades the endoplasmic reticulum and the nucleus.",Non-OADS,/arxiv_data1/oa_pdf/bf/3f/kaup-12-10-1207015.PMC5066936.pdf
"Nature 2015; 522:359-62;PMID:26040717; http://dx.doi.org/10.1038/nature14506 [31] Cho A, Noguchi S. Autophagy in GNE Myopathy.",Non-OADS,/arxiv_data1/oa_pdf/bf/3f/kaup-12-10-1207015.PMC5066936.pdf
"Cell Death Differ 2015; 22:526-39; PMID:25526085; http://dx.doi.org/10.1038/cdd.2014.216 [33] Bell RA, Al-Khalaf M, Megeney LA.",Non-OADS,/arxiv_data1/oa_pdf/bf/3f/kaup-12-10-1207015.PMC5066936.pdf
"Skelet Muscle 2016;6:16; PMID:27054028; http://dx.doi.org/10.1186/s13395-016-0086-6 [34] Luthi AU, Martin SJ.",OADS,/arxiv_data1/oa_pdf/bf/3f/kaup-12-10-1207015.PMC5066936.pdf
"Cell Death Differ 2007; 14:641-50; PMID:17273173;http://dx.doi.org/10.1038/sj.cdd.4402103 [35] Hashimoto T, Kikkawa U, Kamada S. Contribution of caspase(s) to the cell cycle regulation at Mitotic Phase.",OADS,/arxiv_data1/oa_pdf/bf/3f/kaup-12-10-1207015.PMC5066936.pdf
"Plos One 2011; 6:e18449; PMID:21479177; http://dx.doi.org/10.1371/journal.pone.0018449 [36] Zhang J, Kabra NH, Cado D, Kang C, Winoto A. FADD-de ﬁcient T cells exhibit a disaccord in regulation of the cell cycle machinery.",OADS,/arxiv_data1/oa_pdf/bf/3f/kaup-12-10-1207015.PMC5066936.pdf
"J Biol Chem 2001; 276:29815-8; PMID:11390402; http://dx.doi.org/10.1074/jbc.M103838200 [37] Frost V, Al-Mehairi S, Sinclair AJ.",OADS,/arxiv_data1/oa_pdf/bf/3f/kaup-12-10-1207015.PMC5066936.pdf
"Oncogene 2001; 20:2737-48;PMID:11420686; http://dx.doi.org/10.1038/sj.onc.1204367 [38] Helfer B, Boswell BC, Finlay D, Cipres A, Vuori K, Kang TB, Wallach D, Dor ﬂeutner A, Lahti JM, Flynn DC, et al.",OADS,/arxiv_data1/oa_pdf/bf/3f/kaup-12-10-1207015.PMC5066936.pdf
CancerRes 2006; 66:4273-8; PMID:16618751; http://dx.doi.org/10.1158/0008-5472.CAN-05-4183 [39] Kuranaga E. Beyond apoptosis: caspase regulatory mechanisms and functions in vivo.,Non-OADS,/arxiv_data1/oa_pdf/bf/3f/kaup-12-10-1207015.PMC5066936.pdf
"Genes Cells 2012; 17:83-97; PMID:22244258;http://dx.doi.org/10.1111/j.1365-2443.2011.01579.x [40] Lee Y, Grill S, Sanchez A, Murphy-Ryan M, Poss KD.",OADS,/arxiv_data1/oa_pdf/bf/3f/kaup-12-10-1207015.PMC5066936.pdf
"Development 2005; 132:5173-83; PMID:16251209; http://dx.doi.org/10.1242/dev.02101 [41] Floss T, Arnold HH, Braun T. A role for FGF-6 in skeletal muscle regeneration.",OADS,/arxiv_data1/oa_pdf/bf/3f/kaup-12-10-1207015.PMC5066936.pdf
"Gene Dev 1997; 11:2040-51; PMID:9284044; http://dx.doi.org/10.1101/gad.11.16.2040 [42] Dvorak P, Dvorakova D, Hampl A. Fibroblast growth factor sig- naling in embryonic and cancer stem cells.",OADS,/arxiv_data1/oa_pdf/bf/3f/kaup-12-10-1207015.PMC5066936.pdf
Febs Lett 2006; 580:2869-74; PMID:16516203; http://dx.doi.org/10.1016/j.febslet.2006.01.0951874 A. SAERA-VILA ET AL.,OADS,/arxiv_data1/oa_pdf/bf/3f/kaup-12-10-1207015.PMC5066936.pdf
"Cell Signal 2016; 28(9):1196-1204; PMID:27267062; http://dx.doi.org/10.1016/j.cellsig.2016.06.001 [44] Dailey L, Ambrosetti D, Mansukhani A, Basilico C. Mechanisms underlying differential responses to FGF signaling.",OADS,/arxiv_data1/oa_pdf/bf/3f/kaup-12-10-1207015.PMC5066936.pdf
"Cytokine GrowthF R 2005; 16:233-47; http://dx.doi.org/10.1016/j.cytogfr.2005.01.007 [45] Corcelle E, Dierbi N, Mari M, Nebout M, Fiorini C, Fenichel P, Hof- man P, Poujeol P, Mograbi B.",OADS,/arxiv_data1/oa_pdf/bf/3f/kaup-12-10-1207015.PMC5066936.pdf
"Autophagy 2007; 3:57-9; PMID:17102581; http://dx.doi.org/ 10.4161/auto.3424 [46] Kang C, You YJ, Avery L. Dual roles of autophagy in the survival of Caenorhabditis elegans during starvation.",Non-OADS,/arxiv_data1/oa_pdf/bf/3f/kaup-12-10-1207015.PMC5066936.pdf
"Gene Dev 2007; 21:2161-71; PMID:17785524; http://dx.doi.org/10.1101/gad.1573107 [47] Higashijima S, Okamoto H, Ueno N, Hotta Y, Eguchi G. High-fre- quency generation of transgenic zebra ﬁsh which reliably express GFP in whole muscles or the whole body by using promoters ofzebra ﬁsh origin.",Non-OADS,/arxiv_data1/oa_pdf/bf/3f/kaup-12-10-1207015.PMC5066936.pdf
"Methods 2001; 25:402-8; PMID:11846609; http://dx.doi.org/ 10.1006/meth.2001.1262 [49] Craig SE, Thummel R, Ahmed H, Vasta GR, Hyde DR, Hitchcock PF.",OADS,/arxiv_data1/oa_pdf/bf/3f/kaup-12-10-1207015.PMC5066936.pdf
"Invest Ophth Vis Sci 2010; 51:3244-52;http://dx.doi.org/10.1167/iovs.09-4879 [50] Ramachandran R, Fausett BV, Goldman D. Ascl1a regulates Muller glia dedifferentiation and retinal regeneration through a Lin-28-dependent, let-7 microRNA signalling pathway.",Non-OADS,/arxiv_data1/oa_pdf/bf/3f/kaup-12-10-1207015.PMC5066936.pdf
"Nat Cell Biol 2010;12:1101-U106; PMID:20935637; http://dx.doi.org/10.1038/ncb2115 [51] Thummel R, Bai S, Sarras MP, Song PZ, McDermott J, Brewer J, Perry M, Zhang X, Hyde DR, Godwin AR.",OADS,/arxiv_data1/oa_pdf/bf/3f/kaup-12-10-1207015.PMC5066936.pdf
"Dev Dynam 2006; 235:336-46; http://dx.doi.org/ 10.1002/dvdy.20630 [52] Salic A, Mitchison TJ.",OADS,/arxiv_data1/oa_pdf/bf/3f/kaup-12-10-1207015.PMC5066936.pdf
Zebra ﬁsh 2015; 12:312-4; PMID:25942613; http://dx.doi.org/10.1089/zeb.2015.1087AUTOPHAGY 1875,Non-OADS,/arxiv_data1/oa_pdf/bf/3f/kaup-12-10-1207015.PMC5066936.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/9f/12/vhrm-12-387.PMC5066985.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/9f/12/vhrm-12-387.PMC5066985.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Vascular Health and Risk Management  2016:12 387–392Vascular Health and Risk Management Dovepress submit your manuscript | www.dovepress.com Dovepress  387 REVIEW open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/VHRM.S85031International normalized ratio self-testing and  self-management: improving patient outcomes Matteo Pozzi1 Julia Mitchell2 Anna Maria Henaine3 Najib Hanna4 Ola Safi4 Roland Henaine2 1Department of Adult Cardiac  Surgery, “Louis Pradel” Cardiologic  Hospital, Lyon, France; 2Department  of Congenital Cardiac Surgery,  “Louis Pradel” Cardiologic Hospital,  Lyon, France;  3Clinical Pharmacology  Unit, Lebanese University, Beirut,  Lebanon;  4Pediatric Unit, “Hotel Dieu  de France” Hospital, Saint Joseph University, Beirut, Lebanon Abstract:  Long term oral anti-coagulation with vitamin K antagonists is a risk factor of hem- orrhagic or thromebomlic complications.",Non-OADS,/arxiv_data1/oa_pdf/9f/12/vhrm-12-387.PMC5066985.pdf
"Different reasons could explain this problem: the lack of patients’ education, the complex pharmacokinetics Correspondence: Roland Henaine Department of Congenital Cardiac Surgery, “Louis Pradel” Cardiologic Hospital, Avenue du Doyen Lépine, 69394 Lyon, FranceTel + 33 4 72 35 74 78Fax + 33 4 72 34 18 53Email roland.henaine@chu-lyon.frJournal name: Vascular Health and Risk Management  Article Designation: REVIEWY ear: 2016V olume: 12Running head verso: Pozzi et alRunning head recto: INR self-managementDOI: http://dx.doi.org/10.2147/VHRM.S85031",Non-OADS,/arxiv_data1/oa_pdf/9f/12/vhrm-12-387.PMC5066985.pdf
Available from: http://www.has-sante.fr/portail/upload/docs/application/pdf/2009-02/rapport_inr_2009-02-11_11-34-20_386.pdf.,Non-OADS,/arxiv_data1/oa_pdf/9f/12/vhrm-12-387.PMC5066985.pdf
"Vascular Health and Risk Management  2016:12submit your manuscript | www.dovepress.com Dovepress Dovepress Vascular Health and Risk Management  Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/vascular-health-and-risk-management-journal Vascular Health and Risk Management is an international, peer- reviewed journal of therapeutics and risk management, focusing on concise rapid reporting of clinical studies on the processes involved in the maintenance of vascular health; the monitoring, prevention and treatment of vascular disease and its sequelae; and the involvement of metabolic disorders, particularly diabetes.",Non-OADS,/arxiv_data1/oa_pdf/9f/12/vhrm-12-387.PMC5066985.pdf
Visit http://www.dovepress.com/   testimonials.php to read real quotes from published authors.Dovepress 392 Pozzi et al  12.,Non-OADS,/arxiv_data1/oa_pdf/9f/12/vhrm-12-387.PMC5066985.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/89/f5/ott-9-6297.PMC5066987.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 6297–6304OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  6297Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OTT .S11029 5 Prognostic value of endocan expression in  cancers: evidence from meta-analysis Xing Huang1,* Chen Chen2,* Xin wang3,* Jing-yuan Zhang1 Bin-hui Ren3,4 Da-wei Ma1 Lei Xia1 Xin-yu Xu1 Lin Xu3,4 1Department of Pathology, Nanjing  Medical University Affiliated Cancer  Hospital, 2Second Clinical College  of Nanjing Medical University,   3Department of Thoracic Surgery,   Nanjing Medical University  Affiliated Cancer Hospital, 4Jiangsu  Key Laboratory of Molecular and  Translational Cancer Research,   Nanjing Medical University Affiliated  Cancer Hospital, Nanjing, People’s  Republic of China *These authors contributed equally  to this workAbstract:  Endocan is a 50 kDa dermatan sulfate proteoglycan.",Non-OADS,/arxiv_data1/oa_pdf/89/f5/ott-9-6297.PMC5066987.pdf
"Materials and methods Search and selection process A systematic literature search was conducted of the PubMed, Embase, and China  National Knowledge Infrastructure databases, covering all relevant studies published Correspondence: Xin-yu Xu Department of Pathology, Nanjing  Medical University Affiliated Cancer  Hospital, Baiziting 42, Nanjing 210009,  People’s Republic of China Tel +86 25 135 8403 5663 email redxxy@163.co m  Lin Xu Department of Thoracic Surgery, Nanjing  Medical University Affiliated Cancer  Hospital, Baiziting 42, Nanjing 210009,  People’s Republic of China Tel +86 25 158 5068 5683 email xulin83cn@outlook.c om Journal name: OncoTargets and Therapy Article Designation: Review Y ear: 2016 Volume: 9 Running head verso: Huang et al Running head recto: Prognostic value of endocan in cancers DOI: http://dx.doi.org/10.2147/OTT.S110295",Non-OADS,/arxiv_data1/oa_pdf/89/f5/ott-9-6297.PMC5066987.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/89/f5/ott-9-6297.PMC5066987.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/89/f5/ott-9-6297.PMC5066987.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/45/d1/ott-9-6291.PMC5066988.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 6291–6296OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  6291Case repO rTopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S11249 8 primary adenoid cystic carcinoma of the trachea  with thyroid invasion: a case report and literature  review Dianjun Qi1 Liang Feng2 Jian Li3 Bing Liu4 Qingfu Zhang5 1Department of General practice,   2Department of Breast surgery,   3Department of radiology,   4Department of anorectal surgery,   The First affiliated Hospital of China  Medical University, 5Department of  pathology, The First affiliated Hospital  and College of Basic Medical sciences  of China Medical University, shenyang,   people’s republic of ChinaAbstract:  Primary adenoid cystic carcinoma (ACC) of the trachea with thyroid invasion is  very rare.",Non-OADS,/arxiv_data1/oa_pdf/45/d1/ott-9-6291.PMC5066988.pdf
"The subglottic tracheal Correspondence: Qingfu Zhang Department of pathology, The First  Affiliated Hospital and College of Basic  Medical sciences of China Medical  University, Number 155 Nanjing North  street, Heping District, shenyang 110001,  people’s republic of China email qfzhang@cmu.edu.c n Journal name: OncoTargets and Therapy Article Designation: Case report Y ear: 2016 Volume: 9 Running head verso: Qi et al Running head recto: Primary adenoid cystic carcinoma of the trachea with thyroid invasion DOI: http://dx.doi.org/10.2147/OTT.S112498",Non-OADS,/arxiv_data1/oa_pdf/45/d1/ott-9-6291.PMC5066988.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/45/d1/ott-9-6291.PMC5066988.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/45/d1/ott-9-6291.PMC5066988.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/56/d9/ott-9-6059.PMC5066989.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 6059–6063OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  6059Case repO rTopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S11283 3 a patient previously treated with aLK inhibitors  for central nervous system lesions from aLK  rearranged lung cancer: a case report Jumpei Kashima1 Yusuke Okuma1,2 Tsunekazu Hishima3 1Department of Thoracic Oncology  and respiratory Medicine, Tokyo  Metropolitan Cancer and Infectious  diseases Center Komagome Hospital;   2Division of Oncology, research  Center for Medical sciences, The  Jikei University school of Medicine;   3Department of pathology, Tokyo  Metropolitan Cancer and Infectious  diseases Center Komagome Hospital,   T okyo, JapanBackground:  Patients with anaplastic lymphoma kinase (ALK)-rearranged non-small-cell lung  cancer (NSCLC) are now preferentially treated with tyrosine kinase inhibitors (TKIs).",Non-OADS,/arxiv_data1/oa_pdf/56/d9/ott-9-6059.PMC5066989.pdf
"Among the patients enrolled in the PROFILE 1001 and 1005 studies in whom  the disease progression occurred, the most common site of single-organ progression  was the brain.3 Case reports have also shown a low level of cerebrospinal fluid (CSF)  concentrations of crizotinib (0.06%–0.26% of serum levels).4,5 Two mechanisms have  been suggested to explain the progression of tumors treated with crizotinib; these are  an acquired secondary mutation in the ALK gene that is known to confer resistance to  crizotinib, and activation of alternative tumor-growth pathways such as those involv - ing epidermal growth factor (EGFR) and KIT.6,7 Alectinib (CH5424802) has highly  selective inhibitory activity against ALK; a previous study has reported its effective - ness in patients pretreated with other ALK inhibitors, especially in those with brain  metastases.8 However, an in vitro study has shown that alectinib also induced other Correspondence: Yusuke Okuma Department of Thoracic Oncology  and respiratory Medicine, Tokyo  Metropolitan Cancer and Infectious  diseases Center Komagome Hospital,  3-18-22 Honkomagome, Bunkyo,  Tokyo 113-8677, Japan  Tel +81 3 3823 2101 Fax +81 3 3824 1552 email y-okuma@cick.j p Journal name: OncoTargets and Therapy Article Designation: Case report Y ear: 2016 Volume: 9 Running head verso: Kashima et al Running head recto: Rechallenge treatment with crizotinib for leptomeningeal carcinomatosis DOI: http://dx.doi.org/10.2147/OTT.S112833",Non-OADS,/arxiv_data1/oa_pdf/56/d9/ott-9-6059.PMC5066989.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/56/d9/ott-9-6059.PMC5066989.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/56/d9/ott-9-6059.PMC5066989.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/ef/6e/ott-9-6171.PMC5066990.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 6171–6176OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  6171Case seriesopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S10969 3 invasive atypical thymic carcinoid: three case  reports and literature review shan Zhu1,2 Zhong-Tang Wang2 Wen-Zhi Liu2,3 shi-Xiang Zong4 Bao-sheng Li2 1school of Medicine and Life sciences,   University of Jinan- shandong academy  of Medical sciences, 2Department  of radiotherapy, shandong Cancer  Hospital affiliated to shandong  University, Jinan, 3Department of  Clinical Oncology, Taian Central  Hospital, Taian, 4Jinan Hospital, Jinan,   shandong Province, People’s republic  of ChinaAbstract:  Atypical thymic carcinoid is an extremely rare thymic neuroendocrine tumor derived  from the neuroendocrine system.",Non-OADS,/arxiv_data1/oa_pdf/ef/6e/ott-9-6171.PMC5066990.pdf
"The study was approved by  the Ethical Committee of Shandong Cancer Hospital.Correspondence: Bao-sheng Li Department of radiotherapy, shandong  Cancer Hospital Affiliated to Shandong  University, Jiyan road 440, Jinan, 250117,  shandong Province, People’s republic  of China Tel +86 531 6762 6161 Fax +86 531 6762 6161 email baoshli1963@163.co m Journal name: OncoTargets and Therapy Article Designation: Case Series Y ear: 2016 Volume: 9 Running head verso: Zhu et al Running head recto: Atypical thymic carcinoid DOI: http://dx.doi.org/10.2147/OTT.S109693",Non-OADS,/arxiv_data1/oa_pdf/ef/6e/ott-9-6171.PMC5066990.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/ef/6e/ott-9-6171.PMC5066990.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/ef/6e/ott-9-6171.PMC5066990.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/b0/56/ott-9-6257.PMC5066991.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 6257–6263OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  6257Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S11169 1 epidermal growth factor receptor and B7-h3  expression in esophageal squamous tissues  correlate to patient prognosis Jianxiang song1,2,* Woda shi1,2,* Yajun Zhang2 Mingzhong sun3 Xiaodong liang3,4 shiying Zheng1 1Department of cardiothoracic  surgery, The First affiliated hospital  of soochow University, suzhou,   Jiangsu Province, People’s republic of  china; 2Department of cardiothoracic  surgery, 3Department of clinical  laboratory, 4Department of Pathology,   The Third People’s hospital of  Yancheng city, Yancheng, Jiangsu  Province, People’s republic of china *These authors contributed equally  to this workAbstract:  Biomarkers that can serve as diagnostic and prognostic indicators of esophageal  squamous cell carcinoma (ESCC) are urgently needed to help improve patient outcomes.",Non-OADS,/arxiv_data1/oa_pdf/b0/56/ott-9-6257.PMC5066991.pdf
"correspondence: shiying Zheng Department of cardiothoracic surgery,  The First Affiliated Hospital of Soochow  University, no 188, shizi street, suzhou,  Jiangsu Province 215006, People’s  republic of china Tel +86 512 6678 0195 email syzheng88@sina.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Song et al Running head recto: EGFR and B7-H3 in ESCC DOI: http://dx.doi.org/10.2147/OTT.S111691",Non-OADS,/arxiv_data1/oa_pdf/b0/56/ott-9-6257.PMC5066991.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/b0/56/ott-9-6257.PMC5066991.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/b0/56/ott-9-6257.PMC5066991.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/3e/0b/tcrm-12-1533.PMC5066992.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Therapeutics and Clinical Risk Management 2016:12 1533–1543Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  1533ORiginal ReseaRChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/TCRM.S11715 0 impact of statins on risk of new onset diabetes  mellitus: a population-based cohort study using  the Korean national health insurance claims  database Jimin lee1 Y oojin noh1 sooyoung shin1 hong-seok lim2 Rae Woong Park3 soo Kyung Bae4 euichaul Oh4 grace Juyun Kim5 Ju han Kim5 sukhyang lee1 1Division of Clinical Pharmacy,   College of Pharmacy, ajou University,   suwon, south Korea; 2Department  of Cardiology, school of Medicine,   ajou University, suwon, south  Korea; 3Department of Biomedical  informatics, school of Medicine,   ajou University, suwon, south Korea;   4Division of Pharmaceutical sciences,   College of Pharmacy, The Catholic  University of Korea, Bucheon, south  Korea; 5Division of Biomedical  informatics, College of Medicine,   seoul national University, seoul,   south KoreaAbstract:  Statin therapy is beneficial in reducing cardiovascular events and mortalities in  patients with atherosclerotic cardiovascular diseases.",Non-OADS,/arxiv_data1/oa_pdf/3e/0b/tcrm-12-1533.PMC5066992.pdf
"The Expert Panel identified specific patient  groups who are most likely to benefit from statin therapy and recommended initiation  of moderate- or high-intensity statin therapy based on the patient’s risk profile.1 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitors, statins,  are proven to reduce major cardiovascular outcomes,2–4 but there are concerns regarding Correspondence: sukhyang lee Department of Clinical Pharmacy,  College of Pharmacy, ajou University,  206 Worldcup-ro Yeongtong-gu,  suwon 443-749, south Korea Tel +82 31 219 3443 Fax +82 31 219 3435 email suklee@ajou.ac.k r Journal name: Therapeutics and Clinical Risk Management Article Designation: Original Research Y ear: 2016 Volume: 12 Running head verso: Lee et al Running head recto: Impact of statins on risk of new onset diabetes mellitus DOI: http://dx.doi.org/10.2147/TCRM.S117150",Non-OADS,/arxiv_data1/oa_pdf/3e/0b/tcrm-12-1533.PMC5066992.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/3e/0b/tcrm-12-1533.PMC5066992.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/3e/0b/tcrm-12-1533.PMC5066992.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/68/47/ott-9-6127.PMC5066993.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 6127–6135OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  6127Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S8777 8 Prognostic value of microrna-126 and crK  expression in gastric cancer shun Yue1,* huichang shi2,* Jun han3 Tiecheng Zhang1 Weiguo Zhu1 Dahong Zhang1 1Department of Medical Oncology,   huai’an First People’s hospital,   nanjing Medical University, huai’an  city, 2Department of Medical  Oncology, The second People’s  hospital of huai’an, huai’an city,   3Department of Medical Oncology,   Qinghai Province People’s hospital,   Xining city, People’s republic of  china *These authors contributed equally  to this workBackground:  MicroRNA (miR)-126, acting as a tumor suppressor, has been reported to inhibit  the invasion of gastric cancer cells in part by targeting v-crk sarcoma virus CT10 oncogene  homologue (CRK).",Non-OADS,/arxiv_data1/oa_pdf/68/47/ott-9-6127.PMC5066993.pdf
"MicroRNAs (miRNAs), a class of noncoding small molecular single-chain RNAs  including 18–25 nucleotides, have highly conservative, temporal, and tissue-specific correspondence: Dahong Zhang Department of Medical Oncology,  huai’an First People’s hospital, nanjing  Medical University, 6 Beijing road  West, huai’an city, huai’an 223300,  People’s republic of china Tel +86 138 5249 6073 Fax +86 517 8492 2412 email zhangdahong73@126.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Yue et al Running head recto: miR-126/CRK in gastric cancer DOI: http://dx.doi.org/10.2147/OTT.S87778",Non-OADS,/arxiv_data1/oa_pdf/68/47/ott-9-6127.PMC5066993.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/68/47/ott-9-6127.PMC5066993.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/68/47/ott-9-6127.PMC5066993.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/ed/03/opth-10-1977.PMC5066994.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2016:10 1977–1981Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1977Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S11649 8 residual stromal bed thickness correlates with  regression of myopia after lasiK Kosuke Ogasawara Tsuyoshi Onodera Ogasawara eye Clinic, Morioka, JapanPurpose:  The purpose of this study was to evaluate the correlation between residual stromal  bed thickness (hereinafter bed thickness) and regression of myopia after LASIK, taking into  consideration the long-term outcomes.",Non-OADS,/arxiv_data1/oa_pdf/ed/03/opth-10-1977.PMC5066994.pdf
"These patients were also Correspondence: Kosuke Ogasawara Ogasawara eye Clinic, 3-10-12,  Takamatsu, Morioka 020-0114, Japan Tel +81 196 62 3223 Fax +81 196 62 7331 email oga-koke@diamond.broba.c c Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Ogasawara and Onodera Running head recto: Correlation with residual stromal bed thickness and regression of myopia DOI: http://dx.doi.org/10.2147/OPTH.S116498",Non-OADS,/arxiv_data1/oa_pdf/ed/03/opth-10-1977.PMC5066994.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/ed/03/opth-10-1977.PMC5066994.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/ed/03/opth-10-1977.PMC5066994.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/92/9e/opth-10-1965.PMC5066995.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2016:10 1965–1970Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1965Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S11489 0 Causes and correction of dissatisfaction after  implantation of presbyopia-correcting intraocular  lenses allister gibbons Tayyeba K ali Daniel P Waren Kendall e Donaldson Department of Ophthalmology,   Bascom Palmer eye institute,   University of Miami Miller school  of Medicine, Miami, Fl, UsaPurpose:  The purpose of this study was to assess the causes and possible solutions for patient  dissatisfaction after the implantation of presbyopia-correcting intraocular lenses (IOLs).",Non-OADS,/arxiv_data1/oa_pdf/92/9e/opth-10-1965.PMC5066995.pdf
"Typically, options  include monovision or presbyopia-correcting IOLs (PC-IOL).1 It has been reported  that monovision has a lower rate of explantation, but PC-IOLs might achieve higher  rates of spectacle independence for near tasks.2 Most patients who undergo PC-IOL implantation are satisfied with the results.3  In spite of optical tradeoffs, like lower contrast sensitivity or photic phenomena  expected after their implantation, most patients either do not notice these aberra - tions or understand the compromise in quality that was required to achieve spectacle  independence.4–8Correspondence: Kendall e Donaldson Department of Ophthalmology, Bascom  Palmer eye institute, University of Miami  Miller school of Medicine, 3rd Floor,  Crossroads Business Park Building 3,  Plantation, Fl 33324, Usa Tel +1 954 465 2700 Fax +1 954 465 2725 email kdonaldson@med.miami.ed uJournal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Gibbons et al Running head recto: Presbyopia-correcting intraocular lenses DOI: http://dx.doi.org/10.2147/OPTH.S114890",Non-OADS,/arxiv_data1/oa_pdf/92/9e/opth-10-1965.PMC5066995.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/92/9e/opth-10-1965.PMC5066995.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/92/9e/opth-10-1965.PMC5066995.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/94/12/tcrm-12-1525.PMC5066996.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Therapeutics and Clinical Risk Management 2016:12 1525–1532Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  1525ORiginal ReseaRChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/TCRM.S11376 4 Mathematical evaluation of the influence of  multiple factors on implant stability quotient  values in clinical practice: a retrospective study hairong huang1 Daniel Wismeijer1 Xianhong shao2 gang Wu1 1Department of Oral implantology  and Prosthetic Dentistry, academic  Centre for Dentistry amsterdam  (aCTa), MOV e Research institute, VU  University amsterdam and University  of amsterdam, amsterdam, nord- holland, the n etherlands; 2Best &   easy Dental Clinic, hangzhou,   Zhejiang Province, People’s Republic  of ChinaObjectives:  The objective of this study is to mathematically evaluate the influence of multiple  factors on implant stability quotient values in clinical practice.",Non-OADS,/arxiv_data1/oa_pdf/94/12/tcrm-12-1525.PMC5066996.pdf
"The secondary stability is achieved by a biological healing  process – called osseointegration – and it forms a direct structural and functional con - nection between the implant and the neoformed surrounding bone tissues, without any  interpositioned connective tissue.2 In clinical practice, the degree of implant stability is  considered to be an important parameter to estimate the scope of mechanical loading Correspondence: Xianhong shao Best & easy Dental Clinic, Tiyuchang  Road 333, hangzhou 310006, Zhejiang  Province, People’s Republic of China Tel +86 571 8735 0666 Fax +86 571 8735 0760 email anderson6710@hotmail.co m  gang Wu Department of Oral implantology  and Prosthetic Dentistry, academic  Centre for Dentistry amsterdam  (aCTa), MOVe Research institute,  VU University amsterdam and University  of amsterdam, gustav Mahlerlaan 3004,  1081la amsterdam, nord-holland,  the netherlands Tel +31 20 598 0866 Fax +31 20 598 0333 email g.wu@acta.n lJournal name: Therapeutics and Clinical Risk Management Article Designation: Original Research Y ear: 2016 Volume: 12 Running head verso: Huang et al Running head recto: Mathematical assessment of influencing factors for ISQ values DOI: http://dx.doi.org/10.2147/TCRM.S113764",Non-OADS,/arxiv_data1/oa_pdf/94/12/tcrm-12-1525.PMC5066996.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/94/12/tcrm-12-1525.PMC5066996.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/94/12/tcrm-12-1525.PMC5066996.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/75/cd/ott-9-6147.PMC5066997.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 6147–6150OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  6147Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S11529 4 chemotherapy combined with high-dose  extended-field radiotherapy for stage I extranodal  nasal-type natural killer/T -cell lymphoma Jialin luo* caineng cao* Yuan Zhu Peng liu luying liu Ke lu na Zhang ning Zhou Department of Radiation Oncology,   Zhejiang Cancer Hospital, Zhejiang  Key Laboratory of Radiation  Oncology, Hangzhou, People’s  Republic of China *These authors contributed equally  to this workBackground and objective:  The objective of the study was to evaluate the efficiency of  chemotherapy (CT) combined with high-dose extended-field radiotherapy (RT) in stage I  extranodal nasal-type natural killer/T-cell lymphoma (NKTCL).",Non-OADS,/arxiv_data1/oa_pdf/75/cd/ott-9-6147.PMC5066997.pdf
"Patient consent was waived and patient records were  deidentified and anonymized prior to analysis.correspondence: Yuan Zhu Department of Radiation Oncology,  Zhejiang Cancer Hospital, Zhejiang  Key Laboratory of Radiation Oncology,  No 38, Guangji Road, Hangzhou 310022,  People’s Republic of China Tel +86 571 8812 8148 Fax +86 571 8812 2062 email zhuyuan201412@163.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Luo et al Running head recto: Chemotherapy with radiotherapy in stage I extranodal nasal-type NKTCL DOI: http://dx.doi.org/10.2147/OTT.S115294",Non-OADS,/arxiv_data1/oa_pdf/75/cd/ott-9-6147.PMC5066997.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/75/cd/ott-9-6147.PMC5066997.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/75/cd/ott-9-6147.PMC5066997.pdf
"Available at: http://www.nccn.org/professionals/ physician_gls /f_guidelines.asp#nh l. Accessed June 27, 2015.",Non-OADS,/arxiv_data1/oa_pdf/75/cd/ott-9-6147.PMC5066997.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/16/65/ott-9-6265.PMC5066998.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 6265–6272OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  6265Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OTT .S10080 6 Locally advanced rectal cancer: management  challenges RF Kokelaar MD evans M Davies DA Harris J Beynon Department of Colorectal Surgery,   Singleton Hospital, Swansea, UKAbstract:  Between 5% and 10% of patients with rectal cancer present with locally advanced  rectal cancer (LARC), and 10% of rectal cancers recur after surgery, of which half are limited  to locoregional disease only (locally recurrent rectal cancer).",Non-OADS,/arxiv_data1/oa_pdf/16/65/ott-9-6265.PMC5066998.pdf
"Keywords:  rectal cancer, exenteration, pelvic sidewall, sacrectomy Introduction In the UK, 14,000 new cases of rectal cancer are diagnosed every year, and 40,000  in the US, of which between 5% and 10% are locally invasive (T4) at presentation.1,2  Tumors extending beyond the total mesorectal excision (TME) plane may be suit - able for a multivisceral approach if a complete (R0) resection is achievable.3–5 An R0  resection is the single greatest predictor of outcome after surgery for rectal cancer, and  any surgery must be undertaken with the intention of achieving histologically clear  resection margins.4–7 Unfortunately, despite optimal surgery and adjuvant therapies,  10% of patients experience a local recurrence, of which approximately half will have  a locoregional disease only.8 The surgical management of locally advanced (LARC) and locally recurrent rectal  cancers (LRRC) has developed since Brunschwig first described pelvic exenteration for  cervical cancer in 1948.9 Currently, the 5-year survival rate for LARC is between 52%  and 65%,10,11 but is significantly lower in LRRC where 5-year survival is between 35%  and 50%.12,13 Survival for both LARC and LRRC is still worse if the tumor is not  centrally located in the pelvis, especially if it extends to the pelvic sidewall or high  sacrum where it is usually deemed inoperable.14Correspondence: RF Kokelaar Department of Colorectal Surgery,  Singleton Hospital, Sketty Lane, Sketty,  Swansea SA2 8QA, UK Tel +44 1792 285030 email rory.kokelaar@wales.nhs.u kJournal name: OncoTargets and Therapy Article Designation: Review Y ear: 2016 Volume: 9 Running head verso: Kokelaar et al Running head recto: Evolving techniques in anatomically unfavorable rectal cancer surgery DOI: http://dx.doi.org/10.2147/OTT.S100806",Non-OADS,/arxiv_data1/oa_pdf/16/65/ott-9-6265.PMC5066998.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/16/65/ott-9-6265.PMC5066998.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/16/65/ott-9-6265.PMC5066998.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/51/70/tcrm-12-1517.PMC5066999.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Therapeutics and Clinical Risk Management 2016:12 1517–1524Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  1517ORiginal ReseaRChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/TCRM.S11678 9 inappropriateness of medication prescriptions  about chronic kidney disease patients without  dialysis therapy in a Chinese tertiary teaching  hospital Ping Yang na Chen  Rong-Rong Wang  lu li  sai-Ping Jiang Department of Pharmacy, The  First affiliated hospital, College  of Medicine, Zhejiang University,   hangzhou, People’s Republic of ChinaBackground:  With the increasing incidence rate of chronic kidney disease (CKD), inappropri - ate use of medicine in CKD patients is an important issue, as it may cause adverse effects in  patients and progression to chronic renal failure.",Non-OADS,/arxiv_data1/oa_pdf/51/70/tcrm-12-1517.PMC5066999.pdf
"Keywords:  inappropriateness of medication prescriptions, chronic kidney disease, unreasonable  dosage medicines, contraindicated used medicines, cautiously used medicines Introduction Chronic kidney disease (CKD) is defined as abnormalities in kidney structure or  function that have been present for over 3 months, with implications for health.1,2 All  stages of CKD are associated with increased health care use and Medicare expenditure.3  At present, the incidence of CKD is rapidly increasing.4 It has been reported that  there is one medication-related problem for every 2.7 dialysis patients.5 Despite  widespread evidence in the literature, dosing errors in patients with CKD still occur  at an alarming rate.6Correspondence: sai-Ping Jiang Department of Pharmacy, The First  Affiliated Hospital, College of Medicine,  Zhejiang University, 79 Qingchun Road,  hangzhou, 310003, People’s Republic  of China Tel +86 571 8723 3411 Fax +86 571 8723 3411 email j5145@126.co m Journal name: Therapeutics and Clinical Risk Management Article Designation: Original Research Y ear: 2016 Volume: 12 Running head verso: Y ang et al Running head recto: Prescription inappropriateness on kidney disease patients without dialysis DOI: http://dx.doi.org/10.2147/TCRM.S116789",Non-OADS,/arxiv_data1/oa_pdf/51/70/tcrm-12-1517.PMC5066999.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/51/70/tcrm-12-1517.PMC5066999.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/51/70/tcrm-12-1517.PMC5066999.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/0a/39/ott-9-6225.PMC5067000.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 6225–6231OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  6225Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S11319 4 Differential expression of two activating  transcription factor 5 isoforms in papillary  thyroid carcinoma luisa Vicari1,* cristina la rosa2,3,* stefano Forte1 giovanna calabrese1 cristina colarossi2 eleonora aiello2 salvatore salluzzo2 lorenzo Memeo1,2 1iOM ricerca srl, Viagrande cT,   italy; 2Department of experimental  Oncology, istituto Oncologico  del Mediterraneo, Viagrande cT,   italy; 3Department of hematology,   Oncology and Molecular Medicine,   istituto superiore di sanità,   roma, italy *These authors contributed equally  to this workBackground:  Activating transcription factor 5 ( ATF5 ) is a member of the activating  transcription/cAMP response element-binding protein family of basic leucine zipper proteins  that plays an important role in cell survival, differentiation, proliferation, and apoptosis.",Non-OADS,/arxiv_data1/oa_pdf/0a/39/ott-9-6225.PMC5067000.pdf
com Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Vicari et al Running head recto: Expression of two ATF5 isoforms in PTC DOI: http://dx.doi.org/10.2147/OTT.S113194,Non-OADS,/arxiv_data1/oa_pdf/0a/39/ott-9-6225.PMC5067000.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/0a/39/ott-9-6225.PMC5067000.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/0a/39/ott-9-6225.PMC5067000.pdf
Available at https://www.R-project.org /.,Non-OADS,/arxiv_data1/oa_pdf/0a/39/ott-9-6225.PMC5067000.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/1a/3a/ott-9-6203.PMC5067001.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 6203–6210OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  6203Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S10871 2 mir-203 facilitates tumor growth and metastasis  by targeting fibroblast growth factor 2 in breast  cancer shuqian he guihui Zhang he Dong Maoqiang Ma Qing sun Department of Pathology, Qianfoshan  hospital affiliated to shandong  University, Jinan, shandong, People’s  republic of chinaAbstract:  Breast cancer is the second leading cause of cancer mortality in women worldwide.",Non-OADS,/arxiv_data1/oa_pdf/1a/3a/ott-9-6203.PMC5067001.pdf
"miRNAs  mediate posttranslational regulation via base pairing with target messenger RNAs,5  thereby playing an important role in the control of cancer cell growth.6–8 A number  of studies have demonstrated that the expression levels of miRNAs are significantly  changed in at least one tumor type, and the regulation of miRNAs is closely related  to the proliferation and transformation of cancer cells.9 For instance, miR-15a and  miR-16-1 were shown to be downregulated in patients with B-cell chronic lympho - cytic leukemia, while miR-21 was found to be upregulated in human non-small cell  lung cancer.10,11 As the first skin-specific miRNA reported recently, miR-203 not only  involved in regulating embryonic epidermal differentiation, building the protective  layer of skin as well as skin diseases such as psoriasis but also participated in cancer correspondence: Qing sun Department of Pathology, Qianfoshan  Hospital Affiliated to Shandong  University, no 16766, Jingshi road,  Jinan shandong 250014, People’s  republic of china Tel +86 531 8926 8155 Fax +86 531 8926 8191 email sq167660@163.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: He et al Running head recto: Function of miR-203 in breast cancer DOI: http://dx.doi.org/10.2147/OTT.S108712",Non-OADS,/arxiv_data1/oa_pdf/1a/3a/ott-9-6203.PMC5067001.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/1a/3a/ott-9-6203.PMC5067001.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/1a/3a/ott-9-6203.PMC5067001.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/ce/90/ppa-10-2091.PMC5067002.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Patient Preference and Adherence 2016:10 2091–2096Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  2091Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S11743 7 interventions to increase adherence to acne  treatment Sara Moradi T uchayi1 Tiffany M Alexander2 Anish Nadkarni1 Steven R Feldman1,3,4 1Center for Dermatology Research,   Department of Dermatology,  wake  Forest University School of  Medicine, winston-Salem, NC,   2Howard University College  of Medicine, washington, DC,   3Department of Public Health  Sciences, 4Department of Pathology,   wake Forest University  School of  Medicine,  winston-Salem, NC, USABackground:  Adherence to acne medication is poor and is a major reason why treatment plans  are ineffective.",Non-OADS,/arxiv_data1/oa_pdf/ce/90/ppa-10-2091.PMC5067002.pdf
"In PubMed, the search (“acne vulgaris” [all fields] OR Correspondence: Sara Moradi Tuchayi Department of Dermatology,  wake Forest University School of  Medicine, 4618 Country Club Road,  winston-Salem, NC 27104, USA Tel +1 336 716 1763 Fax +1 336 716 7732 email samo_1985@yahoo.co m Journal name: Patient Preference and Adherence Article Designation: Review Y ear: 2016 Volume: 10 Running head verso: Moradi Tuchayi et al Running head recto: Interventions to increase adherence to acne treatment DOI: http://dx.doi.org/10.2147/PPA.S117437",Non-OADS,/arxiv_data1/oa_pdf/ce/90/ppa-10-2091.PMC5067002.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/ce/90/ppa-10-2091.PMC5067002.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/0c/15/opth-10-1931.PMC5067003.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2016:10 1931–1937Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1931Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S11740 3 Outcomes of combined trabecular micro-bypass  and phacoemulsification in a predominantly  hispanic patient population Mark J gallardo1,2 richard a supnet1 Jane ellen giamporcaro3 Dana M hornbeak3 1el Paso eye surgeons, P a, el Paso,   2Department of Ophthalmology,   University of Texas health science  Center at san antonio, san antonio,   TX, 3Division of Clinical research and  Medical affairs, glaukos Corporation,   laguna hills, C a, UsaPurpose:  The purpose of this study was to evaluate intraocular pressure (IOP) and topical ocular  hypotensive medication burden at 12 months postoperatively in a predominantly Hispanic patient  population with primary open-angle glaucoma each implanted with one trabecular micro-bypass  stent during cataract surgery.",Non-OADS,/arxiv_data1/oa_pdf/0c/15/opth-10-1931.PMC5067003.pdf
"However, the compliance issues and complications associated with Correspondence: Mark J gallardo el Paso eye surgeons, Pa, 1201   north Mesa street, suite g, el Paso,   TX 79902, Usa Tel +1 915 542 0279 Fax +1 915 542 0156 email gallardomark@hotmail.co m Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Gallardo et al Running head recto: Trabecular micro-bypass in a Hispanic population DOI: http://dx.doi.org/10.2147/OPTH.S117403",Non-OADS,/arxiv_data1/oa_pdf/0c/15/opth-10-1931.PMC5067003.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/0c/15/opth-10-1931.PMC5067003.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/0c/15/opth-10-1931.PMC5067003.pdf
"Avail - able from: http://micromedex.com/products/product-suites/clinical- knowledge/redboo k. Accessed July 6, 2016.",Non-OADS,/arxiv_data1/oa_pdf/0c/15/opth-10-1931.PMC5067003.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/0f/6c/ott-9-6137.PMC5067004.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 6137–6145OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  6137Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S11807 1 effectiveness of tyrosine kinase inhibitors on  uncommon e709X epidermal growth factor  receptor mutations in non-small-cell lung cancer Jenn-Yu Wu1 Jin-Yuan shih2 1Department of internal Medicine,   national Taiwan University hospital  Yun-lin Branch, Yun-lin, Taiwan;   2Department of internal Medicine,   national Taiwan University hospital,   and college of Medicine, national  Taiwan University, Taipei, TaiwanBackground:  Clinical features of epidermal growth factor receptor (EGFR) mutations: L858R,  deletions in exon 19, T790M, insertions in exon 20, G719X, and L861X in non-small-cell lung  cancer (NSCLC) are well-known.",Non-OADS,/arxiv_data1/oa_pdf/0f/6c/ott-9-6137.PMC5067004.pdf
"Keywords:  EGFR, erlotinib, gefitinib, lung cancer, mutations Introduction Mutations of the epidermal growth factor receptor (EGFR) have influenced the treat - ment decisions in patients with non-small-cell lung cancer (NSCLC) in the recent years.1  EGFR  mutations were found in 30% to 60% of Asian patients and in 10% to 20% of  Caucasian patients with NSCLC.2–4 Apart from their association with ethnicity, EGFR   mutations occur more frequently in NSCLC of never smokers, females, and adenocar - cinoma cell type.5,6 The EGFR tyrosine kinase inhibitors (TKIs), such as erlotinib or  gefitinib, are highly active against advanced NSCLC with EGFR  mutations.7,8 EGFR  mutations exist in exons 18 to 21, and the two major EGFR  mutations are  deletions in exon 19 and L858R in exon 219,10 which constitute about 80% to 90%  of total EGFR  mutations.2–4,11,12 In addition to deletions in exon 19 and L858R, other  categories of EGFR  mutations, which are also well-known, are T790M,13,14 inser - tions (or in-frame duplications) in exon 20,15,16 G719X and L861X.17 T790M can be correspondence: Jin-Yuan shih Department of internal Medicine,  national Taiwan University hospital,  no 7 chung-shan south road,  Taipei, Taiwan Tel +886 2 2356 2905 Fax +886 2 2358 2867 email jyshih@ntu.edu.t w Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Wu and Shih Running head recto: E709X EGFR  mutations DOI: http://dx.doi.org/10.2147/OTT.S118071",Non-OADS,/arxiv_data1/oa_pdf/0f/6c/ott-9-6137.PMC5067004.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/0f/6c/ott-9-6137.PMC5067004.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/0f/6c/ott-9-6137.PMC5067004.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/b3/db/ott-9-6247.PMC5067005.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 6247–6255OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  6247Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S10365 0 mir-144 functions as a tumor suppressor in  breast cancer through inhibiting ZeB1/2-mediated  epithelial mesenchymal transition process Yuliang Pan1,2 Jun Zhang1 huiqun Fu1 liangfang shen2 1Department of Oncology, The Third  Xiangya hospital of central south  University, changsha, hunan, People’s  republic of china; 2Department of  Oncology radiotherapy, Xiangya  hospital of central south University,   changsha, hunan, People’s republic  of chinaAbstract:  Breast cancer is the most common cancer in women worldwide.",Non-OADS,/arxiv_data1/oa_pdf/b3/db/ott-9-6247.PMC5067005.pdf
"Local invasion, metastasis, and chemotherapy resistance are the obstacles for treat - ment of breast cancer.3 These processes are involved in many gene dysregulations,  including coding RNA and noncoding RNA, such as microRNAs (miRNAs).4 miRNAs  are able to silence gene expression by targeting complementary regions of messenger  RNAs (mRNAs) and inhibiting protein translation, which is critical in the development  and the acquisition of malignancy in breast cancer.5 For example, upregulation of miR- 125b conferred a chemoresistant phenotype by targeting Bcl-2 antagonist killer 1, and  maintaining cancer stem-like side population fraction.6–8 Decreased levels of miR-144  in whole blood are observed in at least 13 different cancer and noncancer diseases,  representing the most nonspecific miRNAs, and these results have been validated  in a cohort of 319 samples in three different centers.9 By computational analysis, correspondence: liangfang shen Department of Oncology radiotherapy,  Xiangya hospital of central south  University, 87 Xiangya road, changsha,  hunan 410008, People’s republic  of china email shenliangfang123@sina.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Pan et al Running head recto: Role of miR-144 in breast cancer DOI: http://dx.doi.org/10.2147/OTT.S103650",Non-OADS,/arxiv_data1/oa_pdf/b3/db/ott-9-6247.PMC5067005.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/b3/db/ott-9-6247.PMC5067005.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/b3/db/ott-9-6247.PMC5067005.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/dd/f4/ott-9-6177.PMC5067006.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 6177–6185OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  6177Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S11385 5 Biomarker discovery to improve prediction of  breast cancer survival: using gene expression  profiling, meta-analysis, and tissue validation liwei Meng Yingchun Xu chaoyang Xu Wei Zhang Department of Breast and Thyroid  Surgery, Shaoxing People’s Hospital,   shaoxing hospital of Zhejiang  University, Shaoxing, Zhejiang,   People’s Republic of ChinaPurpose:  Breast cancer is the leading cause of cancer death worldwide in women.",Non-OADS,/arxiv_data1/oa_pdf/dd/f4/ott-9-6177.PMC5067006.pdf
"Breast cancer type and cancer grade are two of the most vital character - istics, and they are the best-established prognostic factors in breast cancer.1–5 Approximately 45%–78% of all invasive breast cancers are associated with ductal  carcinoma in situ (DCIS).6 Invasive ductal carcinoma (IDC) always requires radical  treatment, chemotherapy, and radiotherapy, but conservative treatment is usually correspondence: Wei Zhang Department of Breast and Thyroid  Surgery, Shaoxing People’s Hospital,  shaoxing hospital of Zhejiang  University, 568 Zhongxing North  Road, Shaoxing, Zhejiang 312000,  People’s Republic of China email wzshaoxing@163.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Meng et al Running head recto: Biomarker discovery in IDCs DOI: http://dx.doi.org/10.2147/OTT.S113855",Non-OADS,/arxiv_data1/oa_pdf/dd/f4/ott-9-6177.PMC5067006.pdf
Materials and methods Microarray data analysis of breast cancer Affymetrix Human Genome U133plus2 Array for breast  cancer gene expression microarray and corresponding  clinical data used in this study were downloaded from the publicly available GEO databases ( http://www.ncbi.nlm.nih.,OADS,/arxiv_data1/oa_pdf/dd/f4/ott-9-6177.PMC5067006.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/dd/f4/ott-9-6177.PMC5067006.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/dd/f4/ott-9-6177.PMC5067006.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/98/be/ott-9-6111.PMC5067007.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 6111–6117OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  6111Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S11360 6 association of preoperative levels of selected  blood inflammatory markers with prognosis  in gliomas raushan auezova1 Nurzhan Ryskeldiev1 Aidos Doskaliyev1 Yerbol Kuanyshev1 Berik Zhetpisbaev1 nurgul aldiyarova1 natalia ivanova2 Serik Akshulakov1 lizette auezova3 1Department of Pathology of the  central nervous system, national  centre for neurosurgery, astana,   Kazakhstan; 2Polenov russian  scientific research institute of  neurosurgery (a branch of Federal  almazov north-West Medical  research centre), Ministry of  health of the russian Federation,   Saint-Petersburg, Russia; 3Bioactive  Molecules research group,   Department of chemistry and  Biochemistry, Faculty of sciences-ii,   lebanese University, Beirut, lebanonBackground:  Red cell distribution width (RDW), neutrophil–lymphocyte ratio (NLR), and  platelet count (PLT) routinely tested as part of the complete blood count are indicative of  systemic inflammation.",Non-OADS,/arxiv_data1/oa_pdf/98/be/ott-9-6111.PMC5067007.pdf
"The prognostic role of NLR, the most studied parameter, was shown in multiple  malignancies; a meta-analysis of 100 studies comprising 40,559 patients with different correspondence: lizette auezova Bioactive Molecules research group,  Department of chemistry and  Biochemistry, Faculty of sciences-ii,  lebanese University, Fanar, Beirut,  lebanon Tel +961 70 172 208 email auezova_l@hotmail.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Auezova et al Running head recto: Survival analysis in gliomas DOI: http://dx.doi.org/10.2147/OTT.S113606",Non-OADS,/arxiv_data1/oa_pdf/98/be/ott-9-6111.PMC5067007.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/98/be/ott-9-6111.PMC5067007.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/98/be/ott-9-6111.PMC5067007.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/04/f8/ott-9-6119.PMC5067010.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 6119–6125OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  6119Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OTT .S7703 3 impact of palbociclib combinations on treatment  of advanced estrogen receptor-positive/human  epidermal growth factor 2-negative breast cancer Katalin Boér Department of Medical Oncology,   Szent Margit Hospital, Budapest,   HungaryAbstract:  Breast cancer is a heterogeneous disease with multiple subgroups based on clinical  and molecular characteristics.",Non-OADS,/arxiv_data1/oa_pdf/04/f8/ott-9-6119.PMC5067010.pdf
"Sequential hormone  therapy (alone or in combination) should be used as initial treatment, except in cases Correspondence: Katalin Boér Department of Medical Oncology, Szent  Margit Hospital, No 132 Bécsi Street,  Budapest 1032, Hungary Tel +36 1 250 2420 Fax +36 1 368 6665 email katalin.boer@t-online.h u Journal name: OncoTargets and Therapy Article Designation: Review Y ear: 2016 Volume: 9 Running head verso: Boér Running head recto: Palbociclib combinations on treatment of advanced breast cancer DOI: http://dx.doi.org/10.2147/OTT.S77033 Point your SmartPhone at the code above.",Non-OADS,/arxiv_data1/oa_pdf/04/f8/ott-9-6119.PMC5067010.pdf
Or use: http://youtu.be/PmoHtf8pc5 Mvideo abstract,Non-OADS,/arxiv_data1/oa_pdf/04/f8/ott-9-6119.PMC5067010.pdf
"Available from: http://www.fda.gov/NewsEvents/Newsroom/ PressAnnouncements/ucm432871.ht m. Accessed January 26, 2015.",Non-OADS,/arxiv_data1/oa_pdf/04/f8/ott-9-6119.PMC5067010.pdf
Available from: https://clinicaltrials.gov/ct2/show/NCT0251339 4.,Non-OADS,/arxiv_data1/oa_pdf/04/f8/ott-9-6119.PMC5067010.pdf
Available from: https://clinicaltrials.gov/ct2/ show/NCT0229680 1.,Non-OADS,/arxiv_data1/oa_pdf/04/f8/ott-9-6119.PMC5067010.pdf
Available from: https://clinicaltrials.gov/ct2/show/NCT0249198 3.,Non-OADS,/arxiv_data1/oa_pdf/04/f8/ott-9-6119.PMC5067010.pdf
Available from: https://clinicaltrials.gov/ct2/show/NCT0244194 6.,Non-OADS,/arxiv_data1/oa_pdf/04/f8/ott-9-6119.PMC5067010.pdf
Available from: https://clinicaltrials.gov/ct2/show/NCT0210249 0.,Non-OADS,/arxiv_data1/oa_pdf/04/f8/ott-9-6119.PMC5067010.pdf
Available from: https://clinicaltrials.gov/ ct2/show/NCT0230802 0.,Non-OADS,/arxiv_data1/oa_pdf/04/f8/ott-9-6119.PMC5067010.pdf
Available from: https://clinicaltrials.gov/ct2/ show/NCT0191922 9.,Non-OADS,/arxiv_data1/oa_pdf/04/f8/ott-9-6119.PMC5067010.pdf
Available from:  https://clinicaltrials.gov/ct2/show/NCT0195802 1.,Non-OADS,/arxiv_data1/oa_pdf/04/f8/ott-9-6119.PMC5067010.pdf
Available from: https://clinicaltrials.gov/ct2/show/NCT0242261 5.,Non-OADS,/arxiv_data1/oa_pdf/04/f8/ott-9-6119.PMC5067010.pdf
Available from: http://clinicaltrials.gov/ct2/show/NCT0202850 7.,Non-OADS,/arxiv_data1/oa_pdf/04/f8/ott-9-6119.PMC5067010.pdf
Available  from: https://clinicaltrials.gov/ct2/show/NCT0269048 0.,Non-OADS,/arxiv_data1/oa_pdf/04/f8/ott-9-6119.PMC5067010.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/04/f8/ott-9-6119.PMC5067010.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/04/f8/ott-9-6119.PMC5067010.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/7b/b2/ott-9-6195.PMC5067011.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 6195–6201OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  6195Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S11530 9 everolimus enhances cellular cytotoxicity of  lapatinib via the eukaryotic elongation factor-2  kinase pathway in nasopharyngeal carcinoma cells lin liu1,* Zhi-hui Wang1,* Jun han1 con Tang2 nan chen1 Zhong lin1 Pei-Jian Peng1,* 1Department of Medical Oncology,   2Department of surgical Oncology,   The Fifth affiliated hospital of  sun-Yat-sen University, Zhu hai,   guangdong Province, People’s  republic of china *These authors contributed equally  to this workBackground:  Nasopharyngeal carcinoma (NPC) has a high relapse and metastatic rates; hence,  development of new therapeutics is an immediate requirement.",Non-OADS,/arxiv_data1/oa_pdf/7b/b2/ott-9-6195.PMC5067011.pdf
"In addition, many preclinical correspondence: Pei-Jian Peng Department of Medical Oncology,  The Fifth Affiliated Hospital of Sun-Yat- sen University, 52 Mei hua road east,  Zhu hai 519000, guangdong Province,  People’s republic of china Tel +86 756 2528 020 Fax +86 756 2528 045 email pengpjian@163.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Liu et al Running head recto: Effect and mechanism of lapatinib with everolimus on NPC cells DOI: http://dx.doi.org/10.2147/OTT.S115309",Non-OADS,/arxiv_data1/oa_pdf/7b/b2/ott-9-6195.PMC5067011.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/7b/b2/ott-9-6195.PMC5067011.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/7b/b2/ott-9-6195.PMC5067011.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/ab/73/opth-10-1971.PMC5067012.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2016:10 1971–1975Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1971MethO dOlOgyopen access to scientific and medical research Open Access Full text Article http: //dx.doi.org/10.2147/OPTH.S11661 6 Rapid alkaline methylene blue supravital staining  for assessment of anterior segment infections Katsuji Kiuchi Kiuchi eye Clinic, Joto-ku,   Osaka, JapanPurpose:  To present the Löffler’s alkaline methylene blue technique of staining eye discharges  in eyes with anterior segment infections.",Non-OADS,/arxiv_data1/oa_pdf/ab/73/opth-10-1971.PMC5067012.pdf
"It is generally known that conjunctivitis caused by bacteria has a predominant infil - tration by neutrophils, whereas conjunctivitis caused by viruses has a predominance  of lymphocytes.3,4 Although staphylococci, eg, Haemophilus influenzae , are considered Correspondence: Katsuji Kiuchi Kiuchi eye Clinic, 6-8-16  higashinakahama, Joto-ku,  Osaka 536-0023, Japan tel +81 66 962 3736 Fax +81 66 968 4984 email kkiuchi1@yahoo.co.j p Journal name: Clinical Ophthalmology Article Designation: Methodology Y ear: 2016 Volume: 10 Running head verso: Kiuchi Running head recto: Alkaline methylene blue supravital staining DOI: http://dx.doi.org/10.2147/OPTH.S116616",Non-OADS,/arxiv_data1/oa_pdf/ab/73/opth-10-1971.PMC5067012.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/ab/73/opth-10-1971.PMC5067012.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/ab/73/opth-10-1971.PMC5067012.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/6b/34/ott-9-6273.PMC5067013.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 6273–6279OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  6273Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S11336 9 CT -detected solitary thyroid calcification: an  important imaging feature for papillary carcinoma Tian-tian Yang1,2,* Y ong huang2,* Xu-quan Jing1,2 Xiu-juan gai1,2 Wen-wu li2 1school of Medicine and life sciences,   University of Jinan- shandong academy  of Medical sciences, 2Department of  radiology, shandong cancer hospital  affiliated to shandong University, Jinan,   shandong Province, People’s republic  of china *These authors contributed equally  to this workPurpose:  To evaluate computed tomography (CT) detection of solitary thyroid calcification for  identifying thyroid papillary carcinoma and to determine whether the predictive ability changes  when the size increases after enhancement.",Non-OADS,/arxiv_data1/oa_pdf/6b/34/ott-9-6273.PMC5067013.pdf
"It is generally accepted correspondence: Wen-wu li Department of radiology, shandong  Cancer Hospital affiliated to Shandong  University, no 440 Jiyan road, Jinan,  shandong Province 250117, People’s  republic of china Tel +86 531 6762 6582 Fax +86 531 6762 6582 email lwwzlm@sina.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Y ang et al Running head recto: CT-detected solitary thyroid calcification DOI: http://dx.doi.org/10.2147/OTT.S113369",Non-OADS,/arxiv_data1/oa_pdf/6b/34/ott-9-6273.PMC5067013.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/6b/34/ott-9-6273.PMC5067013.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/6b/34/ott-9-6273.PMC5067013.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/3e/00/ott-9-6233.PMC5067014.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 6233–6246OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  6233Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OTT .S11258 0 Current classification, treatment options, and new  perspectives in the management of adipocytic  sarcomas Alessandro De vita1 Laura Mercatali1 Federica Recine1 Federica Pieri2 Nada Riva1 Alberto Bongiovanni1 Chiara Liverani1 Chiara Spadazzi1 Giacomo Miserocchi1 Dino Amadori1 T oni ibrahim1 1Osteoncology and Rare T umors  Center, Istituto Scientifico Romagnolo  per lo Studio e la Cura dei Tumori  (IRST) IRCCS, Meldola, FC, 2Pathology  Unit, Morgagni-Pierantoni Hospital,   Forlì, ItalyAbstract:  Sarcomas are a heterogeneous group of mesenchymal tumors arising from soft tissue  or bone, with an uncertain etiology and difficult classification.",Non-OADS,/arxiv_data1/oa_pdf/3e/00/ott-9-6233.PMC5067014.pdf
"DDLPS, high-grade MLPS, and PLS have a high propensity to metastasize, Correspondence: Alessandro De vita Osteoncology and Rare Tumors Center,  Istituto Scientifico Romagnolo per lo  Studio e la Cura dei Tumori (iRST)  IRCCS, Via Piero Maroncelli, 40-47014  Meldola, FC, Italy Tel +39 0543 739 100 Fax +39 0543 739 123 email alessandro.devita@irst.emr.i t Journal name: OncoTargets and Therapy Article Designation: Review Y ear: 2016 Volume: 9 Running head verso: De Vita et al Running head recto: Classification and management of adipocytic sarcomas DOI: http://dx.doi.org/10.2147/OTT.S112580",Non-OADS,/arxiv_data1/oa_pdf/3e/00/ott-9-6233.PMC5067014.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/3e/00/ott-9-6233.PMC5067014.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/3e/00/ott-9-6233.PMC5067014.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/be/20/ott-9-6151.PMC5067016.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 6151–6160OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  6151Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S10889 0 mir-139-5p regulates proliferation, apoptosis,  and cell cycle of uterine leiomyoma cells by  targeting TPD52 hong chen1 hong Xu1 Yu-gang Meng1 Yun Zhang2 Jun-ying chen1 Xiao-ning Wei1 1Department of gynaecology,   The First affiliated hospital of  guangxi Medical University, nanning,   guangxi, 2Department of gynaecology,   The People’s hospital of suzhou  high T ech District, suzhou, Jiangsu,   People’s republic of chinaBackground:  Uterine leiomyoma is one of the most common benign tumors in women.",Non-OADS,/arxiv_data1/oa_pdf/be/20/ott-9-6151.PMC5067016.pdf
"Micro-RNAs (miRNAs) are small noncoding RNA molecules ∼22–24 nucleotides  in length and are extensively expressed in organisms.7 They repress gene expression  by binding to the complementary sequences in the 3 ′ untranslated region (3 ′UTR) of  mRNAs to induce their degradation and prevent their translation.8 Growing evidences correspondence: hong chen Department of gynaecology,  The First Affiliated Hospital of Guangxi  Medical University, no 6 shuangyong  road, nanning 530021, guangxi,  People’s republic of china email chenhong20090909@qq.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Chen et al Running head recto: miR-139-5p targeting TPD52 in uterine leiomyoma DOI: http://dx.doi.org/10.2147/OTT.S108890",Non-OADS,/arxiv_data1/oa_pdf/be/20/ott-9-6151.PMC5067016.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/be/20/ott-9-6151.PMC5067016.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/be/20/ott-9-6151.PMC5067016.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/18/f0/tcrm-12-1545.PMC5067017.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Therapeutics and Clinical Risk Management 2016:12 1545–1551Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  1545ORiginal ReseaRChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/TCRM.S9786 3 Comparison of classical diagnostic criteria and  Chinese revised diagnostic criteria for fever of  unknown origin in Chinese patients Jia-Jun li Wen-Xiang huang Zheng-Yu shi Qiu sun Xiao-Juan Xin Jin-Qiu Zhao Zhen Yin Department of infectious Diseases,   The First affiliated hospital of  Chongqing Medical University,   Chongqing, People’s Republic of ChinaBackground:  Fever of unknown origin (FUO) has always been a challenging problem for  physicians since it was first reported half a century ago.",Non-OADS,/arxiv_data1/oa_pdf/18/f0/tcrm-12-1545.PMC5067017.pdf
"In 1991, Durack and Street suggested modifying the third criterion  as follows: “the diagnosis remains uncertain after at least three outpatient visits or at  least 3 days of hospital investigation” (regarded as the “classical diagnostic criteria” Correspondence: Wen-Xiang huang Department of infectious Diseases, The  First Affiliated Hospital of Chongqing  Medical University, no 1 Friendship  Road, Yuanjiagang, Yuzhong District,  Chongqing 400016, People’s Republic  of China Tel +86 23 8901 2427 Fax +86 23 8901 2430 email huangwxian@yeah.ne t Journal name: Therapeutics and Clinical Risk Management Article Designation: Original Research Y ear: 2016 Volume: 12 Running head verso: Li et al Running head recto: Two diagnostic criteria for fever of unknown origin DOI: http://dx.doi.org/10.2147/TCRM.S97863",Non-OADS,/arxiv_data1/oa_pdf/18/f0/tcrm-12-1545.PMC5067017.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/18/f0/tcrm-12-1545.PMC5067017.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/18/f0/tcrm-12-1545.PMC5067017.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/38/a1/ott-9-6211.PMC5067019.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 6211–6224OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  6211Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S11341 7 Influence of MDM2  polymorphisms on squamous  cell carcinoma susceptibility: a meta-analysis huanxin Yu haiyan li Jinling Zhang gang liu Department of Otorhinolaryngology  head and neck surgery, Tianjin  huanhu hospital, Tianjin, People’s  Republic of ChinaPurpose:  Controversial associations between single-nucleotide polymorphisms (rs2279744,  rs937283, rs3730485) of the MDM2  gene and the etiology of squamous cell carcinomas (SCCs)  have been reported.",Non-OADS,/arxiv_data1/oa_pdf/38/a1/ott-9-6211.PMC5067019.pdf
"Keywords:  MDM2, SCC, SNP, meta-analysis Introduction The MDM2  gene maps to chromosome 12q14.3–q15.1 The MDM2 protein forms a  complex with the p53 protein, attenuates the activity of p53, and promotes the subse - quent degradation of p53 by acting as a ubiquitin E3 ligase for p53.2,3 The abnormal  expression of the MDM2 /TP53  genes is linked to carcinogenesis or malignant  transformation.2,4,5 Accumulating evidence supports the link between the alteration of  protein structural/functional behavior and single-nucleotide polymorphisms (SNPs)  within relative genes.6–11 Multiple prediction or detection techniques, such as structural  biology, computational platform, and molecular dynamic simulation, contribute to the  investigation of identification and function of disease-associated SNPs.6–11 The SNPs  of rs2279744 (T309G or SNP309), rs3730485 (del1518+/-) and rs937283 (A2164G),  have been identified in the human MDM2  gene.12,13 Previous reports have shown that  MDM2  polymorphisms are associated with susceptibility to various clinical diseases,  such as bladder cancer,14 hepatocellular carcinoma,15 myelodysplastic syndromes,16  and leukemia.17,18correspondence: huanxin Yu Department of Otorhinolaryngology  head and neck surgery, Tianjin huanhu  hospital, 6 Jizhao road, Jinnan, Tianjin  300350, People’s Republic of China Tel +86 22 6036 7616 Fax +86 22 6036 7651 email yuhuanxin66@163.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Yu et al Running head recto: MDM2  polymorphisms and SCC susceptibility DOI: http://dx.doi.org/10.2147/OTT.S113417",Non-OADS,/arxiv_data1/oa_pdf/38/a1/ott-9-6211.PMC5067019.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/38/a1/ott-9-6211.PMC5067019.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/38/a1/ott-9-6211.PMC5067019.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/5e/6c/ott-9-6161.PMC5067020.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 6161–6169OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  6161CliniC al Trial repO rTopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S10356 5 The influence of the metastasis pattern of  mediastinal lymph nodes on the postoperative  radiotherapy’s efficacy for the IIIA-pN2 non-small- cell lung cancer: a retrospective analysis of  220 patients Baozhong Zhang lujun Zhao Zhiyong Yuan Qingsong pang ping Wang Department of Radiotherapy, Tianjin  Medical University Cancer institute  and Hospital, National Clinical  Research Center for Cancer, Tianjin  Key Laboratory of Cancer Prevention  and Therapy, and Tianjin Lung Cancer  Center, Tianjin, People’s Republic  of ChinaObjective:  The use of postoperative radiotherapy (PORT) remains controversial for  Stage IIIA-N2 non-small-cell lung cancer (NSCLC) patients, a possible reason is that IIIA-pN2  NSCLC diseases are a heterogeneous group with different clinicopathologic features.",Non-OADS,/arxiv_data1/oa_pdf/5e/6c/ott-9-6161.PMC5067020.pdf
"Keywords:  non-small-cell lung cancer (NSCLC), N2, postoperative chemoradiotherapy  (POCRT), LN skip/nonskip, PFS, OS, DMFSCorrespondence: Baozhong Zhang;  ping Wang Department of Radiotherapy, Tianjin  Medical University Cancer institute and  Hospital, Hexi District, Tianjin 300060,  People’s Republic of China Tel +86 22 2334 1405 Fax +86 22 2334 1405 email baozhongtj@163.co m;  tjdoctorwang@163.co m Journal name: OncoTargets and Therapy Article Designation: Clinical Trial Report Y ear: 2016 Volume: 9 Running head verso: Zhang et al Running head recto: Patterns of mediastinal metastases in IIIA-pN2 NSCLC DOI: http://dx.doi.org/10.2147/OTT.S103565",Non-OADS,/arxiv_data1/oa_pdf/5e/6c/ott-9-6161.PMC5067020.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/5e/6c/ott-9-6161.PMC5067020.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/5e/6c/ott-9-6161.PMC5067020.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/01/6a/jmdh-9-529.PMC5067051.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/01/6a/jmdh-9-529.PMC5067051.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Multidisciplinary Healthcare 2016:9 529–536Journal of Multidisciplinary Healthcare Dovepress submit your manuscript | www.dovepress.com Dovepress 529 REVIEW open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JMDH.S95323Managing the pediatric patient with celiac disease:  a multidisciplinary approach Daniela Migliarese Isaac1 Jessica Wu2 Diana R Mager3,4 Justine M T urner1 1Department of Pediatric  Gastroenterology and Nutrition,   Faculty of Medicine and Dentistry,  University of Alberta;  2Alberta Health  Services–Child Health Nutrition Services, Stollery Children’s Hospital;   3Department of Agriculture, Food  and Nutritional Science; 4Department  of Pediatrics, University of Alberta,  Edmonton, AB, CanadaAbstract: Celiac disease (CD) is an autoimmune reaction to gluten, leading to intestinal inflam- mation, villous atrophy, and malabsorption.",Non-OADS,/arxiv_data1/oa_pdf/01/6a/jmdh-9-529.PMC5067051.pdf
"3,7–10 Adolescents have been identified as a subgroup  with a particularly high rate of noncompliance.11Correspondence: Justine M Turner Department of Pediatric Gastroenterology and Nutrition, Edmonton Clinic Health Academy, University of Alberta, 11405 87th Avenue NW, Edmonton, AB T6G 1C9, CanadaTel 1 780 248 5420Fax 1 780 888 353 1157Email Justine.Turner@albertahealthservices.caJournal name: Journal of Multidisciplinary Healthcare Article Designation: REVIEWY ear: 2016V olume: 9Running head verso: Isaac et alRunning head recto: Multidisciplinary care in celiac diseaseDOI: http://dx.doi.org/10.2147/JMDH.S95323",Non-OADS,/arxiv_data1/oa_pdf/01/6a/jmdh-9-529.PMC5067051.pdf
"Journal of Multidisciplinary Healthcare 2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Multidisciplinary Healthcare Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/journal-of-multidisciplinary-healthcare-journalThe Journal of Multidisciplinary Healthcare is an international, peer- reviewed open-access journal that aims to represent and publish research in healthcare areas delivered by practitioners of different disciplines.",Non-OADS,/arxiv_data1/oa_pdf/01/6a/jmdh-9-529.PMC5067051.pdf
Visit http://www.dovepress.com/   testimonials.php to read real quotes from published authors.Dovepress 536 Isaac et al  8.,Non-OADS,/arxiv_data1/oa_pdf/01/6a/jmdh-9-529.PMC5067051.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/5e/b4/mder-9-361.PMC5067052.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/5e/b4/mder-9-361.PMC5067052.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Medical Devices: Evidence and Research 2016:9 361–369Medical Devices: Evidence and Research Dovepress submit your manuscript | www.dovepress.com Dovepress 361 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/MDER.S113752 Usability of a novel disposable autoinjector device  for ixekizumab: results from a qualitative study  and an open-label clinical trial, including patient- reported experience Kristina Callis Duffin1 Michael Bukhalo2 Margaret A Bobonich3 David Shrom4 Fangyi Zhao4 James R Kershner4 Anne Gill4 Beth Pangallo4 Catherine L Shuler4 Jerry Bagel5 1Department of Dermatology,   University of Utah School of  Medicine, Salt Lake City, UT,   2Arlington Dermatology, Arlington  Heights, IL, 3CWRU Schools of  Medicine and Nursing, Case Western Reserve University Cleveland, OH,   4Lilly Research Labs, Eli Lilly and  Company, Lilly Corporate Center,  Indianapolis, IN,  5Psoriasis Treatment  Center of Central New Jersey, East Windsor, NJ, USABackground: Most biologic therapies for psoriasis are delivered via subcutaneous injection.",Non-OADS,/arxiv_data1/oa_pdf/5e/b4/mder-9-361.PMC5067052.pdf
"In patients with Ps, self-injection may be impacted by reduced fine motor skills due to comorbid rheumatoid arthritis Correspondence: David Shrom Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, 46220, USATel +1 317 354 6328Email shromda@lilly.comJournal name: Medical Devices: Evidence and Research Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 9Running head verso: Callis Duffin et alRunning head recto: Usability of the ixekizumab autoinjectorDOI: http://dx.doi.org/10.2147/MDER.S113752",Non-OADS,/arxiv_data1/oa_pdf/5e/b4/mder-9-361.PMC5067052.pdf
Available from: http://www.rxab- bvie.com/pdf/humirapen_PIL.pdf.,Non-OADS,/arxiv_data1/oa_pdf/5e/b4/mder-9-361.PMC5067052.pdf
Available from: http://pi.amgen.,Non-OADS,/arxiv_data1/oa_pdf/5e/b4/mder-9-361.PMC5067052.pdf
"Medical Devices: Evidence and Research 2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress Medical Devices: Evidence and Research Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/medical-devices-evidence-and-research-journalMedical Devices: Evidence and Research is an international, peer- reviewed, open access journal that focuses on the evidence, technology, research, and expert opinion supporting the use and application of   medical devices in the diagnosis, monitoring, treatment and management of clinical conditions and physiological processes.",Non-OADS,/arxiv_data1/oa_pdf/5e/b4/mder-9-361.PMC5067052.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/34/86/ndt-12-2587.PMC5067053.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2016:12 2587–2594Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  2587OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S11602 9 Usability of a novel digital medicine system in  adults with schizophrenia treated with sensor- embedded tablets of aripiprazole Timothy Peters-strickland1 linda Pestreich1 ainslie hatch2 shashank rohatagi1 ross a Baker1 John P Docherty2 lada Markovtsova1 Praveen raja3 Peter J Weiden4 David P Walling5 1Otsuka Pharmaceutical  Development & commercialization,   inc., 2ODh, inc., Princeton, NJ,   3Proteus Digital health, inc.,   redwood city, ca, 4Department  of Psychiatry, University of illinois,   chicago, il, 5cNs Network,   llc, long Beach, ca, UsaObjective:  Digital medicine system (DMS) is a novel drug–device combination that objectively  measures and reports medication ingestion.",Non-OADS,/arxiv_data1/oa_pdf/34/86/ndt-12-2587.PMC5067053.pdf
"Keywords:  adherence, antipsychotics, aripiprazole, digital medicine, schizophrenia,  usability Introduction Suboptimal response to treatment is common for patients with schizophrenia despite  pharmacologic treatment interventions that can reduce the severity of symptoms  and improve outcomes.1,2 One of the factors contributing to suboptimal response is  poor adherence to medication, a frequently observed problem in schizophrenia.3–5  For example, the results from a large, cross-sectional study that examined adherence  retrospectively over 4 years showed that 36% of patients with schizophrenia were  poorly adherent each year and 61% had adherence problems at some point during the  study.6 Poor outcomes associated with nonadherence in schizophrenia include symptom  exacerbation, relapse, and rehospitalization7–9 that result in increased treatment costs.10  Assessment of nonadherence is difficult in clinical practice and most commonly relies correspondence: Timothy Peters- strickland Otsuka Pharmaceutical Development &  commercialization, inc., 508 carnegie  center Boulevard, suite 300, Princeton,  NJ 08540, Usa Tel +1 609 249 6559 Fax +1 609 249 0559 email tim.peters-strickland@ otsuka-us.co m Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2016 Volume: 12 Running head verso: Peters-Strickland et al Running head recto: Usability of digital medicine system DOI: http://dx.doi.org/10.2147/NDT.S116029",Non-OADS,/arxiv_data1/oa_pdf/34/86/ndt-12-2587.PMC5067053.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/34/86/ndt-12-2587.PMC5067053.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/34/86/ndt-12-2587.PMC5067053.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/db/1b/jmdh-9-519.PMC5067054.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/db/1b/jmdh-9-519.PMC5067054.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Multidisciplinary Healthcare 2016:9 519–528Journal of Multidisciplinary Healthcare Dovepress submit your manuscript | www.dovepress.com Dovepress 519 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JMDH.S112713Simulation analysis of resource flexibility on  healthcare processes Yusta W Simwita  Berit I Helgheim  Department of Logistics, Molde  University College, Molde, NorwayPurpose: This paper uses discrete event simulation to explore the best resource flexibility  scenario and examine the effect of implementing resource flexibility on different stages of  patient treatment process.",Non-OADS,/arxiv_data1/oa_pdf/db/1b/jmdh-9-519.PMC5067054.pdf
"5,9 Correspondence: Yusta W Simwita Department of Logistics, Molde University College, Britvegen 2, 6410 Molde, NorwayTel +47 7119 5785Email simwita2009@gmail.comJournal name: Journal of Multidisciplinary Healthcare Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 9Running head verso: Simwita and HelgheimRunning head recto: Simulation analysis of resource flexibilityDOI: http://dx.doi.org/10.2147/JMDH.S112713",Non-OADS,/arxiv_data1/oa_pdf/db/1b/jmdh-9-519.PMC5067054.pdf
"Journal of Multidisciplinary Healthcare 2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Multidisciplinary Healthcare Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/journal-of-multidisciplinary-healthcare-journalThe Journal of Multidisciplinary Healthcare is an international, peer- reviewed open-access journal that aims to represent and publish research in healthcare areas delivered by practitioners of different disciplines.",Non-OADS,/arxiv_data1/oa_pdf/db/1b/jmdh-9-519.PMC5067054.pdf
Visit http://www.dovepress.com/   testimonials.php to read real quotes from published authors.Dovepress 528 Simwita and Helgheim 24.,Non-OADS,/arxiv_data1/oa_pdf/db/1b/jmdh-9-519.PMC5067054.pdf
Available from: http://www.who.int/mediacentre/factsheets/fs358/en/.,Non-OADS,/arxiv_data1/oa_pdf/db/1b/jmdh-9-519.PMC5067054.pdf
Available from: http://www.who.int/workforcealliance/knowledge/resources/mlp2013/en/.,OADS,/arxiv_data1/oa_pdf/db/1b/jmdh-9-519.PMC5067054.pdf
Available from: http://www.who.int/workforcealliance/knowledge/resources/MLHWCountry-CaseStudies_annex5_Tanzania.pdf?ua=1.,OADS,/arxiv_data1/oa_pdf/db/1b/jmdh-9-519.PMC5067054.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/65/4c/ndt-12-2581.PMC5067055.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2016:12 2581–2586Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  2581OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S11627 1 restless leg syndrome in hospitalized psychiatric  patients in lebanon: a pilot study Farid Talih1 Jean ajaltouni1 Firas Kobeissy2 1Department of Psychiatry,   2Department of Biochemistry and  Molecular genetics, Faculty of  Medicine, american University of  Beirut, Beirut, lebanonObjectives:  To characterize and describe the prevalence of restless leg syndrome (RLS) in  hospitalized psychiatric patients and to investigate the correlations between patient profile  and RLS.",Non-OADS,/arxiv_data1/oa_pdf/65/4c/ndt-12-2581.PMC5067055.pdf
"Some antipsychotics can improve nocturnal sleep,  but cause daytime somnolence.8 Selective serotonin reuptake inhibitors can improve  daytime alertness but may exacerbate restless legs syndrome (RLS) at night, causing  reduced sleep quality.8 RLS is a sleep-related movement disorder characterized by an  urge to move the extremities, usually the legs; it has been found to be more prevalent  in females and the elderly.9 The clinical and diagnostic features of RLS as per the  international classification of sleep disorders, third edition, include an urge to move  the legs accompanied by pain or discomfort, exacerbated in the evening and at rest, correspondence: Farid Talih Department of Psychiatry, american  University of Beirut, 3 Dag hammarskjold  Plaza, 8th Floor, New York,  NY 10017-2303, Usa email ft10@aub.edu.l b Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2016 Volume: 12 Running head verso: Talih et al Running head recto: Restless leg syndrome and psychiatric disorders DOI: http://dx.doi.org/10.2147/NDT.S116271",Non-OADS,/arxiv_data1/oa_pdf/65/4c/ndt-12-2581.PMC5067055.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/65/4c/ndt-12-2581.PMC5067055.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/65/4c/ndt-12-2581.PMC5067055.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/ae/02/jep-8-043.PMC5067056.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/ae/02/jep-8-043.PMC5067056.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Experimental Pharmacology 2016:8 43–52Journal of Experimental Pharmacology Dovepress submit your manuscript | www.dovepress.com Dovepress  43 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JEP .S114272Projection neurons in the cortex and  hippocampus: differential effects of chronic khat  and ethanol exposure in adult male rats Paul E Alele1 Daniel Matovu1 Lawrence Imanirampa2 Abayomi M Ajayi3 Gyaviira T Kasule4 1Department of Pharmacology  and Therapeutics, 2Department  of Pharmacy, Faculty of Medicine,   Mbarara University of Science and T echnology, Mbarara, Uganda;   3Department of Pharmacology and  Therapeutics, Faculty of Basic Medical Sciences, College of Medicine,  University of Ibadan, Ibadan, Nigeria;   4Department of Anatomy, Histology  and Embryology, Faculty of Medicine,  Mbarara University of Science and T echnology, Mbarara, UgandaBackground: Recent evidence suggests that many individuals who chew khat recreationally  also drink ethanol to offset the stimulating effect of khat.",Non-OADS,/arxiv_data1/oa_pdf/ae/02/jep-8-043.PMC5067056.pdf
"5,6Correspondence: Paul E Alele Department of Pharmacology and Therapeutics, Faculty of Medicine, Mbarara University of Science and Technology, PO Box 1410, Mbarara, UgandaTel +256 773 573 372Fax +256 485 420 782Email paulalele@must.ac.ugJournal name: Journal of Experimental Pharmacology Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 8Running head verso: Alele et alRunning head recto: Effect of chronic khat and ethanol exposure on rat brain neuronsDOI: http://dx.doi.org/10.2147/JEP .S114272",Non-OADS,/arxiv_data1/oa_pdf/ae/02/jep-8-043.PMC5067056.pdf
"Protocol for ImageJ® analysis of neuron  number and size Neuron counting was done using the image analysis program,  ImageJ, version 1.48 (National Institutes of Health, Baltimore, MD, USA., http://imagej.nih.gov/ij).",OADS,/arxiv_data1/oa_pdf/ae/02/jep-8-043.PMC5067056.pdf
"Journal of Experimental Pharmacology 2016:8submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Experimental Pharmacology Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/journal-of-experimental-pharmacology-journalThe Journal of Experimental Pharmacology is an international, peer- reviewed, open access journal publishing original research, reports, reviews and commentaries on all areas of laboratory and experimental pharmacology.",Non-OADS,/arxiv_data1/oa_pdf/ae/02/jep-8-043.PMC5067056.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/ae/02/jep-8-043.PMC5067056.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/25/3d/jep-8-035.PMC5067057.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/25/3d/jep-8-035.PMC5067057.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Experimental Pharmacology 2016:8 35–42Journal of Experimental Pharmacology Dovepress submit your manuscript | www.dovepress.com Dovepress  35 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JEP .S117545In vitro vasodilatory activity and possible  mechanisms of the crude extracts and fractions  of Moringa stenopetala  (Baker f.) Cufod.",Non-OADS,/arxiv_data1/oa_pdf/25/3d/jep-8-035.PMC5067057.pdf
"KCl bypasses G-protein-coupled receptors and activates smooth muscle by a  mechanism Correspondence: Bekesho Geleta Directorate of Traditional and Modern Medicine Research, Ethiopian Public Health Institute, Arbegnoch Street (Main Street), PO Box 1242, Addis Ababa, Ethiopia Tel +251 9 1109 1969   Email bekeshog@gmail.comJournal name: Journal of Experimental Pharmacology Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 8Running head verso: Geleta et alRunning head recto: Moringa stenopetala in isolated thoracic aorta of guinea pigsDOI: http://dx.doi.org/10.2147/JEP .S117545",Non-OADS,/arxiv_data1/oa_pdf/25/3d/jep-8-035.PMC5067057.pdf
Available from: http://apps.who.int/iris/bit- stream/10665/79059/1/WHO_DCO_WHD_2013.2_eng.pdf.,OADS,/arxiv_data1/oa_pdf/25/3d/jep-8-035.PMC5067057.pdf
"Journal of Experimental Pharmacology 2016:8submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Experimental Pharmacology Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/journal-of-experimental-pharmacology-journalThe Journal of Experimental Pharmacology is an international, peer- reviewed, open access journal publishing original research, reports, reviews and commentaries on all areas of laboratory and experimental pharmacology.",Non-OADS,/arxiv_data1/oa_pdf/25/3d/jep-8-035.PMC5067057.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/25/3d/jep-8-035.PMC5067057.pdf
Available from: http://www.carmma.org/sites/default/files/PDF- uploads/Background%20Report%20on%20Hyper - tension%20-%20English.pdf.,Non-OADS,/arxiv_data1/oa_pdf/25/3d/jep-8-035.PMC5067057.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/33/46/jpr-9-787.PMC5067058.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/33/46/jpr-9-787.PMC5067058.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Pain Research  2016:9 787–796Journal of Pain Research Dovepress submit your manuscript | www.dovepress.com Dovepress  787 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JPR.S117451Local anesthesia for pain control during  transrectal ultrasound-guided prostate biopsy:  a systematic review and meta-analysis Pu Yan*   Xiao-yan Wang*   Wei Huang   Y ong Zhang Beijing Tian Tan Hospital, Capital  Medical University, Neurology Research Division, China National Clinical Research Center for Neurological Disease, Beijing,  People’s  Republic of China *These authors contributed equally to this work.Background: A meta-analysis was performed to evaluate the efficacy and safety of intrarectal  local anesthestic (IRLA), periprostatic nerve block (PPNB), and the combined modalities in  alleviating the pain during transrectal ultrasound (TRUS)-guided prostate biopsy.",Non-OADS,/arxiv_data1/oa_pdf/33/46/jpr-9-787.PMC5067058.pdf
"2 The increased  number of biopsy cores converts into cumulative pain, further increasing the need for anesthesia.Correspondence: Yong Zhang   Department of Urology, Beijing Tian  Tan Hospital, Capital Medical University, No 6 Tiantan Xi Li, Dong Cheng District, Beijing 100050, People’s Republic of China Tel +86 10 6709 8393   Fax +86 10 6709 6611   Email 18610711834@163.comJournal name: Journal of Pain Research  Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 9Running head verso: Y an et alRunning head recto: Anesthesia for pain control during prostate biopsyDOI: http://dx.doi.org/10.2147/JPR.S117451",Non-OADS,/arxiv_data1/oa_pdf/33/46/jpr-9-787.PMC5067058.pdf
"Journal of Pain Research  2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Pain Research  Publish your work in this journal Submit your manuscript here:  https://www.dovepress.com/journal-of-pain-research-journal The Journal of Pain Research is an international, peer reviewed, open  access, online journal that welcomes laboratory and clinical findings   in the fields of pain research and the prevention and management of pain.",Non-OADS,/arxiv_data1/oa_pdf/33/46/jpr-9-787.PMC5067058.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 796 Yan et al  13.,Non-OADS,/arxiv_data1/oa_pdf/33/46/jpr-9-787.PMC5067058.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/6c/63/ndt-12-2595.PMC5067059.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2016:12 2595–2603Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  2595OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S11304 1 impact of aggression, depression, and anxiety  levels on quality of life in epilepsy patients Filiz izci1 Ebru Fındıklı2 Mehmet Akif Camkurt3 Deniz T uncel4 Merve Şahin2 1Department of Psychiatry,   school of Medicine, istanbul Bilim  University, istanbul, 2Department  of Psychiatry, school of Medicine,   sütçü i˙mam University, 3Department  of Psychiatry, Afşin State Hospitale,   4Department of Neurology, school  of Medicine, sütçü i˙mam University,   Kahramanmaraş, T urkeyAbstract:  The aim of this study was to investigate the impact of aggression levels on the quality  of life (QoL) of epilepsy patients.",Non-OADS,/arxiv_data1/oa_pdf/6c/63/ndt-12-2595.PMC5067059.pdf
"As a result, young adults  suffer from impairments in developing healthy personality perception, building up  successful social relations, and gaining autonomy.8 At advancing ages, this manifests  itself in a form of behavioral problems such as depression, feelings of loneliness, correspondence: Filiz izci Department of Psychiatry, school of  Medicine, istanbul Bilim University,  abide-i hürriyet caddesi No 164,  Sisli, Istanbul, Turkey Tel +90 50 5450 3013 email filizizci@yahoo.co m Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2016 Volume: 12 Running head verso: Izci et al Running head recto: Aggression, depression, and anxiety levels in epilepsy patients DOI: http://dx.doi.org/10.2147/NDT.S113041",Non-OADS,/arxiv_data1/oa_pdf/6c/63/ndt-12-2595.PMC5067059.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/6c/63/ndt-12-2595.PMC5067059.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/6c/63/ndt-12-2595.PMC5067059.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/17/a0/jpr-9-803.PMC5067060.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/17/a0/jpr-9-803.PMC5067060.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Pain Research  2016:9 803–806Journal of Pain Research Dovepress submit your manuscript | www.dovepress.com Dovepress  803 EDITORIAL open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JPR.S121505Can we not work together to help family  practitioners become more effective pain  managers?",Non-OADS,/arxiv_data1/oa_pdf/17/a0/jpr-9-803.PMC5067060.pdf
"5 The review article highlighted that “Combined data from four  small studies reveal an NNT [number needed to treat] of 7 for pain reduction with this Correspondence: Jeffrey Fudin 357 Delaware Avenue #214, Delmar, NY 12054, USAEmail jeff@paindr.comJournal name: Journal of Pain Research  Article Designation: EDITORIALY ear: 2016V olume: 9Running head verso: Fudin et alRunning head recto: Help family practitioners become effective pain managersDOI: http://dx.doi.org/10.2147/JPR.S121505",Non-OADS,/arxiv_data1/oa_pdf/17/a0/jpr-9-803.PMC5067060.pdf
"Journal of Pain Research  2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Pain Research  Publish your work in this journal Submit your manuscript here:  https://www.dovepress.com/journal-of-pain-research-journal The Journal of Pain Research is an international, peer reviewed, open  access, online journal that welcomes laboratory and clinical findings   in the fields of pain research and the prevention and management of pain.",Non-OADS,/arxiv_data1/oa_pdf/17/a0/jpr-9-803.PMC5067060.pdf
"Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 806 Fudin et al Dove Medical Press encourages responsible, free and frank academic debate.",Non-OADS,/arxiv_data1/oa_pdf/17/a0/jpr-9-803.PMC5067060.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/fb/26/jbm-7-227.PMC5067061.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/fb/26/jbm-7-227.PMC5067061.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Blood Medicine 2016:7 227–231Journal of Blood Medicine Dovepress submit your manuscript | www.dovepress.com Dovepress  227 Original research open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JBM.S92438a retrospective analysis of 56 children with  hemophagocytic lymphohistiocytosis Yan-rong Wang1 Yi-n ing Qiu2 Yan Bai2 Xian-Feng Wang1 1Department of Pediatrics, The  affiliated shenzhen Third hospital,   guangdong Medical college,   shenzhen, 2Department of Pediatrics,   Union hospital, T ongji Medical  college, huazhong University of  science and T echnology, Wuhan,   People’s republic of chinaAim: The aim of this study was to investigate the etiological factors, clinical features, and  prognostic factors in children with hemophagocytic lymphohistiocytosis (HLH).",Non-OADS,/arxiv_data1/oa_pdf/fb/26/jbm-7-227.PMC5067061.pdf
"The criteria for diagnosis  correspondence: Yan-rong Wang Department of Pediatrics, The Affiliated shenzhen Third hospital, guangdong Medical college, Bulan road 29, longgang  district, shenzhen 518020, People’s republic of chinaTel +86 0755 6122 2333email 123rong@sohu.comJournal name: Journal of Blood Medicine Article Designation: ORIgINAL REsEARCHY ear: 2016V olume: 7Running head verso: Wang et alRunning head recto: Retrospective analysis of children with HLHDOI: http://dx.doi.org/10.2147/JBM.s92438",Non-OADS,/arxiv_data1/oa_pdf/fb/26/jbm-7-227.PMC5067061.pdf
"Journal of Blood Medicine 2016:7submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Blood Medicine Publish your work in this journal Submit your manuscript here: http://www.dovepress.com/journal-of-blood-medicine-journalThe Journal of Blood Medicine is an international, peer-reviewed, open  access, online journal publishing laboratory, experimental and clinical aspects   of all aspect pertaining to blood based medicine including but not limited to:   Transfusion Medicine; Blood collection, Donor issues, Transmittable diseases,   and Blood banking logistics; Immunohematology; Artificial and alternative blood based therapeutics; Hematology; Biotechnology/nanotechnology of blood related medicine; Legal aspects of blood medicine; Historical perspec-tives.",Non-OADS,/arxiv_data1/oa_pdf/fb/26/jbm-7-227.PMC5067061.pdf
Visit http://www.dovepress.com/ testimonials.php to read real quotes from published authors.Dovepress 231 retrospective analysis of children with hlh,Non-OADS,/arxiv_data1/oa_pdf/fb/26/jbm-7-227.PMC5067061.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/1e/2f/jhc-3-055.PMC5067062.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/1e/2f/jhc-3-055.PMC5067062.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Hepatocellular Carcinoma 2016:3 55–61Journal of Hepatocellular Carcinoma Dovepress submit your manuscript | www.dovepress.com Dovepress 55 REVIEW open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JHC.S92732 Minimally invasive image-guided therapies for  hepatocellular carcinoma Mohamed E Abdelsalam1 Ravi Murthy1 Rony Avritscher1 Armeen Mahvash1 Michael J Wallace1 Ahmed O Kaseb2 Bruno C Odisio1 1Department of Interventional  Radiology, 2Department of Medical  Oncology, The University of T exas  MD Anderson Cancer Center,   Houston, TX, USAAbstract:  Hepatocellular carcinoma (HCC) is the fifth most frequently occurring cancer glob- ally and predominantly develops in the setting of various grades of underlying chronic liver  disease, which affects management decisions.",Non-OADS,/arxiv_data1/oa_pdf/1e/2f/jhc-3-055.PMC5067062.pdf
"2 We performed literature search on English language publications in  the PubMed database using the terms hepatocellular carcinoma,  locoregional therapy, Correspondence: Mohamed E Abdelsalam Department of Interventional Radiology, Unit 1471, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston,   TX 77030-4009, USATel +1 713 563 1065Fax +1 713 792 4098Email meabdelsalam@mdanderson.orgJournal name: Journal of Hepatocellular Carcinoma Article Designation: REVIEWY ear: 2016V olume: 3Running head verso: Abdelsalam et alRunning head recto: Minimally invasive image-guided therapies for hepatocellular carcinomaDOI: http://dx.doi.org/10.2147/JHC.S92732",Non-OADS,/arxiv_data1/oa_pdf/1e/2f/jhc-3-055.PMC5067062.pdf
"Journal of Hepatocellular Carcinoma 2016:3submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Hepatocellular Carcinoma Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/journal-of-hepatocellular-carcinoma-journalThe Journal of Hepatocellular Carcinoma is an international, peer- reviewed, open access journal that offers a platform for the dissemina-tion and study of clinical, translational and basic research findings in this rapidly developing field.",Non-OADS,/arxiv_data1/oa_pdf/1e/2f/jhc-3-055.PMC5067062.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 61 Minimally invasive image-guided therapies for hepatocellular carcinoma  43.,Non-OADS,/arxiv_data1/oa_pdf/1e/2f/jhc-3-055.PMC5067062.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/7d/ef/ndt-12-2573.PMC5067063.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2016:12 2573–2579Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  2573OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S10558 8 evaluation of anxiety condition among type 1 and  type 2 diabetic patients aliye Bulut¹ aziz Bulut² ¹Department of Nursing, higher  school of health, Bingol University,   ²Department of general surgery,   Bingol state hospital, Bingol, T urkeyPurpose:  This study was conducted for the purpose of determining the relationship between  type 1 and type 2 diabetic patients and anxiety.",Non-OADS,/arxiv_data1/oa_pdf/7d/ef/ndt-12-2573.PMC5067063.pdf
"Sex, age, and ethnic origin are among the important  risk factors determining type 2 DM.3,4 correspondence: aliye Bulut Department of Nursing, higher  school of health, Bingol University,  12000 Bingol, Turkey Tel +90 505 817 3113 email aliyedemirok@yahoo.co m Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2016 Volume: 12 Running head verso: Bulut and Bulut Running head recto: Anxiety in type 1 and type 2 diabetic patients DOI: http://dx.doi.org/10.2147/NDT.S105588",Non-OADS,/arxiv_data1/oa_pdf/7d/ef/ndt-12-2573.PMC5067063.pdf
"Available from: http://www.idf.org/about-diabete s.  Accessed August 24, 2015.",Non-OADS,/arxiv_data1/oa_pdf/7d/ef/ndt-12-2573.PMC5067063.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/7d/ef/ndt-12-2573.PMC5067063.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/7d/ef/ndt-12-2573.PMC5067063.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/49/b3/ndt-12-2561.PMC5067064.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2016:12 2561–2571Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  2561Case repor Topen access to scientific and medical research open access Full T ext article http: //dx.doi.org/10.2147/NDT .S11690 6 Vagus nerve stimulation balanced disrupted  default-mode network and salience network  in a postsurgical epileptic patient Kailiang Wang1,2 Qi Chai1 Hui Qiao1 Jianguo Zhang2,3 Tinghong Liu1,2 Fangang Meng1,2 1Beijing Neurosurgical Institute,   Capital Medical University, 2Beijing  Key Laboratory of Neurostimulation,   3Department of Neurosurgery, Beijing  Tiantan Hospital, Capital Medical  University, Beijing, people’s republic  of ChinaIntroduction:  In recent years, treatment of intractable epilepsy has become more challenging,  due to an increase in resistance to antiepileptic drugs, as well as diminished success following  resection surgery.",Non-OADS,/arxiv_data1/oa_pdf/49/b3/ndt-12-2561.PMC5067064.pdf
"In recent years, studies have indicated that intractable epilepsy is not a focal but  rather a network disease.9–11 Additionally, a number of studies have shown that intrac - table epilepsy impairs the organizing ability of resting-state networks of the brain,12–15 Correspondence: Fangang Meng Beijing Neurosurgical Institute, Capital  Medical University, 6 Tiantan Xili,  Dongcheng, Beijing 100050, people’s  republic of China Tel +86 10 6709 6767 Fax +86 10 6705 7507 email fgmeng@ccmu.edu.c n Journal name: Neuropsychiatric Disease and Treatment Article Designation: Case report Y ear: 2016 Volume: 12 Running head verso: Wang et al Running head recto: VNS balanced default network and salience network DOI: http://dx.doi.org/10.2147/NDT.S116906",Non-OADS,/arxiv_data1/oa_pdf/49/b3/ndt-12-2561.PMC5067064.pdf
All data preprocessing was carried  out using the SPM8 ( http://www.fil.ion.ucl.ac.uk/sp m) and  DPARSF ( http://www.restfmri.net/forum/DPARS F) toolkits.,OADS,/arxiv_data1/oa_pdf/49/b3/ndt-12-2561.PMC5067064.pdf
"All other brain regions consistently Figure 2 The vagus nerve-stimulation device used for implantation, obtained from pINs Medical (Beijing, people’s republic of China; http://www.pinsmedical.com /).",Non-OADS,/arxiv_data1/oa_pdf/49/b3/ndt-12-2561.PMC5067064.pdf
All data preprocessing was carried out using SPM8  (http://www.fil.ion.uc l.ac.uk/sp m) and DPARSF  (http://www.restfmri.net/ forum/DPARS F) toolkits.,OADS,/arxiv_data1/oa_pdf/49/b3/ndt-12-2561.PMC5067064.pdf
"Seeds were hand- drawn, as shown in Figure S1A and B. Data-result maps were  displayed by MRIcroGL ( http://www.mccauslandcenter.",OADS,/arxiv_data1/oa_pdf/49/b3/ndt-12-2561.PMC5067064.pdf
The similarity of the time series within a cluster was  measured based on the ReHo method.3 The ReHo of the voxel  at the center of the 27 nearest neighboring voxels cluster was  calculated by Kendall’s coefficient-of-concordance algorithm  by REST software ( http://www.restfmri.ne t).,OADS,/arxiv_data1/oa_pdf/49/b3/ndt-12-2561.PMC5067064.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/49/b3/ndt-12-2561.PMC5067064.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/49/b3/ndt-12-2561.PMC5067064.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/63/8a/jmdh-9-511.PMC5067065.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/63/8a/jmdh-9-511.PMC5067065.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Multidisciplinary Healthcare 2016:9 511–518Journal of Multidisciplinary Healthcare Dovepress submit your manuscript | www.dovepress.com Dovepress 511 REVIEW open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JMDH.S109985Buerger’s disease: providing integrated care Peter Klein-Weigel1  Theresa Sophie Volz1  Leonora Zange2  Jutta Richter3 1Clinic of Angiology, 2Clinic of  Cardiology and Nephrology, HELIOS  Klinikum Berlin-Buch, Berlin,   3Medical Faculty, Department of  Rheumatology and Hiller Research Unit Rheumatology, Heinrich-Heine-University Duesseldorf, Duesseldorf,  GermanyAbstract: Buerger’ s disease, also known as thromboangiitis obliterans (TAO), is a segmental  inflammatory disease affecting small- and medium-sized vessels, which is strongly associated  with tobacco use.",Non-OADS,/arxiv_data1/oa_pdf/63/8a/jmdh-9-511.PMC5067065.pdf
"2Correspondence: Peter Klein-Weigel Klinik für Angiologie, HELIOS Klinikum   Berlin-Buch, Schwanebecker Chaussee 50, 13125 Berlin, Germany Tel +49 30 9401 14901   Fax +49 30 9401 54909   Email peter.klein-weigel@helios-kliniken.deJournal name: Journal of Multidisciplinary Healthcare Article Designation: REVIEWY ear: 2016V olume: 9Running head verso: Klein-Weigel et alRunning head recto: Buerger’ s diseaseDOI: http://dx.doi.org/10.2147/JMDH.S109985",Non-OADS,/arxiv_data1/oa_pdf/63/8a/jmdh-9-511.PMC5067065.pdf
"Journal of Multidisciplinary Healthcare 2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Multidisciplinary Healthcare Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/journal-of-multidisciplinary-healthcare-journalThe Journal of Multidisciplinary Healthcare is an international, peer- reviewed open-access journal that aims to represent and publish research in healthcare areas delivered by practitioners of different disciplines.",Non-OADS,/arxiv_data1/oa_pdf/63/8a/jmdh-9-511.PMC5067065.pdf
Visit http://www.dovepress.com/   testimonials.php to read real quotes from published authors.Dovepress 518 Klein-Weigel et al  75.,Non-OADS,/arxiv_data1/oa_pdf/63/8a/jmdh-9-511.PMC5067065.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/2e/f4/mder-9-349.PMC5067066.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/2e/f4/mder-9-349.PMC5067066.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Medical Devices: Evidence and Research 2016:9 349–360Medical Devices: Evidence and Research Dovepress submit your manuscript | www.dovepress.com Dovepress 349 REVIEW open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/MDER.S98889 Lipoprotein apheresis in the management of  severe hypercholesterolemia and of elevation of  lipoprotein(a): current perspectives and patient  selection Ulrich Julius Lipidology and Center for  Extracorporeal Therapy, Department for Internal Medicine III, University Hospital Carl Gustav Carus at the T echnische Universität Dresden,  Dresden, GermanyAbstract: This review reports the current situation with respect to therapeutic options (lifestyle  and drugs) reducing the concentrations of atherogenic low-density lipoprotein cholesterol (LDL-C)  and lipoprotein(a) (Lp[a]).",Non-OADS,/arxiv_data1/oa_pdf/2e/f4/mder-9-349.PMC5067066.pdf
"It must be admitted, however, that the effect  of an optimal diet on low-density lipoprotein cholesterol (LDL-C) levels in severe HCH is rather limited (a 5% reduction is realistic with almost no reduction in patients with homozygous familiar HCH), and no effect of diet on Lp(a) concentrations has Correspondence: Ulrich Julius Lipidology and Center for Extracorporeal Therapy, Department for Internal Medicine III, University Hospital Carl Gustav Carus at the Technische Universität Dresden, Fetscherstr 74,  01307 Dresden, GermanyTel +49 351 458 2306Fax +49 351 458 5306Email ulrich.julius@uniklinikum-dresden.deJournal name: Medical Devices: Evidence and Research Article Designation: REVIEWY ear: 2016V olume: 9Running head verso: JuliusRunning head recto: Lipoprotein apheresis: clinical applicationDOI: http://dx.doi.org/10.2147/MDER.S98889 Video abstract Point your SmartPhone at the code above.",Non-OADS,/arxiv_data1/oa_pdf/2e/f4/mder-9-349.PMC5067066.pdf
Or use: http://youtu.be/XXmNTpG0gF4,Non-OADS,/arxiv_data1/oa_pdf/2e/f4/mder-9-349.PMC5067066.pdf
"Medical Devices: Evidence and Research 2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress Medical Devices: Evidence and Research Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/medical-devices-evidence-and-research-journalMedical Devices: Evidence and Research is an international, peer- reviewed, open access journal that focuses on the evidence, technology, research, and expert opinion supporting the use and application of   medical devices in the diagnosis, monitoring, treatment and management of clinical conditions and physiological processes.",Non-OADS,/arxiv_data1/oa_pdf/2e/f4/mder-9-349.PMC5067066.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/37/7a/main.PMC5067073.pdf
Social integration refers to the degree to whichContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/ssmphSSM -Population Health http://dx.doi.org/10.1016/j.ssmph.2016.05.007 2352-8273/ &2016 The Authors.,OADS,/arxiv_data1/oa_pdf/37/7a/main.PMC5067073.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/37/7a/main.PMC5067073.pdf
"Accessed from 〈http://faculty.washington.edu/kwchan/ Chan-urban.pdf 〉on March 16, 2016.",Non-OADS,/arxiv_data1/oa_pdf/37/7a/main.PMC5067073.pdf
Accessed from 〈http://www.china.org.cn/english/government/207279.,Non-OADS,/arxiv_data1/oa_pdf/37/7a/main.PMC5067073.pdf
"Geriatrics Gerontology International ., http://dx.doi.org/10.1111/ggi.12518 [Epub ahead of print].",Non-OADS,/arxiv_data1/oa_pdf/37/7a/main.PMC5067073.pdf
〈http://www.oecd.org/china/42607972.pdf 〉Accessed 16.03.16.,Non-OADS,/arxiv_data1/oa_pdf/37/7a/main.PMC5067073.pdf
〈http://newpol.org/content/village-elections-china-democracy-or-fa%C3% A7ade 〉Accessed 01.04.16.,Non-OADS,/arxiv_data1/oa_pdf/37/7a/main.PMC5067073.pdf
"BMC Public Health ,12, 524. http://dx.doi.org/10.1186/ 1471-2458-12-524 .",Non-OADS,/arxiv_data1/oa_pdf/37/7a/main.PMC5067073.pdf
"Accessed from 〈http://www.stats.gov.cn/english/press release/201201/t20120120_72112.html 〉on March 13, 2016.",Non-OADS,/arxiv_data1/oa_pdf/37/7a/main.PMC5067073.pdf
"〈http://www.stats.gov.cn/english/PressRelease/201502/t20150228_ 687439.html 〉Retrived December 13, 2015.",Non-OADS,/arxiv_data1/oa_pdf/37/7a/main.PMC5067073.pdf
"〈http://www.who.int/mental_health/suicide-prevention/world_report_2014/ en/ 〉Accessed April 1, 2016.",Non-OADS,/arxiv_data1/oa_pdf/37/7a/main.PMC5067073.pdf
"Population Health Metrics ,3,3 .http://dx.doi.org/10.1186/1478-7954-3-3 .",Non-OADS,/arxiv_data1/oa_pdf/37/7a/main.PMC5067073.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/55/2a/main.PMC5067091.pdf
Contents lists available at ScienceDirect Respiratory Medicine Case Reports journal homepage: www.elsevier.com/locate/rmcr http://dx.doi.org/10.1016/j.rmcr.2016.10.006 2213-0071/ ©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/55/2a/main.PMC5067091.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Respiratory Medicine Case Reports 19 (2016) 169 e172,Non-OADS,/arxiv_data1/oa_pdf/55/2a/main.PMC5067091.pdf
Available from: http://www.ncbi.nlm.nih.gov/pubmed/ 18682431 .,Non-OADS,/arxiv_data1/oa_pdf/55/2a/main.PMC5067091.pdf
Available from: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd ¼Retrieve &db¼PubMed &dopt¼Citation &list_uids ¼23050181 .,OADS,/arxiv_data1/oa_pdf/55/2a/main.PMC5067091.pdf
Available from: http://content.wkhealth.com/ linkback/openurl?sid ¼WKPTLP:landingpage &an¼00005382-201511000- 00011 .,Non-OADS,/arxiv_data1/oa_pdf/55/2a/main.PMC5067091.pdf
This  is  an  open access article under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/13/2b/main.PMC5067092.pdf
http://dx.doi.org/10.1016/j.ijscr.2016.10.013 2210-2612/© 2016  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/13/2b/main.PMC5067092.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f2/8a/main.PMC5067093.pdf
http://dx.doi.org/10.1016/j.idcr.2016.10.003 2214-2509/ ã  2016  The  Authors.,OADS,/arxiv_data1/oa_pdf/f2/8a/main.PMC5067093.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).IDCases  6  (2016)  79–82 Contents  lists  available  at  ScienceDirect IDCases journal  homepage:  www.elsevier.com/locate/idcr,Non-OADS,/arxiv_data1/oa_pdf/f2/8a/main.PMC5067093.pdf
The species identity was http://dx.doi.org/10.1016/j.mmcr.2016.10.002 Received 17 July 2016; Received in revised form 20 September 2016; Accepted 5 October 2016⁎Corresponding author.Medical Mycology Case Reports 13 (2016) 22–24 2211-7539/ © 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/c2/1e/main.PMC5067095.pdf
This is an open access article under the  CC BY-NC-ND license (http://creativecommons.org/licenses/by/4.0/).Available online 06 October 2016 crossmark,Non-OADS,/arxiv_data1/oa_pdf/c2/1e/main.PMC5067095.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/07/3d/main.PMC5067097.pdf
"Its administration is to be repeated for 2 consecutive menstrual cycles, mainly after menstruation, whereas nonmenstruatingContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/cuthreCurrent Therapeutic Research http://dx.doi.org/10.1016/j.curtheres.2016.07.002 0011-393X/ &2016.",Non-OADS,/arxiv_data1/oa_pdf/07/3d/main.PMC5067097.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/07/3d/main.PMC5067097.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1c/24/main.PMC5067098.pdf
Sun http://dx.doi.org/10.1016/j.ijscr.2016.10.004 2210-2612/© 2016  The  Author(s).,Non-OADS,/arxiv_data1/oa_pdf/1c/24/main.PMC5067098.pdf
http://dx.doi.org/10.1016/j.nicl.2016.10.002 2213-1582/© 2016 Published by Elsevier Inc.,Non-OADS,/arxiv_data1/oa_pdf/5f/1e/main.PMC5067101.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5f/1e/main.PMC5067101.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Borderline personality disorderRewardLossMonetary incentive delay Impulsivity Functional magnetic resonance imagingBrain-behavior correlations 1.,Non-OADS,/arxiv_data1/oa_pdf/3e/3d/main.PMC5067102.pdf
"Because of our ap r i o r i anatomical hypothesis regarding the role of the striatum in human reward processing and its relationship to impul- sivity, we performed a between-group region of interest (ROI)-based analyses in the striatum, with an anatomical ROI obtained from the WFU Pickatlas (Wake Forest University; http://fmri.wfubmc.edu/ software/pickatlas ) and a signi ﬁcance level of pb0.05 FWE corrected for the ROI volume.",OADS,/arxiv_data1/oa_pdf/3e/3d/main.PMC5067102.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/3e/3d/main.PMC5067102.pdf
"http://dx.doi.org/10.1037/10500-003 Beblo, T., Mensebach, C., Wingenfeld, K., Rullkoetter, N., Schlosser, N., Driessen, M., 2011.",Non-OADS,/arxiv_data1/oa_pdf/3e/3d/main.PMC5067102.pdf
"109, 37 –52.http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/3e/3d/main.PMC5067102.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/3e/3d/main.PMC5067102.pdf
http://dx.doi.org/10.1016/j.jpsychires.2010.01.007 .,OADS,/arxiv_data1/oa_pdf/3e/3d/main.PMC5067102.pdf
"24 (1), 25 –37.http://dx.doi.org/10.1521/pedi.2010.24.",Non-OADS,/arxiv_data1/oa_pdf/3e/3d/main.PMC5067102.pdf
http://dx.doi.org/10.1177/0269881111416686 .,Non-OADS,/arxiv_data1/oa_pdf/3e/3d/main.PMC5067102.pdf
Available at: http://www.nimh.nih.gov/ about/director/2015/precision-medicine-for-mental-disorders.shtml.,Non-OADS,/arxiv_data1/oa_pdf/54/a4/DialoguesClinNeurosci-18-231.PMC5067141.pdf
"For this, we have  developed PyBios3 (http://pybios.molgen.mpg.de),59,60 a  modeling engine written in Python, an object-oriented  modeling language, with objects corresponding to the  components of the biological networks we are trying to  model.",OADS,/arxiv_data1/oa_pdf/64/c5/DialoguesClinNeurosci-18-253.PMC5067143.pdf
Available at: http://www.top500.org/sta - tistics/perfdevel/.,Non-OADS,/arxiv_data1/oa_pdf/64/c5/DialoguesClinNeurosci-18-253.PMC5067143.pdf
Available at: https://www.google.com/ patents/EP2626433A1?cl=en&dq=Hans+Lehrach&hl=de&sa=X&ved=0ahU KEwjCg5_Yz9nOAhWKCywKHX9YDIwQ6AEISjAF.,OADS,/arxiv_data1/oa_pdf/64/c5/DialoguesClinNeurosci-18-253.PMC5067143.pdf
"However, a position statement from the ACMG asserts  that GS may provide value beyond strictly medical im - plications; for example, GS results that solve a complex  diagnostic puzzle may provide immense psychological  value to patients and families.60 In diagnostic applica - tions, elucidating a molecular diagnosis may provide  clinical utility by predicting prognosis, anticipating fu - 306 Category Organization Resource name Resource description Resource location Databases/  directoriesNational Center for  Biotechnology In- formation (NCBI)ClinVar A public archive of reports of the relation- ships among human variations and pheno- types along with supporting evidence.http://www.ncbi.nlm.",Non-OADS,/arxiv_data1/oa_pdf/e7/02/DialoguesClinNeurosci-18-299.PMC5067147.pdf
"It provides  standards, guidance, education resources,  and a patient registry.https://www.clinicalge- nome.org/ National Center for  Biotechnology In- formation (NCBI) Online Mende- lian Inheritance  in Man (OMIM)A compendium of human genes and ge- netic phenotypes.http://www.ncbi.nlm.",Non-OADS,/arxiv_data1/oa_pdf/e7/02/DialoguesClinNeurosci-18-299.PMC5067147.pdf
"Includes GeneReviews, a searchable  database of expert-authored and peer- reviewed disease descriptions.http://www.ncbi.nlm.",OADS,/arxiv_data1/oa_pdf/e7/02/DialoguesClinNeurosci-18-299.PMC5067147.pdf
"nih.gov/gtr/ Pharmacogenom- ics Knowledgebase  (PharmGKB)PharmGKB da- tabaseA searchable database of human genetic  variations on drug response, including pri- mary genotype and phenotype data, an- notated gene variants, and literature re- views of gene-drug-disease relationships.http://www.pharmgkb.",OADS,/arxiv_data1/oa_pdf/e7/02/DialoguesClinNeurosci-18-299.PMC5067147.pdf
"org  Public Health Part- nersLinks to ge- nomic projects/ informationOverview of resources with links at the  federal and international level regarding  Public Health Genomicshttp://phpartners.org/ public_health_genom- ics.html SNPedia SNPedia A wiki site that shares information about  the effects of variations in DNA, citing  peer-reviewed scientific publications.",OADS,/arxiv_data1/oa_pdf/e7/02/DialoguesClinNeurosci-18-299.PMC5067147.pdf
http://snpedia.com/in- dex.php/SNPedia Vanderbilt-Ingram  Cancer CenterMy Cancer Ge- nomeSearchable database of cancer mutations  that inform tumor-specific treatment and  prognosis.http://www.mycan- cergenome.org/ Table I.   Online genomic information resources.,Non-OADS,/arxiv_data1/oa_pdf/e7/02/DialoguesClinNeurosci-18-299.PMC5067147.pdf
"Thus, the clinical utility of most SFs is limited  307Professional  educationCenters for Disease  Control and Preven- tion (CDC)Public Health  GenomicsThe Office of Public Health Genomics  hosts and links to a variety of genomic  resources for health care providers, includ- ing a weekly update, blog, podcasts, A-Z  resource guide, and reports and publica- tions.http://www.cdc.gov/ genomics/ National Human  Genome Research  Institute Current Top- ics In Genome  AnalysisA lecture series covering contemporary  topics in genomics and bioinformatics.https://www.genome.",Non-OADS,/arxiv_data1/oa_pdf/e7/02/DialoguesClinNeurosci-18-299.PMC5067147.pdf
"gov/12514286/current- topics-in-genome-analy- sis-2016/ National Society of  Genetic CounselorsNSGC 2015  Online Course:  Personalized  and Precision  MedicineA series of 10 prerecorded presentations  by leaders in the personalized and preci- sion medicine community.http://nsgc.org/p/cm/ld/ fid=378 Scripps Translation- al Science Institute Scripps Genom- ics PrimerA multifaceted genomics learning tool,  including interactive tutorials, a genom- ics glossary, links to online resources, a  recommended reading list, and slide sets  covering topics such as sequencing, GWAS,  cancer genomics and pharmacogenomics.http://www.stsiweb.",Non-OADS,/arxiv_data1/oa_pdf/e7/02/DialoguesClinNeurosci-18-299.PMC5067147.pdf
"org/index.php/educa- tion_training/primer/ Counseling and  teaching toolsUniversity of Utah Genetic Science  Learning CenterEducational modules on various genetic  topics, including pharmacogenomics, ge- netic variation, and other basic topics.http://learn.genetics.",Non-OADS,/arxiv_data1/oa_pdf/e7/02/DialoguesClinNeurosci-18-299.PMC5067147.pdf
Includes Medicine’s Future: a  Genomics Curriculum for Clinicians pro- gram that can be hosted for CME credit.http://www.nchpeg.org/ index.php Wellcome Trust  Sanger Instituteyourgenome.,Non-OADS,/arxiv_data1/oa_pdf/e7/02/DialoguesClinNeurosci-18-299.PMC5067147.pdf
"orgOnline educational tools, including anima- tions, activities, and a glossaryhttp://www.yourge- nome.org/ Table I.",Non-OADS,/arxiv_data1/oa_pdf/e7/02/DialoguesClinNeurosci-18-299.PMC5067147.pdf
Available at: https://clinicalgenome.org/working-groups/actionabil - ity/projects-initiatives/actionability-evidence-based-summaries/.,Non-OADS,/arxiv_data1/oa_pdf/e7/02/DialoguesClinNeurosci-18-299.PMC5067147.pdf
Available  at: http://www.fda.gov/drugs/scienceresearch/researchareas/pharmaco - genetics/ucm083378.htm.,Non-OADS,/arxiv_data1/oa_pdf/5e/33/DialoguesClinNeurosci-18-313.PMC5067148.pdf
Available at: http://www.cypalleles.ki.se/cyp2d6.,Non-OADS,/arxiv_data1/oa_pdf/5e/33/DialoguesClinNeurosci-18-313.PMC5067148.pdf
Available at: http://www.hug-ge.ch/sites/interhug/files/structures/phar - macologie_et_toxicologie_cliniques/documents/substrats_et_inhibiteurs_ a5.pdf.,OADS,/arxiv_data1/oa_pdf/5e/33/DialoguesClinNeurosci-18-313.PMC5067148.pdf
Available at: http://www.pharmgkb.org.,Non-OADS,/arxiv_data1/oa_pdf/5e/33/DialoguesClinNeurosci-18-313.PMC5067148.pdf
Available at: http://www.accessdata.fda.gov/scripts/cder/ drugsatfda/.,Non-OADS,/arxiv_data1/oa_pdf/67/e2/DialoguesClinNeurosci-18-323.PMC5067149.pdf
Available at: http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ ref.cgi?showRare=on&chooseRs=coding&go=Go&locusId=1806.,OADS,/arxiv_data1/oa_pdf/67/e2/DialoguesClinNeurosci-18-323.PMC5067149.pdf
"Developmental  Cognitive  Neuroscience  21  (2016)  26–41 Contents  lists  available  at  ScienceDirect Developmental  Cognitive  Neuroscience jo  ur  nal  ho  me  pag  e:  http://www.elsevier.com/locate/dcn A  developmental neuroscience perspective  on  affect-biased  attention Santiago Morales∗,  Xiaoxue  Fu, Koraly E.  Pérez-Edgar The  Pennsylvania  State  University,  Department  of  Psychology,  140  Moore  Building,  University  Park,  PA  16802,  United  States a  r  t  i  c  l  e  i  n  f  o Article  history: Received  31 March 2016 Received in  revised  form  17  August  2016 Accepted  22 August  2016 Available online  28  August  2016 Keywords:Affect-biased attention Attention  bias TemperamentEmotionBrain development Individual  differencesa  b  s  t  r  a  c  t There  is  growing  interest  regarding  the  impact  of  affect-biased  attention  on  psychopathology.",Non-OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"Indeed,  laboratory  manipulations  using http://dx.doi.org/10.1016/j.dcn.2016.08.001 1878-9293/© 2016  The  Authors.",Non-OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.,Non-OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"18 (2), 166–172, http://dx.doi.org/10.1016/j.conb.2008.06.006 .",OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"Neuroscience 118  (4),  1099–1120,  http://dx.doi.org/10.1016/S0306-4522(02)01001-1 .",OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"118  (1), 28–33,  http://dx.doi.org/10.1037/a0012589 .",Non-OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"Emotion,  http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"16  (10),  606–619,  http://dx.doi.org/ 10.1038/nrn4025 .",Non-OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"6  (2),  196–202,  http://dx.doi.org/10.1038/ nn1001 .",Non-OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"Anxiety  25  (1),  55–63,  http://dx.doi.org/10.1002/da.20269 .",Non-OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"15  (4),  600–609,  http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"133  (1),  1–24,  http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"Psychiatry  51  (8),  859–870, http://dx.doi.org/10.1111/j.1469-7610.2010.02251.x .",Non-OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"16  (8),  1388–1411,  http://dx.doi.org/10.1162/ 0898929042304741 .",Non-OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"1156  (1),  118–140, http://dx.doi.org/10.1111/j.1749-6632.2009.04468.x .",Non-OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"59  (8),  1484–1504,  http://dx.doi.org/10.1080/02724980543000204 .",Non-OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"17  (1),  66–72,  http://dx.doi.org/10.1037/0893-164X.17.1.66 .",Non-OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"4,  52–64,  http://dx.doi.org/10.1016/j.dcn.2012.11.001 .",OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"Psychopathol.,  http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"Psychiatry  54  (6),  678–685, http://dx.doi.org/10.1111/jcpp.12024 .",Non-OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"28  (1),  97–107,  http://dx.doi.org/10.1016/j.janxdis.2013.11.",OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"8,  65–76, http://dx.doi.org/10.1016/j.dcn.2013.10.003 .",OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"Neuropsychologia 47  (5),  1386–1389, http://dx.doi.org/10.1016/j.neuropsychologia.2009.01.026 .",Non-OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"33  (9),  1063–1073, http://dx.doi.org/10.1038/ijo.2009.138 .",Non-OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"40  (6), 677–687, http://dx.doi.org/10.1016/S0005-7967(01)00086-9 .",Non-OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"42  (4), 656–665,  http://dx.doi.org/10.1037/0012-1649.42.4.656 .",Non-OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"Psychiatry  48  (9),  928–935,  http://dx.doi.org/10.1097/CHI.",Non-OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"30  (2),  203–216, http://dx.doi.org/10.1016/j.cpr.2009.11.003 .",OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"48  (1),  74–78, http://dx.doi.org/10.1016/j.brat.2009.09.003 .",OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"Psychiatry 51 (10),  1066–1075.e1,  http://dx.doi.org/10.1016/j.jaac.2012.08.002 .",Non-OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"(formerly Zeitschrift Für Experimentelle  Psychologie)  58  (3),  171–179,  http://dx.doi.org/ 10.1027/1618-3169/a000083 .",Non-OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"141,  210–221, http://dx.doi.org/10.1016/j.jecp.2015.09.012 .",OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"52  (1),  337–367  http://doi.org/10.1146/annurev.psych.52.1.337 .",Non-OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"44  (9),  1321–1329, http://dx.doi.org/10.1016/j.brat.2005.10.004 .",OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"Child  Development 77  (3),  680–695  http://doi.org/10.1111/j.1467-8624.2006.00897.x .",Non-OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"J.  Psychiatry  206 (1),  7–16,  http://dx.doi.org/10.1192/bjp.bp.114.146761 .",Non-OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"85  (2),  397–404,  http://dx.doi.org/10.1111/cdev.12126 .",Non-OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"32  (1),  10–21, http://dx.doi.org/10.1207/S15374424JCCP3201 02.",Non-OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"Psychiatry  51  (4),  497–517,  http://dx.doi.org/10.1111/j.1469- 7610.2010.02228.x .",Non-OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"76  (1-2),  1–10,  http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"Emotion  2  (1),  3–11,  http://dx.doi.org/10.1037/1528-3542.2.1.3 .",Non-OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"46  (4),  450–461,  http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"5  (5),  e1000381,  http://dx.doi.org/ 10.1371/journal.pcbi.1000381 .",Non-OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"14  (3), 340–347,  http://dx.doi.org/10.1162/089892902317361886 .",Non-OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"70 (2),  209–220,  http://dx.doi.org/10.1016/j.bandc.2009.02.002 .",OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"13  (4),  315–332,  http://dx.doi.org/10.1007/ s10567-010-0078-8 .",Non-OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"35  (3),  431–439,  http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
Radboud  University Nijmegen (Retrieved from http://fransfolkvord.nl/wp-content/uploads/2014/ 12/ThesisFransFolkvord  Childrens-Reactivity-to-Embedded-Food-Cues-in- Advergames.pdf#page=141 ).,Non-OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"51  (17), 1920–1931,  http://dx.doi.org/10.1016/j.visres.2011.07.002 .",Non-OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"Gen.  130  (4),  681–700, http://dx.doi.org/10.1037/0096-3445.130.4.681 .",Non-OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"72  (1),  1–21,  http://dx.doi.org/10.1111/1467-8624.00262 .",Non-OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"Psychiatry  67  (4),  371–377,  http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"50  (24), 2766–2774,  http://dx.doi.org/10.1016/j.visres.2010.09.024 .",OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"82  (6),  1738–1750,  http://dx.doi.org/10.1111/j.1467-8624.",Non-OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"PLoS  One  8  (1),  e53286,  http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"28  (2),  307–337,  http://dx.doi.org/10.1016/j.cpr.2007.",OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"36  (6),  611–620,  http://dx.doi.org/10.1007/s10865-012-9455-8 .",Non-OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"Neurosci.,  4584–4593, http://dx.doi.org/10.1523/JNEUROSCI.3446–12.2013 .",Non-OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"2  (10),  861–863,  http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"113  (3),  386–398,  http://dx.doi.org/10.1037/ 0021-843x.113.3.386 .",Non-OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"26  (2),  133–144,  http://dx.doi.org/10.1002/per.1842 .",Non-OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"26  (24),  6399–6405, http://dx.doi.org/10.1523/JNEUROSCI.0666-06.2006 .",Non-OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"Psychol.,  1–7,  http://dx.doi.org/10.1080/15374416.2014.",Non-OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"40,  76–90,  http://dx.doi.org/10.1016/j.cpr.2015.06.001 .",OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"Neuropsychopharmacology 40  (1),  207–224,  http://dx.doi.org/10.1038/npp.2014.189 .",Non-OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"Emotion  15  (2),  151–161,  http://dx.doi.org/10.1037/ emo0000037 .",Non-OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"21  (4),  237–242,  http://dx.doi.org/10.1177/ 0963721412448651 .",Non-OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"44, 51–57,  http://dx.doi.org/10.1016/j.addbeh.2014.11.018 .",OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"Sci.,  http://dx.doi.org/10.1177/ 2167702615601000 .",OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"111  (45),  16208–16213,  http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"142,  334–343, http://dx.doi.org/10.1016/j.jecp.2015.09.009 .",OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"55  (6),  2212–2225,  http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"24  (24), 5506–5515, http://dx.doi.org/10.1523/JNEUROSCI.0292-04.2004 .",Non-OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"17  (6),  425–433,  http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"Infancy  16 (2), 198–210,  http://dx.doi.org/10.1111/j.1532-7078.2010.00036.x .",Non-OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"66  (2),  163–179, http://dx.doi.org/10.1006/jecp.1997.2376 .",Non-OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"22  (2),  201–219,  http://dx.doi.org/10.1023/A:1007540608596 .",Non-OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"72  (4),  1091–1111,  http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"42  (10),  1183–1192,  http://dx.doi.org/10.1016/j.",Non-OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"Emotion  19  (5), 771–780,  http://dx.doi.org/10.1080/02699930441000418 .",Non-OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"18  (5),  736–750,  http://dx.doi.org/ 10.1111/desc.12251 .",Non-OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"85  (4),  1503–1518,  http://dx.doi.org/10.1111/ cdev.12206 .",Non-OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"Psychiatry  53 (4),  447–455,  http://dx.doi.org/10.1016/j.jaac.2013.12.019 .",Non-OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"17  (5), 667–681,  http://dx.doi.org/10.1111/desc.12158 .",Non-OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"43  (3),  235–243,  http://dx.doi.org/ 10.1348/0144665031752989 .",Non-OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"30  (6),  718–729,  http://dx.doi.org/10.1016/j.neubiorev.2006.06.001 .",OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"10  (1),  37–47,  http://dx.doi.org/10.1038/ nrn2554 .",Non-OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"21  (3),  200–204,  http://dx.doi.org/10.1177/0963721411435841 .",Non-OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"78  (1), 232–245,  http://dx.doi.org/10.1111/j.1467-8624.2007.00994.x .",Non-OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"106  (39),  16841–16846,  http://dx.doi.org/ 10.1073/pnas.0904551106 .",Non-OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"Anxiety  32  (6),  383–391,  http://dx.doi.org/10.1002/ da.22344 .",Non-OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"19  (3), 284–289,  http://dx.doi.org/10.1111/j.1467-9280.2008.02081.x .",Non-OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"13  (1),  221–228,  http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"17  (2),  239–247, http://dx.doi.org/10.1111/desc.12110 .",Non-OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"19 (6),  375–379,  http://dx.doi.org/10.1177/0963721410388801 .",Non-OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"12  (2),  305–313, http://dx.doi.org/10.1111/j.1467-7687.2008.00767.x .LoBue,  V.,  2010a.",Non-OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"107  (1),  59–66, http://dx.doi.org/10.1016/j.jecp.2010.04.005 .",OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"Emotion  24  (1),  180–187,  http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"7  (1),  38–42,  http://dx.doi.org/10.1111/ cdep.12012 .",Non-OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"37  (3),  387–399, http://dx.doi.org/10.1007/s10802-008-9284-y .",Non-OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"33 (1),  8–20,  http://dx.doi.org/10.1207/S15374424JCCP3301  2.",Non-OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"95  (1),  15–20,  http://dx.doi.org/10.1037/0021-843X.95.1.15 .",Non-OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"Psychiatry 44 (1),  64–87,  http://dx.doi.org/10.1111/1469-7610.00103 .",Non-OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"Emotion  13  (6),  673–690,  http://dx.doi.org/ 10.1080/026999399379032 .",Non-OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"33  (3),  293–303,  http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"28  (2),  559–562,  http://dx.doi.org/10.1037/ a0036086 .",Non-OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"Psychopharmacology  (Berl)  180  (2),  333–341,  http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"46  (5),  656–667,  http://dx.doi.org/10.1016/j.brat.",OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"Clinical  Psychology,  http://dx.doi.org/10.1002/jclp.",Non-OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"J. Psychiatry  165  (1),  90–98,  http://dx.doi.org/10.1176/appi.ajp.2007.06111917 .",Non-OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"43  (6),  1067–1078, http://dx.doi.org/10.1007/s10802-014-9963-9 .",Non-OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"19  (5),  853–862  http://doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"Sci., http://dx.doi.org/10.1111/desc.12391 .",OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"Change  20  (03),  131–142,  http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"J. Psychiatry  172  (12),  1242–1250,  http://dx.doi.org/10.1176/appi.ajp.2015.",Non-OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"56  (1),  58,  http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"58  (4),  889,  http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"Neuropsychologia 41  (2),  147–155,  http://dx.doi.org/10.1016/S0028- 3932(02)00145-8 .",Non-OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"108  (3),  483–522,  http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"14  (4),  681–706,  http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"Emotion  10  (3),  349–357, http://dx.doi.org/10.1037/a0018486 .",Non-OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"46  (6),  1723–1730,  http://dx.doi.org/10.1037/ a0021064 .",Non-OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"39  (6),  885–895,  http://dx.doi.org/10.1007/s10802-011-9495-5 .",Non-OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"82  (3),  337–343,  http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"42–56,  Retrieved  from  http://www.karger.com/Article/Pdf/ 354350 .",Non-OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"25  (7),  1371–1379,  http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"78  (4),  1037–1051,  http://dx.doi.org/ 10.1111/j.1467-8624.2007.01051.x .",Non-OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"11  (1),  60–68,  http://dx.doi.org/10.1111/j.1467-7687.2007.",Non-OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"4  (2),  134–142,  http://dx.doi.org/10.1093/scan/nsn046 .",Non-OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"86  (5),  1321–1332,  http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"35  (1),  73–89,  http://dx.doi.org/10.1146/ annurev-neuro-062111-150525 .",Non-OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"Neuroimaging 83  (3),  127–138,  http://dx.doi.org/10.1016/S0925-4927(98)00036-5 .",OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"Anxiety  Stress  Coping  17  (1),  23–36,  http://dx.doi.org/10.1080/ 10615800310001601458 .",Non-OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"Emotion  22  (7), 1209–1227, http://dx.doi.org/10.1080/02699930701686008 .",Non-OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"58  (1),  1–23, http://dx.doi.org/10.1146/annurev.psych.58.110405.085516 .",Non-OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"2014,  e405094,  http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"1129  (1),  193–199, http://dx.doi.org/10.1196/annals.1417.011 .",Non-OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"NeuroImage  59  (3),  2142–2154  http://doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"7  (5), 367–379,  http://dx.doi.org/10.1038/nrn1903 .",Non-OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"6,  http://dx.doi.org/ 10.3389/fnhum.2012.00143 .",Non-OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"125  (6),  840–851, http://dx.doi.org/10.1037/abn0000184 .",Non-OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"23  (11),  1345–1355,  http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"6  (04),  635  http://doi.org/10.1017/ S0954579400004715 .",Non-OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"Psychiatry  47  (10),  1189–1196,  http://dx.doi.org/10.1097/CHI.",Non-OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"29  (3),  171–184,  http://dx.doi.org/10.1891/0889-8391.29.3.171 .",Non-OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"60 (1),  141–171,  http://dx.doi.org/10.1146/annurev.psych.60.",Non-OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"Neuropsychologia 42 (8),  1029–1040,  http://dx.doi.org/10.1016/j.",Non-OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"45  (3),  607–615,  http://dx.doi.org/10.1016/j.brat.2006.",OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"43  (4),  733–745,  http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"36  (04), 393–414, http://dx.doi.org/10.1017/S0140525x12000660 .",Non-OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"19  (7), 595–605,  http://dx.doi.org/10.1002/per.554 .",Non-OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"Science 300 (5627),  1952–1953,  http://dx.doi.org/10.1126/science.1083703 .",Non-OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"Psychiatry  17  (10),  1042–1050,  http://dx.doi.org/10.1038/mp.2011.96 .",Non-OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"Disorders  4  (1),  17,  http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"Anxiety  29  (4),  282–294,  http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"Anxiety  30  (1),  14–21,  http://dx.doi.org/ 10.1002/da.21986 .",Non-OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"31  (3), 501–510,  http://dx.doi.org/10.1016/j.infbeh.2008.02.001 .",Non-OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"123 (2), 131–135,  http://dx.doi.org/10.1037/a0015095 .",Non-OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"34  (6), 835–844,  http://dx.doi.org/10.1016/j.neubiorev.2009.11.010 .",Non-OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"Emotion  26  (6), 1069–1083,  http://dx.doi.org/10.1080/02699931.2011.638910 .",Non-OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"5,  http://dx.doi.org/ 10.3389/fpsyg.2014.00922 .",Non-OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"61  (Suppl  1), S119–S127,  http://dx.doi.org/10.1177/0883073891006001121 .",Non-OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"11  (10),  697–709,  http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"33  (8),  1124–1136, http://dx.doi.org/10.1177/0146167207301030 .",Non-OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"Emotion  11  (1),  127–138, http://dx.doi.org/10.1037/a0021301 .",Non-OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"18  (5),  713–722  http://doi.org/ 10.1111/desc.12261 .",Non-OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"Psychol.,  http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"Bull.,  http://dx.doi.org/10.1037/a0034834 .",Non-OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"Pain  8  (3),  227–236,  http://dx.doi.org/10.1016/j.ejpain.",OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"34  (1),  33–39,  http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"44  (11),  1555–1563,  http://dx.doi.org/ 10.1016/j.brat.2005.11.008 .Van  Dijk,  K.R.A.,  Sabuncu,  M.R.,  Buckner,  R.L.,  2012.",Non-OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"40,  84–90,  http://dx.doi.org/10.1016/j.addbeh.2014.09.004 .",OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"7  (11),  1271–1278,  http://dx.doi.org/10.1038/ nn1341 .",Non-OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"46  (1),  114–121, http://dx.doi.org/10.1016/j.brat.2007.11.002 .",OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"Emotion  22  (7),  1306–1326,  http://dx.doi.org/10.1080/02699930701755530 .",Non-OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"89 (4), 320–337, http://dx.doi.org/ 10.1016/j.jecp.2004.06.003 .",OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"60  (2),  112–125,  http://dx.doi.org/10.1080/ 00049530701549346 .",Non-OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"Psychiatry  47  (4),  435–442,  http://dx.doi.org/10.1097/CHI.",Non-OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"4,  77–84,  http://dx.doi.org/10.1016/j.dcn.2012.09.004 .",OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"44  (3),  607–616,  http://dx.doi.org/10.1017/ S0033291713000779 .",Non-OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"15  (1),  377–402,  http://dx.doi.org/10.1146/ annurev.ne.15.030192.002113 .",Non-OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"30  (5),  561–569,  http://dx.doi.org/10.1037/a0024291 .",Non-OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"Psychiatry  45  (1),  136–143,  http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"34 (12), 1123–1132, http://dx.doi.org/10.1037/hea0000225 .",Non-OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"35  (1), 205–213, http://dx.doi.org/10.1037/0012-1649.35.1.205 .",Non-OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"181  (3),  477–485,  http://dx.doi.org/10.1007/ s00213-005-0004-9 .",Non-OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"3  (5),  772–788,  http://dx.doi.org/10.1177/ 2167702614551572 .",Non-OADS,/arxiv_data1/oa_pdf/c7/d8/main.PMC5067218.pdf
"Accordingly, the gait of our participants while they crossed the virtual plank wasReceived: 15 June 2016 Revised: 2 September 2016 Accepted: 22 September 2016 Heliyon 2 (2016) e00173 http://dx.doi.org/10.1016/j.heliyon.2016.e00173 2405-8440/© 2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/52/0f/main.PMC5067243.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/52/0f/main.PMC5067243.pdf
On Article No~e00173 2 http://dx.doi.org/10.1016/j.heliyon.2016.e00173 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/52/0f/main.PMC5067243.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/52/0f/main.PMC5067243.pdf
Article No~e00173 3 http://dx.doi.org/10.1016/j.heliyon.2016.e00173 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/52/0f/main.PMC5067243.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/52/0f/main.PMC5067243.pdf
Article No~e00173 4 http://dx.doi.org/10.1016/j.heliyon.2016.e00173 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/52/0f/main.PMC5067243.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/52/0f/main.PMC5067243.pdf
This pattern constitutes an ascendingranking with the two ground conditions on one of its sides and the two height Article No~e00173 5 http://dx.doi.org/10.1016/j.heliyon.2016.e00173 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/52/0f/main.PMC5067243.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/52/0f/main.PMC5067243.pdf
Article No~e00173 6 http://dx.doi.org/10.1016/j.heliyon.2016.e00173 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/52/0f/main.PMC5067243.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/52/0f/main.PMC5067243.pdf
Article No~e00173 7 http://dx.doi.org/10.1016/j.heliyon.2016.e00173 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/52/0f/main.PMC5067243.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/52/0f/main.PMC5067243.pdf
These brain circuits were found to be Article No~e00173 8 http://dx.doi.org/10.1016/j.heliyon.2016.e00173 2405-8440/© 2016 The Authors.,OADS,/arxiv_data1/oa_pdf/52/0f/main.PMC5067243.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/52/0f/main.PMC5067243.pdf
Article No~e00173 9 http://dx.doi.org/10.1016/j.heliyon.2016.e00173 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/52/0f/main.PMC5067243.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/52/0f/main.PMC5067243.pdf
Article No~e00173 10 http://dx.doi.org/10.1016/j.heliyon.2016.e00173 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/52/0f/main.PMC5067243.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/52/0f/main.PMC5067243.pdf
Article No~e00173 11 http://dx.doi.org/10.1016/j.heliyon.2016.e00173 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/52/0f/main.PMC5067243.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/52/0f/main.PMC5067243.pdf
Article No~e00173 12 http://dx.doi.org/10.1016/j.heliyon.2016.e00173 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/52/0f/main.PMC5067243.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/52/0f/main.PMC5067243.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 InternationalLicense (http://creativecommons.org/licenses/by-nc/4.0/), which per- mits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the originalauthor(s) and the source, provide a link to the Creative Commonslicense, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/c7/f5/10620_2016_Article_4291.PMC5067290.pdf
"HCV Guidance: Recommendations for Testing, Managing, and Treat-ing Hepatitis C. Available at: http://www.hcvguidelines.org/ ; 2016.",Non-OADS,/arxiv_data1/oa_pdf/c7/f5/10620_2016_Article_4291.PMC5067290.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which per-mits any noncommercial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/d2/db/10620_2016_Article_4239.PMC5067291.pdf
"Therneau T. A Package for Survival Analysis in S , Version 2.38; 2015. http://CRAN.R-project.org/package=survival .",Non-OADS,/arxiv_data1/oa_pdf/d2/db/10620_2016_Article_4239.PMC5067291.pdf
"R Foundation for Statistical Computing, Vienna, Austria; 2013. http://www.R-project.org/ .",Non-OADS,/arxiv_data1/oa_pdf/d2/db/10620_2016_Article_4239.PMC5067291.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which per-mits any noncommercial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/b2/90/10620_2016_Article_4280.PMC5067292.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9f/47/main.PMC5067293.pdf
"The pathohistology  of  the  dissected  tissue  demonstrated  that  the  histol- ogy  was  moderately  differentiated  adenocarcinoma,  and  the  depth of  the gastric cancer  was  pT1b2  (submucosal  layer:  ∼1000  /H9262m, tumor  size:  10  mm  ×  10  mm)  with  vertical  and  horizontal  negative http://dx.doi.org/10.1016/j.ijscr.2016.10.009 2210-2612/© 2016  The  Authors.",Non-OADS,/arxiv_data1/oa_pdf/9f/47/main.PMC5067293.pdf
This  is  an  open access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6f/71/main.PMC5067294.pdf
CT  imaging  of  the  abdomen  and  pelvis  showed  irreg- ular  thickening  of  the  gastric  wall  with  involvement  of  the  body http://dx.doi.org/10.1016/j.ijscr.2016.10.007 2210-2612/© 2016  The  Author(s).,Non-OADS,/arxiv_data1/oa_pdf/6f/71/main.PMC5067294.pdf
"Retrieved January  10,  2016,  from  http://seer.cancer.gov/statfacts/html/nhl.html .",Non-OADS,/arxiv_data1/oa_pdf/6f/71/main.PMC5067294.pdf
http://dx.doi.org/ .,Non-OADS,/arxiv_data1/oa_pdf/6f/71/main.PMC5067294.pdf
"Retrieved  April  24,  2016,  from  https://www.nlm.nih.",Non-OADS,/arxiv_data1/oa_pdf/6f/71/main.PMC5067294.pdf
This  is  an  open  access  article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a9/c7/main.PMC5067295.pdf
A  single  tangential  injury  was  identiﬁed  on  the  postero- http://dx.doi.org/10.1016/j.ijscr.2015.12.025 2210-2612/© 2016  Published  by  Elsevier  Ltd  on  behalf  of  IJS  Publishing  Group  Ltd.,Non-OADS,/arxiv_data1/oa_pdf/a9/c7/main.PMC5067295.pdf
This  is  an  open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/01/3b/main.PMC5067296.pdf
http://dx.doi.org/10.1016/j.ijscr.2016.10.019 2210-2612/© 2016  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/01/3b/main.PMC5067296.pdf
"27  (2016)  187–189,  http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/01/3b/main.PMC5067296.pdf
"70  (2012) 1459–1463,  http://dx.doi.org/10.1016/j.joms.2011.05.003 .",Non-OADS,/arxiv_data1/oa_pdf/01/3b/main.PMC5067296.pdf
"36  (1983)  52–55, http://dx.doi.org/10.1016/0007-1226(83)90011-5 .",Non-OADS,/arxiv_data1/oa_pdf/01/3b/main.PMC5067296.pdf
"36  (1983) 1–8,  http://dx.doi.org/10.1016/0007-1226(83)90002-4 .",Non-OADS,/arxiv_data1/oa_pdf/01/3b/main.PMC5067296.pdf
"48 (2010)  253–260,  http://dx.doi.org/10.1016/j.bjoms.2009.09.017 .",OADS,/arxiv_data1/oa_pdf/01/3b/main.PMC5067296.pdf
"Wax,  The  double-barreled radial forearm  osteocutaneous  free  ﬂap,  Laryngoscope  (2015)  340–344, http://dx.doi.org/10.1002/lary.25388 .",Non-OADS,/arxiv_data1/oa_pdf/01/3b/main.PMC5067296.pdf
"20  (2014)  279–284,  http://dx.doi.org/10.12809/hkmj134113 .",Non-OADS,/arxiv_data1/oa_pdf/01/3b/main.PMC5067296.pdf
"45  (2016) 163–166,  http://dx.doi.org/10.1016/j.ijom.2015.09.022 .",OADS,/arxiv_data1/oa_pdf/01/3b/main.PMC5067296.pdf
"37  (2008)  672–674, http://dx.doi.org/10.1016/j.ijom.2008.01.012 .",OADS,/arxiv_data1/oa_pdf/01/3b/main.PMC5067296.pdf
"40  (2004)  99–102,  http://dx.doi.org/10.1016/S1368- 8375(03)00133-7 .",Non-OADS,/arxiv_data1/oa_pdf/01/3b/main.PMC5067296.pdf
This  is  an  open  access  article under the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/8d/a3/main.PMC5067297.pdf
http://dx.doi.org/10.1016/j.ijscr.2016.10.018 2210-2612/© 2016  Published  by  Elsevier  Ltd  on  behalf  of  IJS  Publishing  Group  Ltd.,Non-OADS,/arxiv_data1/oa_pdf/8d/a3/main.PMC5067297.pdf
This  is  an  open access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b7/23/main.PMC5067298.pdf
"Thoraco-abdominal  CT  detected an  elevated  right  diaphragm  due  to  herniation  of  liver,  gallblad- http://dx.doi.org/10.1016/j.ijscr.2016.10.015 2210-2612/© 2016  The  Authors.",Non-OADS,/arxiv_data1/oa_pdf/b7/23/main.PMC5067298.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/98/32/main.PMC5067299.pdf
"The  clinical  diagnosis  at  the  time  was  carcinoma  of  the  ampulla of  Vater,  exposed  protruded  type,  T3b  (Du2,  Panc2),  N1,  H0,  P0, M1  (LYN),  c-Stage  IV  in  the  classiﬁcation  of  biliary  tract  cancers established  by  the  Japanese  Society  of  Hepato-Biliary-Pancreatic http://dx.doi.org/10.1016/j.ijscr.2016.09.050 2210-2612/© 2016  The  Author(s).",Non-OADS,/arxiv_data1/oa_pdf/98/32/main.PMC5067299.pdf
"Received:  July 1, 2015    Revised:  October 16, 2015 Accepted:  December 28, 2015    Available online:  June 1, 2016  Correspondence:  Hae-Y oung Kim, DDS, PhD Department of Health Policy and Management, College of Health Sciences, Ko - rea University, 145 Anam-ro, Seongbuk-gu, Seoul 02841, Republic of Korea Tel: +82-2-3290-5667, Fax: +82-2-940-2879, E-mail:  kimhaey@korea.ac.kr cc This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduc - tion in any medium, provided the original work is properly cited.http://dx.doi.org/10.4306/pi.2016.13.5.473",Non-OADS,/arxiv_data1/oa_pdf/00/00/pi-13-473.PMC5067340.pdf
"Received:  January 6, 2016    Revised:  January 24, 2016 Accepted:  January 28, 2016    Available online:  July 11, 2016  Correspondence:  Seog Ju Kim, MD, PhD  Department of Psychiatry, Sungkyunkwan University School of Medicine, Sam - sung Medical Center, 81 Irwon-ro, Gangnam-gu, Seoul 06351, Republic of  Korea Tel: +82-2-3410-3583, Fax: +82-2-3410-0050, E-mail:  psychical@hanmail.net cc This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduc - tion in any medium, provided the original work is properly cited.Print ISSN 1738-3684 / On-line ISSN 1976-3026 OPEN ACCESS http://dx.doi.org/10.4306/pi.2016.13.5.480ORIGINAL ARTICLE 480  Copyright © 2016 Korean Neuropsychiatric Association",Non-OADS,/arxiv_data1/oa_pdf/14/e5/pi-13-480.PMC5067341.pdf
"Received:  December 30, 2015    Revised:  March 7, 2016 Accepted:  March 21, 2016    Available online:  September 12, 2016  Correspondence:  Eui-Jung Kim, MD, PhD  Department of Psychiatry, Ewha Womans University, Mokdong Hospital,  1071 Anyangcheon-ro, Y angcheon-gu, Seoul 07985, Republic of Korea Tel: +82-2-2650-5164, Fax: +82-2-2650-2649, E-mail:  christie@ewha.ac.kr cc This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduc - tion in any medium, provided the original work is properly cited.Print ISSN 1738-3684 / On-line ISSN 1976-3026 OPEN ACCESS http://dx.doi.org/10.4306/pi.2016.13.5.488ORIGINAL ARTICLE 488  Copyright © 2016 Korean Neuropsychiatric Association",Non-OADS,/arxiv_data1/oa_pdf/80/f4/pi-13-488.PMC5067342.pdf
"Received:  July 18, 2015    Revised:  September 8, 2015 Accepted:  September 14, 2015    Available online:  September 15, 2016  Correspondence:  Sung Man Chang, MD Department of Psychiatry, Kyungpook National University Hospital, 130 Dong- deok-ro, Jung-gu, Daegu 41944, Republic of Korea Tel: +82-53-420-5753, Fax: +82-53-426-5361, E-mail:  psyjang@knu.ac.kr cc This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduc - tion in any medium, provided the original work is properly cited.http://dx.doi.org/10.4306/pi.2016.13.5.496",Non-OADS,/arxiv_data1/oa_pdf/7f/30/pi-13-496.PMC5067343.pdf
"Received: July 28, 2015    Revised: November 20, 2015 Accepted:  December 8, 2015    Available online: April 6, 2016  Correspondence: Hyun Kook Lim, MD, PhD Department of Psychiatry, St. Vincent’s Hospital, College of Medicine, The Cath- olic University of Korea, 93 Jungbu-daero, Paldal-gu, Suwon 16247, Republic of  Korea Tel: +82-31-249-8273, Fax: +82-31-248-6758, E-mail: drblues@catholic.ac.kr cc This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduc - tion in any medium, provided the original work is properly cited.http://dx.doi.org/10.4306/pi.2016.13.5.504",Non-OADS,/arxiv_data1/oa_pdf/3d/65/pi-13-504.PMC5067344.pdf
"Received:  July 7, 2015    Revised:  November 11, 2015 Accepted:  December 1, 2015    Available online:  March 23, 2016  Correspondence:  Siekyeong Kim, MD, PhD  Department of Psychiatry, Chungbuk National University College of Medi - cine, 1 Chungdae-ro, Seowon-gu, Cheongju 28644, Republic of Korea Tel: +82-43-269-6364, Fax: +82-43-267-7951 E-mail:  poshong@chungbuk.ac.kr cc This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduc - tion in any medium, provided the original work is properly cited.Print ISSN 1738-3684 / On-line ISSN 1976-3026 OPEN ACCESS http://dx.doi.org/10.4306/pi.2016.13.5.511ORIGINAL ARTICLE   Copyright © 2016 Korean Neuropsychiatric Association   511",Non-OADS,/arxiv_data1/oa_pdf/fe/68/pi-13-511.PMC5067345.pdf
Image processing All images were processed using FreeSurfer (v. 5.3.0) with  the default settings (http://surfer.nmr.mgh.harvard.edu) on a  Mac Pro 64-bit OS X platform.,OADS,/arxiv_data1/oa_pdf/fe/68/pi-13-511.PMC5067345.pdf
Statistical analysis Analyses were conducted using the R statistical package v.  2.15.3 as described in the website (http://r-project.org) with  appropriate packages.,OADS,/arxiv_data1/oa_pdf/fe/68/pi-13-511.PMC5067345.pdf
"Kinikli, Denizli 20070, Turkey Tel: +90-532-554-02-60, Fax: +90-258-296-60-01, E-mail: hherken@pau.edu.tr cc This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduc - tion in any medium, provided the original work is properly cited.http://dx.doi.org/10.4306/pi.2016.13.5.518",Non-OADS,/arxiv_data1/oa_pdf/2b/e9/pi-13-518.PMC5067346.pdf
"Received: August 20, 2015    Revised: December 12, 2015 Accepted:  January 8, 2016    Available online: March 28, 2016  Correspondence: Jong-Chul Y ang, MD, PhD Department of Psychiatry, Chonbuk National University Medical School, 20  Geonji-ro, Deokjin-gu, Jeonju 54907, Republic of Korea Tel: +82-63-250-2580, Fax: +82-63-275-3157, E-mail: yangjc@jbnu.ac.kr  Correspondence: Y ong-Ku Kim, MD, PhD Department of Psychiatry, Korea University Ansan Hospital, Korea University  College of Medicine, 122 Jeokgeum-ro, Danwon-gu, Ansan 15355, Republic of  Korea Tel: +82-31-412-5140, Fax: +82-31-412-5144, E-mail: yongku@korea.ac.kr  cc This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduc - tion in any medium, provided the original work is properly cited.http://dx.doi.org/10.4306/pi.2016.13.5.526",Non-OADS,/arxiv_data1/oa_pdf/9d/1e/pi-13-526.PMC5067347.pdf
"Received:  September 26, 2015    Revised:  December 13, 2015 Accepted:  December 16, 2015    Available online:  April 6, 2016  Correspondence:  Yia-Ping Liu, MD, PhD  Department of Physiology and Biophysics, National Defense Medical Center,  Department of Psychiatry, Tri-Service General Hospital No.161, Section 6, Min- Chuan East Road, Taipei 114, Taiwan, Republic of China Tel: 886-2-87923100, ext 18614, Fax: 886-2-87923153 E-mail:  yiaping@ndmctsgh.edu.tw cc This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduc - tion in any medium, provided the original work is properly cited.http://dx.doi.org/10.4306/pi.2016.13.5.531",Non-OADS,/arxiv_data1/oa_pdf/cf/ae/pi-13-531.PMC5067348.pdf
"Received:  August 5, 2015    Revised:  January 26, 2016 Accepted:  February 12, 2016    Available online:  July 11, 2016  Correspondence:  Cem Ismail Kucukali, MD Department of Neuroscience, Institute of Experimental Medicine, Istanbul  University, Istanbul, Turkey Tel: +90 212 4142000-33325, Fax: +90 212 5324171 E-mail:  cemsmile@gmail.com cc This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduc - tion in any medium, provided the original work is properly cited.Print ISSN 1738-3684 / On-line ISSN 1976-3026 OPEN ACCESS http://dx.doi.org/10.4306/pi.2016.13.5.541ORIGINAL ARTICLE   Copyright © 2016 Korean Neuropsychiatric Association   541",Non-OADS,/arxiv_data1/oa_pdf/90/33/pi-13-541.PMC5067349.pdf
Linkage disequilibri - um among chemokine gene polymophisms was assessed using  D’ and r2 values obtained through the Haploview program  (http://www.broad.mit.edu/mpg/haploview/documentation.,OADS,/arxiv_data1/oa_pdf/90/33/pi-13-541.PMC5067349.pdf
"Received:  October 4, 2015    Revised:  December 22, 2015 Accepted:  December 22, 2015    Available online:  July 11, 2016  Correspondence:  Ioan Ovidiu Sirbu, MD, PhD  University of Medicine and Pharmacy “Victor Babes” Timisoara Biochemis - try Department, 2 Eftimie Murgu, Timisoara 300041, Romania Tel: +40-730656429, Fax: +40-256220484, E-mail:  ovidiu.sirbu@umft.ro  Correspondence:  Catalin Marian, MD, PhD   University of Medicine and Pharmacy “Victor Babes” Timisoara Biochemis - try Department, 2 Eftimie Murgu, Timisoara 300041, Romania Tel: +40-730656429, Fax: +40-256220484, E-mail:  cmarian@umft.ro cc This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduc - tion in any medium, provided the original work is properly cited.Print ISSN 1738-3684 / On-line ISSN 1976-3026 OPEN ACCESS http://dx.doi.org/10.4306/pi.2016.13.5.549ORIGINAL ARTICLE   Copyright © 2016 Korean Neuropsychiatric Association   549",Non-OADS,/arxiv_data1/oa_pdf/cf/84/pi-13-549.PMC5067350.pdf
"The miR list was divided in two sublists, up-regulated (cut- off=2) and down-regulated were imported as such into the  miRWalk2.0 algorithm (http://www.umm.uni-heidelberg.de/ apps/zmf/mirwalk/)39 and used for 3’UTR target predictions  (minimum seed length 7, p-value=0.05).",OADS,/arxiv_data1/oa_pdf/cf/84/pi-13-549.PMC5067350.pdf
Supplementary Materials The online-only Data Supplement is available with this ar - ticle at http://dx.doi.org/10.4306/pi.2016.13.5.549.,OADS,/arxiv_data1/oa_pdf/cf/84/pi-13-549.PMC5067350.pdf
"Baltimore,  MD 21205, USA Tel: +1-410-645-0103, Fax: +1-410-614-7469, E-mail: slee226@jhu.edu cc This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduc - tion in any medium, provided the original work is properly cited.http://dx.doi.org/10.4306/pi.2016.13.5.558",Non-OADS,/arxiv_data1/oa_pdf/8e/7c/pi-13-558.PMC5067351.pdf
"Received:  September 24, 2015    Revised:  January 12, 2016 Accepted:  February 5, 2016    Available online:  July 11, 2016  Correspondence:  Y eni Kim, MD, PhD        Department of Child and Adolescent Psychiatry, National Center for Mental  Health, 398 Neungdong-ro, Gwangjin-gu, Seoul 04933, Republic of Korea Tel: +82-2-2204-0301, Fax: +82-2-2204-0356, E-mail:  yeni1004@gmail.com cc This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduc - tion in any medium, provided the original work is properly cited.http://dx.doi.org/10.4306/pi.2016.13.5.566",Non-OADS,/arxiv_data1/oa_pdf/26/de/pi-13-566.PMC5067352.pdf
"Received:  September 12, 2015    Revised:  January 5, 2016 Accepted:  January 24, 2016    Available online:  June 1, 2016  Correspondence:  Thammanard Charernboon, MD, MSc, FRCPsychT  Department of Psychiatry, Faculty of Medicine, Phahon Y othin Road, Tham - masat University, Pathumthani 12120, Thailand Tel: +66-2-926-9204, Fax: +66-2-926-9830, E-mail:  dr.thammanard@gmail.com cc This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduc - tion in any medium, provided the original work is properly cited.http://dx.doi.org/10.4306/pi.2016.13.5.571",Non-OADS,/arxiv_data1/oa_pdf/44/f5/pi-13-571.PMC5067353.pdf
"Received:  November 13, 2015    Revised:  December 22, 2015 Accepted:  January 23, 2016    Available online:  July 11, 2016  Correspondence:  Luis-Joaquin Garcia-Lopez, PhD Department of Psychology, Division of Clinical Psychology, University of  Jaen,  Building C5, Campus Lagunillas, Jean 23071, Spain Tel: +34-953213214, Fax: +34-953211814 E-mail:  ljgarcia@ujaen.es, ljgarlo@cop.es cc This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduc - tion in any medium, provided the original work is properly cited.Print ISSN 1738-3684 / On-line ISSN 1976-3026 OPEN ACCESS http://dx.doi.org/10.4306/pi.2016.13.5.574BRIEF REPORT 574  Copyright © 2016 Korean Neuropsychiatric Association",Non-OADS,/arxiv_data1/oa_pdf/dc/53/pi-13-574.PMC5067354.pdf
"Received:  August 11, 2015    Revised:  October 26, 2015 Accepted:  October 26, 2015    Available online:  March 23, 2016  Correspondence:  Soohyun Joe, MD, PhD  Bugok National Hospital, 145 Bugok-ro, Bugok-myeon, Changnyeong 50365,  Republic of Korea Tel: +82-55-536-6440, Fax: +82-55-536-6444, E-mail:  biophilia1p@daum.net cc This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduc - tion in any medium, provided the original work is properly cited.http://dx.doi.org/10.4306/pi.2016.13.5.577",Non-OADS,/arxiv_data1/oa_pdf/1d/f7/pi-13-577.PMC5067355.pdf
"Received:  July 1, 2015    Revised:  December 18, 2015 Accepted:  December 28, 2015    Available online:  April 6, 2016  Correspondence:  Giulia Simonetti, PhD  Dipartimento di Science Mediche e Chirurgiche, Università di Bologna, Via  Massarenti 9, 40138 Bologna, Italy Tel: +39 0512144873, +39 0512143152 Fax: +39 051345806 E-mail:  simgiu@hotmail.it cc This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduc - tion in any medium, provided the original work is properly cited.Print ISSN 1738-3684 / On-line ISSN 1976-3026 OPEN ACCESS http://dx.doi.org/10.4306/pi.2016.13.5.580CASE REPORT  580  Copyright © 2016 Korean Neuropsychiatric Association",Non-OADS,/arxiv_data1/oa_pdf/f1/d7/pi-13-580.PMC5067356.pdf
"European Public Assessment Report of Ammonaps, European Medi - cine Agency, publishing on http://www.ema.europa.eu/docs/it_IT/ document_library/EPAR__Product_Information/human/000219/ WC500024753.pdf4.",OADS,/arxiv_data1/oa_pdf/f1/d7/pi-13-580.PMC5067356.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/79/62/main.PMC5067379.pdf
E-mail address: a.m.idhrees@gmail.com (M. Idhrees).Available online at www.sciencedirect.com ScienceDirect journal homepage: www.elsevier.com/locate/ihj http://dx.doi.org/10.1016/j.ihj.2015.07.007 0019-4832/ #2015 Cardiological Society of India.,Non-OADS,/arxiv_data1/oa_pdf/79/62/main.PMC5067379.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/79/62/main.PMC5067379.pdf
Saha).Available online at www.sciencedirect.com ScienceDirect journal homepage: www.elsevier.com/locate/ihj http://dx.doi.org/10.1016/j.ihj.2015.03.019 0019-4832/ #2015 Cardiological Society of India.,Non-OADS,/arxiv_data1/oa_pdf/0c/18/main.PMC5067380.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/0c/18/main.PMC5067380.pdf
2013 Jul;96:83 –88.http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/0c/18/main.PMC5067380.pdf
2014 Jan;29:69 –75.http://dx.doi.org/10.3346/ jkms.2014.29.1.69 [Epub 2013 Dec 26].,OADS,/arxiv_data1/oa_pdf/0c/18/main.PMC5067380.pdf
2015 Mar;23:267 – 270. http://dx.doi.org/10.1177/0218492314544158 .,Non-OADS,/arxiv_data1/oa_pdf/0c/18/main.PMC5067380.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ab/91/main.PMC5067381.pdf
E-mail address: drtanveerahmad@gmail.com (T. Ahmad).Available online at www.sciencedirect.com ScienceDirect journal homepage: www.elsevier.com/locate/ihj http://dx.doi.org/10.1016/j.ihj.2015.07.021 0019-4832/ #2015 Cardiological Society of India.,Non-OADS,/arxiv_data1/oa_pdf/ab/91/main.PMC5067381.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ab/91/main.PMC5067381.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7b/b5/main.PMC5067382.pdf
Nair).Available online at www.sciencedirect.com ScienceDirect journal homepage: www.elsevier.com/locate/ihj http://dx.doi.org/10.1016/j.ihj.2015.07.029 0019-4832/ #2015 Cardiological Society of India.,Non-OADS,/arxiv_data1/oa_pdf/7b/b5/main.PMC5067382.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7b/b5/main.PMC5067382.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/ by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/af/22/main.PMC5067383.pdf
E-mail address: vaibhavshukla7777@gmail.com (V. Shukla).Available online at www.sciencedirect.com ScienceDirect journal homepage: www.elsevier.com/locate/ihj http://dx.doi.org/10.1016/j.ihj.2015.07.005 0019-4832/ #2016 Published by Elsevier B.V. on behalf of Cardiological Society of India.,Non-OADS,/arxiv_data1/oa_pdf/af/22/main.PMC5067383.pdf
This is an open access article under the CC BY- NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/af/22/main.PMC5067383.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/56/6f/main.PMC5067384.pdf
Ranjith).Available online at www.sciencedirect.com ScienceDirect journal homepage: www.elsevier.com/locate/ihj http://dx.doi.org/10.1016/j.ihj.2015.07.037 0019-4832/ #2015 Cardiological Society of India.,Non-OADS,/arxiv_data1/oa_pdf/56/6f/main.PMC5067384.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/56/6f/main.PMC5067384.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/31/c6/main.PMC5067385.pdf
E-mail address: shegugilbert@yahoo.co.in (S. Gilbert).Available online at www.sciencedirect.com ScienceDirect journal homepage: www.elsevier.com/locate/ihj http://dx.doi.org/10.1016/j.ihj.2015.07.015 0019-4832/ #2015 Cardiological Society of India.,Non-OADS,/arxiv_data1/oa_pdf/31/c6/main.PMC5067385.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/31/c6/main.PMC5067385.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c8/36/main.PMC5067386.pdf
Raut).Available online at www.sciencedirect.com ScienceDirect journal homepage: www.elsevier.com/locate/ihj http://dx.doi.org/10.1016/j.ihj.2015.06.003 0019-4832/ #2015 Cardiological Society of India.,Non-OADS,/arxiv_data1/oa_pdf/c8/36/main.PMC5067386.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c8/36/main.PMC5067386.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7e/d8/main.PMC5067387.pdf
E-mail address: shilpajv@yahoo.co.in (S. Jayaprakash).Available online at www.sciencedirect.com ScienceDirect journal homepage: www.elsevier.com/locate/ihj http://dx.doi.org/10.1016/j.ihj.2015.07.026 0019-4832/ #2015 Cardiological Society of India.,Non-OADS,/arxiv_data1/oa_pdf/7e/d8/main.PMC5067387.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7e/d8/main.PMC5067387.pdf
"EDITORIAL Hip Pelvis 28(3): 133, 2016 http://dx.doi.org/10.5371/hp.2016.28.3.133 Copyright ⓒ2016 by Korean Hip Society 133Print ISSN 2287-3260 Online ISSN 2287-3279 Hip & Pelvis is the official academic journal of the Korean Hip Society and has the longest tradition andunparalleled academic achievement among others in theKorean Orthopaedic Association.",Non-OADS,/arxiv_data1/oa_pdf/14/ad/hp-28-133.PMC5067388.pdf
"Sang Hong Lee, MD President of the Korean Hip SocietyOn the Occasion of PMC Registration of Hip & Pelvis Sang Hong Lee, MD Department of Orthopaedic Surgery, Chosun University Hospital, Gwangju, Korea Submitted: September 12, 2016  Final acceptance: September 13, 2016 Address reprint request toSang Hong Lee, MDDepartment of Orthopaedic Surgery, Chosun University Hospital,365 Pilmun-daero, Dong-gu, Gwangju 61453, KoreaTEL: +82-62-220-3147  FAX: +82-62-226-3379 E-mail: shalee@chosun.ac.kr This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use,distribution, and reproduction in any medium, provided the original work isproperly cited.",Non-OADS,/arxiv_data1/oa_pdf/14/ad/hp-28-133.PMC5067388.pdf
"REVIEW ARTICLE Hip Pelvis 28(3): 134-141, 2016 http://dx.doi.org/10.5371/hp.2016.28.3.134 Copyright ⓒ2016 by Korean Hip Society 134Print ISSN 2287-3260 Online ISSN 2287-3279 INTRODUCTION Recent advances in prosthetic materials, shapes, and articulating surfaces of total hip arthroplasty (THA)have helped, to some degree, overcome wear, one of themost chronic complications.",Non-OADS,/arxiv_data1/oa_pdf/bc/12/hp-28-134.PMC5067389.pdf
"Key Words : Large femoral head, Instability, Dislocation, Total hip arthroplasty Submitted: July 5, 2016  1st revision: August 8, 2016 Final acceptance: August 17, 2016 Address reprint request toMyung-Rae Cho, MDDepartment of Orthopaedic Surgery, Daegu Catholic UniversityMedical Center, 33 Duryugongwon-ro 17-gil, Nam-gu, Daegu42472, KoreaTEL: +82-53-650-4277  FAX: +82-53-652-4272 E-mail: cmr0426@cu.ac.kr This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use,distribution, and reproduction in any medium, provided the original work isproperly cited.",Non-OADS,/arxiv_data1/oa_pdf/bc/12/hp-28-134.PMC5067389.pdf
"ORIGINAL ARTICLE Hip Pelvis 28(3): 142-147, 2016 http://dx.doi.org/10.5371/hp.2016.28.3.142 Copyright ⓒ2016 by Korean Hip Society 142Print ISSN 2287-3260 Online ISSN 2287-3279 INTRODUCTION The use of a modular neck in total hip arthroplasty (THA) was first introduced by Toni et al.1)in 2001.",Non-OADS,/arxiv_data1/oa_pdf/de/18/hp-28-142.PMC5067390.pdf
"Key Words : Modular neck, Modular stem, Arthroplasty, Replacement, Hip Submitted: May 6, 2016  1st revision: July 4, 2016 Final acceptance: July 18, 2016 Address reprint request toKye Young Han, MD, PhDDepartment of Orthopaedic Surgery, Kangwon National UniversityHospital, 156 Baengnyeong-ro, Chuncheon 24289, KoreaTEL: +82-33-258-9256  FAX: +82-33-244-2205 E-mail: hkyljh@kangwon.ac.kr This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use,distribution, and reproduction in any medium, provided the original work isproperly cited.",Non-OADS,/arxiv_data1/oa_pdf/de/18/hp-28-142.PMC5067390.pdf
"ORIGINAL ARTICLE Hip Pelvis 28(3): 148-156, 2016 http://dx.doi.org/10.5371/hp.2016.28.3.148 Copyright ⓒ2016 by Korean Hip Society 148Print ISSN 2287-3260 Online ISSN 2287-3279 INTRODUCTION Femoral fractures are mostly treated without causing significant long-term morbidity.",Non-OADS,/arxiv_data1/oa_pdf/19/84/hp-28-148.PMC5067391.pdf
"Key Words : Femur, Atypical femoral fracture, Femoral nonunion, Periprosthetic fractures, Teriparatide Submitted: June 23, 2016  1st revision: July 26, 2016 Final acceptance: August 3, 2016 Address reprint request toJeong Joon Yoo, MD, PhDDepartment of Orthopaedic Surgery, Seoul National UniversityCollege of Medicine, 101 Daehak-ro, Jongno-gu, Seoul 03080,KoreaTEL: +82-2-2072-1994  FAX: +82-2-764-2718 E-mail: jjyos@snu.ac.kr This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use,distribution, and reproduction in any medium, provided the original work isproperly cited.",Non-OADS,/arxiv_data1/oa_pdf/19/84/hp-28-148.PMC5067391.pdf
"ORIGINAL ARTICLE Hip Pelvis 28(3): 157-163, 2016 http://dx.doi.org/10.5371/hp.2016.28.3.157 Copyright ⓒ2016 by Korean Hip Society 157Print ISSN 2287-3260 Online ISSN 2287-3279 INTRODUCTION During resident programs, residents are required todevelop knowledge, technical skills, patient communication skills, and advanced social skills to facilitate interactionswith co-workers 1).",Non-OADS,/arxiv_data1/oa_pdf/9e/3c/hp-28-157.PMC5067392.pdf
"Key Words : Hip, Pelvis, Korean Orthopaedic In-Training Examination (KOITE) Submitted: July 15, 2016  1st revision: August 28, 2016 Final acceptance: August 30, 2016 Address reprint request toJai Hyung Park, MD, PhDDepartment of Orthopedic Surgery, Kangbuk Samsung Hospital,29 Saemunan-ro, Jongno-gu, Seoul 03181, KoreaTEL: +82-2-2001-2168  FAX: +82-2-2001-2176 E-mail: wonnypia@hanmail.net This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use,distribution, and reproduction in any medium, provided the original work isproperly cited.",Non-OADS,/arxiv_data1/oa_pdf/9e/3c/hp-28-157.PMC5067392.pdf
"CASE REPORT Hip Pelvis 28(3): 164-168, 2016 http://dx.doi.org/10.5371/hp.2016.28.3.164 Copyright ⓒ2016 by Korean Hip Society 164Print ISSN 2287-3260 Online ISSN 2287-3279 The factors that prevent concentric reduction of the hip in traumatic fracture-dislocation are usually a bonyfragment and infrequently soft tissues such as a tornacetabular labrum, a ruptured capsule, or a ligamentumteres.",Non-OADS,/arxiv_data1/oa_pdf/6f/6f/hp-28-164.PMC5067393.pdf
"Key Words : Hip, Arthroscopic surgery, Hip Injuries/surgery, Labral tear, Hip dislocation Submitted: April 24, 2016  1st revision: June 22, 2016 Final acceptance: July 1, 2016 Address reprint request toDeuk-Soo Hwang, MD, PhDDepartment of Orthopaedic Surgery, Chungnam NationalUniversity School of Medicine, 282 Munwha-ro, Jung-gu, Daejeon35015, KoreaTEL: +82-42-338-2480  FAX: +82-42-338-2482 E-mail: dshwang@cnu.ac.kr This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use,distribution, and reproduction in any medium, provided the original work isproperly cited.",Non-OADS,/arxiv_data1/oa_pdf/6f/6f/hp-28-164.PMC5067393.pdf
"CASE REPORT Hip Pelvis 28(3): 169-172, 2016 http://dx.doi.org/10.5371/hp.2016.28.3.169 Copyright ⓒ2016 by Korean Hip Society 169Print ISSN 2287-3260 Online ISSN 2287-3279 Stress fractures in children are commonly reported in the tibia, fibula, femur and metatarsals, and femoralneck stress fractures are rare 1).",Non-OADS,/arxiv_data1/oa_pdf/fb/63/hp-28-169.PMC5067394.pdf
"Key Words : Femur neck, Stress fractures, Child, Bilateral Submitted: April 11, 2016  1st revision: June 23, 2016 2nd revision: August 18, 2016  Final acceptance: August 19, 2016 Address reprint request toKyung-Soon Park, MD, PhDDepartment of Orthopedic Surgery, Center for Joint Disease,Chonnam National University Hwasun Hospital, 322 Seoyang-ro,Hwasun-eup, Hwasun 58128, KoreaTEL: +82-61-379-7677, 7676  FAX: +82-61-379-7681 E-mail: chiasma@hanmail.net This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use,distribution, and reproduction in any medium, provided the original work isproperly cited.",Non-OADS,/arxiv_data1/oa_pdf/fb/63/hp-28-169.PMC5067394.pdf
"CASE REPORT Hip Pelvis 28(3): 173-177, 2016 http://dx.doi.org/10.5371/hp.2016.28.3.173 Copyright ⓒ2016 by Korean Hip Society 173Print ISSN 2287-3260 Online ISSN 2287-3279 Brown tumor refers to a change of skeletones that develops as one of the complications of hyperparathyroidism,where cystic and fibrous changes of bone occur 1,2).",Non-OADS,/arxiv_data1/oa_pdf/1f/5d/hp-28-173.PMC5067395.pdf
"Key Words : Femur, Fractures, Hyperparathyroidism, Osteitis fibrosa cystica Submitted: June 14, 2016  1st revision: August 23, 2016 Final acceptance: September 22, 2016 Address reprint request toGyu-Min Kong, MD, PhDDepartment of Orthopaedic Surgery, Inje University Busan PaikHospital, Bokjiro 75, Busanjin-gu, Busan 47392, KoreaTEL: +82-51-890-6390  FAX: +82-51-862-6619 E-mail: docos@naver.com This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use,distribution, and reproduction in any medium, provided the original work isproperly cited.",Non-OADS,/arxiv_data1/oa_pdf/1f/5d/hp-28-173.PMC5067395.pdf
"CASE REPORT Hip Pelvis 28(3): 178-181, 2016 http://dx.doi.org/10.5371/hp.2016.28.3.178 Copyright ⓒ2016 by Korean Hip Society 178Print ISSN 2287-3260 Online ISSN 2287-3279 The tensor fascia latae and gluteus medius and minimus are known as primary hip abductor muscles.",Non-OADS,/arxiv_data1/oa_pdf/9e/45/hp-28-178.PMC5067396.pdf
"Key Words : Hip, Abductor deficiency, Reconstruction, Gluteus maximus Submitted: May 31, 2016  1st revision: July 12, 2016 Final acceptance: July 15, 2016 Address reprint request toYoung Ho Cho, MDDepartment of Orthopaedic Surgery, Daegu Fatima Hospital, 99Ayangro, Dong-gu, Daegu 41199, KoreaTEL: +82-53-940-7324  FAX: +82-53-954-7417 E-mail: femur1973@gmail.com This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use,distribution, and reproduction in any medium, provided the original work isproperly cited.",Non-OADS,/arxiv_data1/oa_pdf/9e/45/hp-28-178.PMC5067396.pdf
"CASE REPORT Hip Pelvis 28(3): 182-186, 2016 http://dx.doi.org/10.5371/hp.2016.28.3.182 Copyright ⓒ2016 by Korean Hip Society 182Print ISSN 2287-3260 Online ISSN 2287-3279 Xanthoma is an abnormal deposition of cholesterol or triglycerides, which can occur in any part of the bodyand in many different disease states.",Non-OADS,/arxiv_data1/oa_pdf/96/86/hp-28-182.PMC5067397.pdf
"Key Words : Primary intraosseous xanthoma, Normolipidemic, Proximal femur Submitted: June 16, 2016  1st revision: July 25, 2016 Final acceptance: August 1, 2016 Address reprint request toNam Hoon Moon, MDDepartment of Orthopaedic Surgery, Pusan National UniversityHospital, 179 Gudeok-ro, Seo-gu, Busan 49241, KoreaTEL: +82-51-240-7248  FAX: +82-51-247-8395 E-mail: namhoonmoon@gmail.com This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use,distribution, and reproduction in any medium, provided the original work isproperly cited.",Non-OADS,/arxiv_data1/oa_pdf/96/86/hp-28-182.PMC5067397.pdf
"CASE REPORT Hip Pelvis 28(3): 187-190, 2016 http://dx.doi.org/10.5371/hp.2016.28.3.187 Copyright ⓒ2016 by Korean Hip Society 187Print ISSN 2287-3260 Online ISSN 2287-3279 Various directions of stress transmitted to the bone depending on muscle contraction, which occurs duringthe most of physical activities as it used.",Non-OADS,/arxiv_data1/oa_pdf/84/57/hp-28-187.PMC5067398.pdf
"Key Words : Ischium, Pelvis, Stress fractures Submitted: July 8, 2016  1st revision: August 31, 2016 Final acceptance: September 6, 2016 Address reprint request toSeung Rim Yi, MDDepartment of Orthopedic Surgery, National Police Hospital, 123Songi-ro, Songpa-gu, Seoul 05715, KoreaTEL: +82-2-3400-1246  FAX: +82-2-3400-1249 E-mail: ysr@police.go.kr This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use,distribution, and reproduction in any medium, provided the original work isproperly cited.",Non-OADS,/arxiv_data1/oa_pdf/84/57/hp-28-187.PMC5067398.pdf
"http://www.multivu.com/play ers/English/7223452-boston-sci entific-watchman-fda-approval/ (accessed March 13, 2016).",Non-OADS,/arxiv_data1/oa_pdf/84/f3/jgc-13-08-645.PMC5067424.pdf
"2.6  Statistical analysis  All analyses were performe d with R (http://www.R-pro- ject.org) and EmpowerStats software (http://www.empow- erstats.com, X&Y solutions, Inc., Boston, MA, USA).",OADS,/arxiv_data1/oa_pdf/d1/ae/jgc-13-08-712.PMC5067433.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c7/a2/main.PMC5067438.pdf
E-mail address: cmayuresh24@gmail.com (M. Chaudhari).Available online at www.sciencedirect.com ScienceDirect journal homepage: www.elsevier.com/locate/ihj http://dx.doi.org/10.1016/j.ihj.2015.08.026 0019-4832/ #2015 Cardiological Society of India.,Non-OADS,/arxiv_data1/oa_pdf/c7/a2/main.PMC5067438.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c7/a2/main.PMC5067438.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to:  Dr. Sabrina Alves Fernandes,  PhD,  Postgr aduate Program at Universidade Federal de Ciências da  Saúde de Porto Alegre (UFCSPA), Rua Professor Duplan 72/01,  Porto Alegre, RS 90420-060,  Brazil.",Non-OADS,/arxiv_data1/oa_pdf/44/8c/WJH-8-1205.PMC5067440.pdf
The PA has been  Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.4254/wjh.v8.i29.1205World J Hepatol   2016  October 18; 8(29): 1205-1211 ISSN 1948-5182 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.,Non-OADS,/arxiv_data1/oa_pdf/44/8c/WJH-8-1205.PMC5067440.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/44/8c/WJH-8-1205.PMC5067440.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Unsolicited manuscript Correspondence to:  Dr. Nada M Melhem, PhD, Associate  Professor  of Infectious Diseases and Microbiology, Medical  Laboratory Sciences Program, Faculty of Health Sciences, American  University of Beirut, 11-0236 Riad El Solh, Beirut 1107-2020,  Lebanon.",Non-OADS,/arxiv_data1/oa_pdf/e0/65/WJH-8-1212.PMC5067441.pdf
"Sera samples from  vaccinated and non-vaccinated participants were tested  for the presence of anti-HBs antibodies as a measure  of protection against hepatitis B, hepatitis B surface  antigen and hepatitis B core antibody as indicators of Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.4254/wjh.v8.i29.1212World J Hepatol   2016  October 18; 8(29): 1212-1221 ISSN 1948-5182 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/e0/65/WJH-8-1212.PMC5067441.pdf
wjgnet.com/ 1948-5182 /full/v8/i29/1212.htm  DOI: http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e0/65/WJH-8-1212.PMC5067441.pdf
"Available from:  URL: http://www.who.int/csr/disease/hepatitis/whocdscsrlyo20022/ en/index4.htm l  31 Mahfouz R , Rayes R, Mahfoud Z, Bazarbachi A, Zaatari G.  Distribution of killer cell immunoglobulin-like receptors genotypes  in the Lebanese population.",Non-OADS,/arxiv_data1/oa_pdf/e0/65/WJH-8-1212.PMC5067441.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/e0/65/WJH-8-1212.PMC5067441.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to:  Ashwani Koul, Professor,  Department of  Biophysics, Basic Medical Sciences Block Ⅱ, Panjab University,  South Campus, Sec-25, Chandigarh 160014,  India.",Non-OADS,/arxiv_data1/oa_pdf/d4/17/WJH-8-1222.PMC5067442.pdf
"In addition, enhanced activities of hexokinase,  phosphoglucoisomerase, aldolase, glucose-6-phosphate  Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.4254/wjh.v8.i29.1222World J Hepatol   2016  October 18; 8(29): 1222-1233 ISSN 1948-5182 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/d4/17/WJH-8-1222.PMC5067442.pdf
World J Hepatol  2016; 8(29): 1222-1233   Available from: URL:  http://www.wjgnet.com/ 1948-5182 /full/v8/ i29/1222.htm  DOI: http://dx.doi.org/10.4254/wjh.v8.i29.1222 INTRODUCTION The continuous rising trend in cancer worldwide neces­ sitates potential action against this deadly disease.,Non-OADS,/arxiv_data1/oa_pdf/d4/17/WJH-8-1222.PMC5067442.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/d4/17/WJH-8-1222.PMC5067442.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Unsolicited manuscript Correspondence to:  Eny Maria Goloni-Bertollo, MD,  São  José do Rio Preto Medical School, FAMERP and Medical School  Fundation, FUNFARME, Av.",Non-OADS,/arxiv_data1/oa_pdf/ad/ab/WJH-8-1234.PMC5067443.pdf
MINITAB-14.0 Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.4254/wjh.v8.i29.1234World J Hepatol   2016  October 18; 8(29): 1234-1243 ISSN 1948-5182 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.,Non-OADS,/arxiv_data1/oa_pdf/ad/ab/WJH-8-1234.PMC5067443.pdf
World J Hepatol  2016;  8(29): 1234-1243  Available from: URL:  http://www.wjgnet.,OADS,/arxiv_data1/oa_pdf/ad/ab/WJH-8-1234.PMC5067443.pdf
htm  DOI: http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ad/ab/WJH-8-1234.PMC5067443.pdf
"Available from: URL: http://www.cancer.org/ cancer/news/study-smoking-dramatically-increases-liver-cancer- risk 40 Raphe R , Duca WJ, Arroyo PCJ, Silva RC, Silva RF.",Non-OADS,/arxiv_data1/oa_pdf/ad/ab/WJH-8-1234.PMC5067443.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/ad/ab/WJH-8-1234.PMC5067443.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Unsolicited manuscript Correspondence to:  Giovanni Galati, MD,  Unit of Internal  Medicine and Hepatology, Department of Medicine, Università  Campus Bio-Medico di Roma, via Álvaro del Portillo 21, 00128  Rome, Italy.",Non-OADS,/arxiv_data1/oa_pdf/f5/aa/WJH-8-1244.PMC5067444.pdf
Core tip:  B cells lymphoma is one of the most chall -Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.4254/wjh.v8.i29.1244World J Hepatol   2016  October 18; 8(29): 1244-1250 ISSN 1948-5182 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.,Non-OADS,/arxiv_data1/oa_pdf/f5/aa/WJH-8-1244.PMC5067444.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/f5/aa/WJH-8-1244.PMC5067444.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/11/ac/main.PMC5067445.pdf
Bhalgat).Available online at www.sciencedirect.com ScienceDirect journal homepage: www.elsevier.com/locate/ihj http://dx.doi.org/10.1016/j.ihj.2015.11.035 0019-4832/ #2015 Cardiological Society of India.,Non-OADS,/arxiv_data1/oa_pdf/11/ac/main.PMC5067445.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/11/ac/main.PMC5067445.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/cc/63/main.PMC5067446.pdf
E-mail address: arungopi@gmail.com (A. Gopi).Available online at www.sciencedirect.com ScienceDirect journal homepage: www.elsevier.com/locate/ihj http://dx.doi.org/10.1016/j.ihj.2015.08.012 0019-4832/ #2015 Cardiological Society of India.,Non-OADS,/arxiv_data1/oa_pdf/cc/63/main.PMC5067446.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/cc/63/main.PMC5067446.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e8/d6/main.PMC5067447.pdf
E-mail address: drsubhani03@gmail.com (S. Subhani).Available online at www.sciencedirect.com ScienceDirect journal homepage: www.elsevier.com/locate/ihj http://dx.doi.org/10.1016/j.ihj.2015.07.048 0019-4832/ #2015 Cardiological Society of India.,Non-OADS,/arxiv_data1/oa_pdf/e8/d6/main.PMC5067447.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e8/d6/main.PMC5067447.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/74/e8/main.PMC5067448.pdf
E-mail address: Ksunilverma02@gmail.com.Available online at www.sciencedirect.com ScienceDirect journal homepage: www.elsevier.com/locate/ihj http://dx.doi.org/10.1016/j.ihj.2015.10.374 0019-4832/ #2015 Cardiological Society of India.,Non-OADS,/arxiv_data1/oa_pdf/74/e8/main.PMC5067448.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/74/e8/main.PMC5067448.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f4/c0/main.PMC5067450.pdf
E-mail address: sarweshwarm@gmail.com.Available online at www.sciencedirect.com ScienceDirect journal homepage: www.elsevier.com/locate/ihj http://dx.doi.org/10.1016/j.ihj.2015.08.016 0019-4832/ #2015 Cardiological Society of India.,Non-OADS,/arxiv_data1/oa_pdf/f4/c0/main.PMC5067450.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f4/c0/main.PMC5067450.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/83/d8/main.PMC5067451.pdf
E-mail address: thrudeep1@yahoo.com (S. Thrudeep).Available online at www.sciencedirect.com ScienceDirect journal homepage: www.elsevier.com/locate/ihj http://dx.doi.org/10.1016/j.ihj.2015.07.053 0019-4832/ #2015 Cardiological Society of India.,Non-OADS,/arxiv_data1/oa_pdf/83/d8/main.PMC5067451.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/83/d8/main.PMC5067451.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/2f/fa/main.PMC5067452.pdf
E-mail address: drczencir@hotmail.com (C. Zencir).Available online at www.sciencedirect.com ScienceDirect journal homepage: www.elsevier.com/locate/ihj http://dx.doi.org/10.1016/j.ihj.2015.11.037 0019-4832/ #2015 Cardiological Society of India.,Non-OADS,/arxiv_data1/oa_pdf/2f/fa/main.PMC5067452.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/2f/fa/main.PMC5067452.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7a/8e/main.PMC5067453.pdf
E-mail address: drstak@yahoo.com (S. Tak).Available online at www.sciencedirect.com ScienceDirect journal homepage: www.elsevier.com/locate/ihj http://dx.doi.org/10.1016/j.ihj.2015.08.010 0019-4832/ #2015 Cardiological Society of India.,Non-OADS,/arxiv_data1/oa_pdf/7a/8e/main.PMC5067453.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7a/8e/main.PMC5067453.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/24/e7/main.PMC5067454.pdf
E-mail address: ﬁlizkizilirmak@hotmail.com (F. Kizilirmak).Available online at www.sciencedirect.com ScienceDirect journal homepage: www.elsevier.com/locate/ihj http://dx.doi.org/10.1016/j.ihj.2015.11.041 0019-4832/ #2015 Cardiological Society of India.,Non-OADS,/arxiv_data1/oa_pdf/24/e7/main.PMC5067454.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/24/e7/main.PMC5067454.pdf
E-mail address: nnader@buffalo.edu (N.D. Nader).Available online at www.sciencedirect.com ScienceDirect journal homepage: www.elsevier.com/locate/ihj http://dx.doi.org/10.1016/j.ihj.2015.11.005 0019-4832/Published by Elsevier B.V. on behalf of Cardiological Society of India.,Non-OADS,/arxiv_data1/oa_pdf/a4/36/main.PMC5067455.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a4/36/main.PMC5067455.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e3/1a/main.PMC5067456.pdf
Kumar).Available online at www.sciencedirect.com ScienceDirect journal homepage: www.elsevier.com/locate/ihj http://dx.doi.org/10.1016/j.ihj.2015.11.021 0019-4832/ #2015 Cardiological Society of India.,Non-OADS,/arxiv_data1/oa_pdf/e3/1a/main.PMC5067456.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e3/1a/main.PMC5067456.pdf
http://dx.doi.org/10.4103/09713026.69356 .,Non-OADS,/arxiv_data1/oa_pdf/e3/1a/main.PMC5067456.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/8a/7a/main.PMC5067457.pdf
Gangurde).Available online at www.sciencedirect.com ScienceDirect journal homepage: www.elsevier.com/locate/ihj http://dx.doi.org/10.1016/j.ihj.2015.11.001 0019-4832/ #2015 Cardiological Society of India.,Non-OADS,/arxiv_data1/oa_pdf/8a/7a/main.PMC5067457.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/8a/7a/main.PMC5067457.pdf
E-mail address: vaibhavjain1000@yahoo.co.in (V. Jain).Available online at www.sciencedirect.com ScienceDirect journal homepage: www.elsevier.com/locate/ihj http://dx.doi.org/10.1016/j.ihj.2015.07.043 0019-4832/ #2015 Cardiological Society of India.,Non-OADS,/arxiv_data1/oa_pdf/74/7f/main.PMC5067458.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/74/7f/main.PMC5067458.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/24/61/main.PMC5067459.pdf
E-mail address: drhemant.chaturvedi@gmail.com (H. Chaturvedi).Available online at www.sciencedirect.com ScienceDirect journal homepage: www.elsevier.com/locate/ihj http://dx.doi.org/10.1016/j.ihj.2015.08.011 0019-4832/ #2015 Cardiological Society of India.,Non-OADS,/arxiv_data1/oa_pdf/24/61/main.PMC5067459.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/24/61/main.PMC5067459.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/fa/b0/main.PMC5067460.pdf
E-mail address: a51hauzkhas@gmail.com (J.C. Mohan).Available online at www.sciencedirect.com ScienceDirect journal homepage: www.elsevier.com/locate/ihj http://dx.doi.org/10.1016/j.ihj.2015.09.012 0019-4832/ #2015 Cardiological Society of India.,Non-OADS,/arxiv_data1/oa_pdf/fa/b0/main.PMC5067460.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/fa/b0/main.PMC5067460.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ea/2e/main.PMC5067461.pdf
E-mail address: a51hauzkhas@gmail.com (J.C. Mohan).Available online at www.sciencedirect.com ScienceDirect journal homepage: www.elsevier.com/locate/ihj http://dx.doi.org/10.1016/j.ihj.2015.10.301 0019-4832/ #2015 Cardiological Society of India.,Non-OADS,/arxiv_data1/oa_pdf/ea/2e/main.PMC5067461.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ea/2e/main.PMC5067461.pdf
E-mail address: hya00@fayoum.edu.eg (H. Younan).Available online at www.sciencedirect.com ScienceDirect journal homepage: www.elsevier.com/locate/ihj http://dx.doi.org/10.1016/j.ihj.2015.11.010 0019-4832/ #2015 Cardiological Society of India.,Non-OADS,/arxiv_data1/oa_pdf/e7/e0/main.PMC5067462.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e7/e0/main.PMC5067462.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/10/fd/main.PMC5067463.pdf
E-mail address: drajaybahl@hotmail.com (A. Bahl).Available online at www.sciencedirect.com ScienceDirect journal homepage: www.elsevier.com/locate/ihj http://dx.doi.org/10.1016/j.ihj.2015.11.020 0019-4832/ #2015 Cardiological Society of India.,Non-OADS,/arxiv_data1/oa_pdf/10/fd/main.PMC5067463.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/10/fd/main.PMC5067463.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/46/0d/main.PMC5067464.pdf
E-mail address: dr.ameta@gmail.com (D. Ameta).Available online at www.sciencedirect.com ScienceDirect journal homepage: www.elsevier.com/locate/ihj http://dx.doi.org/10.1016/j.ihj.2015.07.045 0019-4832/ #2015 Cardiological Society of India.,Non-OADS,/arxiv_data1/oa_pdf/46/0d/main.PMC5067464.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/46/0d/main.PMC5067464.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/84/38/main.PMC5067465.pdf
Abhishek).Available online at www.sciencedirect.com ScienceDirect journal homepage: www.elsevier.com/locate/ihj http://dx.doi.org/10.1016/j.ihj.2015.09.031 0019-4832/ #2015 Cardiological Society of India.,Non-OADS,/arxiv_data1/oa_pdf/84/38/main.PMC5067465.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/84/38/main.PMC5067465.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to:  Hsun-Chin Chao, MD, Associate Pro- fessor, Division of Gastroenterology, Department of Pediatrics,  Chang Gung Children’s Hospital, Chang Gung Memorial  Hospital, Chang Gung University College of Medicine, 5 Fu- Hsing Street, Gueishan District, Taoyuan City 33305,  Taiwan.",Non-OADS,/arxiv_data1/oa_pdf/43/42/WJGE-8-635.PMC5067470.pdf
Local steroid injection and  electrocauterization can aug ment the effect of EBD.Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.4253/wjge.v8.i18.635World J Gastrointest Endosc   2016 October 16; 8(18): 635-645 ISSN 1948-5190 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.,Non-OADS,/arxiv_data1/oa_pdf/43/42/WJGE-8-635.PMC5067470.pdf
World J Gastrointest Endosc  2016; 8(18):  635-645  Available from: URL:  http://www.wjgnet.com/1948-5190/ full/v8/i18/635.htm  DOI: http://dx.doi.org/10.4253/wjge.,Non-OADS,/arxiv_data1/oa_pdf/43/42/WJGE-8-635.PMC5067470.pdf
"© 2016 Baishideng Publishing Group Inc. All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/43/42/WJGE-8-635.PMC5067470.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscriptCorrespondence to:  Roberto Di Mitri, MD,  Gastroenterology  and Endoscopy Unit, ARNAS Civico-Di Cristina-Benfratelli  Hospital, Piazza N. Leotta 4, 90127 Palermo,  Italy.",Non-OADS,/arxiv_data1/oa_pdf/41/c0/WJGE-8-646.PMC5067471.pdf
The  mean common bile duct (CBD) dilation was 19.2 mm Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.4253/wjge.v8.i18.646World J Gastrointest Endosc   2016 October 16; 8(18): 646-652 ISSN 1948-5190 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.,Non-OADS,/arxiv_data1/oa_pdf/41/c0/WJGE-8-646.PMC5067471.pdf
"World J Gastrointest Endosc  2016; 8(18): 646-652   Available from: URL:  http://www.wjgnet.com/1948-5190/full/ v8/i18/646.htm  DOI: http://dx.doi.org/10.4253/wjge.v8.i18.646 INTRODUCTION Endoscopic sphincterotomy (EST) during endoscopic  retrograde cholangiopancreatography (ERCP) represents  the standard endoscopic treatment for common bile  duct (CBD) stones, present in up to 10% of patients  who underwent cholecistectomy[1].",Non-OADS,/arxiv_data1/oa_pdf/41/c0/WJGE-8-646.PMC5067471.pdf
"© 2016 Baishideng Publishing Group Inc. All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/41/c0/WJGE-8-646.PMC5067471.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Edward J Ciaccio, PhD, Celiac Disease  Center, Department of Medicine, Columbia University Medical  Center, 630 West 168th Street, New York, NY 10032,  United States.",Non-OADS,/arxiv_data1/oa_pdf/6f/53/WJGE-8-653.PMC5067472.pdf
Improvement in this descriptor will  require incorporating flexibility to the prototypical Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.4253/wjge.v8.i18.653World J Gastrointest Endosc   2016 October 16; 8(18): 653-662 ISSN 1948-5190 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.,Non-OADS,/arxiv_data1/oa_pdf/6f/53/WJGE-8-653.PMC5067472.pdf
World J Gastrointest Endosc  2016;  8(18): 653-662   Available from: URL:  http://www.wjgnet.,Non-OADS,/arxiv_data1/oa_pdf/6f/53/WJGE-8-653.PMC5067472.pdf
com/1948-5190/full/v8/i18/653.htm  DOI: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/6f/53/WJGE-8-653.PMC5067472.pdf
"© 2016 Baishideng Publishing Group Inc. All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/6f/53/WJGE-8-653.PMC5067472.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ Manuscript source: Invited manuscript Correspondence to: Jin Kan Sai, MD,  Department of  Gastroenterology, Juntendo University School of Medicine, 2-1-1  Hongo, Bunkyo-ku, Tokyo 113-8421,  Japan.",Non-OADS,/arxiv_data1/oa_pdf/aa/b9/WJGE-8-663.PMC5067473.pdf
The incidence of pancreatitis and the  difference in serum amylase level after the procedure  were examined and compared with those associated  with 8-mm EBS alone in 32 patients of historical control  (contr ol group).Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.4253/wjge.v8.i18.663World J Gastrointest Endosc   2016 October 16; 8(18): 663-668 ISSN 1948-5190 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.,Non-OADS,/arxiv_data1/oa_pdf/aa/b9/WJGE-8-663.PMC5067473.pdf
"© 2016 Baishideng Publishing Group Inc. All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/aa/b9/WJGE-8-663.PMC5067473.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to:  Qiang Cai, MD, PhD, Professor  of  Medicine,  Director of Advanced Endoscopy Fellowship,  Department of Internal Medicine, Division of Digestive Diseases,  Emory University School of Medicine, 1365 Clifton Road,  B1262, Atlanta, GA 30322, United States.",Non-OADS,/arxiv_data1/oa_pdf/c2/39/WJGE-8-669.PMC5067474.pdf
This is the first case of a repeat submucosal  tunneling done at the same site of a prior POEM Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.4253/wjge.v8.i18.669World J Gastrointest Endosc   2016 October 16; 8(18): 669-673 ISSN 1948-5190 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.,Non-OADS,/arxiv_data1/oa_pdf/c2/39/WJGE-8-669.PMC5067474.pdf
World J Gastrointest Endosc  2016; 8(18): 669-673   Available from: URL:  http://www.wjgnet.com/1948-5190/full/v8/ i18/669.htm  DOI: http://dx.doi.org/10.4 253/wjge.v8.i18.669 INTRODUCTION Per oral en doscopic myotomy (POEM) is a novel endos­ copic procedure for achalasia treatment.,Non-OADS,/arxiv_data1/oa_pdf/c2/39/WJGE-8-669.PMC5067474.pdf
"© 2016 Baishideng Publishing Group Inc. All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/c2/39/WJGE-8-669.PMC5067474.pdf
"See: http://creativecommons.org/ licenses/by ­nc/4.0/ Manuscript source:  Unsolicited manuscript Correspondence to:  Laimas Jonaitis, MD, PhD, Department  of Gastroenterology, Medical Academy, Lithuanian University of  Health Sciences, Eivenių 2, 50009 Kaunas, Lithuania.",Non-OADS,/arxiv_data1/oa_pdf/93/7f/WJGE-8-674.PMC5067475.pdf
Key words:  Plexiform angiomyxoid myofibroblastic  tumor; Intramural; Mesenchymal; Submucosal; AntrumSubmit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.4253/wjge.v8.i18.674World J Gastrointest Endosc   2016 October 16; 8(18): 674-678 ISSN 1948-5190 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.,Non-OADS,/arxiv_data1/oa_pdf/93/7f/WJGE-8-674.PMC5067475.pdf
World J Gastrointest Endosc  2016; 8(18): 674­678   Available from: URL:  http://www.wjgnet.com/1948 ­5190/full/ v8/i18/674.htm  DOI: http://dx.doi.org/10.4253/wjge.v8.i18.674 INTRODUCTION Plexiform angiomyxoid myofibroblastic tumor (PAMT)  is a benign mesenchymal tumor of stomach.,Non-OADS,/arxiv_data1/oa_pdf/93/7f/WJGE-8-674.PMC5067475.pdf
"© 2016 Baishideng Publishing Group Inc. All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/93/7f/WJGE-8-674.PMC5067475.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source: Unsolicited manuscript Correspondence to:  Guilherme Francisco Gomes, MD,  Endoscopy Unit, Nossa Senhora das Graças Hospital, Rua Mon  Ivo Zanlorenzi, 1850 CEP 81210000, Curitiba 81830,  Brazil.",Non-OADS,/arxiv_data1/oa_pdf/ff/69/WJGE-8-679.PMC5067476.pdf
Core tip:  Meckel’s diverticulum (MD) is estimated to  affect 1%-2% of the general population and has 4%-6% Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.4253/wjge.v8.i18.679World J Gastrointest Endosc   2016 October 16; 8(18): 679-683 ISSN 1948-5190 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.,Non-OADS,/arxiv_data1/oa_pdf/ff/69/WJGE-8-679.PMC5067476.pdf
World J  Gastrointest Endosc  2016; 8(18): 679-683  Available from: URL:   http://www.wjgnet.com/1948-5190/full/v8/i18/679.htm  DOI:  http://dx.doi.org/10.4253/wjge.v8.i18.679 INTRODUCTION Meckel’s diverticulum ( MD) is a congenital true diver­ ticulum that develops from a patent omphalo ­mesen­ teric duct[1].,Non-OADS,/arxiv_data1/oa_pdf/ff/69/WJGE-8-679.PMC5067476.pdf
"© 2016 Baishideng Publishing Group Inc. All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/ff/69/WJGE-8-679.PMC5067476.pdf
Pahwa).Available online at www.sciencedirect.com ScienceDirect journal homepage: www.elsevier.com/locate/ihj http://dx.doi.org/10.1016/j.ihj.2015.10.383 0019-4832/ #2016 Published by Elsevier B.V. on behalf of Cardiological Society of India.,Non-OADS,/arxiv_data1/oa_pdf/0b/7e/main.PMC5067477.pdf
This is an open access article under the CC BY- NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/0b/7e/main.PMC5067477.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source: Invited manuscriptCorrespondence to:  Hideki Okamoto, MD, Associate  Professor, Department of  Japanese-Oriental (Kampo) Medicine,  Chiba University School of Medicine, 1-8-1 Inohana, Chuo-ku,  Chiba 260-8670 , Japan.",Non-OADS,/arxiv_data1/oa_pdf/7d/dc/WJCC-4-310.PMC5067493.pdf
"Twenty- four patients out of the 281 patients identified met the  following three conditions and were eligible for further  investigation of the effectiveness of Kampo treatment:  At least one course of cancer chemotherapy had been  administered; numbness and pain appeared after the  chemotherapy; and CIPN was diagnosed before they  were given Kampo treatment.ORIGINAL ARTICLE 310 October 16, 2016 |Volume 4 |Issue 10 | WJCC|www.wjgnet.comEfficacy of Japanese traditional (Kampo) medicine for  treating chemotherapy-induced peripheral neuropathy: A  retrospective case series studySubmit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.12998/wjcc.v4.i10.310World J Clin Cases   2016 October 16; 4(10): 310-317  ISSN 2307-8960 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.World Journal of Clinical Cases WJCC Retrospective Study",Non-OADS,/arxiv_data1/oa_pdf/7d/dc/WJCC-4-310.PMC5067493.pdf
World J Clin Cases  2016; 4(10): 310-317   Available from: URL: http://www.wjgnet.com/2307-8960/full/ v4/i10/310.htm   DOI: http://dx.doi.org/ 10.12998 /wjcc.v4.i10.310 INTRODUCTION Peripheral neuropathy is one of the most serious side  effects in cancer chemotherapies.,Non-OADS,/arxiv_data1/oa_pdf/7d/dc/WJCC-4-310.PMC5067493.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/7d/dc/WJCC-4-310.PMC5067493.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Amir Reza Vosoughi, MD, Assistant  Professor of Orthopedic Surgery, Foot and Ankle Surgeon, Bone  and Joint Diseases Research Center, Shiraz University of Medical  Sciences, Shiraz 71948-15644,  Iran.",Non-OADS,/arxiv_data1/oa_pdf/53/8b/WJCC-4-318.PMC5067494.pdf
"In total, 39 feet had recurrence ORIGINAL ARTICLE 318 October 16, 2016 |Volume 4 |Issue 10 | WJCC|www.wjgnet.comFactors associated with recurrence of clubfoot treated by  the Ponseti methodSubmit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.12998/wjcc.v4.i10.318World J Clin Cases   2016 October 16; 4(10): 318-322  ISSN 2307-8960 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.World Journal of Clinical Cases WJCC Retrospective Study",Non-OADS,/arxiv_data1/oa_pdf/53/8b/WJCC-4-318.PMC5067494.pdf
World J Clin Cases  2016; 4(10): 318-322  Available  from: URL: http://www.wjgnet.com/2307-8960/full/v4/i10/318.,Non-OADS,/arxiv_data1/oa_pdf/53/8b/WJCC-4-318.PMC5067494.pdf
htm  DOI: http://dx.doi.org/ 10.12998 /wjcc.v4.i10.318 INTRODUCTION Talipes equinovarus or clubfoot is one of the most  common congenital deformities of the lower limb with  an incidence of about 1 in 1000 live births[1].,Non-OADS,/arxiv_data1/oa_pdf/53/8b/WJCC-4-318.PMC5067494.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/53/8b/WJCC-4-318.PMC5067494.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to:  Abdulkadir Koçer, MD, MSc, Profesor  of Neurology, Department of Neurology, Göztepe Teaching  Hospital, Istanbul Medeniyet University Medical Faculty, Erkin  Street, Number 4, 34100 Istanbul,  Turkey.",Non-OADS,/arxiv_data1/oa_pdf/f0/77/WJCC-4-323.PMC5067495.pdf
"Key words:  Migraine; Headache; Chronic migraine;  Refractory mi graine; Greater occipital nerve; Nerve  blockORIGINAL ARTICLE 323 October 16, 2016 |Volume 4 |Issue 10 | WJCC|www.wjgnet.comGreater occipital nerve blocks in the treatment of refractory  chronic migraine: An observational report of nine casesSubmit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.12998/wjcc.v4.i10.323World J Clin Cases   2016 October 16; 4(10): 323-327  ISSN 2307-8960 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.World Journal of Clinical Cases WJCC Observational Study",Non-OADS,/arxiv_data1/oa_pdf/f0/77/WJCC-4-323.PMC5067495.pdf
World J Clin Cases  2016; 4(10): 323-327  Available from:  URL: http://www.wjgnet.com/2307-8960/full/v4/i10/323.htm    DOI: http://dx.doi.org/ 10.12998 /wjcc.v4.i10.323 INTRODUCTION Migraine is a common problem recently classified as  an important cause of morbidity by the Global Burden  of Disease 2010 and sometimes its treatment can be  difficult[1].,Non-OADS,/arxiv_data1/oa_pdf/f0/77/WJCC-4-323.PMC5067495.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/f0/77/WJCC-4-323.PMC5067495.pdf
"See: http://creativecommons.org/ licenses/by ­nc/4.0/ Manuscript source:  Unsolicited manuscript Correspondence to:  Paolo Fraticelli, MD, Clinica Medica,  Department of Internal Medicine, Università Politecnica delle  Marche, Ospedali Riuniti, via Conca, 60020 Ancona,  Italy.",Non-OADS,/arxiv_data1/oa_pdf/f4/af/WJCC-4-328.PMC5067496.pdf
"Core tip:  Imatinib mesila te is the mainstay therapy CASE REPORT 328 October 16, 2016 |Volume 4 |Issue 10 | WJCC|www.wjgnet.comIdiopathic hypereosinophilic syndrome presenting with  severe vasculitis successfully treated with imatinibSubmit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.12998/wjcc.v4.i10.328World J Clin Cases   2016 October 16; 4(10): 328-332  ISSN 2307-8960 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.World Journal of Clinical Cases WJCC",Non-OADS,/arxiv_data1/oa_pdf/f4/af/WJCC-4-328.PMC5067496.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/f4/af/WJCC-4-328.PMC5067496.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to:  Calogero Pagliarello, MD,  Section  of Dermatology, Department of Clinical and Experimental  Medicine, University of Parma, via Gramsci 14, 43100 Parma,  Italy.",Non-OADS,/arxiv_data1/oa_pdf/ba/27/WJCC-4-333.PMC5067497.pdf
"Pagliarello C, Peccerillo F, Zucchi A, Tortorella RG, Ricci R,  Stanganelli I, Feliciani C, Di Nuzzo S. Lesion presenting with a CASE REPORT 333 October 16, 2016 |Volume 4 |Issue 10 | WJCC|www.wjgnet.comLesion presenting with a “blue amber” patternSubmit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.12998/wjcc.v4.i10.333World J Clin Cases   2016 October 16; 4(10): 333-335  ISSN 2307-8960 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.World Journal of Clinical Cases WJCC",Non-OADS,/arxiv_data1/oa_pdf/ba/27/WJCC-4-333.PMC5067497.pdf
"World J Clin Cases  2016; 4(10): 333-335   Available from: URL: http://www.wjgnet.com/2307-8960/full/ v4/i10/333.htm   DOI: http://dx.doi.org/ 10.12998 /wjcc.v4.i10.333 INTRODUCTION Atypical fibroxanthoma (AFX) is an uncommon, locally  aggressive malignant fibrohistiocytic tumour with a  tendency for recurrence and a low metastatic potential[1].",Non-OADS,/arxiv_data1/oa_pdf/ba/27/WJCC-4-333.PMC5067497.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/ba/27/WJCC-4-333.PMC5067497.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ Manuscript source: Invited manuscript Correspondence to:  Akbar Khan, MD, Medical Director,  Medicor Cancer Centres Inc., 4576 Yonge St., Suite 301, Toronto,  ON M2N 6N4, Canada.",Non-OADS,/arxiv_data1/oa_pdf/7b/0e/WJCC-4-336.PMC5067498.pdf
"However, DCA can  also act as a cytostatic agent, without causing apoptosis CASE REPORT 336 October 16, 2016 |Volume 4 |Issue 10 | WJCC|www.wjgnet.comLong-term stabilization of stage 4 colon cancer using  sodium dichloroacetate therapySubmit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.12998/wjcc.v4.i10.336World J Clin Cases   2016 October 16; 4(10): 336-343  ISSN 2307-8960 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.World Journal of Clinical Cases WJCC",Non-OADS,/arxiv_data1/oa_pdf/7b/0e/WJCC-4-336.PMC5067498.pdf
"Based on the  National Cancer Institute’s SEER cancer statistics  review 1975-2011, the 5-year relative survival rate for  females diagnosed with stage IV colon/rectal cancer  was 14.4% ( http://seer.cancer.gov/csr/1975_2013 /).",Non-OADS,/arxiv_data1/oa_pdf/7b/0e/WJCC-4-336.PMC5067498.pdf
"A clinical trial of DCA in multiple myeloma patients  is currently underway to contribute to this pool of  data (Australia New Zealand Clinical Trials Register  #ACTRN12615000226505, http://www.anzctr .org.a u).",Non-OADS,/arxiv_data1/oa_pdf/7b/0e/WJCC-4-336.PMC5067498.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/7b/0e/WJCC-4-336.PMC5067498.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to:  Fikri M Abu-Zidan, MD, FACS, FRCS,  PhD,  Dip Applied Statistics  Professor,  Acute Care Surgeon,  Point-of-Care Sonographer, Statistical Consultant, Department  of Surgery, College of Medicine and  Health Sciences, UAE  University, Tawam Street, P.O.",Non-OADS,/arxiv_data1/oa_pdf/41/7f/WJCC-4-344.PMC5067499.pdf
"Core tip:  The indications of point-of-care ultrasound in  the management of multiple trauma patients have been CASE REPORT 344 October 16, 2016 |Volume 4 |Issue 10 | WJCC|www.wjgnet.comSurgeon-performed point-of-care ultrasound in severe eye  trauma: Report of two cases Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.12998/wjcc.v4.i10.344World J Clin Cases   2016 October 16; 4(10): 344-350  ISSN 2307-8960 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.World Journal of Clinical Cases WJCC",Non-OADS,/arxiv_data1/oa_pdf/41/7f/WJCC-4-344.PMC5067499.pdf
"World J Clin Cases  2016; 4(10): 344-350  Available from: URL:  http://www.wjgnet.com/2307-8960/full/v4/i10/344.htm   DOI:  http://dx.doi.org/ 10.12998 /wjcc.v4.i10.344 INTRODUCTION The indications for point-of-care ultrasound (POCUS)  in the management of patients with multiple trauma  including the abdomen, chest and extremities have  been evolving[1].",Non-OADS,/arxiv_data1/oa_pdf/41/7f/WJCC-4-344.PMC5067499.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/41/7f/WJCC-4-344.PMC5067499.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to:  Dr. Vivek B Kute, MD, DM Nephrology  (Gold Medalist), FASN, Associate Professor,  Department of  Nephrology and Clinical Transplantation, Institute of Kidney  Diseases and Research Center , Dr. HL Trivedi Institute of  Transplantation Sciences (IKDRC-ITS), Civil Hospital Campus,  Ahmedabad 380016, Gujarat, India.",Non-OADS,/arxiv_data1/oa_pdf/dc/fb/WJCC-4-351.PMC5067500.pdf
"We believe  that this is first repo rt from India where three-way KPD CASE REPORT 351 October 16, 2016 |Volume 4 |Issue 10 | WJCC|www.wjgnet.comIncreasing access to kidney transplantatio n  for sensitized  recipient through  three-way kidney paired donation with  desensitization: The first Indian repor tSubmit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.12998/wjcc.v4.i10.351World J Clin Cases   2016 October 16; 4(10): 351-355  ISSN 2307-8960 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.World Journal of Clinical Cases WJCC",Non-OADS,/arxiv_data1/oa_pdf/dc/fb/WJCC-4-351.PMC5067500.pdf
Increasing  access to kidney transplantatio n for sensitized recipient through   three-way kidney paired donation with desensitization: The first  Indian repor t. World J Clin Cases  2016; 4(10): 351-355  Available  from: URL: http://www.wjgnet.com/2307-8960/full/v4/i10/351.,Non-OADS,/arxiv_data1/oa_pdf/dc/fb/WJCC-4-351.PMC5067500.pdf
htm  DOI: http://dx.doi.org/ 10.12998 /wjcc.v4.i10.351 INTRODUCTION Living donor kidney t ransplantation (LDKT) is the opti­ mal modality with the best long term outcome for end  stage renal disease (ESRD) patients.,Non-OADS,/arxiv_data1/oa_pdf/dc/fb/WJCC-4-351.PMC5067500.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/dc/fb/WJCC-4-351.PMC5067500.pdf
): a possible new compound for reduction of body weight by increasing lean muscle mass.NutraCos 1: 1-2. http://www.forslean.com/clinicalstudies.html.,Non-OADS,/arxiv_data1/oa_pdf/62/16/PTR-30-732.PMC5067548.pdf
"Ongoing trials will beidentiﬁed through ClinicalTrials.gov (https://clini-caltrials.gov/) and the World Health Organization(WHO) International Clinical Trials Registry Plat-form (ICTRP) (http://www.who.int/ictrp/en/).Databases will be searched again before guidelinepublication, allowing the section steering commit- tees to reference any new studies.",Non-OADS,/arxiv_data1/oa_pdf/77/84/MUS-53-503.PMC5067551.pdf
"GI Motility Online 2006. doi:10.1038/gimo35, Published 16 May 2006. http://www.nature.com/gimo/contents/pt1/full/gimo35.html.",OADS,/arxiv_data1/oa_pdf/77/84/MUS-53-503.PMC5067551.pdf
"http://www.casp-uk.net/#!casp-tools-checklists/c18f8/.Accessed October 2, 2015.",Non-OADS,/arxiv_data1/oa_pdf/77/84/MUS-53-503.PMC5067551.pdf
Process and methods guides; 2012. http://publications.nice.org.uk/pmg6/.,Non-OADS,/arxiv_data1/oa_pdf/77/84/MUS-53-503.PMC5067551.pdf
"SurveyMonkey, Inc. http://www.surveymonkey.com.",OADS,/arxiv_data1/oa_pdf/77/84/MUS-53-503.PMC5067551.pdf
Available from URL: http://lilly.mediaroom.com/index.php?s=9042&item=137348.Accessed18May2015.,Non-OADS,/arxiv_data1/oa_pdf/f7/d1/DOM-18-425.PMC5067552.pdf
Available from URL: http://www.pmda.go.jp/files/000206818.pdf.,Non-OADS,/arxiv_data1/oa_pdf/f7/d1/DOM-18-425.PMC5067552.pdf
Available from URL: http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/002835/human_med_001790.jsp&mid=WC0b01ac058001d124.Accessed18May2015.,Non-OADS,/arxiv_data1/oa_pdf/f7/d1/DOM-18-425.PMC5067552.pdf
Available from URL: http://www.fda.gov/downloads/Drugs/.../Guidances/UCM192750.pdf.Accessed16December2014.,Non-OADS,/arxiv_data1/oa_pdf/f7/d1/DOM-18-425.PMC5067552.pdf
Available from URL: https://www.diabetes.org.uk/Documents/Position%20statements/diabetes-uk-position-statement-biosimilar-insulins-1013.pdf.,Non-OADS,/arxiv_data1/oa_pdf/f7/d1/DOM-18-425.PMC5067552.pdf
http://nccd.cdc.gov/USCS/SurvivalData.aspx 2010.,Non-OADS,/arxiv_data1/oa_pdf/73/99/OSP4-2-40.PMC5067555.pdf
Alignments were deposited at TreeBASE(http://treebase.org/treebase-web/home.html) with the study accession number S18437 available at http://purl.org/phylo/treebase/phylows/study/TB2:S18437.,OADS,/arxiv_data1/oa_pdf/54/f3/JPY-52-305.PMC5067557.pdf
VideoEndocrinology 2015; http://online.liebertpub.com/doi/full/10 ⋅1089/ve.2015 ⋅0056 [accessed 21 December 2015].,Non-OADS,/arxiv_data1/oa_pdf/f3/2f/BJS-103-537.PMC5067567.pdf
"Presented at the 18th Annual Meeting of theNorth American Neuromodulation Society, December 11-14, 2014, http://www.epostersonline.com/nans2014/node/59.",Non-OADS,/arxiv_data1/oa_pdf/af/82/NER-19-522.PMC5067570.pdf
"Presented at the 17th Annual Meeting of the North American Neuromodulation Society, December 5–8, 2013. http://www.epostersonline.com/nans2013/node/346.",Non-OADS,/arxiv_data1/oa_pdf/af/82/NER-19-522.PMC5067570.pdf
"Presented at the 17th Annual Meeting of the North American Neuromodulation Society, December 5–8, 2013.http://www.epostersonline.com/nans2013/node/345.",Non-OADS,/arxiv_data1/oa_pdf/af/82/NER-19-522.PMC5067570.pdf
2007. http://professional.medtronic.com/wcm/groups/mdtcom_sg/@mdt/@neuro/ documents/documents/idd-ptm8835-manl.pdf.,Non-OADS,/arxiv_data1/oa_pdf/af/82/NER-19-522.PMC5067570.pdf
"Presented at the 14th Annual Meeting of the North American Neuromodulation Society, December 2–5, 2010. http://www.slideserve.com/uri/use-of-the-personal -therapy-manager-with-prialt-ziconotide- intrathecal-infusion-for-patient-controlled-analgesia-case.",Non-OADS,/arxiv_data1/oa_pdf/af/82/NER-19-522.PMC5067570.pdf
"Presented at the 53rd ASH Annual Meeting and Exposition; December 10-13, 2011. http://oncology.by/uplds/ASH/MAC/webprogramcd/Paper4 3779.html.",Non-OADS,/arxiv_data1/oa_pdf/af/82/NER-19-522.PMC5067570.pdf
"Presented at the 17th Annual Meeting of the North American Neuromodulation Society, December 5-8, 2013. http://www.epostersonline.com/nans2013/node/338.",Non-OADS,/arxiv_data1/oa_pdf/af/82/NER-19-522.PMC5067570.pdf
"Presented at the American Academy of Physical Medicine and Rehabili- tation Annual Assembly, November 15-18, 2012. http://www.choa.org/Childrens- Hospital-Services/Rehabilitation/Meet-the -Team/Elizabeth-Poplawski/~/media/CHOA/ Documents/Services/Rehabilitation/ITB-ﬂe x-poster.pdf.",Non-OADS,/arxiv_data1/oa_pdf/af/82/NER-19-522.PMC5067570.pdf
"Baseli ne covariates includ- ed in these models were sociodemographic, laboratory meas- ures, subjective (patient-repo rted), and physician-diagnosed comorbidities (Supplementary Table 1, available on the Arth- ritis Care & Research web site at http://onlinelibrary.wiley.",OADS,/arxiv_data1/oa_pdf/d4/6b/ACR-68-308.PMC5067571.pdf
"(Numbers of patientswho achieved [or did not achieve] targets at each time pointare tabulated in Supplementary Table 3, available on the Arth- ritis Care & Research web site at http://onlinelibrary.wiley.",Non-OADS,/arxiv_data1/oa_pdf/d4/6b/ACR-68-308.PMC5067571.pdf
"As with the M-HAQ data, baseline covariates signiﬁ- cantly associated with improved HRQOL on the EQ-5Dincluded lower M-HAQ scores (i.e., less physical dysfunc-tion) and shorter RA duration across all 3 disease mea-sures (Supplementary Table 4, available on the Arthritis Care & Research web site at http://onlinelibrary.wiley.",Non-OADS,/arxiv_data1/oa_pdf/d4/6b/ACR-68-308.PMC5067571.pdf
"For numbers of patients who achieved (or did not achieve) the target at each time point, see Supplementary Table 3, available on the Arthritis Care & Research web site at http://onlinelibrary.wiley.com/doi/10.1002/acr.22678/abstract.312 Alemao et al",Non-OADS,/arxiv_data1/oa_pdf/d4/6b/ACR-68-308.PMC5067571.pdf
URL: http://www.cdc.gov/arthritis/data_statis-tics/arthritis-related-stats.htm.,OADS,/arxiv_data1/oa_pdf/d4/6b/ACR-68-308.PMC5067571.pdf
URL: http://www.ahrq.gov/rice/EQ5Dscore.htm.,OADS,/arxiv_data1/oa_pdf/d4/6b/ACR-68-308.PMC5067571.pdf
http://dhsprogram.com/ pubs/pdf/FR248/FR248.pdf.,Non-OADS,/arxiv_data1/oa_pdf/9b/37/JMWH-61-196.PMC5067583.pdf
http://www.mchip.net/ mchipcloseout3/files/Scale%20Brief.pdf Published 2014.,Non-OADS,/arxiv_data1/oa_pdf/9b/37/JMWH-61-196.PMC5067583.pdf
http://dx.doi.org/10.1016/j.midw.2013.10.026.,OADS,/arxiv_data1/oa_pdf/9b/37/JMWH-61-196.PMC5067583.pdf
"Na- tional Reproductive Health Strategy, 2012-2016. http://moph.gov.",Non-OADS,/arxiv_data1/oa_pdf/9b/37/JMWH-61-196.PMC5067583.pdf
It was organized through WSACS – the Abdominal Com- partment Society (http://WSACS.org).,Non-OADS,/arxiv_data1/oa_pdf/ca/de/BJS-103-709.PMC5067589.pdf
We have developed a new computational combi- natorial system UMD-Predictor (http://umd-predictor.eu) to efﬁciently annotate cDNA substitutions of all human transcripts for their potential pathogenicity.,Non-OADS,/arxiv_data1/oa_pdf/73/43/HUMU-37-439.PMC5067603.pdf
Only 55% of disease-causing genes have been identiﬁed and international initia- tives are organized to speed up genes identiﬁcation and drug devel- opment such as the International Rare Disease Research Consortium (IRDIRC - http://www.irdirc.org).,Non-OADS,/arxiv_data1/oa_pdf/73/43/HUMU-37-439.PMC5067603.pdf
This interface integrates the d3.js (http://d3js.org/) and jquery (http://jquery.com/) libraries to ensure easy access to the system (http://umd-predictor.eu).,OADS,/arxiv_data1/oa_pdf/73/43/HUMU-37-439.PMC5067603.pdf
"All theoretical substitutions of protein-coding transcripts (280,315,899 mutations) have then been modeled, computed, and stored in a PostgreSQL (http://www.postgresql.org/) database allowing rapid analysis of large datasets.",OADS,/arxiv_data1/oa_pdf/73/43/HUMU-37-439.PMC5067603.pdf
It is freely available for noncommercial use athttp://umd-predictor.eu.,Non-OADS,/arxiv_data1/oa_pdf/73/43/HUMU-37-439.PMC5067603.pdf
"All data were generated using the “ci.cvAUC” function of the “cvAUC” package (https://github.com/ledell/cvAUC) for the ROCR R-package [Sing et al., 2005].",OADS,/arxiv_data1/oa_pdf/73/43/HUMU-37-439.PMC5067603.pdf
"All data were generated using the “ci.cvAUC” function of the “cvAUC” package (https://github.com/ledell/cvAUC) for the ROCR R-package [Sing et al., 2005].",OADS,/arxiv_data1/oa_pdf/73/43/HUMU-37-439.PMC5067603.pdf
It can also be used for any variant evaluation through a user-friendly interface at http://umd-predictor.eu.,Non-OADS,/arxiv_data1/oa_pdf/73/43/HUMU-37-439.PMC5067603.pdf
"For exhaustive pathogenicity pre- diction of all variation types, UMD-Predictor should be combined with other speciﬁc systems such as the Human Splicing Finder (HSF – http://www.umd.be/HSF3/) [Desmet et al., 2009] that is able to predict the pathogenicity of intronic variants.",Non-OADS,/arxiv_data1/oa_pdf/73/43/HUMU-37-439.PMC5067603.pdf
Available at: http://evs.nci.,Non-OADS,/arxiv_data1/oa_pdf/94/9d/LIV-36-1125.PMC5067610.pdf
"Reverse transcription was performed using alfalfa mosaic virus reverse transcriptase(AMV, TaKaRa, http://www.takara-bio.com/ ).",Non-OADS,/arxiv_data1/oa_pdf/56/a0/JIPB-58-679.PMC5067611.pdf
"Reverse transcription was performed using alfalfa mosaic virus reverse transcriptase (AMV, TaKaRa,http://www.takara-bio.com/ ).",Non-OADS,/arxiv_data1/oa_pdf/56/a0/JIPB-58-679.PMC5067611.pdf
"The subcellularlocalizationofAtTMEM18-GFP fusionproteinintheroots,pollengrains and pollen tubes was visualized under a confocal micro-scope (LSM510, Carl Zeiss, Germany, http://www.zeiss.com ).",OADS,/arxiv_data1/oa_pdf/56/a0/JIPB-58-679.PMC5067611.pdf
http://www.nce-pod.org.uk/2010report1/downloads/PN_report.pdf (accessed24/08/2015).,Non-OADS,/arxiv_data1/oa_pdf/fc/46/ANAE-71-573.PMC5067617.pdf
"The Royal College of Nurses, 2010. http://www.bbraun.it/documents/RCN-Guidlines-for-IV-therapy.pdf (accessed 24/08/2015).",Non-OADS,/arxiv_data1/oa_pdf/fc/46/ANAE-71-573.PMC5067617.pdf
6. http://www.nrls.npsa.nhs.uk/patient-safety-data/organisation- patient-safety-incident-reports/ (accessed 17/10/2015).,Non-OADS,/arxiv_data1/oa_pdf/fc/46/ANAE-71-573.PMC5067617.pdf
http://medusa.wales.,Non-OADS,/arxiv_data1/oa_pdf/fc/46/ANAE-71-573.PMC5067617.pdf
12. http://www.rch.org.au/uploadedFiles/Main/Content/anaes/ a_procedural_guide_to_midline_insertion.pdf.,Non-OADS,/arxiv_data1/oa_pdf/fc/46/ANAE-71-573.PMC5067617.pdf
https://www.nice.org.uk/guidance/mtg24 (accessed 24/08/2015).,Non-OADS,/arxiv_data1/oa_pdf/fc/46/ANAE-71-573.PMC5067617.pdf
https://www.rcr.ac.uk/sites/default/ﬁles/ .../BFCR(10)4_Stand_ contrast.pdf (accessed 24/08/2015).,Non-OADS,/arxiv_data1/oa_pdf/fc/46/ANAE-71-573.PMC5067617.pdf
National Safety Stan- dards for Invasive Procedures 2015. https://www.england.nh-s.uk/patientsafety/never-events/natssips/ (accessed 08/01/ 2016).,Non-OADS,/arxiv_data1/oa_pdf/fc/46/ANAE-71-573.PMC5067617.pdf
Retrieved November 2015. http://www.nextgenscience.org/sites/ngss/ ﬁles/Appendix%20H%20-%20The%20Nature%20of%20Science%20in%20the%20Next%20Generation%20 Science%20Standards%204.15.13.pdf.,Non-OADS,/arxiv_data1/oa_pdf/ce/8e/SCE-100-459.PMC5067621.pdf
Retrieved November 2015 from: https://www.gov.uk/government/uploads/system/uploads/attachment_data/ﬁle/456438/Progress_ 8_school_performance_measure_2015_updated_August_2015.pdf.,Non-OADS,/arxiv_data1/oa_pdf/ce/8e/SCE-100-459.PMC5067621.pdf
Retrieved from: http://sdsu-dspace.calstate.edu/bitstream/handle/10211.10/3436/Hart_Randall.pdf?sequence =1.,OADS,/arxiv_data1/oa_pdf/ce/8e/SCE-100-459.PMC5067621.pdf
"Retrieved from http://resubjectreview.recouncil.org.uk/re-review-report Rose, N. (2013).",Non-OADS,/arxiv_data1/oa_pdf/ce/8e/SCE-100-459.PMC5067621.pdf
Avail- ablefromURL:http://www.novo-pi.com/victoza.pdf.Accessed12August2015.22.,Non-OADS,/arxiv_data1/oa_pdf/a4/f2/DOM-18-475.PMC5067625.pdf
AvailablefromURL:http://www.azpicentral.com/byetta/pi_byetta.pdf#page=1.Accessed12August2015.,Non-OADS,/arxiv_data1/oa_pdf/a4/f2/DOM-18-475.PMC5067625.pdf
"Statens Serum Institut, Copenhagen, Denmark (https://www.ssi.dk/) [28] and the British National Guideline Centre [29].",Non-OADS,/arxiv_data1/oa_pdf/7a/6a/AJH-91-271.PMC5067626.pdf
"Wnt Signaling and the Formation of Embryonic Polarity In most bilaterians, intracellular components of the Wnt/ β-catenin signaling pathway are key players for the establishment of axial polarity and consequently, the role of this pathway has been studied extensivelyTABLE 1 |List of Techniques and Tools Available for Culturing and Experimental Manipulation of Nematostella Culture and Care of Nematostella Culture and spawning Hand and Uhlinger4; Fritzenwanker and Technau9; Genikhovich et al.,31 Inducing and staging regenerationAmiel et al.,32; Dubuc et al.,33; Bossert et al.,34 Spatiotemporal gene expression mRNA in situ Wolenski et al.,13; Genikhovich et al.,31 Immunolocalization Wolenski et al.,13 Transgenic reporters Renfer et al.,12; Ikmi et al.,35 Gene function Morpholino Magie et al.,36; Rentzsch et al.,37; Layden et al.,38 mRNA misexpression Wikramanayake et al.,39; Layden et al.,38 CRISPR/Cas9, TALEN/Fok1 Ikmi et al.,35 Inducible promoters Ikmi et al.,35 Genome and ‘omics ’level analysis Annotated genome (Putnam et al.,23) http://genome.jgi-psf.org/Nemve1/Nemve1.home.html, http://cnidarians.bu.edu/ stellabase/index.cgi, http://metazoa.ensembl.org/Nematostella_vectensis/Info/Index Transcriptomes Tulin et al.,29; Helm et al.,28http:// ﬁgshare.com/articles/ Nematostella_vectensis_transcriptome_and_gene_models_v2_0/807696 ChIP-Seq protocol Schwaiger et al.,27 RNA-seq protocol Helm et al.,28; Tulin et al.,29 Microarray approaches Röttinger et al.,40; Fritz et al.,11; Sinigaglia et al.,41Overview wires.wiley.com/devbio 412 © 2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/97/ff/WDEV-5-408.PMC5067631.pdf
"[13]To facilitate chemical-bonding analyses and other methods for a multitude of systems and applications, we are offering the LOBSTER(Local Orbital Basis Suite Towards Electronic-Structure Reconstruction)software free-of-charge for non-commercial purposes at http://www.cohp.de.",Non-OADS,/arxiv_data1/oa_pdf/e2/68/JCC-37-1030.PMC5067632.pdf
[22] http://www.boost.org.,Non-OADS,/arxiv_data1/oa_pdf/e2/68/JCC-37-1030.PMC5067632.pdf
"[23] G. Guennebaud, B. Jacob, http://eigen.tuxfamily.org, 2010 .",Non-OADS,/arxiv_data1/oa_pdf/e2/68/JCC-37-1030.PMC5067632.pdf
"In addi-tion, the results shown here are based on data generated by the The CancerGenome Atlas (TCGA) Research Network (http://cancergenome.nih.gov/) andthe India Project Team of the ICGC (https://icgc.org/).",OADS,/arxiv_data1/oa_pdf/15/a2/HED-38-E2021.PMC5067633.pdf
http://www.stat- can.gc.ca/eng/survey/household/5071 (accessedFebruary 2015).,OADS,/arxiv_data1/oa_pdf/ca/a7/IJCP-70-196.PMC5067635.pdf
"Fact Sheet #311: Obe- sity and overweight, accessed February 2015. http://www.who.int/mediacentre/factsheets/fs311/en/in-dex.html (accessed February 2015).",Non-OADS,/arxiv_data1/oa_pdf/ca/a7/IJCP-70-196.PMC5067635.pdf
"2010. http://www.dove.us/Social-Mission/campaign-for-real-beauty.aspx 30 Kolotkin RL, Crosby RD, Kosloski KD, Williams GR.",Non-OADS,/arxiv_data1/oa_pdf/ca/a7/IJCP-70-196.PMC5067635.pdf
Accessed June 2014.Available from: http://www.cdc.gov/chronicdisease/overview/in-dex.htm.,Non-OADS,/arxiv_data1/oa_pdf/bd/52/OSP4-2-69.PMC5067636.pdf
Available from http://www.health.gov.au/antenatal (accessed 20/8/15).,Non-OADS,/arxiv_data1/oa_pdf/7a/f1/AJO-56-142.PMC5067656.pdf
Available from: http:// http://www.nursingmidwiferyboard.gov.au/Codes-Guidelines- Statements/Professional-standards.aspx (accessed 20/8/15).,Non-OADS,/arxiv_data1/oa_pdf/7a/f1/AJO-56-142.PMC5067656.pdf
Available from: http://www.ranzcog.edu.au/college-statements- guidelines.html#obstetrics (Accessed 20/8/15).,Non-OADS,/arxiv_data1/oa_pdf/7a/f1/AJO-56-142.PMC5067656.pdf
Available from http://health.vic.gov.au/clinrisk/ (Accessed 20/8/15).,Non-OADS,/arxiv_data1/oa_pdf/7a/f1/AJO-56-142.PMC5067656.pdf
Available from http://www.ihi.org/resources/Pages/Tools/default.aspx (Accessed 20/8/15).,OADS,/arxiv_data1/oa_pdf/7a/f1/AJO-56-142.PMC5067656.pdf
Available from: http://www.syfpeithi.de/0-Home.htm.60.,Non-OADS,/arxiv_data1/oa_pdf/61/35/AJT-16-1193.PMC5067673.pdf
Available from: http://www.iedb.org/home_v3.php.,Non-OADS,/arxiv_data1/oa_pdf/61/35/AJT-16-1193.PMC5067673.pdf
Available from: http://www.allelefrequencies.net/ 64.,OADS,/arxiv_data1/oa_pdf/61/35/AJT-16-1193.PMC5067673.pdf
"3.3    Sequence analysis of E77 In order to identify the E77 regulatory element, the pcDNA/GFP/Zeo vector containing E77 was sequenced  and analyzed using the basic local alignment search  tool (BLAST; http://blast.ncbi.nlm.nih.gov) and CHO-blast (http://www.chogenome.org).",OADS,/arxiv_data1/oa_pdf/64/78/BIOT-11-633.PMC5067685.pdf
"NW_003619835.1 (scaffold16408), NW_003615552.1 (scaffold6389),  and NW_003613979.1 (scaffold1936) are the accession numbers from the CHOblast search (http://blast.chogenome.org/index.php).",OADS,/arxiv_data1/oa_pdf/64/78/BIOT-11-633.PMC5067685.pdf
EU559333.1 and  EU204642.1 are the accession numbers from nucleotide BLAST in NCBI (http://blast.ncbi.nlm.nih.gov).,Non-OADS,/arxiv_data1/oa_pdf/64/78/BIOT-11-633.PMC5067685.pdf
"© 2016 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim www.biotechnology-journal.comForum Silk route to the acceptance and re-implementation   of bacteriophage therapy Wilbert Sybesma, Jean-Paul Pirnay http://dx.doi.org/10.1002/biot.201600023 Commentary Microbial production of mammalian melatonin – a promising  solution to melatonin industry Tao Sun, Lei Chen and Weiwen Zhang http://dx.doi.org/10.1002/biot.201500604 Research Article Extracellular vesicles concentration is a promising and  important parameter for industrial bioprocess monitoring Apolonija Bedina-Zavec, Veronika Kralj-Iglic ˇ, Matjaž Brinc,  Tanja Ficko-Trc ˇek, Drago Kuzman, Ana Schweiger and Gregor Anderluh http://dx.doi.org/10.1002/biot.201500049 Research Article Dynamics of immature mAb glycoform secretion during   CHO cell culture: An integrated modelling framework Ioscani Jimenez del Val, Yuzhou Fan and Dietmar Weilguny http://dx.doi.org/10.1002/biot.201400663 Research Article An artificial self-sufficient cytochrome P450 directly nitrates  fluorinated tryptophan analogs with a different regio-selectivity Ran Zuo, Yi Zhang, Jose C. Huguet-Tapia, Mishal Mehta,  Evelina Dedic, Steven D. Bruner, Rosemary Loria and Yousong Ding http://dx.doi.org/10.1002/biot.201500416Research Article A novel regulatory element (E77) isolated from CHO-K1  genomic DNA enhances stable gene expression in Chinese  hamster ovary cells Shin-Young Kang, Yeon-Gu Kim, Seunghee Kang, Hong W.  Lee and Eun G. Lee http://dx.doi.org/10.1002/biot.201500464 Research Article Exploring mild enzymatic sustainable routes for the synthesis  of bio-degradable aromatic-aliphatic oligoesters Alessandro Pellis, Alice Guarneri, Martin Brandauer,  Enrique Herrero Acero, Henricus Peerlings, Lucia Gardossi and Georg M. Guebitz http://dx.doi.org/10.1002/biot.201500544 Research Article MapMaker and PathTracer for tracking carbon in genome-scale  metabolic models Christopher J. Tervo and Jennifer L. Reed http://dx.doi.org/10.1002/biot.201500267 Research Article Human pluripotent stem cell culture density modulates YAP  signaling Cheston Hsiao, Michael Lampe, Songkhun Nillasithanukroh,  Wenqing Han, Xiaojun Lian and Sean P. Palecek http://dx.doi.org/10.1002/biot.201500374 Research Article High-throughput cell quantification assays for use in cell  purification development – enabling technologies for cell  production Sarah Zimmermann, Sarah Gretzinger, Christian Scheeder,  Marie-Luise Schwab, Stefan A. Oelmeier, Anna Osberghaus, Eric Gottwald and Jürgen Hubbuch http://dx.doi.org/10.1002/biot.201500577Biotechnology Journal – list of articles published in the May 2016 issue.",Non-OADS,/arxiv_data1/oa_pdf/64/78/BIOT-11-633.PMC5067685.pdf
"Image is provided by Aleksandre Ujmajuridze, Jon Caplin, Nino Chanishvili, and Aidan Coffey   authors of “Silk route to the acceptance and re-implementation of bacteriophage therapy”   (http://dx.doi.org/10.1002/biot.201600023).",Non-OADS,/arxiv_data1/oa_pdf/64/78/BIOT-11-633.PMC5067685.pdf
"Research Article Functionalized silk assembled from a recombinant spider silk  fusion protein (Z-4RepCT) produced in the methylotrophic  yeast Pichia pastoris Ronnie Jansson, Cheuk H Lau, Takuya Ishida, Margareta  Ramström, Mats Sandgren and My Hedhammar http://dx.doi.org/10.1002/biot.201500412 Research Article Rapid ester biosynthesis screening reveals a high activity  alcohol-O-acyltransferase (AATase) from tomato fruit Jyun-Liang Lin, Jie Zhu and Ian Wheeldon http://dx.doi.org/10.1002/biot.201500406Research Article An integrated practical implementation of continuous aqueous  two-phase systems for the recovery of human IgG: From the  microfluidic device to a multistage bench-scale mixer-settler  device Edith Espitia-Saloma, Patricia Vázquez-Villegas, Marco  Rito-Palomares and Oscar Aguilar http://dx.doi.org/10.1002/biot.201400565 Rapid Communication Glucose-based microbial production of the hormone melatonin  in yeast Saccharomyces cerevisiae Susanne M. Germann, Simo A. Baallal Jacobsen, Konstantin  Schneider, Scott J. Harrison, Niels B. Jensen, Xiao Chen, Steen G. Stahlhut, Irina Borodina, Hao Luo, Jiangfeng Zhu, Jérôme Maury and Jochen Forster http://dx.doi.org/10.1002/biot.201500143 © 2016 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim www.biotechnology-journal.com",Non-OADS,/arxiv_data1/oa_pdf/64/78/BIOT-11-633.PMC5067685.pdf
Available from URL: http://www.evidence.nhs.uk/formulary/bnf/current/6-endocrine-system/61-drugs-used-in-diabetes.Accessed1October2015.27.,Non-OADS,/arxiv_data1/oa_pdf/e1/c7/DOM-18-401.PMC5067688.pdf
Available from URL: http://www.hscic.gov.uk/qof.. Accessed1October2015.,Non-OADS,/arxiv_data1/oa_pdf/e1/c7/DOM-18-401.PMC5067688.pdf
"Theseconserved residues form theactive center ofeach relaxase andallow cleavage ofaphosphodiester bond located ataspecific plasmid DNAsequence called thenicsite.Each plasmid contains aparticular relaxase ,recognizing adifferent[*]S.Sagredo, Dr.G.Moncalian, Prof. Dr.F.delaCruz Departame ntodeBiolog(o[3xa Molecular eInstituto deBiomedic ina yBiotecnolog(o[3xa deCantabria, Universida ddeCantabria-C onsejo Superior deInvestig aciones Cient(o[3xfica s-SODERCAN Albert Einstein 22,39011 Santander (Spain) E-mail :delacruz@un ican.es Dr.T.Pirzer,A.Aghebat Rafat, M.A.Goetzfried , Prof. Dr.F.C.Simmel Physik-Dep artment E14andZNN/WSI ,TUMunich AmCoulomb wall 4a,85748 Garchi ng(Germa ny) E-mail :simmel@tu m.de Supportin ginforma tion andtheORCID identifica tion number(s) for theauthor(s) ofthisarticle canbefound under http://dx.doi.org/ 10.",Non-OADS,/arxiv_data1/oa_pdf/27/c2/ANIE-55-4348.PMC5067690.pdf
"In agreement with speci ﬁc neuronal programing by 5 mM RA, genes encoding the early endodermal markers GDF-1, GDF-3,and HNF-4 (https://www.rndsystems.com/research-area/ early-endodermal-lineage-markers) are downregulated in RA treated ESCs (Terranova et al., 2015).",OADS,/arxiv_data1/oa_pdf/d7/24/JCP-231-1199.PMC5067692.pdf
"DAS28-ESR remission rates at week 24 were also higher in patients receiving CZP 200 mgand CZP 400 mg compared to patients receiving placebo(MTX ,15 mg/week: 7.6%, 9.8%, and 1.0%; MTX $15 mg/week: 15.6%, 13.4%, and 1.8%) (see Supplemen- tary Figure 1A, available on the Arthritis Care & Research web site at http://onlinelibrary.wiley.com/doi/10.1002/ acr.22676/abstract).",Non-OADS,/arxiv_data1/oa_pdf/59/65/ACR-68-299.PMC5067694.pdf
"Patients receiving CZP 200 mg or CZP 400 mg were more likely to report LDA at week 24 com-pared to placebo patients (MTX ,15 mg/week: 15.1%, 19.8%, and 1.5%; MTX $15 mg/week: 27.2%, 24.4%, and 4.4%) with treatment effect being similar across baseline MTX dose categories (Supplementary Figure 1B, availableat http://onlinelibrary.wiley.com/doi/10.1002/acr.22676/ abstract).",Non-OADS,/arxiv_data1/oa_pdf/59/65/ACR-68-299.PMC5067694.pdf
"(see Supplementary Figure 2A, available on the Arthritis Care & Research web site at http://onlinelibrary.wiley.",Non-OADS,/arxiv_data1/oa_pdf/59/65/ACR-68-299.PMC5067694.pdf
"com/doi/10.1002/acr.22676/abstract) and joint space nar- rowing scores (see Supplementary Figure 2B, available at http://onlinelibrary.wiley.com/ doi/10.1002/acr.22676/abstract) at week 24 were markedly lower in patients receiving CZP 200 mg or CZP 400 mg compared with those receiving place- bo (see Supplementary Figure 2).",Non-OADS,/arxiv_data1/oa_pdf/59/65/ACR-68-299.PMC5067694.pdf
"In all treat- ment groups, the overall incidence of TEAEs appeared to be higher with increasing baseline dose of MTX (see Supplementary Table 1, available on the Arthritis Care & Research web site at http://onlinelibrary.wiley.com/doi/ 10.1002/acr.22676/abstract).",Non-OADS,/arxiv_data1/oa_pdf/59/65/ACR-68-299.PMC5067694.pdf
"Incidence rates of withdrawaldue to TEAEs were low across the treatment groups and similar in all MTX dose categories (Supplementary Table 1, available at http://onlinelibrary.wiley.com/doi/10.1002/acr.",Non-OADS,/arxiv_data1/oa_pdf/59/65/ACR-68-299.PMC5067694.pdf
"Available at: http://www.cdpr.ca.gov/docs/pur/purmain.htm (accessed onJuly 23, 2009).",Non-OADS,/arxiv_data1/oa_pdf/af/6d/APA-105-e107.PMC5067698.pdf
See: http://creativecommons.org/licenses/by-nc/2.0/ http://creativecommons.org/licenses/by-nc/2.0/legalcode REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/88/b9/bmjqir-u209593-w4322.PMC5067707.pdf
"The Joint Commission, National Patient Safety Goals Effective January 1, 2014 http://www.jointcommission.org/assets/1/6/HAP_NPSG_Chapter_2014.pdf Accessed: 15 September 2014 2.",Non-OADS,/arxiv_data1/oa_pdf/88/b9/bmjqir-u209593-w4322.PMC5067707.pdf
Reconcile Medications at All Transition Points [Online] http://www.ihi.org/resources/Pages/Changes/ReconcileMedicationsatAllTransitionPoints.aspx Accessed: 15 September 2014 5.,Non-OADS,/arxiv_data1/oa_pdf/88/b9/bmjqir-u209593-w4322.PMC5067707.pdf
"Building a case for medication reconciliation, ISMP Medication SafetyAlert, Acute Care, [Online] https://www.ismp.org/newsletters/acutecare/articles/20050421.asp Accessed: 15 September2014 6.",Non-OADS,/arxiv_data1/oa_pdf/88/b9/bmjqir-u209593-w4322.PMC5067707.pdf
"Improving Care Transitions:Optimizing Medication Reconciliation [Online] http://www.pharmacist.com/sites/default/files/files/2012_improving_care_transitions.pdfAccessed: 15 September 2014 4 Taha H, et al.BMJ Quality Improvement Reports 2016; 5:u209593.w4322.",Non-OADS,/arxiv_data1/oa_pdf/88/b9/bmjqir-u209593-w4322.PMC5067707.pdf
See: http://creativecommons.org/licenses/by-nc/2.0/ http://creativecommons.org/licenses/by-nc/2.0/legalcode REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/84/02/bmjqir-u209822-w4076.PMC5067709.pdf
See: http://creativecommons.org/licenses/by-nc/2.0/ http://creativecommons.org/licenses/by-nc/2.0/legalcode REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/30/f3/bmjqir-u211725-w4724.PMC5067713.pdf
"Health Affairs Blog , 2012: http://healthaffairs.org/blog/ 2012/02/24/the-stage-2-meaningful-use-of-ehrs-proposed-rules-no-surprises/.",Non-OADS,/arxiv_data1/oa_pdf/30/f3/bmjqir-u211725-w4724.PMC5067713.pdf
Available from http://www.ismp.org/Tools/guidelines/StandardOrderSets.pdf (accessed 2015 Mar 15) 14.,Non-OADS,/arxiv_data1/oa_pdf/30/f3/bmjqir-u211725-w4724.PMC5067713.pdf
: +1 913 909 7141.Contents lists available at ScienceDirect Indian Heart Journal journal homepage: www.elsevier.com/locate/ihj http://dx.doi.org/10.1016/j.ihj.2016.04.018 0019-4832/ /C2232016 Published by Elsevier B.V. on behalf of Cardiological Society of India.,Non-OADS,/arxiv_data1/oa_pdf/0e/68/main.PMC5067722.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/bb/d8/main.PMC5067724.pdf
E-mail address: anisabarupal@yahoo.com (A. Baroopal).Available online at www.sciencedirect.com ScienceDirect journal homepage: www.elsevier.com/locate/ihj http://dx.doi.org/10.1016/j.ihj.2016.02.020 0019-4832/ #2016 Cardiological Society of India.,Non-OADS,/arxiv_data1/oa_pdf/bb/d8/main.PMC5067724.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/bb/d8/main.PMC5067724.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/af/6f/main.PMC5067725.pdf
E-mail address: ozcanozeke@gmail.com (O. Kirbas).Available online at www.sciencedirect.com ScienceDirect journal homepage: www.elsevier.com/locate/ihj http://dx.doi.org/10.1016/j.ihj.2016.03.025 0019-4832/ #2016 Cardiological Society of India.,Non-OADS,/arxiv_data1/oa_pdf/af/6f/main.PMC5067725.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/af/6f/main.PMC5067725.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/35/9d/main.PMC5067726.pdf
Bedi).Available online at www.sciencedirect.com ScienceDirect journal homepage: www.elsevier.com/locate/ihj http://dx.doi.org/10.1016/j.ihj.2016.03.028 0019-4832/ #2016 Cardiological Society of India.,Non-OADS,/arxiv_data1/oa_pdf/35/9d/main.PMC5067726.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/35/9d/main.PMC5067726.pdf
E-mail address: dramit_malviya@rediffmail.com (A. Malviya).Contents lists available at ScienceDirect Indian Heart Journal journal homepage: www.elsevier.com/locate/ihj http://dx.doi.org/10.1016/j.ihj.2016.04.003 0019-4832/ /C2232016 Cardiological Society of India.,Non-OADS,/arxiv_data1/oa_pdf/5a/a7/main.PMC5067727.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5a/a7/main.PMC5067727.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/49/87/main.PMC5067729.pdf
E-mail address: reyhandedeoglu@gmail.com (R. Dedeoglu).Available online at www.sciencedirect.com ScienceDirect journal homepage: www.elsevier.com/locate/ihj http://dx.doi.org/10.1016/j.ihj.2016.03.010 0019-4832/ #2016 Cardiological Society of India.,Non-OADS,/arxiv_data1/oa_pdf/49/87/main.PMC5067729.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/49/87/main.PMC5067729.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/54/34/main.PMC5067731.pdf
E-mail address: bq.hanu@yahoo.com (V. Magarkar).Contents lists available at ScienceDirect Indian Heart Journal journal homepage: www.elsevier.com/locate/ihj http://dx.doi.org/10.1016/j.ihj.2016.04.021 0019-4832/ /C2232016 Cardiological Society of India.,Non-OADS,/arxiv_data1/oa_pdf/54/34/main.PMC5067731.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/54/34/main.PMC5067731.pdf
Available at: https://www.escardio.org/ Guidelines-&-Education/Journals-and-publications/ESC-journals-family/E-journal-of- Cardiology-Practice/Volume-12/Appropriate-use-of-non-invasive-testing-for-diagnosis- of-stable-coronary-artery .,Non-OADS,/arxiv_data1/oa_pdf/54/34/main.PMC5067731.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/8c/97/main.PMC5067732.pdf
E-mail address: dr.yaman@windowslive.com (M. Yaman).Contents lists available at ScienceDirect Indian Heart Journal journal homepage: www.elsevier.com/locate/ihj http://dx.doi.org/10.1016/j.ihj.2016.04.011 0019-4832/ /C2232016 Cardiological Society of India.,Non-OADS,/arxiv_data1/oa_pdf/8c/97/main.PMC5067732.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/8c/97/main.PMC5067732.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/bd/4a/main.PMC5067733.pdf
Dhariwal).Available online at www.sciencedirect.com ScienceDirect journal homepage: www.elsevier.com/locate/ihj http://dx.doi.org/10.1016/j.ihj.2016.03.023 0019-4832/ #2016 Cardiological Society of India.,Non-OADS,/arxiv_data1/oa_pdf/bd/4a/main.PMC5067733.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/bd/4a/main.PMC5067733.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/75/8b/main.PMC5067734.pdf
Patil).Available online at www.sciencedirect.com ScienceDirect journal homepage: www.elsevier.com/locate/ihj http://dx.doi.org/10.1016/j.ihj.2016.03.020 0019-4832/ #2016 Cardiological Society of India.,Non-OADS,/arxiv_data1/oa_pdf/75/8b/main.PMC5067734.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/75/8b/main.PMC5067734.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/76/02/main.PMC5067735.pdf
"E-mail addresses: mohamadlazkani@gmail.com (M. Lazkani), ashish.pershad@bannerhealth.com (A. Pershad).Contents lists available at ScienceDirect Indian Heart Journal journal homepage: www.elsevier.com/locate/ihj http://dx.doi.org/10.1016/j.ihj.2016.04.010 0019-4832/ /C2232016 Cardiological Society of India.",Non-OADS,/arxiv_data1/oa_pdf/76/02/main.PMC5067735.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/76/02/main.PMC5067735.pdf
2012;5(April (4)):367– 379. http://dx.doi.org/10.1016/j.jcin.2012.02.006 .,OADS,/arxiv_data1/oa_pdf/76/02/main.PMC5067735.pdf
2015;8(February (2)):245– 253. http://dx.doi.org/10.1016/j.jcin.2014.08.014 .,OADS,/arxiv_data1/oa_pdf/76/02/main.PMC5067735.pdf
http://dx.doi.org/10.1002/ccd.25370 .M.,Non-OADS,/arxiv_data1/oa_pdf/76/02/main.PMC5067735.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1d/21/main.PMC5067736.pdf
E-mail address: draniruddhavyas@gmail.com (A. Vyas).Available online at www.sciencedirect.com ScienceDirect journal homepage: www.elsevier.com/locate/ihj http://dx.doi.org/10.1016/j.ihj.2016.03.032 0019-4832/ #2016 Cardiological Society of India.,Non-OADS,/arxiv_data1/oa_pdf/1d/21/main.PMC5067736.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1d/21/main.PMC5067736.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ef/87/main.PMC5067737.pdf
E-mail address: ganesh.sapkal24@yahoo.com (G. Sapkal).Available online at www.sciencedirect.com ScienceDirect journal homepage: www.elsevier.com/locate/ihj http://dx.doi.org/10.1016/j.ihj.2016.03.005 0019-4832/ #2016 Cardiological Society of India.,Non-OADS,/arxiv_data1/oa_pdf/ef/87/main.PMC5067737.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ef/87/main.PMC5067737.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f7/85/main.PMC5067738.pdf
E-mail address: lachikarathmand@yahoo.com (L. Devegowda).Available online at www.sciencedirect.com ScienceDirect journal homepage: www.elsevier.com/locate/ihj http://dx.doi.org/10.1016/j.ihj.2016.03.008 0019-4832/ #2016 Cardiological Society of India.,Non-OADS,/arxiv_data1/oa_pdf/f7/85/main.PMC5067738.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f7/85/main.PMC5067738.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/02/b2/main.PMC5067759.pdf
E-mail address: a51hauzkhas@gmail.com (J.C. Mohan).Available online at www.sciencedirect.com ScienceDirect journal homepage: www.elsevier.com/locate/ihj http://dx.doi.org/10.1016/j.ihj.2016.03.030 0019-4832/ #2016 Cardiological Society of India.,Non-OADS,/arxiv_data1/oa_pdf/02/b2/main.PMC5067759.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/02/b2/main.PMC5067759.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/71/8e/main.PMC5067760.pdf
E-mail address: cardioramachandra@gmail.com (R. Barik).Available online at www.sciencedirect.com ScienceDirect journal homepage: www.elsevier.com/locate/ihj http://dx.doi.org/10.1016/j.ihj.2016.02.011 0019-4832/ #2016 Cardiological Society of India.,Non-OADS,/arxiv_data1/oa_pdf/71/8e/main.PMC5067760.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/71/8e/main.PMC5067760.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/95/72/main.PMC5067761.pdf
E-mail address: rhythm_divine46@yahoo.com (S. Mehrotra).Contents lists available at ScienceDirect Indian Heart Journal journal homepage: www.elsevier.com/locate/ihj http://dx.doi.org/10.1016/j.ihj.2016.04.005 0019-4832/ /C2232016 Cardiological Society of India.,Non-OADS,/arxiv_data1/oa_pdf/95/72/main.PMC5067761.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/95/72/main.PMC5067761.pdf
http://dx.doi.org/10.1016/j.hrthm.2009.05.020 .,OADS,/arxiv_data1/oa_pdf/95/72/main.PMC5067761.pdf
http://dx.doi.org/10.1007/s10840-005-3797-x .,Non-OADS,/arxiv_data1/oa_pdf/95/72/main.PMC5067761.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Available online at www.sciencedirect.com ScienceDirect journal homepage: www.elsevier.com/locate/ihj http://dx.doi.org/10.1016/j.ihj.2016.02.014 0019-4832/ #2016 Cardiological Society of India.,Non-OADS,/arxiv_data1/oa_pdf/54/c0/main.PMC5067762.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/54/c0/main.PMC5067762.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f9/b5/main.PMC5067763.pdf
E-mail address: mertilkerh@yahoo.com (M.ro ğlu).Available online at www.sciencedirect.com ScienceDirect journal homepage: www.elsevier.com/locate/ihj http://dx.doi.org/10.1016/j.ihj.2016.03.006 0019-4832/ #2016 Cardiological Society of India.,Non-OADS,/arxiv_data1/oa_pdf/f9/b5/main.PMC5067763.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f9/b5/main.PMC5067763.pdf
E-mail address: konlampropoulos@yahoo.gr (K. Lampropoulos).Available online at www.sciencedirect.com ScienceDirect journal homepage: www.elsevier.com/locate/ihj http://dx.doi.org/10.1016/j.ihj.2016.01.021 0019-4832/ #2016 Cardiological Society of India.,Non-OADS,/arxiv_data1/oa_pdf/13/dc/main.PMC5067764.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/13/dc/main.PMC5067764.pdf
2015. http://dx.doi.org/10.1016/S0140-6736(15) .,OADS,/arxiv_data1/oa_pdf/13/dc/main.PMC5067764.pdf
http://dx.doi.org/10.1056/ NEJMoa1308789 .,Non-OADS,/arxiv_data1/oa_pdf/13/dc/main.PMC5067764.pdf
Bhagwat).Available online at www.sciencedirect.com ScienceDirect journal homepage: www.elsevier.com/locate/ihj http://dx.doi.org/10.1016/j.ihj.2016.01.013 0019-4832/ #2016 Cardiological Society of India.,Non-OADS,/arxiv_data1/oa_pdf/3c/bd/main.PMC5067766.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3c/bd/main.PMC5067766.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3c/32/main.PMC5067767.pdf
: +91 040 23404156; fax: +91 40 23310076.Contents lists available at ScienceDirect Indian Heart Journal journal homepage: www.elsevier.com/locate/ihj http://dx.doi.org/10.1016/j.ihj.2016.04.026 0019-4832/ /C2232016 Cardiological Society of India.,Non-OADS,/arxiv_data1/oa_pdf/3c/32/main.PMC5067767.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3c/32/main.PMC5067767.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3c/61/main.PMC5067768.pdf
E-mail address: rsharmacvs@hotmail.com (R. Sharma).Available online at www.sciencedirect.com ScienceDirect journal homepage: www.elsevier.com/locate/ihj http://dx.doi.org/10.1016/j.ihj.2016.02.024 0019-4832/ #2016 Cardiological Society of India.,Non-OADS,/arxiv_data1/oa_pdf/3c/61/main.PMC5067768.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3c/61/main.PMC5067768.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d3/bf/main.PMC5067769.pdf
"Abbreviations: LV, left ventricle; RV, right ventricle; AO, aortic root; LA, left atrium; MVO, mitral valve ori ﬁce; LVOT, left ventricular outﬂow tract.Available online at www.sciencedirect.com ScienceDirect journal homepage: www.elsevier.com/locate/ihj http://dx.doi.org/10.1016/j.ihj.2016.01.001 0019-4832/ #2016 Cardiological Society of India.",Non-OADS,/arxiv_data1/oa_pdf/d3/bf/main.PMC5067769.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d3/bf/main.PMC5067769.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6d/7f/main.PMC5067770.pdf
E-mail address: mahimsaran2011@gmail.com (M. Saran).Available online at www.sciencedirect.com ScienceDirect journal homepage: www.elsevier.com/locate/ihj http://dx.doi.org/10.1016/j.ihj.2015.12.017 0019-4832/ #2016 Cardiological Society of India.,Non-OADS,/arxiv_data1/oa_pdf/6d/7f/main.PMC5067770.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6d/7f/main.PMC5067770.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d4/74/main.PMC5067771.pdf
"Abbreviations: LA, left atrium; AN, aneurysm; LV, left ventricle; RV, right ventricle; RA, right atrium; AO, aortic root; TEE, trans esophageal echocardiography; LVOT, left ventricular out ﬂow tract.Available online at www.sciencedirect.com ScienceDirect journal homepage: www.elsevier.com/locate/ihj http://dx.doi.org/10.1016/j.ihj.2015.12.020 0019-4832/ #2015 Cardiological Society of India.",Non-OADS,/arxiv_data1/oa_pdf/d4/74/main.PMC5067771.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d4/74/main.PMC5067771.pdf
2015. http://dx.doi.org/10.1053/j.jvca.2015.07.023 .,OADS,/arxiv_data1/oa_pdf/d4/74/main.PMC5067771.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5c/44/main.PMC5067772.pdf
Rao).Contents lists available at ScienceDirect Indian Heart Journal journal homepage: www.elsevier.com/locate/ihj http://dx.doi.org/10.1016/j.ihj.2016.05.001 0019-4832/ /C2232016 Published by Elsevier B.V. on behalf of Cardiological Society of India.,Non-OADS,/arxiv_data1/oa_pdf/5c/44/main.PMC5067772.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c5/e8/main.PMC5067773.pdf
2Corresponding author's present af ﬁliation.Available online at www.sciencedirect.com ScienceDirect journal homepage: www.elsevier.com/locate/ihj http://dx.doi.org/10.1016/j.ihj.2016.02.005 0019-4832/ #2016 Cardiological Society of India.,Non-OADS,/arxiv_data1/oa_pdf/c5/e8/main.PMC5067773.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c5/e8/main.PMC5067773.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/ by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b9/d1/main.PMC5067779.pdf
E-mail address: drnimitcshah@yahoo.co.uk (N.C. Shah).Available online at www.sciencedirect.com ScienceDirect journal homepage: www.elsevier.com/locate/ihj http://dx.doi.org/10.1016/j.ihj.2016.02.015 0019-4832/ #2016 Published by Elsevier B.V. on behalf of Cardiological Society of India.,Non-OADS,/arxiv_data1/oa_pdf/b9/d1/main.PMC5067779.pdf
This is an open access article under the CC BY- NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b9/d1/main.PMC5067779.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/61/3e/main.PMC5067780.pdf
E-mail address: allamvasant@gmail.com (A. Vasanth Kumar).Available online at www.sciencedirect.com ScienceDirect journal homepage: www.elsevier.com/locate/ihj http://dx.doi.org/10.1016/j.ihj.2016.01.012 0019-4832/ #2016 Cardiological Society of India.,Non-OADS,/arxiv_data1/oa_pdf/61/3e/main.PMC5067780.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/61/3e/main.PMC5067780.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7f/a6/main.PMC5067781.pdf
Raut).Available online at www.sciencedirect.com ScienceDirect journal homepage: www.elsevier.com/locate/ihj http://dx.doi.org/10.1016/j.ihj.2016.03.004 0019-4832/ #2016 Cardiological Society of India.,Non-OADS,/arxiv_data1/oa_pdf/7f/a6/main.PMC5067781.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7f/a6/main.PMC5067781.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/24/35/main.PMC5067782.pdf
E-mail address: gupta98tanya@gmail.com.Available online at www.sciencedirect.com ScienceDirect journal homepage: www.elsevier.com/locate/ihj http://dx.doi.org/10.1016/j.ihj.2016.01.018 0019-4832/ #2016 Cardiological Society of India.,Non-OADS,/arxiv_data1/oa_pdf/24/35/main.PMC5067782.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/24/35/main.PMC5067782.pdf
E-mail address: rajeshvijay999@hotmail.com (R. Vijayvergiya).Available online at www.sciencedirect.com ScienceDirect journal homepage: www.elsevier.com/locate/ihj http://dx.doi.org/10.1016/j.ihj.2015.12.009 0019-4832/ #2015 Cardiological Society of India.,Non-OADS,/arxiv_data1/oa_pdf/43/f3/main.PMC5067783.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/43/f3/main.PMC5067783.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/94/58/main.PMC5067784.pdf
E-mail address: uupaputti@gmail.com (A. Udupa).Available online at www.sciencedirect.com ScienceDirect journal homepage: www.elsevier.com/locate/ihj http://dx.doi.org/10.1016/j.ihj.2016.02.021 0019-4832/ #2016 Cardiological Society of India.,Non-OADS,/arxiv_data1/oa_pdf/94/58/main.PMC5067784.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/94/58/main.PMC5067784.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/20/93/main.PMC5067785.pdf
Agarwala).Contents lists available at ScienceDirect Indian Heart Journal journal homepage: www.elsevier.com/locate/ihj http://dx.doi.org/10.1016/j.ihj.2016.05.002 0019-4832/ /C2232016 Cardiological Society of India.,Non-OADS,/arxiv_data1/oa_pdf/20/93/main.PMC5067785.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/20/93/main.PMC5067785.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/10/ee/main.PMC5067787.pdf
E-mail address: ranjitknath@yahoo.com (R.K. Nath).Available online at www.sciencedirect.com ScienceDirect journal homepage: www.elsevier.com/locate/ihj http://dx.doi.org/10.1016/j.ihj.2016.02.023 0019-4832/ #2016 Cardiological Society of India.,Non-OADS,/arxiv_data1/oa_pdf/10/ee/main.PMC5067787.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/10/ee/main.PMC5067787.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/89/db/main.PMC5067788.pdf
E-mail address: Pankaj_jariwala@hotmail.com (P. Jariwala).Available online at www.sciencedirect.com ScienceDirect journal homepage: www.elsevier.com/locate/ihj http://dx.doi.org/10.1016/j.ihj.2016.01.006 0019-4832/ #2016 Cardiological Society of India.,Non-OADS,/arxiv_data1/oa_pdf/89/db/main.PMC5067788.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/89/db/main.PMC5067788.pdf
"2012;3:87 –90[Internet, cited 2013 Oct 9] Available from: http://www.wjon.",Non-OADS,/arxiv_data1/oa_pdf/89/db/main.PMC5067788.pdf
"2008;123:208 –209 [Internet, cited 2013 Oct 9]; Available from: http://www.ncbi.nlm.nih.gov/ pubmed/17363082 .. 4.Petrich A, Cho SI, Billett H. Primary cardiac lymphoma: an analysis of presentation, treatment, and outcome patterns.",OADS,/arxiv_data1/oa_pdf/89/db/main.PMC5067788.pdf
"1985;16:315 –317 [Internet, cited 2014 May 3]; Available from: http://linkinghub.elsevier.com/ retrieve/pii/S0046817785800216 .",Non-OADS,/arxiv_data1/oa_pdf/89/db/main.PMC5067788.pdf
"2011;149:358 –363 [Internet, cited 2014 May 3]; Available from: http://www.ncbi.nlm.nih.gov/pubmed/ 20227122 .",OADS,/arxiv_data1/oa_pdf/89/db/main.PMC5067788.pdf
1995;4:141 –145 [Internet]; Available from: http://www.sciencedirect.com/ science/article/pii/105488079400063W .,Non-OADS,/arxiv_data1/oa_pdf/89/db/main.PMC5067788.pdf
2014;05:1 –3 [Internet]; Available from: http://www.omicsgroup.org/journals/precursor-bcell- lymphoblastic-primary-cardiac-lymphoma-2165-7831.,Non-OADS,/arxiv_data1/oa_pdf/89/db/main.PMC5067788.pdf
2013;2013:1 –5 [Internet]; Available from: http://www.hindawi.com/journals/lymph/2013/ 290585/ .indian heart journal 68 (2016) s253–s257 S257,Non-OADS,/arxiv_data1/oa_pdf/89/db/main.PMC5067788.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/58/43/main.PMC5067789.pdf
E-mail address: carmine.pizzi@unibo.it (C. Pizzi).Available online at www.sciencedirect.com ScienceDirect journal homepage: www.elsevier.com/locate/ihj http://dx.doi.org/10.1016/j.ihj.2016.01.010 0019-4832/ #2016 Cardiological Society of India.,Non-OADS,/arxiv_data1/oa_pdf/58/43/main.PMC5067789.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/58/43/main.PMC5067789.pdf
E-mail address: rajeshvijay999@hotmail.com (R. Vijayvergiya).Available online at www.sciencedirect.com ScienceDirect journal homepage: www.elsevier.com/locate/ihj http://dx.doi.org/10.1016/j.ihj.2016.01.007 0019-4832/ #2016 Cardiological Society of India.,Non-OADS,/arxiv_data1/oa_pdf/97/f9/main.PMC5067790.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/97/f9/main.PMC5067790.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f3/d5/main.PMC5067791.pdf
E-mail address: vk3532@gmail.com (V. Kumar).Available online at www.sciencedirect.com ScienceDirect journal homepage: www.elsevier.com/locate/ihj http://dx.doi.org/10.1016/j.ihj.2016.02.010 0019-4832/ #2016 Cardiological Society of India.,Non-OADS,/arxiv_data1/oa_pdf/f3/d5/main.PMC5067791.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f3/d5/main.PMC5067791.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/0e/ee/main.PMC5067792.pdf
E-mail address: geetesh.manik@gmail.com (G. Manik).Contents lists available at ScienceDirect Indian Heart Journal journal homepage: www.elsevier.com/locate/ihj http://dx.doi.org/10.1016/j.ihj.2016.05.016 0019-4832/ /C2232016 Cardiological Society of India.,Non-OADS,/arxiv_data1/oa_pdf/0e/ee/main.PMC5067792.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/0e/ee/main.PMC5067792.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/ by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/18/e8/main.PMC5067793.pdf
E-mail address: drmithunjv@gmail.com (M.J. Varghese).Available online at www.sciencedirect.com ScienceDirect journal homepage: www.elsevier.com/locate/ihj http://dx.doi.org/10.1016/j.ihj.2016.01.015 0019-4832/ #2016 Published by Elsevier B.V. on behalf of Cardiological Society of India.,Non-OADS,/arxiv_data1/oa_pdf/18/e8/main.PMC5067793.pdf
This is an open access article under the CC BY- NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/18/e8/main.PMC5067793.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3a/ec/main.PMC5067796.pdf
"E-mail addresses: suneeshmed@gmail.com ,suneeshcmc@yahoo.com (S. Kalliath).Contents lists available at ScienceDirect Indian Heart Journal journal homepage: www.elsevier.com/locate/ihj http://dx.doi.org/10.1016/j.ihj.2016.07.019 0019-4832/ /C2232016 Published by Elsevier B.V. on behalf of Cardiological Society of India.",Non-OADS,/arxiv_data1/oa_pdf/3a/ec/main.PMC5067796.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/96/fa/main.PMC5067797.pdf
E-mail address: gaurangamajumdar@hotmail.com (G. Majumdar).Contents lists available at ScienceDirect Indian Heart Journal journal homepage: www.elsevier.com/locate/ihj http://dx.doi.org/10.1016/j.ihj.2016.07.017 0019-4832/ /C2232016 Cardiological Society of India.,Non-OADS,/arxiv_data1/oa_pdf/96/fa/main.PMC5067797.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/96/fa/main.PMC5067797.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/10/d9/main.PMC5067798.pdf
Patil).Contents lists available at ScienceDirect Indian Heart Journal journal homepage: www.elsevier.com/locate/ihj http://dx.doi.org/10.1016/j.ihj.2016.05.012 0019-4832/ /C2232016 Published by Elsevier B.V. on behalf of Cardiological Society of India.,Non-OADS,/arxiv_data1/oa_pdf/10/d9/main.PMC5067798.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e1/d5/main.PMC5067800.pdf
E-mail address: drapande@gmail.com (A. Pande).Contents lists available at ScienceDirect Indian Heart Journal journal homepage: www.elsevier.com/locate/ihj http://dx.doi.org/10.1016/j.ihj.2016.07.022 0019-4832/ /C2232016 Published by Elsevier B.V. on behalf of Cardiological Society of India.,Non-OADS,/arxiv_data1/oa_pdf/e1/d5/main.PMC5067800.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d2/28/main.PMC5067803.pdf
"E-mail addresses: nemesi800@hotmail.com (S. Asciutto), eluisalafranca@gmail.com (E. La Franca), Giuseppe.cirrincione@arnascivico.it (G. Cirrincione), marco.caruso@arnascivico.it (M. Caruso).Contents lists available at ScienceDirect Indian Heart Journal journal homepage: www.elsevier.com/locate/ihj http://dx.doi.org/10.1016/j.ihj.2016.08.005 0019-4832/ /C2232016 Published by Elsevier B.V. on behalf of Cardiological Society of India.",Non-OADS,/arxiv_data1/oa_pdf/d2/28/main.PMC5067803.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e4/d9/main.PMC5067805.pdf
Gupta).Contents lists available at ScienceDirect Indian Heart Journal journal homepage: www.elsevier.com/locate/ihj http://dx.doi.org/10.1016/j.ihj.2016.07.005 0019-4832/ /C2232016 Published by Elsevier B.V. on behalf of Cardiological Society of India.,Non-OADS,/arxiv_data1/oa_pdf/e4/d9/main.PMC5067805.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/03/d5/main.PMC5067806.pdf
E-mail address: nikhs85@gmail.com (N. Raut).Contents lists available at ScienceDirect Indian Heart Journal journal homepage: www.elsevier.com/locate/ihj http://dx.doi.org/10.1016/j.ihj.2016.07.008 0019-4832/ /C2232016 Published by Elsevier B.V. on behalf of Cardiological Society of India.,Non-OADS,/arxiv_data1/oa_pdf/03/d5/main.PMC5067806.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/62/d6/main.PMC5067808.pdf
E-mail address: yashlokhandwala@hotmail.com (Y. Lokhandwala).Contents lists available at ScienceDirect Indian Heart Journal journal homepage: www.elsevier.com/locate/ihj http://dx.doi.org/10.1016/j.ihj.2016.07.018 0019-4832/ /C2232016 Cardiological Society of India.,Non-OADS,/arxiv_data1/oa_pdf/62/d6/main.PMC5067808.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/62/d6/main.PMC5067808.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f7/ea/main.PMC5067809.pdf
E-mail address: draggarwal.pankaj@gmail.com (P. Aggarwal).Contents lists available at ScienceDirect Indian Heart Journal journal homepage: www.elsevier.com/locate/ihj http://dx.doi.org/10.1016/j.ihj.2016.08.006 0019-4832/ /C2232016 Cardiological Society of India.,Non-OADS,/arxiv_data1/oa_pdf/f7/ea/main.PMC5067809.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f7/ea/main.PMC5067809.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f3/90/main.PMC5067811.pdf
E-mail address: rahulanna@gmail.com (R. Choudhary).Contents lists available at ScienceDirect Indian Heart Journal journal homepage: www.elsevier.com/locate/ihj http://dx.doi.org/10.1016/j.ihj.2016.08.003 0019-4832/ /C2232016 Cardiological Society of India.,Non-OADS,/arxiv_data1/oa_pdf/f3/90/main.PMC5067811.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f3/90/main.PMC5067811.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a5/5c/main.PMC5067813.pdf
Gopalamurugan).Available online at www.sciencedirect.com ScienceDirect journal homepage: www.elsevier.com/locate/ihj http://dx.doi.org/10.1016/j.ihj.2016.03.022 0019-4832/ #2016 Cardiological Society of India.,Non-OADS,/arxiv_data1/oa_pdf/a5/5c/main.PMC5067813.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a5/5c/main.PMC5067813.pdf
E-mail address: rodrigue_garcia@hotmail.fr (R. Garcia).Contents lists available at ScienceDirect Indian Heart Journal journal homepage: www.elsevier.com/locate/ihj http://dx.doi.org/10.1016/j.ihj.2016.06.003 0019-4832/ /C2232016 Published by Elsevier B.V. on behalf of Cardiological Society of India.,Non-OADS,/arxiv_data1/oa_pdf/7f/90/main.PMC5067814.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/62/11/main.PMC5067825.pdf
cThese authors contributed equally to this work.Contents lists available at ScienceDirect Indian Heart Journal journal homepage: www.elsevier.com/locate/ihj http://dx.doi.org/10.1016/j.ihj.2016.05.014 0019-4832/ /C2232016 Published by Elsevier B.V. on behalf of Cardiological Society of India.,Non-OADS,/arxiv_data1/oa_pdf/62/11/main.PMC5067825.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f6/df/main.PMC5067828.pdf
"Contents lists available at ScienceDirect Indian Pacing and Electrophysiology Journal journal homepage: www.elsevier.com /locate/IPEJ http://dx.doi.org/10.1016/j.ipej.2016.07.003 0972-6292/Copyright ©2016, Indian Heart Rhythm Society.",Non-OADS,/arxiv_data1/oa_pdf/f6/df/main.PMC5067828.pdf
"Contents lists available at ScienceDirect Journal of Traditional and Complementary Medicine journal homepage: http://www.elsevier .com/locate/jtcme http://dx.doi.org/10.1016/j.jtcme.2015.03.007 2225-4110/Copyright ©2015, Center for Food and Biomolecules, National Taiwan University.",Non-OADS,/arxiv_data1/oa_pdf/70/18/main.PMC5067829.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Journal of Traditional and Complementary Medicine 6 (2016) 337 e342,Non-OADS,/arxiv_data1/oa_pdf/70/18/main.PMC5067829.pdf
2006;2:7. http://dx.doi.org/10.1186/ 1746-4269-2-7 .,Non-OADS,/arxiv_data1/oa_pdf/70/18/main.PMC5067829.pdf
"Contents lists available at ScienceDirect Journal of Traditional and Complementary Medicine journal homepage: http://www.elsevier .com/locate/jtcme http://dx.doi.org/10.1016/j.jtcme.2015.03.005 2225-4110/Copyright ©2015, Center for Food and Biomolecules, National Taiwan University.",Non-OADS,/arxiv_data1/oa_pdf/91/d8/main.PMC5067830.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Journal of Traditional and Complementary Medicine 6 (2016) 332 e336,Non-OADS,/arxiv_data1/oa_pdf/91/d8/main.PMC5067830.pdf
"This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits any non-commercial use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.AIDS RESEARCH AND HUMAN RETROVIRUSES Volume 32, Number 10/11, 2016Mary Ann Liebert, Inc.DOI: 10.1089/aid.2015.0332 1072",Non-OADS,/arxiv_data1/oa_pdf/13/d3/aid.2015.0332.PMC5067831.pdf
"This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits any non-commercial use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.NUCLEIC ACID THERAPEUTICS Volume 26, Number 5, 2016Mary Ann Liebert, Inc.DOI: 10.1089/nat.2016.0619 277",Non-OADS,/arxiv_data1/oa_pdf/71/0c/nat.2016.0619.PMC5067832.pdf
"Contents lists available at ScienceDirect Indian Pacing and Electrophysiology Journal journal homepage: www.elsevier.com/locate/IPEJ http://dx.doi.org/10.1016/j.ipej.2016.08.002 0972-6292/Copyright ©2016, Indian Heart Rhythm Society.",Non-OADS,/arxiv_data1/oa_pdf/4c/e3/main.PMC5067834.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/69/a4/main.PMC5067836.pdf
E-mail address: draggarwal.pankaj@gmail.com (P. Aggarwal).Contents lists available at ScienceDirect Indian Heart Journal journal homepage: www.elsevier.com/locate/ihj http://dx.doi.org/10.1016/j.ihj.2016.08.011 0019-4832/ /C2232016 Published by Elsevier B.V. on behalf of Cardiological Society of India.,Non-OADS,/arxiv_data1/oa_pdf/69/a4/main.PMC5067836.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/21/01/main.PMC5067837.pdf
"Contents lists available at ScienceDirect Indian Pacing and Electrophysiology Journal journal homepage: www.elsevier.com/locate/IPEJ http://dx.doi.org/10.1016/j.ipej.2016.08.007 0972-6292/Copyright ©2016, Indian Heart Rhythm Society.",Non-OADS,/arxiv_data1/oa_pdf/21/01/main.PMC5067837.pdf
"Contents lists available at ScienceDirect Journal of Traditional and Complementary Medicine journal homepage: http://www.elsevier .com/locate/jtcme http://dx.doi.org/10.1016/j.jtcme.2015.03.009 2225-4110/Copyright ©2015, Center for Food and Biomolecules, National Taiwan University.",Non-OADS,/arxiv_data1/oa_pdf/47/09/main.PMC5067838.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Journal of Traditional and Complementary Medicine 6 (2016) 377 e382,Non-OADS,/arxiv_data1/oa_pdf/47/09/main.PMC5067838.pdf
18. http://www.oxforddictionaries.com/de ﬁnition/english/feel-good-factor?,Non-OADS,/arxiv_data1/oa_pdf/47/09/main.PMC5067838.pdf
25. http://indiabudget.nic.in/es2011-12/estat1.pdf .,Non-OADS,/arxiv_data1/oa_pdf/47/09/main.PMC5067838.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/8b/d2/main.PMC5067839.pdf
"Contents lists available at ScienceDirect Indian Pacing and Electrophysiology Journal journal homepage: www.elsevier.com/locate/IPEJ http://dx.doi.org/10.1016/j.ipej.2016.08.006 0972-6292/Copyright ©2016, Indian Heart Rhythm Society.",Non-OADS,/arxiv_data1/oa_pdf/8b/d2/main.PMC5067839.pdf
"Contents lists available at ScienceDirect Journal of Traditional and Complementary Medicine journal homepage: http://www.elsevier .com/locate/jtcme http://dx.doi.org/10.1016/j.jtcme.2015.07.005 2225-4110/Copyright ©2016, Center for Food and Biomolecules, National Taiwan University.",Non-OADS,/arxiv_data1/oa_pdf/8f/60/main.PMC5067840.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Journal of Traditional and Complementary Medicine 6 (2016) 370 e376,Non-OADS,/arxiv_data1/oa_pdf/8f/60/main.PMC5067840.pdf
"Contents lists available at ScienceDirect Journal of Traditional and Complementary Medicine journal homepage: http://www.elsevier .com/locate/jtcme http://dx.doi.org/10.1016/j.jtcme.2015.05.001 2225-4110/Copyright ©2015, Center for Food and Biomolecules, National Taiwan University.",Non-OADS,/arxiv_data1/oa_pdf/73/60/main.PMC5067843.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Journal of Traditional and Complementary Medicine 6 (2016) 347 e354,Non-OADS,/arxiv_data1/oa_pdf/73/60/main.PMC5067843.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/34/6e/main.PMC5067844.pdf
"Contents lists available at ScienceDirect Indian Pacing and Electrophysiology Journal journal homepage: www.elsevier.com/locate/IPEJ http://dx.doi.org/10.1016/j.ipej.2016.06.002 0972-6292/Copyright ©2016, Indian Heart Rhythm Society.",Non-OADS,/arxiv_data1/oa_pdf/34/6e/main.PMC5067844.pdf
Europace 2012;14:60 e5.http://dx.doi.org/ 10.1093/europace/eur271 .,Non-OADS,/arxiv_data1/oa_pdf/34/6e/main.PMC5067844.pdf
J Cardiovasc Electrophysiol 2014 Dec 27.http://dx.doi.org/10.1111/jce.12606 [Epub ahead of print].,Non-OADS,/arxiv_data1/oa_pdf/34/6e/main.PMC5067844.pdf
"Contents lists available at ScienceDirect Journal of Traditional and Complementary Medicine journal homepage: http://www.elsevier .com/locate/jtcme http://dx.doi.org/10.1016/j.jtcme.2015.10.003 2225-4110/Copyright ©2016, Center for Food and Biomolecules, National Taiwan University.",Non-OADS,/arxiv_data1/oa_pdf/9f/d6/main.PMC5067845.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Journal of Traditional and Complementary Medicine 6 (2016) 404 e408,Non-OADS,/arxiv_data1/oa_pdf/9f/d6/main.PMC5067845.pdf
"Contents lists available at ScienceDirect Journal of Traditional and Complementary Medicine journal homepage: http://www.elsevier .com/locate/jtcme http://dx.doi.org/10.1016/j.jtcme.2015.09.002 2225-4110/Copyright ©2016, Center for Food and Biomolecules, National Taiwan University.",Non-OADS,/arxiv_data1/oa_pdf/17/09/main.PMC5067847.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Journal of Traditional and Complementary Medicine 6 (2016) 399 e403,Non-OADS,/arxiv_data1/oa_pdf/17/09/main.PMC5067847.pdf
Available from: http://www.who.int/mediacentre/factsheets/ fs194/en/ .,Non-OADS,/arxiv_data1/oa_pdf/17/09/main.PMC5067847.pdf
2013;2013. http://dx.doi.org/ 10.1155/2013/760969 .,Non-OADS,/arxiv_data1/oa_pdf/17/09/main.PMC5067847.pdf
2013;13. http://dx.doi.org/10.1186/1472-6882-13-190 [online].,Non-OADS,/arxiv_data1/oa_pdf/17/09/main.PMC5067847.pdf
"Contents lists available at ScienceDirect Journal of Traditional and Complementary Medicine journal homepage: http://www.elsevier .com/locate/jtcme http://dx.doi.org/10.1016/j.jtcme.2015.10.004 2225-4110/Copyright ©2016, Center for Food and Biomolecules, National Taiwan University.",Non-OADS,/arxiv_data1/oa_pdf/95/b5/main.PMC5067848.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Journal of Traditional and Complementary Medicine 6 (2016) 409 e412,Non-OADS,/arxiv_data1/oa_pdf/95/b5/main.PMC5067848.pdf
"Contents lists available at ScienceDirect Journal of Traditional and Complementary Medicine journal homepage: http://www.elsevier .com/locate/jtcme http://dx.doi.org/10.1016/j.jtcme.2014.12.008 2225-4110/Copyright ©2015, Center for Food and Biomolecules, National Taiwan University.",Non-OADS,/arxiv_data1/oa_pdf/32/eb/main.PMC5067849.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Journal of Traditional and Complementary Medicine 6 (2016) 321 e326,Non-OADS,/arxiv_data1/oa_pdf/32/eb/main.PMC5067849.pdf
Available from: http://www.who.int/mediacentre/ factsheets/2003/fs134/en/ .,Non-OADS,/arxiv_data1/oa_pdf/32/eb/main.PMC5067849.pdf
Available from: http://nccam.nih.gov/ health/ .Accessed November 2011.,OADS,/arxiv_data1/oa_pdf/32/eb/main.PMC5067849.pdf
Available from: http://tcm.moh.gov.my/v4/ .,OADS,/arxiv_data1/oa_pdf/32/eb/main.PMC5067849.pdf
Available from: http://www.sabahsnakegrassherb.com/ 2013/03/present-for-nutans-also-known-as-sabah.html .,Non-OADS,/arxiv_data1/oa_pdf/32/eb/main.PMC5067849.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b3/3c/main.PMC5067850.pdf
"Contents lists available at ScienceDirect Indian Pacing and Electrophysiology Journal journal homepage: www.elsevier.com /locate/IPEJ http://dx.doi.org/10.1016/j.ipej.2016.08.008 0972-6292/Copyright ©2016, Indian Heart Rhythm Society.",Non-OADS,/arxiv_data1/oa_pdf/b3/3c/main.PMC5067850.pdf
"This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits any noncommercial use,distribution, and reproduction in any medium, provided the original author(s) and the source are credited.AIDS RESEARCH AND HUMAN RETROVIRUSES Volume 32, Number 10/11, 2016Mary Ann Liebert, Inc.DOI: 10.1089/aid.2016.0120 944",Non-OADS,/arxiv_data1/oa_pdf/d5/a1/aid.2016.0120.PMC5067853.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/fc/71/main.PMC5067854.pdf
"Contents lists available at ScienceDirect Indian Pacing and Electrophysiology Journal journal homepage: www.elsevier.com /locate/IPEJ http://dx.doi.org/10.1016/j.ipej.2016.08.001 0972-6292/Copyright ©2016, Indian Heart Rhythm Society.",Non-OADS,/arxiv_data1/oa_pdf/fc/71/main.PMC5067854.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/56/68/main.PMC5067855.pdf
E-mail address: rajiva.ms@gmail.com (R. Ananthakrishna).Available online at www.sciencedirect.com ScienceDirect journal homepage: www.elsevier.com/locate/ihj http://dx.doi.org/10.1016/j.ihj.2016.02.016 0019-4832/ #2016 Cardiological Society of India.,Non-OADS,/arxiv_data1/oa_pdf/56/68/main.PMC5067855.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/56/68/main.PMC5067855.pdf
"Contents lists available at ScienceDirect Journal of Traditional and Complementary Medicine journal homepage: http://www.elsevier .com/locate/jtcme http://dx.doi.org/10.1016/j.jtcme.2015.08.006 2225-4110/Copyright ©2016, Center for Food and Biomolecules, National Taiwan University.",Non-OADS,/arxiv_data1/oa_pdf/8d/47/main.PMC5067857.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Journal of Traditional and Complementary Medicine 6 (2016) 395 e398,Non-OADS,/arxiv_data1/oa_pdf/8d/47/main.PMC5067857.pdf
"Contents lists available at ScienceDirect Journal of Traditional and Complementary Medicine journal homepage: http://www.elsevier .com/locate/jtcme http://dx.doi.org/10.1016/j.jtcme.2015.02.001 2225-4110/Copyright ©2016, Center for Food and Biomolecules, National Taiwan University.",Non-OADS,/arxiv_data1/oa_pdf/fd/ad/main.PMC5067858.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Journal of Traditional and Complementary Medicine 6 (2016) 327 e331,Non-OADS,/arxiv_data1/oa_pdf/fd/ad/main.PMC5067858.pdf
"Contents lists available at ScienceDirect Journal of Traditional and Complementary Medicine journal homepage: http://www.elsevier .com/locate/jtcme http://dx.doi.org/10.1016/j.jtcme.2015.07.002 2225-4110/Copyright ©2016, Center for Food and Biomolecules, National Taiwan University.",Non-OADS,/arxiv_data1/oa_pdf/46/d5/main.PMC5067859.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Journal of Traditional and Complementary Medicine 6 (2016) 362 e369,Non-OADS,/arxiv_data1/oa_pdf/46/d5/main.PMC5067859.pdf
"Contents lists available at ScienceDirect Journal of Traditional and Complementary Medicine journal homepage: http://www.elsevier .com/locate/jtcme http://dx.doi.org/10.1016/j.jtcme.2015.02.002 2225-4110/Copyright ©2016, Center for Food and Biomolecules, National Taiwan University.",Non-OADS,/arxiv_data1/oa_pdf/e7/d2/main.PMC5067860.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Journal of Traditional and Complementary Medicine 6 (2016) 343 e346,Non-OADS,/arxiv_data1/oa_pdf/e7/d2/main.PMC5067860.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/47/99/main.PMC5067861.pdf
"Contents lists available at ScienceDirect Indian Pacing and Electrophysiology Journal journal homepage: www.elsevier.com /locate/IPEJ http://dx.doi.org/10.1016/j.ipej.2016.08.005 0972-6292/Copyright ©2016, Indian Heart Rhythm Society.",Non-OADS,/arxiv_data1/oa_pdf/47/99/main.PMC5067861.pdf
"Contents lists available at ScienceDirect Journal of Traditional and Complementary Medicine journal homepage: http://www.elsevier .com/locate/jtcme http://dx.doi.org/10.1016/j.jtcme.2015.08.007 2225-4110/Copyright ©2016, Center for Food and Biomolecules, National Taiwan University.",Non-OADS,/arxiv_data1/oa_pdf/ff/1b/main.PMC5067862.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Journal of Traditional and Complementary Medicine 6 (2016) 389 e394,Non-OADS,/arxiv_data1/oa_pdf/ff/1b/main.PMC5067862.pdf
"This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits any noncommercial use,distribution, and reproduction in any medium, provided the original author(s) and the source are credited.AIDS RESEARCH AND HUMAN RETROVIRUSES Volume 32, Number 10/11, 2016Mary Ann Liebert, Inc.DOI: 10.1089/aid.2015.0381 1005",Non-OADS,/arxiv_data1/oa_pdf/9b/aa/aid.2015.0381.PMC5067863.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/22/95/main.PMC5067864.pdf
"Contents lists available at ScienceDirect Indian Pacing and Electrophysiology Journal journal homepage: www.elsevier.com /locate/IPEJ http://dx.doi.org/10.1016/j.ipej.2016.08.003 0972-6292/Copyright ©2016, Indian Heart Rhythm Society.",Non-OADS,/arxiv_data1/oa_pdf/22/95/main.PMC5067864.pdf
"Contents lists available at ScienceDirect Journal of Traditional and Complementary Medicine journal homepage: http://www.elsevier .com/locate/jtcme http://dx.doi.org/10.1016/j.jtcme.2015.07.001 2225-4110/Copyright ©2016, Center for Food and Biomolecules, National Taiwan University.",Non-OADS,/arxiv_data1/oa_pdf/00/a3/main.PMC5067865.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Journal of Traditional and Complementary Medicine 6 (2016) 355 e361,Non-OADS,/arxiv_data1/oa_pdf/00/a3/main.PMC5067865.pdf
2011. http://dx.doi.org/10.1155/2011/862153 .,Non-OADS,/arxiv_data1/oa_pdf/00/a3/main.PMC5067865.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c9/19/main.PMC5067866.pdf
E-mail address: drkarabulut@yahoo.com (A. Karabulut).Contents lists available at ScienceDirect Indian Heart Journal journal homepage: www.elsevier.com/locate/ihj http://dx.doi.org/10.1016/j.ihj.2016.05.009 0019-4832/ /C2232016 Published by Elsevier B.V. on behalf of Cardiological Society of India.,Non-OADS,/arxiv_data1/oa_pdf/c9/19/main.PMC5067866.pdf
"It may also be published in forthcoming issues of other journals.Contents lists available at ScienceDirect Indian Heart Journal journal homepage: www.elsevier.com/locate/ihj http://dx.doi.org/10.1016/j.ihj.2016.09.003 0019-4832/ /C2232016 Published by Elsevier, a division of Reed Elsevier India, Pvt.",Non-OADS,/arxiv_data1/oa_pdf/60/ec/main.PMC5067869.pdf
This is an open access article und er the CC BY- NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/60/ec/main.PMC5067869.pdf
Available from: http://www.mciindia.,Non-OADS,/arxiv_data1/oa_pdf/60/ec/main.PMC5067869.pdf
Available from: http://www.mciindia.org/circulars/Circular-03.09.,Non-OADS,/arxiv_data1/oa_pdf/60/ec/main.PMC5067869.pdf
http://dx.doi.org/ 10.5062/F41V5BZM .,Non-OADS,/arxiv_data1/oa_pdf/60/ec/main.PMC5067869.pdf
http://en.indexcopernicus.com/ [accessed 01.,Non-OADS,/arxiv_data1/oa_pdf/60/ec/main.PMC5067869.pdf
Available from: http://scholarlyoa.com/2013/11/ 21/index-copernicus-has-no-value [accessed 20.12.15].,Non-OADS,/arxiv_data1/oa_pdf/60/ec/main.PMC5067869.pdf
"Contents lists available at ScienceDirect Journal of Traditional and Complementary Medicine journal homepage: http://www.elsevier .com/locate/jtcme http://dx.doi.org/10.1016/j.jtcme.2015.08.004 2225-4110/Copyright ©2016, Center for Food and Biomolecules, National Taiwan University.",Non-OADS,/arxiv_data1/oa_pdf/db/c2/main.PMC5067870.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Journal of Traditional and Complementary Medicine 6 (2016) 383 e388,Non-OADS,/arxiv_data1/oa_pdf/db/c2/main.PMC5067870.pdf
Available in http://www.plantzafrica.com/planthij/ hypoesaristata.htm [Last accessed 15.07.15].,Non-OADS,/arxiv_data1/oa_pdf/db/c2/main.PMC5067870.pdf
"This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits any non-commercial use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.AIDS RESEARCH AND HUMAN RETROVIRUSES Volume 32, Number 10/11, 2016Mary Ann Liebert, Inc.DOI: 10.1089/aid.2015.0378 964",Non-OADS,/arxiv_data1/oa_pdf/28/1d/aid.2015.0378.PMC5067876.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4d/0e/main.PMC5067924.pdf
1936-5233/16http://dx.doi.org/10.1016/j.tranon.2016.08.009,OADS,/arxiv_data1/oa_pdf/4d/0e/main.PMC5067924.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e5/db/main.PMC5067925.pdf
1936-5233/16http://dx.doi.org/10.1016/j.tranon.2016.08.002,OADS,/arxiv_data1/oa_pdf/e5/db/main.PMC5067925.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.or g/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c2/c9/main.PMC5067926.pdf
1936-5233/16http://dx.doi.org/10.1016/j.tranon.2016.07.006,OADS,/arxiv_data1/oa_pdf/c2/c9/main.PMC5067926.pdf
"Published by Elsevier Inc. on behalf of Neoplasia Press, Inc.This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/92/0c/main.PMC5067927.pdf
1936-5233/16http://dx.doi.org/10.1016/j.tranon.2016.08.011,OADS,/arxiv_data1/oa_pdf/92/0c/main.PMC5067927.pdf
1936-5233/16http://dx.doi.org/10.1016/j.tranon.2016.07.004,OADS,/arxiv_data1/oa_pdf/d4/fa/main.PMC5067928.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c5/d7/main.PMC5067929.pdf
1936-5233/16http://dx.doi.org/10.1016/j.tranon.2016.07.008,OADS,/arxiv_data1/oa_pdf/c5/d7/main.PMC5067929.pdf
Immunohistochemistry Scoring Staining for HSV-1 in xenograft tumors was quantified by ImageJ software ( http://rsb.info.nih.gov/ij/ ).,OADS,/arxiv_data1/oa_pdf/c5/d7/main.PMC5067929.pdf
"Contents lists available at ScienceDirect Journal of Traditional and Complementary Medicine journal homepage: http://www.elsevier .com/locate/jtcme http://dx.doi.org/10.1016/j.jtcme.2015.11.004 2225-4110/Copyright ©2016, Center for Food and Biomolecules, National Taiwan University.",Non-OADS,/arxiv_data1/oa_pdf/34/d3/main.PMC5067930.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Journal of Traditional and Complementary Medicine 6 (2016) 424 e430,Non-OADS,/arxiv_data1/oa_pdf/34/d3/main.PMC5067930.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b8/66/main.PMC5067931.pdf
1936-5233/16http://dx.doi.org/10.1016/j.tranon.2016.07.002,OADS,/arxiv_data1/oa_pdf/b8/66/main.PMC5067931.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/dd/56/main.PMC5067932.pdf
1936-5233/16http://dx.doi.org/10.1016/j.tranon.2016.08.010,OADS,/arxiv_data1/oa_pdf/dd/56/main.PMC5067932.pdf
"Contents lists available at ScienceDirect Journal of Traditional and Complementary Medicine journal homepage: http://www.elsevier .com/locate/jtcme http://dx.doi.org/10.1016/j.jtcme.2015.11.001 2225-4110/Copyright ©2016, Center for Food and Biomolecules, National Taiwan University.",Non-OADS,/arxiv_data1/oa_pdf/0c/81/main.PMC5067934.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Journal of Traditional and Complementary Medicine 6 (2016) 413 e423,Non-OADS,/arxiv_data1/oa_pdf/0c/81/main.PMC5067934.pdf
"Contents lists available at ScienceDirect Journal of Traditional and Complementary Medicine journal homepage: http://www.elsevier .com/locate/jtcme http://dx.doi.org/10.1016/j.jtcme.2015.12.004 2225-4110/Copyright ©2016, Center for Food and Biomolecules, National Taiwan University.",Non-OADS,/arxiv_data1/oa_pdf/29/ab/main.PMC5067935.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Journal of Traditional and Complementary Medicine 6 (2016) 431 e436,Non-OADS,/arxiv_data1/oa_pdf/29/ab/main.PMC5067935.pdf
"Contents lists available at ScienceDirect Journal of Traditional and Complementary Medicine journal homepage: http://www.elsevier .com/locate/jtcme http://dx.doi.org/10.1016/j.jtcme.2015.12.003 2225-4110/Copyright ©2016, Center for Food and Biomolecules, National Taiwan University.",Non-OADS,/arxiv_data1/oa_pdf/0f/55/main.PMC5067939.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Journal of Traditional and Complementary Medicine 6 (2016) 437 e441,Non-OADS,/arxiv_data1/oa_pdf/0f/55/main.PMC5067939.pdf
1991;57: 1e7.http://dx.doi.org/10.1055/s-2006-960004 [Epub 1991/02/01].,Non-OADS,/arxiv_data1/oa_pdf/0f/55/main.PMC5067939.pdf
2007;595:1 e75.http://dx.doi.org/10.1007/978-0-387- 46401-5_1 [Epub 2007/06/16].,Non-OADS,/arxiv_data1/oa_pdf/0f/55/main.PMC5067939.pdf
http://dx.doi.org/10.1002/ptr.1553 .,Non-OADS,/arxiv_data1/oa_pdf/0f/55/main.PMC5067939.pdf
http://dx.doi.org/10.1097/MCO.0b013e32834bfe94 [Epub 2011/10/ 12].,Non-OADS,/arxiv_data1/oa_pdf/0f/55/main.PMC5067939.pdf
2009;41:40 e59.http://dx.doi.org/10.1016/j.biocel.2008.06.010 [Epub 2008/07/ 30].,OADS,/arxiv_data1/oa_pdf/0f/55/main.PMC5067939.pdf
http://dx.doi.org/10.1056/nejm199306103282306 [Epub 1993/06/10].,OADS,/arxiv_data1/oa_pdf/0f/55/main.PMC5067939.pdf
http://dx.doi.org/10.1002/med.10024 [Epub 2002/12/25].,Non-OADS,/arxiv_data1/oa_pdf/0f/55/main.PMC5067939.pdf
http://dx.doi.org/10.1089/wound.2013.0517 .,Non-OADS,/arxiv_data1/oa_pdf/0f/55/main.PMC5067939.pdf
2007;22:60 e64.http://dx.doi.org/ 10.1007/bf02913315 [Epub 2007/09/01].,Non-OADS,/arxiv_data1/oa_pdf/0f/55/main.PMC5067939.pdf
Available from: http://www.ncbi.nlm.nih.gov/books/NBK53238/ .,Non-OADS,/arxiv_data1/oa_pdf/0f/55/main.PMC5067939.pdf
http://dx.doi.org/10.1016/j.placenta.2005.05.011 [Epub 2005/07/21].,OADS,/arxiv_data1/oa_pdf/0f/55/main.PMC5067939.pdf
"2013;2013. http://dx.doi.org/10.1155/2013/ 184539 , 184539.",Non-OADS,/arxiv_data1/oa_pdf/0f/55/main.PMC5067939.pdf
2012;2012:728325. http://dx.doi.org/ 10.1155/2012/728325 .,Non-OADS,/arxiv_data1/oa_pdf/0f/55/main.PMC5067939.pdf
http://dx.doi.org/10.1158/0008-5472.can-06- 4257 .,Non-OADS,/arxiv_data1/oa_pdf/0f/55/main.PMC5067939.pdf
http://dx.doi.org/10.1007/s11523-014-0321-1 .,Non-OADS,/arxiv_data1/oa_pdf/0f/55/main.PMC5067939.pdf
2009;30: 85e94.http://dx.doi.org/10.1016/j.tips.2008.11.002 .,OADS,/arxiv_data1/oa_pdf/0f/55/main.PMC5067939.pdf
http://dx.doi.org/10.1007/978-0-387-46401-5_7 .,Non-OADS,/arxiv_data1/oa_pdf/0f/55/main.PMC5067939.pdf
http://dx.doi.org/ 10.1016/j.bbrc.2004.06.119 [Epub 2004/09/11].,OADS,/arxiv_data1/oa_pdf/0f/55/main.PMC5067939.pdf
"Published by Oxford University Press on behalf of The Gerontological Society of America.987 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/59/21/gbv031.PMC5067949.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by- nc-nd/4.0/ rThe Author(s) 2016Microbiota and chronic kidney diseases RJF Felizardo et al 9 Clinical & Translational Immunology",Non-OADS,/arxiv_data1/oa_pdf/f4/09/cti201636a.PMC5067952.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ rThe Author(s) 2016Potential strategies of microbiota modulation in in ﬂammatory diseases AT Vieira et al 8 Clinical & Translational Immunology",Non-OADS,/arxiv_data1/oa_pdf/b1/98/cti201638a.PMC5067953.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Hepatocellular carcinomaHepatectomyThe BCLC stagingPortal hypertension Contents 1 .,Non-OADS,/arxiv_data1/oa_pdf/3c/88/main.PMC5067978.pdf
http://dx.doi.org/10.1016/j.bbacli.2016.10.0012214-6474/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/3c/88/main.PMC5067978.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3c/88/main.PMC5067978.pdf
"(2016), http://dx.doi.org/10.1002/jso.24434 (Epub ahead of print).",Non-OADS,/arxiv_data1/oa_pdf/3c/88/main.PMC5067978.pdf
"(2016), http://dx.doi.org/10.1016/j.jhep.2016.1007.1022 (Epub ahead of print).",OADS,/arxiv_data1/oa_pdf/3c/88/main.PMC5067978.pdf
"(2016), http://dx.doi.org/10.1111/liv.13208 (Epub ahead of print).",Non-OADS,/arxiv_data1/oa_pdf/3c/88/main.PMC5067978.pdf
"(2016), http://dx.doi.org/10.1097/SLA.0000000000001922 (Epub ahead of print).",Non-OADS,/arxiv_data1/oa_pdf/3c/88/main.PMC5067978.pdf
"(2016), http://dx.doi.org/10.1111/liv.13107 (Epub ahead of print).",Non-OADS,/arxiv_data1/oa_pdf/3c/88/main.PMC5067978.pdf
"(2016), http://dx.doi.org/10.1016/j.jhep.2016.1005.1044 (Epub ahead of print).",OADS,/arxiv_data1/oa_pdf/3c/88/main.PMC5067978.pdf
http://dx.doi.org/10.1016/j.pmedr.2016.10.001 2211-3355/© 2016 Published by Elsevier Inc.,Non-OADS,/arxiv_data1/oa_pdf/9b/6a/main.PMC5067980.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9b/6a/main.PMC5067980.pdf
Contents lists available at ScienceDirect Preventive Medicine Reports journal homepage: http://ees.elsevier.com/pmedr,Non-OADS,/arxiv_data1/oa_pdf/9b/6a/main.PMC5067980.pdf
Censo 2010 http://www.ibge.gov.br/ home/estatistica/populacao/censo2010/default_resultados_universo.shtm .,Non-OADS,/arxiv_data1/oa_pdf/9b/6a/main.PMC5067980.pdf
URL: http://www.climatempo.com.br/climatologia/558/saopaulo-sp .,Non-OADS,/arxiv_data1/oa_pdf/9b/6a/main.PMC5067980.pdf
Infocidade 2013 URL: http://infocidade.prefeitura.sp.gov.,Non-OADS,/arxiv_data1/oa_pdf/9b/6a/main.PMC5067980.pdf
"Available at: http://www.euro.who.int/__data/assets/ pdf_ﬁle/0010/263629/WHO-Expert-Meeting-Methods-and-tools-for-assessing- thehealth-risks-of-air-pollution-at-local ,-national-and-international-level.pdf.545 T.H.",OADS,/arxiv_data1/oa_pdf/9b/6a/main.PMC5067980.pdf
Available from  http://www.who.int/mediacentre/factsheets/fs317/en/.2015 updated January 2015 and [last  accessed on 2015 Aug 20].,OADS,/arxiv_data1/oa_pdf/c6/2c/PM-12-424.PMC5068118.pdf
Natural Product Res 2015;http://dx.doi.,OADS,/arxiv_data1/oa_pdf/80/13/PM-12-431.PMC5068119.pdf
Available form: http://www.ncbi.,Non-OADS,/arxiv_data1/oa_pdf/b7/00/PM-12-436.PMC5068120.pdf
[About 7  p.] Available from: http://www.hindawi.com/journals/ijac/2012/259217/ 26.,Non-OADS,/arxiv_data1/oa_pdf/dc/26/PM-12-446.PMC5068122.pdf
"Available from: (http://www.jbc.org) ABOUT AUTHOR Dr. Mohamed A. Farag , Specializing in metabolomics and natural products  chemistry, Dr. Mohamed A. Farag completed his PhD at Texas Tech  University, USA, in 2003.",Non-OADS,/arxiv_data1/oa_pdf/dc/26/PM-12-446.PMC5068122.pdf
"Biomed Res  Int 2009; Article ID 769568, 10 pages http://dx.doi.org/10.1155/2009/769568.",OADS,/arxiv_data1/oa_pdf/c2/21/PM-12-454.PMC5068123.pdf
"Hong Kong SAR,  China:  Geneva, Switzerland; December 2013; Available from: http://www.apps.who.int/iris/ bitstream/10665/92455/1/9789241506090_eng.pdf?ua=1 .",Non-OADS,/arxiv_data1/oa_pdf/13/23/PM-12-471.PMC5068126.pdf
